id	sid	tid	token	lemma	pos
dti-2660	1	1	dti	dti	PROPN
dti-2660	1	2	drug	drug	PROPN
dti-2660	1	3	target	target	NOUN
dti-2660	1	4	insights	insight	NOUN
dti-2660	1	5	2023	2023	NUM
dti-2660	1	6	;	;	PUNCT
dti-2660	1	7	17	17	NUM
dti-2660	1	8	:	:	SYM
dti-2660	1	9	126	126	NUM
dti-2660	1	10	-	-	SYM
dti-2660	1	11	137	137	NUM
dti-2660	1	12	issn	issn	PROPN
dti-2660	1	13	1177	1177	NUM
dti-2660	1	14	-	-	SYM
dti-2660	1	15	3928	3928	NUM
dti-2660	1	16	|	|	ADV
dti-2660	1	17	doi	doi	NOUN
dti-2660	1	18	:	:	PUNCT
dti-2660	1	19	10.33393	10.33393	NUM
dti-2660	1	20	/	/	SYM
dti-2660	1	21	dti.2023.2660	dti.2023.2660	NOUN
dti-2660	1	22	review	review	NOUN
dti-2660	1	23	drug	drug	NOUN
dti-2660	1	24	target	target	NOUN
dti-2660	1	25	insights	insight	NOUN
dti-2660	1	26	issn	issn	VERB
dti-2660	1	27	1177	1177	NUM
dti-2660	1	28	-	-	SYM
dti-2660	1	29	3928	3928	NUM
dti-2660	1	30	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2660	1	31	©	©	PROPN
dti-2660	1	32	2022	2022	NUM
dti-2660	1	33	the	the	DET
dti-2660	1	34	authors	author	NOUN
dti-2660	1	35	.	.	PUNCT
dti-2660	2	1	this	this	DET
dti-2660	2	2	article	article	NOUN
dti-2660	2	3	is	be	AUX
dti-2660	2	4	published	publish	VERB
dti-2660	2	5	by	by	ADP
dti-2660	2	6	aboutscience	aboutscience	NOUN
dti-2660	2	7	and	and	CCONJ
dti-2660	2	8	licensed	license	VERB
dti-2660	2	9	under	under	ADP
dti-2660	2	10	creative	creative	ADJ
dti-2660	2	11	commons	common	NOUN
dti-2660	2	12	attribution	attribution	NOUN
dti-2660	2	13	-	-	PUNCT
dti-2660	2	14	noncommercial	noncommercial	ADJ
dti-2660	2	15	4.0	4.0	NUM
dti-2660	2	16	international	international	NOUN
dti-2660	2	17	(	(	PUNCT
dti-2660	2	18	cc	cc	NOUN
dti-2660	2	19	by	by	ADP
dti-2660	2	20	-	-	PUNCT
dti-2660	2	21	nc	nc	PROPN
dti-2660	2	22	4.0	4.0	NUM
dti-2660	2	23	)	)	PUNCT
dti-2660	2	24	.	.	PUNCT
dti-2660	3	1	commercial	commercial	ADJ
dti-2660	3	2	use	use	NOUN
dti-2660	3	3	is	be	AUX
dti-2660	3	4	not	not	PART
dti-2660	3	5	permitted	permit	VERB
dti-2660	3	6	and	and	CCONJ
dti-2660	3	7	is	be	AUX
dti-2660	3	8	subject	subject	ADJ
dti-2660	3	9	to	to	ADP
dti-2660	3	10	publisher	publisher	NOUN
dti-2660	3	11	’s	’s	PART
dti-2660	3	12	permissions	permission	NOUN
dti-2660	3	13	.	.	PUNCT
dti-2660	4	1	full	full	ADJ
dti-2660	4	2	information	information	NOUN
dti-2660	4	3	is	be	AUX
dti-2660	4	4	available	available	ADJ
dti-2660	4	5	at	at	ADP
dti-2660	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2660	4	7	management	management	NOUN
dti-2660	4	8	of	of	ADP
dti-2660	4	9	urinary	urinary	ADJ
dti-2660	4	10	tract	tract	NOUN
dti-2660	4	11	infections	infection	NOUN
dti-2660	4	12	in	in	ADP
dti-2660	4	13	the	the	DET
dti-2660	4	14	era	era	NOUN
dti-2660	4	15	of	of	ADP
dti-2660	4	16	antimicrobial	antimicrobial	ADJ
dti-2660	4	17	resistance	resistance	NOUN
dti-2660	4	18	ria	ria	PROPN
dti-2660	4	19	pothoven	pothoven	PROPN
dti-2660	4	20	florence	florence	PROPN
dti-2660	4	21	and	and	CCONJ
dti-2660	4	22	andros	andros	PROPN
dti-2660	4	23	gynos	gyno	NOUN
dti-2660	4	24	klinieken	klinieken	PROPN
dti-2660	4	25	,	,	PUNCT
dti-2660	4	26	the	the	DET
dti-2660	4	27	hague	hague	NOUN
dti-2660	4	28	,	,	PUNCT
dti-2660	4	29	the	the	DET
dti-2660	4	30	netherlands	netherlands	PROPN
dti-2660	4	31	abstract	abstract	ADJ
dti-2660	4	32	urinary	urinary	ADJ
dti-2660	4	33	tract	tract	NOUN
dti-2660	4	34	infections	infection	NOUN
dti-2660	4	35	(	(	PUNCT
dti-2660	4	36	utis	utis	NOUN
dti-2660	4	37	)	)	PUNCT
dti-2660	4	38	are	be	AUX
dti-2660	4	39	among	among	ADP
dti-2660	4	40	the	the	DET
dti-2660	4	41	most	most	ADV
dti-2660	4	42	common	common	ADJ
dti-2660	4	43	infections	infection	NOUN
dti-2660	4	44	globally	globally	ADV
dti-2660	4	45	,	,	PUNCT
dti-2660	4	46	imposing	impose	VERB
dti-2660	4	47	a	a	DET
dti-2660	4	48	substantial	substantial	ADJ
dti-2660	4	49	personal	personal	ADJ
dti-2660	4	50	and	and	CCONJ
dti-2660	4	51	economic	economic	ADJ
dti-2660	4	52	burden	burden	NOUN
dti-2660	4	53	on	on	ADP
dti-2660	4	54	individuals	individual	NOUN
dti-2660	4	55	and	and	CCONJ
dti-2660	4	56	health	health	NOUN
dti-2660	4	57	resources	resource	NOUN
dti-2660	4	58	.	.	PUNCT
dti-2660	5	1	despite	despite	SCONJ
dti-2660	5	2	international	international	ADJ
dti-2660	5	3	health	health	NOUN
dti-2660	5	4	concerns	concern	NOUN
dti-2660	5	5	and	and	CCONJ
dti-2660	5	6	sustained	sustain	VERB
dti-2660	5	7	public	public	ADJ
dti-2660	5	8	awareness	awareness	NOUN
dti-2660	5	9	campaigns	campaign	NOUN
dti-2660	5	10	about	about	ADP
dti-2660	5	11	the	the	DET
dti-2660	5	12	emergence	emergence	NOUN
dti-2660	5	13	of	of	ADP
dti-2660	5	14	resistant	resistant	ADJ
dti-2660	5	15	microorganisms	microorganism	NOUN
dti-2660	5	16	through	through	ADP
dti-2660	5	17	the	the	DET
dti-2660	5	18	inappropriate	inappropriate	ADJ
dti-2660	5	19	therapeutic	therapeutic	ADJ
dti-2660	5	20	use	use	NOUN
dti-2660	5	21	of	of	ADP
dti-2660	5	22	antimicrobial	antimicrobial	ADJ
dti-2660	5	23	agents	agent	NOUN
dti-2660	5	24	,	,	PUNCT
dti-2660	5	25	the	the	DET
dti-2660	5	26	problem	problem	NOUN
dti-2660	5	27	of	of	ADP
dti-2660	5	28	antimicrobial	antimicrobial	ADJ
dti-2660	5	29	resistance	resistance	NOUN
dti-2660	5	30	(	(	PUNCT
dti-2660	5	31	amr	amr	NOUN
dti-2660	5	32	)	)	PUNCT
dti-2660	5	33	is	be	AUX
dti-2660	5	34	worsening	worsen	VERB
dti-2660	5	35	,	,	PUNCT
dti-2660	5	36	and	and	CCONJ
dti-2660	5	37	amr	amr	NOUN
dti-2660	5	38	in	in	ADP
dti-2660	5	39	utis	utis	NOUN
dti-2660	5	40	represents	represent	VERB
dti-2660	5	41	a	a	DET
dti-2660	5	42	critical	critical	ADJ
dti-2660	5	43	global	global	ADJ
dti-2660	5	44	healthcare	healthcare	NOUN
dti-2660	5	45	issue	issue	NOUN
dti-2660	5	46	.	.	PUNCT
dti-2660	6	1	this	this	DET
dti-2660	6	2	narrative	narrative	NOUN
dti-2660	6	3	review	review	NOUN
dti-2660	6	4	summarizes	summarize	VERB
dti-2660	6	5	evidence	evidence	NOUN
dti-2660	6	6	-	-	PUNCT
dti-2660	6	7	based	base	VERB
dti-2660	6	8	scientific	scientific	ADJ
dti-2660	6	9	material	material	NOUN
dti-2660	6	10	,	,	PUNCT
dti-2660	6	11	recommendations	recommendation	NOUN
dti-2660	6	12	from	from	ADP
dti-2660	6	13	the	the	DET
dti-2660	6	14	current	current	ADJ
dti-2660	6	15	medical	medical	ADJ
dti-2660	6	16	literature	literature	NOUN
dti-2660	6	17	,	,	PUNCT
dti-2660	6	18	and	and	CCONJ
dti-2660	6	19	the	the	DET
dti-2660	6	20	latest	late	ADJ
dti-2660	6	21	clinical	clinical	ADJ
dti-2660	6	22	guidelines	guideline	NOUN
dti-2660	6	23	on	on	ADP
dti-2660	6	24	antibiotic	antibiotic	ADJ
dti-2660	6	25	and	and	CCONJ
dti-2660	6	26	antibiotic	antibiotic	ADJ
dti-2660	6	27	-	-	PUNCT
dti-2660	6	28	sparing	spare	VERB
dti-2660	6	29	strategies	strategy	NOUN
dti-2660	6	30	for	for	ADP
dti-2660	6	31	managing	manage	VERB
dti-2660	6	32	urological	urological	ADJ
dti-2660	6	33	infections	infection	NOUN
dti-2660	6	34	,	,	PUNCT
dti-2660	6	35	including	include	VERB
dti-2660	6	36	practical	practical	ADJ
dti-2660	6	37	approaches	approach	NOUN
dti-2660	6	38	to	to	PART
dti-2660	6	39	improve	improve	VERB
dti-2660	6	40	the	the	DET
dti-2660	6	41	management	management	NOUN
dti-2660	6	42	of	of	ADP
dti-2660	6	43	patients	patient	NOUN
dti-2660	6	44	with	with	ADP
dti-2660	6	45	acute	acute	ADJ
dti-2660	6	46	and	and	CCONJ
dti-2660	6	47	recurrent	recurrent	ADJ
dti-2660	6	48	utis	utis	NOUN
dti-2660	6	49	(	(	PUNCT
dti-2660	6	50	rutis	rutis	NOUN
dti-2660	6	51	)	)	PUNCT
dti-2660	6	52	in	in	ADP
dti-2660	6	53	routine	routine	ADJ
dti-2660	6	54	clinical	clinical	ADJ
dti-2660	6	55	practice	practice	NOUN
dti-2660	6	56	.	.	PUNCT
dti-2660	7	1	novel	novel	ADJ
dti-2660	7	2	emerging	emerge	VERB
dti-2660	7	3	therapies	therapy	NOUN
dti-2660	7	4	and	and	CCONJ
dti-2660	7	5	prophylaxis	prophylaxis	NOUN
dti-2660	7	6	options	option	NOUN
dti-2660	7	7	are	be	AUX
dti-2660	7	8	described	describe	VERB
dti-2660	7	9	as	as	ADP
dti-2660	7	10	potential	potential	ADJ
dti-2660	7	11	alternatives	alternative	NOUN
dti-2660	7	12	to	to	PART
dti-2660	7	13	overcome	overcome	VERB
dti-2660	7	14	the	the	DET
dti-2660	7	15	abuse	abuse	NOUN
dti-2660	7	16	and	and	CCONJ
dti-2660	7	17	overuse	overuse	NOUN
dti-2660	7	18	of	of	ADP
dti-2660	7	19	antibiotics	antibiotic	NOUN
dti-2660	7	20	and	and	CCONJ
dti-2660	7	21	the	the	DET
dti-2660	7	22	practical	practical	ADJ
dti-2660	7	23	application	application	NOUN
dti-2660	7	24	of	of	ADP
dti-2660	7	25	the	the	DET
dti-2660	7	26	guideline	guideline	NOUN
dti-2660	7	27	recommendations	recommendation	NOUN
dti-2660	7	28	and	and	CCONJ
dti-2660	7	29	issues	issue	NOUN
dti-2660	7	30	relating	relate	VERB
dti-2660	7	31	to	to	ADP
dti-2660	7	32	best	good	ADJ
dti-2660	7	33	practice	practice	NOUN
dti-2660	7	34	in	in	ADP
dti-2660	7	35	managing	manage	VERB
dti-2660	7	36	utis	utis	NOUN
dti-2660	7	37	.	.	PUNCT
dti-2660	8	1	keywords	keyword	NOUN
dti-2660	8	2	:	:	PUNCT
dti-2660	8	3	antibiotic	antibiotic	ADJ
dti-2660	8	4	,	,	PUNCT
dti-2660	8	5	antibiotic	antibiotic	ADJ
dti-2660	8	6	sparing	sparing	NOUN
dti-2660	8	7	,	,	PUNCT
dti-2660	8	8	antimicrobial	antimicrobial	ADJ
dti-2660	8	9	resistance	resistance	NOUN
dti-2660	8	10	,	,	PUNCT
dti-2660	8	11	prophylaxis	prophylaxis	NOUN
dti-2660	8	12	,	,	PUNCT
dti-2660	8	13	recurrence	recurrence	NOUN
dti-2660	8	14	,	,	PUNCT
dti-2660	8	15	urinary	urinary	ADJ
dti-2660	8	16	tract	tract	NOUN
dti-2660	8	17	infections	infection	NOUN
dti-2660	8	18	received	receive	VERB
dti-2660	8	19	:	:	PUNCT
dti-2660	8	20	september	september	PROPN
dti-2660	8	21	11	11	NUM
dti-2660	8	22	,	,	PUNCT
dti-2660	8	23	2023	2023	NUM
dti-2660	8	24	accepted	accept	VERB
dti-2660	8	25	:	:	PUNCT
dti-2660	8	26	november	november	PROPN
dti-2660	8	27	21	21	NUM
dti-2660	8	28	,	,	PUNCT
dti-2660	8	29	2023	2023	NUM
dti-2660	8	30	published	publish	VERB
dti-2660	8	31	online	online	ADV
dti-2660	8	32	:	:	PUNCT
dti-2660	8	33	december	december	PROPN
dti-2660	8	34	20	20	NUM
dti-2660	8	35	,	,	PUNCT
dti-2660	8	36	2023	2023	NUM
dti-2660	8	37	corresponding	correspond	VERB
dti-2660	8	38	author	author	NOUN
dti-2660	8	39	:	:	PUNCT
dti-2660	8	40	ria	ria	PROPN
dti-2660	8	41	pothoven	pothoven	PROPN
dti-2660	8	42	florence	florence	PROPN
dti-2660	8	43	rijswijk	rijswijk	PROPN
dti-2660	8	44	laan	laan	PROPN
dti-2660	8	45	van	van	PROPN
dti-2660	8	46	vredenoord	vredenoord	PROPN
dti-2660	8	47	1	1	NUM
dti-2660	8	48	-	-	SYM
dti-2660	8	49	7	7	NUM
dti-2660	8	50	,	,	PUNCT
dti-2660	8	51	2289	2289	NUM
dti-2660	8	52	da	da	PROPN
dti-2660	8	53	rijswijk	rijswijk	NOUN
dti-2660	8	54	postbus	postbus	NOUN
dti-2660	8	55	1005	1005	NUM
dti-2660	8	56	,	,	PUNCT
dti-2660	8	57	2280	2280	NUM
dti-2660	8	58	ca	can	AUX
dti-2660	8	59	rijswijk	rijswijk	VERB
dti-2660	8	60	the	the	DET
dti-2660	8	61	netherlands	netherlands	PROPN
dti-2660	8	62	andros	andros	PROPN
dti-2660	8	63	clinics	clinics	PROPN
dti-2660	8	64	den	den	PROPN
dti-2660	8	65	haag	haag	PROPN
dti-2660	8	66	madame	madame	PROPN
dti-2660	8	67	curielaan	curielaan	PROPN
dti-2660	8	68	10	10	NUM
dti-2660	8	69	2289	2289	NUM
dti-2660	8	70	ca	can	AUX
dti-2660	8	71	rijswijk	rijswijk	VERB
dti-2660	8	72	the	the	DET
dti-2660	8	73	netherlands	netherlands	PROPN
dti-2660	8	74	ria.pothoven@florence.nl	ria.pothoven@florence.nl	PUNCT
dti-2660	8	75	(	(	PUNCT
dti-2660	8	76	1,2	1,2	NUM
dti-2660	8	77	)	)	PUNCT
dti-2660	8	78	.	.	PUNCT
dti-2660	9	1	specifically	specifically	ADV
dti-2660	9	2	,	,	PUNCT
dti-2660	9	3	the	the	DET
dti-2660	9	4	age	age	NOUN
dti-2660	9	5	-	-	PUNCT
dti-2660	9	6	standardized	standardize	VERB
dti-2660	9	7	incidence	incidence	NOUN
dti-2660	9	8	rate	rate	NOUN
dti-2660	9	9	of	of	ADP
dti-2660	9	10	utis	utis	NOUN
dti-2660	9	11	increased	increase	VERB
dti-2660	9	12	from	from	ADP
dti-2660	9	13	4,715	4,715	NUM
dti-2660	9	14	individuals	individual	NOUN
dti-2660	9	15	per	per	ADP
dti-2660	9	16	100,00	100,00	NUM
dti-2660	9	17	population	population	NOUN
dti-2660	9	18	in	in	ADP
dti-2660	9	19	1990	1990	NUM
dti-2660	9	20	to	to	ADP
dti-2660	9	21	5,229	5,229	NUM
dti-2660	9	22	per	per	ADP
dti-2660	9	23	100,000	100,000	NUM
dti-2660	9	24	in	in	ADP
dti-2660	9	25	2019	2019	NUM
dti-2660	9	26	,	,	PUNCT
dti-2660	9	27	and	and	CCONJ
dti-2660	9	28	the	the	DET
dti-2660	9	29	number	number	NOUN
dti-2660	9	30	of	of	ADP
dti-2660	9	31	deaths	death	NOUN
dti-2660	9	32	related	relate	VERB
dti-2660	9	33	to	to	ADP
dti-2660	9	34	utis	utis	NOUN
dti-2660	9	35	increased	increase	VERB
dti-2660	9	36	from	from	ADP
dti-2660	9	37	approximately	approximately	ADV
dti-2660	9	38	99,000	99,000	NUM
dti-2660	9	39	in	in	ADP
dti-2660	9	40	1990	1990	NUM
dti-2660	9	41	to	to	ADP
dti-2660	9	42	237,000	237,000	NUM
dti-2660	9	43	in	in	ADP
dti-2660	9	44	2019	2019	NUM
dti-2660	9	45	(	(	PUNCT
dti-2660	9	46	1,2	1,2	NUM
dti-2660	9	47	)	)	PUNCT
dti-2660	9	48	.	.	PUNCT
dti-2660	10	1	the	the	DET
dti-2660	10	2	incidence	incidence	NOUN
dti-2660	10	3	of	of	ADP
dti-2660	10	4	utis	utis	NOUN
dti-2660	10	5	was	be	AUX
dti-2660	10	6	more	more	ADV
dti-2660	10	7	prominent	prominent	ADJ
dti-2660	10	8	in	in	ADP
dti-2660	10	9	higher	high	ADJ
dti-2660	10	10	sociodemographic	sociodemographic	ADJ
dti-2660	10	11	regions	region	NOUN
dti-2660	10	12	,	,	PUNCT
dti-2660	10	13	together	together	ADV
dti-2660	10	14	with	with	ADP
dti-2660	10	15	an	an	DET
dti-2660	10	16	increasing	increase	VERB
dti-2660	10	17	mortality	mortality	NOUN
dti-2660	10	18	rate	rate	NOUN
dti-2660	10	19	,	,	PUNCT
dti-2660	10	20	whereas	whereas	SCONJ
dti-2660	10	21	countries	country	NOUN
dti-2660	10	22	with	with	ADP
dti-2660	10	23	lower	low	ADJ
dti-2660	10	24	sociodemographic	sociodemographic	ADJ
dti-2660	10	25	development	development	NOUN
dti-2660	10	26	or	or	CCONJ
dti-2660	10	27	a	a	DET
dti-2660	10	28	higher	high	ADJ
dti-2660	10	29	baseline	baseline	NOUN
dti-2660	10	30	disease	disease	NOUN
dti-2660	10	31	burden	burden	NOUN
dti-2660	10	32	showed	show	VERB
dti-2660	10	33	notable	notable	ADJ
dti-2660	10	34	rates	rate	NOUN
dti-2660	10	35	of	of	ADP
dti-2660	10	36	decline	decline	NOUN
dti-2660	10	37	over	over	ADP
dti-2660	10	38	the	the	DET
dti-2660	10	39	three	three	NUM
dti-2660	10	40	decades	decade	NOUN
dti-2660	10	41	.	.	PUNCT
dti-2660	11	1	the	the	DET
dti-2660	11	2	burden	burden	NOUN
dti-2660	11	3	of	of	ADP
dti-2660	11	4	utis	utis	NOUN
dti-2660	11	5	was	be	AUX
dti-2660	11	6	higher	high	ADJ
dti-2660	11	7	in	in	ADP
dti-2660	11	8	females	female	NOUN
dti-2660	11	9	and	and	CCONJ
dti-2660	11	10	tended	tend	VERB
dti-2660	11	11	to	to	PART
dti-2660	11	12	increase	increase	VERB
dti-2660	11	13	with	with	ADP
dti-2660	11	14	age	age	NOUN
dti-2660	11	15	,	,	PUNCT
dti-2660	11	16	particularly	particularly	ADV
dti-2660	11	17	in	in	ADP
dti-2660	11	18	regions	region	NOUN
dti-2660	11	19	with	with	ADP
dti-2660	11	20	a	a	DET
dti-2660	11	21	higher	high	ADJ
dti-2660	11	22	sociodemographic	sociodemographic	ADJ
dti-2660	11	23	status	status	NOUN
dti-2660	11	24	(	(	PUNCT
dti-2660	11	25	1	1	NUM
dti-2660	11	26	)	)	PUNCT
dti-2660	11	27	.	.	PUNCT
dti-2660	12	1	utis	utis	NOUN
dti-2660	12	2	present	present	ADJ
dti-2660	12	3	a	a	DET
dti-2660	12	4	critical	critical	ADJ
dti-2660	12	5	global	global	ADJ
dti-2660	12	6	healthcare	healthcare	PROPN
dti-2660	12	7	issue	issue	NOUN
dti-2660	12	8	,	,	PUNCT
dti-2660	12	9	particularly	particularly	ADV
dti-2660	12	10	as	as	ADP
dti-2660	12	11	,	,	PUNCT
dti-2660	12	12	along	along	ADP
dti-2660	12	13	with	with	ADP
dti-2660	12	14	other	other	ADJ
dti-2660	12	15	infectious	infectious	ADJ
dti-2660	12	16	diseases	disease	NOUN
dti-2660	12	17	,	,	PUNCT
dti-2660	12	18	antimicrobial	antimicrobial	ADJ
dti-2660	12	19	resistance	resistance	NOUN
dti-2660	12	20	(	(	PUNCT
dti-2660	12	21	amr	amr	NOUN
dti-2660	12	22	)	)	PUNCT
dti-2660	12	23	in	in	ADP
dti-2660	12	24	utis	utis	NOUN
dti-2660	12	25	is	be	AUX
dti-2660	12	26	a	a	DET
dti-2660	12	27	continuing	continue	VERB
dti-2660	12	28	challenge	challenge	NOUN
dti-2660	12	29	.	.	PUNCT
dti-2660	13	1	despite	despite	SCONJ
dti-2660	13	2	global	global	ADJ
dti-2660	13	3	health	health	NOUN
dti-2660	13	4	concerns	concern	NOUN
dti-2660	13	5	and	and	CCONJ
dti-2660	13	6	sustained	sustain	VERB
dti-2660	13	7	public	public	ADJ
dti-2660	13	8	awareness	awareness	NOUN
dti-2660	13	9	campaigns	campaign	NOUN
dti-2660	13	10	about	about	ADP
dti-2660	13	11	the	the	DET
dti-2660	13	12	emergence	emergence	NOUN
dti-2660	13	13	of	of	ADP
dti-2660	13	14	resistant	resistant	ADJ
dti-2660	13	15	microorganisms	microorganism	NOUN
dti-2660	13	16	through	through	ADP
dti-2660	13	17	the	the	DET
dti-2660	13	18	inappropriate	inappropriate	ADJ
dti-2660	13	19	therapeutic	therapeutic	ADJ
dti-2660	13	20	use	use	NOUN
dti-2660	13	21	of	of	ADP
dti-2660	13	22	antimicrobial	antimicrobial	ADJ
dti-2660	13	23	agents	agent	NOUN
dti-2660	13	24	,	,	PUNCT
dti-2660	13	25	the	the	DET
dti-2660	13	26	amr	amr	ADJ
dti-2660	13	27	problem	problem	NOUN
dti-2660	13	28	is	be	AUX
dti-2660	13	29	worsening	worsen	VERB
dti-2660	13	30	(	(	PUNCT
dti-2660	13	31	5	5	NUM
dti-2660	13	32	-	-	SYM
dti-2660	13	33	7	7	NUM
dti-2660	13	34	)	)	PUNCT
dti-2660	13	35	.	.	PUNCT
dti-2660	14	1	in	in	ADP
dti-2660	14	2	this	this	DET
dti-2660	14	3	narrative	narrative	NOUN
dti-2660	14	4	review	review	NOUN
dti-2660	14	5	we	we	PRON
dti-2660	14	6	summarize	summarize	VERB
dti-2660	14	7	the	the	DET
dti-2660	14	8	evidence	evidence	NOUN
dti-2660	14	9	from	from	ADP
dti-2660	14	10	the	the	DET
dti-2660	14	11	scientific	scientific	ADJ
dti-2660	14	12	literature	literature	NOUN
dti-2660	14	13	and	and	CCONJ
dti-2660	14	14	recommendations	recommendation	NOUN
dti-2660	14	15	from	from	ADP
dti-2660	14	16	the	the	DET
dti-2660	14	17	latest	late	ADJ
dti-2660	14	18	clinical	clinical	ADJ
dti-2660	14	19	guidelines	guideline	NOUN
dti-2660	14	20	on	on	ADP
dti-2660	14	21	the	the	DET
dti-2660	14	22	management	management	NOUN
dti-2660	14	23	of	of	ADP
dti-2660	14	24	urological	urological	ADJ
dti-2660	14	25	infections	infection	NOUN
dti-2660	14	26	and	and	CCONJ
dti-2660	14	27	suggest	suggest	VERB
dti-2660	14	28	practical	practical	ADJ
dti-2660	14	29	approaches	approach	NOUN
dti-2660	14	30	to	to	PART
dti-2660	14	31	improve	improve	VERB
dti-2660	14	32	the	the	DET
dti-2660	14	33	management	management	NOUN
dti-2660	14	34	of	of	ADP
dti-2660	14	35	patients	patient	NOUN
dti-2660	14	36	with	with	ADP
dti-2660	14	37	acute	acute	ADJ
dti-2660	14	38	and	and	CCONJ
dti-2660	14	39	recurrent	recurrent	ADJ
dti-2660	14	40	utis	utis	NOUN
dti-2660	14	41	(	(	PUNCT
dti-2660	14	42	rutis	rutis	NOUN
dti-2660	14	43	)	)	PUNCT
dti-2660	14	44	.	.	PUNCT
dti-2660	15	1	novel	novel	ADJ
dti-2660	15	2	emerging	emerge	VERB
dti-2660	15	3	therapies	therapy	NOUN
dti-2660	15	4	and	and	CCONJ
dti-2660	15	5	prophylaxis	prophylaxis	NOUN
dti-2660	15	6	options	option	NOUN
dti-2660	15	7	are	be	AUX
dti-2660	15	8	described	describe	VERB
dti-2660	15	9	as	as	ADP
dti-2660	15	10	potential	potential	ADJ
dti-2660	15	11	alternatives	alternative	NOUN
dti-2660	15	12	to	to	PART
dti-2660	15	13	overcome	overcome	VERB
dti-2660	15	14	the	the	DET
dti-2660	15	15	abuse	abuse	NOUN
dti-2660	15	16	and	and	CCONJ
dti-2660	15	17	overuse	overuse	NOUN
dti-2660	15	18	of	of	ADP
dti-2660	15	19	antibiotics	antibiotic	NOUN
dti-2660	15	20	,	,	PUNCT
dti-2660	15	21	including	include	VERB
dti-2660	15	22	new	new	ADJ
dti-2660	15	23	clinical	clinical	ADJ
dti-2660	15	24	outcomes	outcome	NOUN
dti-2660	15	25	on	on	ADP
dti-2660	15	26	the	the	DET
dti-2660	15	27	use	use	NOUN
dti-2660	15	28	of	of	ADP
dti-2660	15	29	glycosaminoglycan	glycosaminoglycan	ADJ
dti-2660	15	30	(	(	PUNCT
dti-2660	15	31	gag	gag	NOUN
dti-2660	15	32	)	)	PUNCT
dti-2660	15	33	therapy	therapy	NOUN
dti-2660	15	34	in	in	ADP
dti-2660	15	35	the	the	DET
dti-2660	15	36	management	management	NOUN
dti-2660	15	37	of	of	ADP
dti-2660	15	38	rutis	rutis	ADJ
dti-2660	15	39	introduction	introduction	NOUN
dti-2660	15	40	urinary	urinary	ADJ
dti-2660	15	41	tract	tract	NOUN
dti-2660	15	42	infections	infection	NOUN
dti-2660	15	43	(	(	PUNCT
dti-2660	15	44	utis	utis	NOUN
dti-2660	15	45	)	)	PUNCT
dti-2660	15	46	are	be	AUX
dti-2660	15	47	among	among	ADP
dti-2660	15	48	the	the	DET
dti-2660	15	49	most	most	ADV
dti-2660	15	50	common	common	ADJ
dti-2660	15	51	infections	infection	NOUN
dti-2660	15	52	globally	globally	ADV
dti-2660	15	53	,	,	PUNCT
dti-2660	15	54	imposing	impose	VERB
dti-2660	15	55	a	a	DET
dti-2660	15	56	substantial	substantial	ADJ
dti-2660	15	57	personal	personal	ADJ
dti-2660	15	58	and	and	CCONJ
dti-2660	15	59	economic	economic	ADJ
dti-2660	15	60	burden	burden	NOUN
dti-2660	15	61	on	on	ADP
dti-2660	15	62	individuals	individual	NOUN
dti-2660	15	63	and	and	CCONJ
dti-2660	15	64	health	health	NOUN
dti-2660	15	65	resources	resource	NOUN
dti-2660	15	66	(	(	PUNCT
dti-2660	15	67	1,2	1,2	NUM
dti-2660	15	68	)	)	PUNCT
dti-2660	15	69	.	.	PUNCT
dti-2660	16	1	data	datum	NOUN
dti-2660	16	2	from	from	ADP
dti-2660	16	3	the	the	DET
dti-2660	16	4	global	global	ADJ
dti-2660	16	5	burden	burden	NOUN
dti-2660	16	6	of	of	ADP
dti-2660	16	7	disease	disease	NOUN
dti-2660	16	8	study	study	VERB
dti-2660	16	9	2019	2019	NUM
dti-2660	16	10	(	(	PUNCT
dti-2660	16	11	3,4	3,4	NUM
dti-2660	16	12	)	)	PUNCT
dti-2660	16	13	have	have	AUX
dti-2660	16	14	been	be	AUX
dti-2660	16	15	used	use	VERB
dti-2660	16	16	to	to	PART
dti-2660	16	17	investigate	investigate	VERB
dti-2660	16	18	the	the	DET
dti-2660	16	19	incidence	incidence	NOUN
dti-2660	16	20	,	,	PUNCT
dti-2660	16	21	mortality	mortality	NOUN
dti-2660	16	22	,	,	PUNCT
dti-2660	16	23	and	and	CCONJ
dti-2660	16	24	disability	disability	NOUN
dti-2660	16	25	-	-	PUNCT
dti-2660	16	26	adjusted	adjust	VERB
dti-2660	16	27	life	life	NOUN
dti-2660	16	28	years	year	NOUN
dti-2660	16	29	(	(	PUNCT
dti-2660	16	30	dalys	daly	NOUN
dti-2660	16	31	)	)	PUNCT
dti-2660	16	32	related	relate	VERB
dti-2660	16	33	to	to	ADP
dti-2660	16	34	utis	utis	NOUN
dti-2660	16	35	globally	globally	ADV
dti-2660	16	36	,	,	PUNCT
dti-2660	16	37	by	by	ADP
dti-2660	16	38	region	region	NOUN
dti-2660	16	39	,	,	PUNCT
dti-2660	16	40	and	and	CCONJ
dti-2660	16	41	by	by	ADP
dti-2660	16	42	country	country	NOUN
dti-2660	16	43	from	from	ADP
dti-2660	16	44	1990	1990	NUM
dti-2660	16	45	to	to	ADP
dti-2660	16	46	2019	2019	NUM
dti-2660	16	47	.	.	PUNCT
dti-2660	17	1	globally	globally	ADV
dti-2660	17	2	,	,	PUNCT
dti-2660	17	3	there	there	PRON
dti-2660	17	4	were	be	VERB
dti-2660	17	5	an	an	DET
dti-2660	17	6	estimated	estimate	VERB
dti-2660	17	7	405	405	NUM
dti-2660	17	8	million	million	NUM
dti-2660	17	9	cases	case	NOUN
dti-2660	17	10	,	,	PUNCT
dti-2660	17	11	237,000	237,000	NUM
dti-2660	17	12	deaths	death	NOUN
dti-2660	17	13	,	,	PUNCT
dti-2660	17	14	and	and	CCONJ
dti-2660	17	15	5.2	5.2	NUM
dti-2660	17	16	million	million	NUM
dti-2660	17	17	dalys	daly	NOUN
dti-2660	17	18	associated	associate	VERB
dti-2660	17	19	with	with	ADP
dti-2660	17	20	utis	utis	NOUN
dti-2660	17	21	in	in	ADP
dti-2660	17	22	2019	2019	NUM
dti-2660	17	23	,	,	PUNCT
dti-2660	17	24	with	with	ADP
dti-2660	17	25	a	a	DET
dti-2660	17	26	2.4	2.4	NUM
dti-2660	17	27	times	time	NOUN
dti-2660	17	28	growth	growth	NOUN
dti-2660	17	29	in	in	ADP
dti-2660	17	30	deaths	death	NOUN
dti-2660	17	31	from	from	ADP
dti-2660	17	32	1990	1990	NUM
dti-2660	17	33	to	to	ADP
dti-2660	17	34	2019	2019	NUM
dti-2660	17	35	,	,	PUNCT
dti-2660	17	36	accompanied	accompany	VERB
dti-2660	17	37	by	by	ADP
dti-2660	17	38	an	an	DET
dti-2660	17	39	increasing	increase	VERB
dti-2660	17	40	age	age	NOUN
dti-2660	17	41	-	-	PUNCT
dti-2660	17	42	standardized	standardize	VERB
dti-2660	17	43	mortality	mortality	NOUN
dti-2660	17	44	rate	rate	NOUN
dti-2660	17	45	over	over	ADP
dti-2660	17	46	time	time	NOUN
dti-2660	17	47	https://doi.org/10.33393/dti.2023.2660	https://doi.org/10.33393/dti.2023.2660	NOUN
dti-2660	17	48	https://doi.org/dti.2023.2522	https://doi.org/dti.2023.2522	PROPN
dti-2660	17	49	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	PROPN
dti-2660	17	50	pothoven	pothoven	NOUN
dti-2660	17	51	drug	drug	NOUN
dti-2660	17	52	target	target	NOUN
dti-2660	17	53	insights	insight	NOUN
dti-2660	17	54	2023	2023	NUM
dti-2660	17	55	;	;	PUNCT
dti-2660	17	56	17	17	NUM
dti-2660	17	57	:	:	SYM
dti-2660	17	58	127	127	NUM
dti-2660	17	59	©	©	PROPN
dti-2660	17	60	2023	2023	NUM
dti-2660	17	61	the	the	DET
dti-2660	17	62	authors	author	NOUN
dti-2660	17	63	.	.	PUNCT
dti-2660	18	1	published	publish	VERB
dti-2660	18	2	by	by	ADP
dti-2660	18	3	aboutscience	aboutscience	NOUN
dti-2660	18	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2660	18	5	and	and	CCONJ
dti-2660	18	6	the	the	DET
dti-2660	18	7	practical	practical	ADJ
dti-2660	18	8	application	application	NOUN
dti-2660	18	9	of	of	ADP
dti-2660	18	10	the	the	DET
dti-2660	18	11	guideline	guideline	NOUN
dti-2660	18	12	recommendations	recommendation	NOUN
dti-2660	18	13	and	and	CCONJ
dti-2660	18	14	issues	issue	NOUN
dti-2660	18	15	relating	relate	VERB
dti-2660	18	16	to	to	ADP
dti-2660	18	17	best	good	ADJ
dti-2660	18	18	practice	practice	NOUN
dti-2660	18	19	in	in	ADP
dti-2660	18	20	the	the	DET
dti-2660	18	21	management	management	NOUN
dti-2660	18	22	of	of	ADP
dti-2660	18	23	utis	utis	NOUN
dti-2660	18	24	.	.	PUNCT
dti-2660	19	1	methods	method	NOUN
dti-2660	19	2	the	the	DET
dti-2660	19	3	present	present	ADJ
dti-2660	19	4	review	review	NOUN
dti-2660	19	5	is	be	AUX
dti-2660	19	6	based	base	VERB
dti-2660	19	7	on	on	ADP
dti-2660	19	8	relevant	relevant	ADJ
dti-2660	19	9	articles	article	NOUN
dti-2660	19	10	retrieved	retrieve	VERB
dti-2660	19	11	from	from	ADP
dti-2660	19	12	pubmed	pubmed	PROPN
dti-2660	19	13	/	/	SYM
dti-2660	19	14	medline	medline	PROPN
dti-2660	19	15	and	and	CCONJ
dti-2660	19	16	google	google	PROPN
dti-2660	19	17	scholar	scholar	NOUN
dti-2660	19	18	guided	guide	VERB
dti-2660	19	19	by	by	ADP
dti-2660	19	20	material	material	NOUN
dti-2660	19	21	presented	present	VERB
dti-2660	19	22	at	at	ADP
dti-2660	19	23	an	an	DET
dti-2660	19	24	interactive	interactive	ADJ
dti-2660	19	25	scientific	scientific	ADJ
dti-2660	19	26	workshop	workshop	NOUN
dti-2660	19	27	sponsored	sponsor	VERB
dti-2660	19	28	by	by	ADP
dti-2660	19	29	ibsa	ibsa	NOUN
dti-2660	19	30	institut	institut	PROPN
dti-2660	19	31	biochimique	biochimique	PROPN
dti-2660	19	32	sa	sa	PROPN
dti-2660	19	33	(	(	PUNCT
dti-2660	19	34	ibsa	ibsa	PROPN
dti-2660	19	35	)	)	PUNCT
dti-2660	19	36	during	during	ADP
dti-2660	19	37	the	the	DET
dti-2660	19	38	38th	38th	ADJ
dti-2660	19	39	annual	annual	ADJ
dti-2660	19	40	european	european	ADJ
dti-2660	19	41	association	association	PROPN
dti-2660	19	42	of	of	ADP
dti-2660	19	43	urology	urology	NOUN
dti-2660	19	44	(	(	PUNCT
dti-2660	19	45	eau	eau	PROPN
dti-2660	19	46	)	)	PUNCT
dti-2660	19	47	congress	congress	PROPN
dti-2660	19	48	(	(	PUNCT
dti-2660	19	49	eau23	eau23	PROPN
dti-2660	19	50	)	)	PUNCT
dti-2660	19	51	that	that	PRON
dti-2660	19	52	was	be	AUX
dti-2660	19	53	held	hold	VERB
dti-2660	19	54	from	from	ADP
dti-2660	19	55	march	march	PROPN
dti-2660	19	56	10	10	NUM
dti-2660	19	57	to	to	ADP
dti-2660	19	58	13	13	NUM
dti-2660	19	59	,	,	PUNCT
dti-2660	19	60	2023	2023	NUM
dti-2660	19	61	,	,	PUNCT
dti-2660	19	62	in	in	ADP
dti-2660	19	63	milan	milan	PROPN
dti-2660	19	64	,	,	PUNCT
dti-2660	19	65	italy	italy	PROPN
dti-2660	19	66	.	.	PUNCT
dti-2660	20	1	the	the	DET
dti-2660	20	2	workshop	workshop	NOUN
dti-2660	20	3	addressed	address	VERB
dti-2660	20	4	the	the	DET
dti-2660	20	5	management	management	NOUN
dti-2660	20	6	of	of	ADP
dti-2660	20	7	utis	utis	NOUN
dti-2660	20	8	against	against	ADP
dti-2660	20	9	the	the	DET
dti-2660	20	10	background	background	NOUN
dti-2660	20	11	of	of	ADP
dti-2660	20	12	increasing	increase	VERB
dti-2660	20	13	amr	amr	NOUN
dti-2660	20	14	,	,	PUNCT
dti-2660	20	15	focusing	focus	VERB
dti-2660	20	16	on	on	ADP
dti-2660	20	17	the	the	DET
dti-2660	20	18	widespread	widespread	ADJ
dti-2660	20	19	problem	problem	NOUN
dti-2660	20	20	due	due	ADP
dti-2660	20	21	to	to	ADP
dti-2660	20	22	the	the	DET
dti-2660	20	23	overor	overor	NOUN
dti-2660	20	24	inappropriate	inappropriate	ADJ
dti-2660	20	25	use	use	NOUN
dti-2660	20	26	of	of	ADP
dti-2660	20	27	antibiotics	antibiotic	NOUN
dti-2660	20	28	and	and	CCONJ
dti-2660	20	29	the	the	DET
dti-2660	20	30	related	related	ADJ
dti-2660	20	31	threat	threat	NOUN
dti-2660	20	32	of	of	ADP
dti-2660	20	33	amr	amr	NOUN
dti-2660	20	34	in	in	ADP
dti-2660	20	35	patients	patient	NOUN
dti-2660	20	36	with	with	ADP
dti-2660	20	37	utis	utis	NOUN
dti-2660	20	38	.	.	PUNCT
dti-2660	21	1	papers	paper	NOUN
dti-2660	21	2	presented	present	VERB
dti-2660	21	3	as	as	ADP
dti-2660	21	4	part	part	NOUN
dti-2660	21	5	of	of	ADP
dti-2660	21	6	the	the	DET
dti-2660	21	7	workshop	workshop	NOUN
dti-2660	21	8	were	be	AUX
dti-2660	21	9	augmented	augment	VERB
dti-2660	21	10	by	by	ADP
dti-2660	21	11	searching	search	VERB
dti-2660	21	12	the	the	DET
dti-2660	21	13	databases	database	NOUN
dti-2660	21	14	for	for	ADP
dti-2660	21	15	additional	additional	ADJ
dti-2660	21	16	publications	publication	NOUN
dti-2660	21	17	necessary	necessary	ADJ
dti-2660	21	18	to	to	PART
dti-2660	21	19	advance	advance	VERB
dti-2660	21	20	the	the	DET
dti-2660	21	21	discussion	discussion	NOUN
dti-2660	21	22	or	or	CCONJ
dti-2660	21	23	provide	provide	VERB
dti-2660	21	24	additional	additional	ADJ
dti-2660	21	25	evidence	evidence	NOUN
dti-2660	21	26	.	.	PUNCT
dti-2660	22	1	original	original	ADJ
dti-2660	22	2	research	research	NOUN
dti-2660	22	3	papers	paper	NOUN
dti-2660	22	4	published	publish	VERB
dti-2660	22	5	in	in	ADP
dti-2660	22	6	english	english	PROPN
dti-2660	22	7	in	in	ADP
dti-2660	22	8	internationally	internationally	ADV
dti-2660	22	9	recognized	recognize	VERB
dti-2660	22	10	journals	journal	NOUN
dti-2660	22	11	and	and	CCONJ
dti-2660	22	12	online	online	ADJ
dti-2660	22	13	journals	journal	NOUN
dti-2660	22	14	were	be	AUX
dti-2660	22	15	selected	select	VERB
dti-2660	22	16	preferentially	preferentially	ADV
dti-2660	22	17	,	,	PUNCT
dti-2660	22	18	but	but	CCONJ
dti-2660	22	19	review	review	VERB
dti-2660	22	20	articles	article	NOUN
dti-2660	22	21	that	that	PRON
dti-2660	22	22	added	add	VERB
dti-2660	22	23	to	to	ADP
dti-2660	22	24	the	the	DET
dti-2660	22	25	understanding	understanding	NOUN
dti-2660	22	26	of	of	ADP
dti-2660	22	27	the	the	DET
dti-2660	22	28	management	management	NOUN
dti-2660	22	29	of	of	ADP
dti-2660	22	30	utis	utis	NOUN
dti-2660	22	31	in	in	ADP
dti-2660	22	32	the	the	DET
dti-2660	22	33	era	era	NOUN
dti-2660	22	34	of	of	ADP
dti-2660	22	35	amr	amr	NOUN
dti-2660	22	36	were	be	AUX
dti-2660	22	37	also	also	ADV
dti-2660	22	38	selected	select	VERB
dti-2660	22	39	.	.	PUNCT
dti-2660	23	1	identified	identify	VERB
dti-2660	23	2	articles	article	NOUN
dti-2660	23	3	were	be	AUX
dti-2660	23	4	reviewed	review	VERB
dti-2660	23	5	for	for	ADP
dti-2660	23	6	relevance	relevance	NOUN
dti-2660	23	7	,	,	PUNCT
dti-2660	23	8	with	with	ADP
dti-2660	23	9	preference	preference	NOUN
dti-2660	23	10	given	give	VERB
dti-2660	23	11	to	to	ADP
dti-2660	23	12	recent	recent	ADJ
dti-2660	23	13	papers	paper	NOUN
dti-2660	23	14	.	.	PUNCT
dti-2660	24	1	the	the	DET
dti-2660	24	2	eau	eau	PROPN
dti-2660	24	3	presents	present	VERB
dti-2660	24	4	programs	program	NOUN
dti-2660	24	5	of	of	ADP
dti-2660	24	6	cutting	cut	VERB
dti-2660	24	7	-	-	PUNCT
dti-2660	24	8	edge	edge	NOUN
dti-2660	24	9	urological	urological	ADJ
dti-2660	24	10	science	science	NOUN
dti-2660	24	11	at	at	ADP
dti-2660	24	12	their	their	PRON
dti-2660	24	13	annual	annual	ADJ
dti-2660	24	14	congress	congress	NOUN
dti-2660	24	15	,	,	PUNCT
dti-2660	24	16	including	include	VERB
dti-2660	24	17	the	the	DET
dti-2660	24	18	presentation	presentation	NOUN
dti-2660	24	19	of	of	ADP
dti-2660	24	20	the	the	DET
dti-2660	24	21	latest	late	ADJ
dti-2660	24	22	edition	edition	NOUN
dti-2660	24	23	of	of	ADP
dti-2660	24	24	the	the	DET
dti-2660	24	25	eau	eau	PROPN
dti-2660	24	26	guidelines	guideline	NOUN
dti-2660	24	27	on	on	ADP
dti-2660	24	28	urological	urological	ADJ
dti-2660	24	29	infections	infection	NOUN
dti-2660	24	30	.	.	PUNCT
dti-2660	25	1	these	these	DET
dti-2660	25	2	widely	widely	ADV
dti-2660	25	3	respected	respect	VERB
dti-2660	25	4	clinical	clinical	ADJ
dti-2660	25	5	guidelines	guideline	NOUN
dti-2660	25	6	,	,	PUNCT
dti-2660	25	7	which	which	PRON
dti-2660	25	8	provide	provide	VERB
dti-2660	25	9	medical	medical	ADJ
dti-2660	25	10	professionals	professional	NOUN
dti-2660	25	11	with	with	ADP
dti-2660	25	12	best	good	ADJ
dti-2660	25	13	evidence	evidence	NOUN
dti-2660	25	14	-	-	PUNCT
dti-2660	25	15	based	base	VERB
dti-2660	25	16	information	information	NOUN
dti-2660	25	17	and	and	CCONJ
dti-2660	25	18	recommendations	recommendation	NOUN
dti-2660	25	19	for	for	ADP
dti-2660	25	20	preventing	prevent	VERB
dti-2660	25	21	and	and	CCONJ
dti-2660	25	22	treating	treat	VERB
dti-2660	25	23	utis	utis	NOUN
dti-2660	25	24	and	and	CCONJ
dti-2660	25	25	male	male	ADJ
dti-2660	25	26	accessory	accessory	ADJ
dti-2660	25	27	gland	gland	NOUN
dti-2660	25	28	infections	infection	NOUN
dti-2660	25	29	(	(	PUNCT
dti-2660	25	30	8)	8)	NUM
dti-2660	25	31	,	,	PUNCT
dti-2660	25	32	reinforce	reinforce	VERB
dti-2660	25	33	the	the	DET
dti-2660	25	34	material	material	NOUN
dti-2660	25	35	presented	present	VERB
dti-2660	25	36	in	in	ADP
dti-2660	25	37	this	this	DET
dti-2660	25	38	review	review	NOUN
dti-2660	25	39	.	.	PUNCT
dti-2660	26	1	the	the	DET
dti-2660	26	2	guidelines	guideline	NOUN
dti-2660	26	3	also	also	ADV
dti-2660	26	4	address	address	VERB
dti-2660	26	5	important	important	ADJ
dti-2660	26	6	public	public	ADJ
dti-2660	26	7	health	health	NOUN
dti-2660	26	8	aspects	aspect	NOUN
dti-2660	26	9	of	of	ADP
dti-2660	26	10	infection	infection	NOUN
dti-2660	26	11	control	control	NOUN
dti-2660	26	12	and	and	CCONJ
dti-2660	26	13	antimicrobial	antimicrobial	ADJ
dti-2660	26	14	stewardship	stewardship	NOUN
dti-2660	26	15	,	,	PUNCT
dti-2660	26	16	including	include	VERB
dti-2660	26	17	the	the	DET
dti-2660	26	18	growing	grow	VERB
dti-2660	26	19	problem	problem	NOUN
dti-2660	26	20	of	of	ADP
dti-2660	26	21	resistance	resistance	NOUN
dti-2660	26	22	among	among	ADP
dti-2660	26	23	uropathogenic	uropathogenic	ADJ
dti-2660	26	24	bacteria	bacteria	NOUN
dti-2660	26	25	,	,	PUNCT
dti-2660	26	26	the	the	DET
dti-2660	26	27	overuse	overuse	NOUN
dti-2660	26	28	and	and	CCONJ
dti-2660	26	29	misuse	misuse	NOUN
dti-2660	26	30	of	of	ADP
dti-2660	26	31	antibiotics	antibiotic	NOUN
dti-2660	26	32	,	,	PUNCT
dti-2660	26	33	and	and	CCONJ
dti-2660	26	34	the	the	DET
dti-2660	26	35	lack	lack	NOUN
dti-2660	26	36	of	of	ADP
dti-2660	26	37	new	new	ADJ
dti-2660	26	38	antibiotics	antibiotic	NOUN
dti-2660	26	39	.	.	PUNCT
dti-2660	27	1	the	the	DET
dti-2660	27	2	european	european	PROPN
dti-2660	27	3	association	association	PROPN
dti-2660	27	4	of	of	ADP
dti-2660	27	5	urology	urology	NOUN
dti-2660	27	6	nurses	nurse	NOUN
dti-2660	27	7	(	(	PUNCT
dti-2660	27	8	eaun	eaun	PROPN
dti-2660	27	9	)	)	PUNCT
dti-2660	27	10	,	,	PUNCT
dti-2660	27	11	which	which	PRON
dti-2660	27	12	has	have	AUX
dti-2660	27	13	been	be	AUX
dti-2660	27	14	developing	develop	VERB
dti-2660	27	15	practice	practice	NOUN
dti-2660	27	16	guidelines	guideline	NOUN
dti-2660	27	17	for	for	ADP
dti-2660	27	18	european	european	ADJ
dti-2660	27	19	urology	urology	NOUN
dti-2660	27	20	nurses	nurse	NOUN
dti-2660	27	21	since	since	SCONJ
dti-2660	27	22	2004	2004	NUM
dti-2660	27	23	,	,	PUNCT
dti-2660	27	24	also	also	ADV
dti-2660	27	25	hosted	host	VERB
dti-2660	27	26	their	their	PRON
dti-2660	27	27	annual	annual	ADJ
dti-2660	27	28	meeting	meeting	NOUN
dti-2660	27	29	(	(	PUNCT
dti-2660	27	30	eaun23	eaun23	NOUN
dti-2660	27	31	)	)	PUNCT
dti-2660	27	32	in	in	ADP
dti-2660	27	33	conjunction	conjunction	NOUN
dti-2660	27	34	with	with	ADP
dti-2660	27	35	eau23	eau23	NOUN
dti-2660	27	36	,	,	PUNCT
dti-2660	27	37	providing	provide	VERB
dti-2660	27	38	a	a	DET
dti-2660	27	39	forum	forum	NOUN
dti-2660	27	40	for	for	ADP
dti-2660	27	41	leading	lead	VERB
dti-2660	27	42	urology	urology	NOUN
dti-2660	27	43	nursing	nursing	NOUN
dti-2660	27	44	and	and	CCONJ
dti-2660	27	45	medical	medical	ADJ
dti-2660	27	46	professionals	professional	NOUN
dti-2660	27	47	to	to	PART
dti-2660	27	48	share	share	VERB
dti-2660	27	49	evidence	evidence	NOUN
dti-2660	27	50	-	-	PUNCT
dti-2660	27	51	based	base	VERB
dti-2660	27	52	research	research	NOUN
dti-2660	27	53	of	of	ADP
dti-2660	27	54	particular	particular	ADJ
dti-2660	27	55	relevance	relevance	NOUN
dti-2660	27	56	to	to	ADP
dti-2660	27	57	urological	urological	ADJ
dti-2660	27	58	care	care	NOUN
dti-2660	27	59	from	from	ADP
dti-2660	27	60	a	a	DET
dti-2660	27	61	nursing	nursing	NOUN
dti-2660	27	62	perspective	perspective	NOUN
dti-2660	27	63	.	.	PUNCT
dti-2660	28	1	a	a	DET
dti-2660	28	2	patient	patient	ADJ
dti-2660	28	3	awareness	awareness	NOUN
dti-2660	28	4	campaign	campaign	NOUN
dti-2660	28	5	was	be	AUX
dti-2660	28	6	also	also	ADV
dti-2660	28	7	introduced	introduce	VERB
dti-2660	28	8	at	at	ADP
dti-2660	28	9	the	the	DET
dti-2660	28	10	congress	congress	PROPN
dti-2660	28	11	to	to	PART
dti-2660	28	12	inform	inform	VERB
dti-2660	28	13	and	and	CCONJ
dti-2660	28	14	raise	raise	VERB
dti-2660	28	15	awareness	awareness	NOUN
dti-2660	28	16	of	of	ADP
dti-2660	28	17	the	the	DET
dti-2660	28	18	correct	correct	ADJ
dti-2660	28	19	recognition	recognition	NOUN
dti-2660	28	20	of	of	ADP
dti-2660	28	21	symptoms	symptom	NOUN
dti-2660	28	22	and	and	CCONJ
dti-2660	28	23	treatment	treatment	NOUN
dti-2660	28	24	of	of	ADP
dti-2660	28	25	utis	utis	NOUN
dti-2660	28	26	,	,	PUNCT
dti-2660	28	27	involving	involve	VERB
dti-2660	28	28	patients	patient	NOUN
dti-2660	28	29	,	,	PUNCT
dti-2660	28	30	patient	patient	ADJ
dti-2660	28	31	organizations	organization	NOUN
dti-2660	28	32	,	,	PUNCT
dti-2660	28	33	and	and	CCONJ
dti-2660	28	34	physicians	physician	NOUN
dti-2660	28	35	in	in	ADP
dti-2660	28	36	managing	manage	VERB
dti-2660	28	37	bacterial	bacterial	ADJ
dti-2660	28	38	infections	infection	NOUN
dti-2660	28	39	according	accord	VERB
dti-2660	28	40	to	to	ADP
dti-2660	28	41	the	the	DET
dti-2660	28	42	eau	eau	PROPN
dti-2660	28	43	guidelines	guideline	NOUN
dti-2660	28	44	.	.	PUNCT
dti-2660	29	1	a	a	DET
dti-2660	29	2	video	video	NOUN
dti-2660	29	3	supporting	support	VERB
dti-2660	29	4	the	the	DET
dti-2660	29	5	campaign	campaign	NOUN
dti-2660	29	6	,	,	PUNCT
dti-2660	29	7	uti	uti	PROPN
dti-2660	29	8	and	and	CCONJ
dti-2660	29	9	the	the	DET
dti-2660	29	10	use	use	NOUN
dti-2660	29	11	of	of	ADP
dti-2660	29	12	antibiotics	antibiotic	NOUN
dti-2660	29	13	,	,	PUNCT
dti-2660	29	14	clearly	clearly	ADV
dti-2660	29	15	and	and	CCONJ
dti-2660	29	16	directly	directly	ADV
dti-2660	29	17	explains	explain	VERB
dti-2660	29	18	several	several	ADJ
dti-2660	29	19	aspects	aspect	NOUN
dti-2660	29	20	of	of	ADP
dti-2660	29	21	urological	urological	ADJ
dti-2660	29	22	disorders	disorder	NOUN
dti-2660	29	23	and	and	CCONJ
dti-2660	29	24	is	be	AUX
dti-2660	29	25	available	available	ADJ
dti-2660	29	26	,	,	PUNCT
dti-2660	29	27	along	along	ADP
dti-2660	29	28	with	with	ADP
dti-2660	29	29	other	other	ADJ
dti-2660	29	30	information	information	NOUN
dti-2660	29	31	,	,	PUNCT
dti-2660	29	32	in	in	ADP
dti-2660	29	33	the	the	DET
dti-2660	29	34	eau	eau	PROPN
dti-2660	29	35	patient	patient	PROPN
dti-2660	29	36	information	information	NOUN
dti-2660	29	37	portal	portal	NOUN
dti-2660	29	38	at	at	ADP
dti-2660	29	39	online	online	NOUN
dti-2660	29	40	.	.	PUNCT
dti-2660	30	1	management	management	NOUN
dti-2660	30	2	of	of	ADP
dti-2660	30	3	utis	utis	NOUN
dti-2660	30	4	in	in	ADP
dti-2660	30	5	times	time	NOUN
dti-2660	30	6	of	of	ADP
dti-2660	30	7	increasing	increase	VERB
dti-2660	30	8	amr	amr	NOUN
dti-2660	30	9	there	there	PRON
dti-2660	30	10	is	be	VERB
dti-2660	30	11	increasing	increase	VERB
dti-2660	30	12	interest	interest	NOUN
dti-2660	30	13	in	in	ADP
dti-2660	30	14	infectious	infectious	ADJ
dti-2660	30	15	diseases	disease	NOUN
dti-2660	30	16	,	,	PUNCT
dti-2660	30	17	and	and	CCONJ
dti-2660	30	18	the	the	DET
dti-2660	30	19	eau	eau	PROPN
dti-2660	30	20	guidelines	guideline	NOUN
dti-2660	30	21	on	on	ADP
dti-2660	30	22	urological	urological	ADJ
dti-2660	30	23	infections	infection	NOUN
dti-2660	30	24	have	have	AUX
dti-2660	30	25	become	become	VERB
dti-2660	30	26	the	the	DET
dti-2660	30	27	second	second	ADJ
dti-2660	30	28	most	most	ADV
dti-2660	30	29	downloaded	download	VERB
dti-2660	30	30	of	of	ADP
dti-2660	30	31	all	all	DET
dti-2660	30	32	european	european	ADJ
dti-2660	30	33	clinical	clinical	ADJ
dti-2660	30	34	guidelines	guideline	NOUN
dti-2660	30	35	after	after	ADP
dti-2660	30	36	prostate	prostate	NOUN
dti-2660	30	37	cancer	cancer	NOUN
dti-2660	30	38	guidelines	guideline	NOUN
dti-2660	30	39	.	.	PUNCT
dti-2660	31	1	in	in	ADP
dti-2660	31	2	parallel	parallel	NOUN
dti-2660	31	3	,	,	PUNCT
dti-2660	31	4	the	the	DET
dti-2660	31	5	issue	issue	NOUN
dti-2660	31	6	of	of	ADP
dti-2660	31	7	amr	amr	PROPN
dti-2660	31	8	in	in	ADP
dti-2660	31	9	urological	urological	ADJ
dti-2660	31	10	infections	infection	NOUN
dti-2660	31	11	,	,	PUNCT
dti-2660	31	12	as	as	ADP
dti-2660	31	13	in	in	ADP
dti-2660	31	14	other	other	ADJ
dti-2660	31	15	infections	infection	NOUN
dti-2660	31	16	,	,	PUNCT
dti-2660	31	17	is	be	AUX
dti-2660	31	18	increasingly	increasingly	ADV
dti-2660	31	19	recognized	recognize	VERB
dti-2660	31	20	as	as	ADP
dti-2660	31	21	an	an	DET
dti-2660	31	22	urgent	urgent	ADJ
dti-2660	31	23	public	public	ADJ
dti-2660	31	24	health	health	NOUN
dti-2660	31	25	priority	priority	NOUN
dti-2660	31	26	(	(	PUNCT
dti-2660	31	27	6,9	6,9	NUM
dti-2660	31	28	)	)	PUNCT
dti-2660	31	29	.	.	PUNCT
dti-2660	32	1	an	an	DET
dti-2660	32	2	independent	independent	ADJ
dti-2660	32	3	review	review	NOUN
dti-2660	32	4	on	on	ADP
dti-2660	32	5	amr	amr	PROPN
dti-2660	32	6	commissioned	commission	VERB
dti-2660	32	7	in	in	ADP
dti-2660	32	8	july	july	PROPN
dti-2660	32	9	2014	2014	NUM
dti-2660	32	10	by	by	ADP
dti-2660	32	11	the	the	DET
dti-2660	32	12	uk	uk	PROPN
dti-2660	32	13	government	government	NOUN
dti-2660	32	14	to	to	PART
dti-2660	32	15	address	address	VERB
dti-2660	32	16	the	the	DET
dti-2660	32	17	challenge	challenge	NOUN
dti-2660	32	18	of	of	ADP
dti-2660	32	19	amr	amr	PROPN
dti-2660	32	20	estimated	estimate	VERB
dti-2660	32	21	that	that	SCONJ
dti-2660	32	22	failure	failure	NOUN
dti-2660	32	23	to	to	PART
dti-2660	32	24	address	address	VERB
dti-2660	32	25	the	the	DET
dti-2660	32	26	problem	problem	NOUN
dti-2660	32	27	could	could	AUX
dti-2660	32	28	lead	lead	VERB
dti-2660	32	29	to	to	ADP
dti-2660	32	30	10	10	NUM
dti-2660	32	31	million	million	NUM
dti-2660	32	32	deaths	death	NOUN
dti-2660	32	33	globally	globally	ADV
dti-2660	32	34	per	per	ADP
dti-2660	32	35	year	year	NOUN
dti-2660	32	36	by	by	ADP
dti-2660	32	37	2050	2050	NUM
dti-2660	32	38	,	,	PUNCT
dti-2660	32	39	costing	cost	VERB
dti-2660	32	40	an	an	DET
dti-2660	32	41	estimated	estimate	VERB
dti-2660	32	42	us$	us$	SYM
dti-2660	32	43	100	100	NUM
dti-2660	32	44	trillion	trillion	NUM
dti-2660	32	45	if	if	SCONJ
dti-2660	32	46	action	action	NOUN
dti-2660	32	47	is	be	AUX
dti-2660	32	48	not	not	PART
dti-2660	32	49	taken	take	VERB
dti-2660	32	50	(	(	PUNCT
dti-2660	32	51	7	7	NUM
dti-2660	32	52	)	)	PUNCT
dti-2660	32	53	.	.	PUNCT
dti-2660	33	1	the	the	DET
dti-2660	33	2	latest	late	ADJ
dti-2660	33	3	predictive	predictive	ADJ
dti-2660	33	4	models	model	NOUN
dti-2660	33	5	of	of	ADP
dti-2660	33	6	the	the	DET
dti-2660	33	7	world	world	PROPN
dti-2660	33	8	health	health	NOUN
dti-2660	33	9	organization	organization	NOUN
dti-2660	33	10	(	(	PUNCT
dti-2660	33	11	who	who	PRON
dti-2660	33	12	)	)	PUNCT
dti-2660	33	13	amr	amr	NOUN
dti-2660	33	14	collaborators	collaborator	NOUN
dti-2660	33	15	estimate	estimate	VERB
dti-2660	33	16	that	that	SCONJ
dti-2660	33	17	there	there	PRON
dti-2660	33	18	were	be	VERB
dti-2660	33	19	4.95	4.95	NUM
dti-2660	33	20	million	million	NUM
dti-2660	33	21	deaths	death	NOUN
dti-2660	33	22	associated	associate	VERB
dti-2660	33	23	with	with	ADP
dti-2660	33	24	bacterial	bacterial	ADJ
dti-2660	33	25	amr	amr	NOUN
dti-2660	33	26	globally	globally	ADV
dti-2660	33	27	in	in	ADP
dti-2660	33	28	2019	2019	NUM
dti-2660	33	29	(	(	PUNCT
dti-2660	33	30	6	6	NUM
dti-2660	33	31	)	)	PUNCT
dti-2660	33	32	.	.	PUNCT
dti-2660	34	1	this	this	PRON
dti-2660	34	2	includes	include	VERB
dti-2660	34	3	1.27	1.27	NUM
dti-2660	34	4	million	million	NUM
dti-2660	34	5	deaths	death	NOUN
dti-2660	34	6	directly	directly	ADV
dti-2660	34	7	attributable	attributable	ADJ
dti-2660	34	8	to	to	ADP
dti-2660	34	9	bacterial	bacterial	ADJ
dti-2660	34	10	amr	amr	NOUN
dti-2660	34	11	and	and	CCONJ
dti-2660	34	12	3.57	3.57	NUM
dti-2660	34	13	million	million	NUM
dti-2660	34	14	associated	associate	VERB
dti-2660	34	15	with	with	ADP
dti-2660	34	16	amr	amr	PROPN
dti-2660	34	17	.	.	PUNCT
dti-2660	35	1	just	just	ADV
dti-2660	35	2	six	six	NUM
dti-2660	35	3	pathogens	pathogen	NOUN
dti-2660	35	4	were	be	AUX
dti-2660	35	5	each	each	PRON
dti-2660	35	6	responsible	responsible	ADJ
dti-2660	35	7	for	for	ADP
dti-2660	35	8	over	over	ADP
dti-2660	35	9	250,000	250,000	NUM
dti-2660	35	10	deaths	death	NOUN
dti-2660	35	11	attributable	attributable	ADJ
dti-2660	35	12	to	to	ADP
dti-2660	35	13	or	or	CCONJ
dti-2660	35	14	associated	associate	VERB
dti-2660	35	15	with	with	ADP
dti-2660	35	16	bacterial	bacterial	ADJ
dti-2660	35	17	amr	amr	NOUN
dti-2660	35	18	:	:	PUNCT
dti-2660	35	19	escherichia	escherichia	NOUN
dti-2660	35	20	coli	coli	NOUN
dti-2660	35	21	,	,	PUNCT
dti-2660	35	22	staphylococcus	staphylococcus	NOUN
dti-2660	35	23	aureus	aureus	NOUN
dti-2660	35	24	,	,	PUNCT
dti-2660	35	25	klebsiella	klebsiella	NOUN
dti-2660	35	26	pneumoniae	pneumoniae	NOUN
dti-2660	35	27	,	,	PUNCT
dti-2660	35	28	streptococcus	streptococcus	VERB
dti-2660	35	29	pneumoniae	pneumoniae	NOUN
dti-2660	35	30	,	,	PUNCT
dti-2660	35	31	acinetobacter	acinetobacter	ADV
dti-2660	35	32	baumannii	baumannii	PROPN
dti-2660	35	33	,	,	PUNCT
dti-2660	35	34	and	and	CCONJ
dti-2660	35	35	pseudomonas	pseudomonas	PROPN
dti-2660	35	36	aeruginosa	aeruginosa	NOUN
dti-2660	35	37	(	(	PUNCT
dti-2660	35	38	fig	fig	NOUN
dti-2660	35	39	.	.	NOUN
dti-2660	35	40	1	1	NUM
dti-2660	35	41	)	)	PUNCT
dti-2660	35	42	.	.	PUNCT
dti-2660	36	1	together	together	ADV
dti-2660	36	2	,	,	PUNCT
dti-2660	36	3	they	they	PRON
dti-2660	36	4	were	be	AUX
dti-2660	36	5	responsible	responsible	ADJ
dti-2660	36	6	for	for	ADP
dti-2660	36	7	929,000	929,000	NUM
dti-2660	36	8	deaths	death	NOUN
dti-2660	36	9	(	(	PUNCT
dti-2660	36	10	6	6	NUM
dti-2660	36	11	)	)	PUNCT
dti-2660	36	12	.	.	PUNCT
dti-2660	37	1	of	of	ADP
dti-2660	37	2	these	these	PRON
dti-2660	37	3	,	,	PUNCT
dti-2660	37	4	utis	utis	PROPN
dti-2660	37	5	were	be	AUX
dti-2660	37	6	the	the	DET
dti-2660	37	7	fourth	fourth	ADJ
dti-2660	37	8	most	most	ADV
dti-2660	37	9	prevalent	prevalent	ADJ
dti-2660	37	10	infectious	infectious	ADJ
dti-2660	37	11	syndrome	syndrome	NOUN
dti-2660	37	12	associated	associate	VERB
dti-2660	37	13	with	with	ADP
dti-2660	37	14	global	global	ADJ
dti-2660	37	15	deaths	death	NOUN
dti-2660	37	16	attributable	attributable	ADJ
dti-2660	37	17	to	to	ADP
dti-2660	37	18	or	or	CCONJ
dti-2660	37	19	associated	associate	VERB
dti-2660	37	20	with	with	ADP
dti-2660	37	21	amr	amr	NOUN
dti-2660	37	22	,	,	PUNCT
dti-2660	37	23	after	after	ADP
dti-2660	37	24	lower	low	ADJ
dti-2660	37	25	respiratory	respiratory	ADJ
dti-2660	37	26	infections	infection	NOUN
dti-2660	37	27	and	and	CCONJ
dti-2660	37	28	all	all	DET
dti-2660	37	29	related	related	ADJ
dti-2660	37	30	infections	infection	NOUN
dti-2660	37	31	in	in	ADP
dti-2660	37	32	the	the	DET
dti-2660	37	33	thorax	thorax	NOUN
dti-2660	37	34	,	,	PUNCT
dti-2660	37	35	bloodstream	bloodstream	NOUN
dti-2660	37	36	infections	infection	NOUN
dti-2660	37	37	,	,	PUNCT
dti-2660	37	38	and	and	CCONJ
dti-2660	37	39	peritoneal	peritoneal	ADJ
dti-2660	37	40	and	and	CCONJ
dti-2660	37	41	intra	intra	ADJ
dti-2660	37	42	-	-	ADJ
dti-2660	37	43	abdominal	abdominal	ADJ
dti-2660	37	44	infections	infection	NOUN
dti-2660	37	45	(	(	PUNCT
dti-2660	37	46	6	6	NUM
dti-2660	37	47	)	)	PUNCT
dti-2660	37	48	.	.	PUNCT
dti-2660	38	1	classification	classification	NOUN
dti-2660	38	2	and	and	CCONJ
dti-2660	38	3	diagnosis	diagnosis	NOUN
dti-2660	38	4	utis	utis	NOUN
dti-2660	38	5	can	can	AUX
dti-2660	38	6	be	be	AUX
dti-2660	38	7	classified	classify	VERB
dti-2660	38	8	differently	differently	ADV
dti-2660	38	9	,	,	PUNCT
dti-2660	38	10	but	but	CCONJ
dti-2660	38	11	a	a	DET
dti-2660	38	12	system	system	NOUN
dti-2660	38	13	developed	develop	VERB
dti-2660	38	14	by	by	ADP
dti-2660	38	15	the	the	DET
dti-2660	38	16	eau	eau	PROPN
dti-2660	38	17	section	section	NOUN
dti-2660	38	18	of	of	ADP
dti-2660	38	19	infections	infection	NOUN
dti-2660	38	20	in	in	ADP
dti-2660	38	21	urology	urology	NOUN
dti-2660	38	22	and	and	CCONJ
dti-2660	38	23	the	the	DET
dti-2660	38	24	european	european	ADJ
dti-2660	38	25	society	society	NOUN
dti-2660	38	26	for	for	ADP
dti-2660	38	27	infections	infection	NOUN
dti-2660	38	28	in	in	ADP
dti-2660	38	29	urology	urology	NOUN
dti-2660	38	30	(	(	PUNCT
dti-2660	38	31	esiu	esiu	NOUN
dti-2660	38	32	)	)	PUNCT
dti-2660	38	33	and	and	CCONJ
dti-2660	38	34	adopted	adopt	VERB
dti-2660	38	35	by	by	ADP
dti-2660	38	36	the	the	DET
dti-2660	38	37	eau	eau	PROPN
dti-2660	38	38	provides	provide	VERB
dti-2660	38	39	a	a	DET
dti-2660	38	40	valuable	valuable	ADJ
dti-2660	38	41	classification	classification	NOUN
dti-2660	38	42	tool	tool	NOUN
dti-2660	38	43	.	.	PUNCT
dti-2660	39	1	the	the	DET
dti-2660	39	2	eau	eau	PROPN
dti-2660	39	3	/	/	SYM
dti-2660	39	4	esiu	esiu	NOUN
dti-2660	39	5	system	system	NOUN
dti-2660	39	6	classifies	classify	VERB
dti-2660	39	7	utis	utis	NOUN
dti-2660	39	8	according	accord	VERB
dti-2660	39	9	to	to	ADP
dti-2660	39	10	the	the	DET
dti-2660	39	11	prevalence	prevalence	NOUN
dti-2660	39	12	of	of	ADP
dti-2660	39	13	risk	risk	NOUN
dti-2660	39	14	factors	factor	NOUN
dti-2660	39	15	(	(	PUNCT
dti-2660	39	16	uncomplicated	uncomplicated	ADJ
dti-2660	39	17	and	and	CCONJ
dti-2660	39	18	complicated	complicated	ADJ
dti-2660	39	19	utis	utis	NOUN
dti-2660	39	20	)	)	PUNCT
dti-2660	39	21	,	,	PUNCT
dti-2660	39	22	localization	localization	NOUN
dti-2660	39	23	(	(	PUNCT
dti-2660	39	24	lower	low	ADJ
dti-2660	39	25	and	and	CCONJ
dti-2660	39	26	upper	upper	ADJ
dti-2660	39	27	utis	utis	NOUN
dti-2660	39	28	)	)	PUNCT
dti-2660	39	29	,	,	PUNCT
dti-2660	39	30	the	the	DET
dti-2660	39	31	frequency	frequency	NOUN
dti-2660	39	32	of	of	ADP
dti-2660	39	33	occurrence	occurrence	NOUN
dti-2660	39	34	(	(	PUNCT
dti-2660	39	35	rare	rare	ADJ
dti-2660	39	36	and	and	CCONJ
dti-2660	39	37	recurrent	recurrent	ADJ
dti-2660	39	38	)	)	PUNCT
dti-2660	39	39	,	,	PUNCT
dti-2660	39	40	relapse	relapse	NOUN
dti-2660	39	41	or	or	CCONJ
dti-2660	39	42	reinfection	reinfection	NOUN
dti-2660	39	43	,	,	PUNCT
dti-2660	39	44	and	and	CCONJ
dti-2660	39	45	in	in	ADP
dti-2660	39	46	women	woman	NOUN
dti-2660	39	47	and	and	CCONJ
dti-2660	39	48	men	man	NOUN
dti-2660	39	49	(	(	PUNCT
dti-2660	39	50	8)	8)	NUM
dti-2660	39	51	.	.	PUNCT
dti-2660	39	52	that	that	PRON
dti-2660	39	53	is	is	ADV
dti-2660	39	54	,	,	PUNCT
dti-2660	39	55	the	the	DET
dti-2660	39	56	system	system	NOUN
dti-2660	39	57	is	be	AUX
dti-2660	39	58	based	base	VERB
dti-2660	39	59	on	on	ADP
dti-2660	39	60	the	the	DET
dti-2660	39	61	clinical	clinical	ADJ
dti-2660	39	62	presentation	presentation	NOUN
dti-2660	39	63	of	of	ADP
dti-2660	39	64	the	the	DET
dti-2660	39	65	uti	uti	PROPN
dti-2660	39	66	,	,	PUNCT
dti-2660	39	67	the	the	DET
dti-2660	39	68	anatomical	anatomical	ADJ
dti-2660	39	69	level	level	NOUN
dti-2660	39	70	of	of	ADP
dti-2660	39	71	the	the	DET
dti-2660	39	72	uti	uti	PROPN
dti-2660	39	73	,	,	PUNCT
dti-2660	39	74	the	the	DET
dti-2660	39	75	grade	grade	NOUN
dti-2660	39	76	of	of	ADP
dti-2660	39	77	severity	severity	NOUN
dti-2660	39	78	of	of	ADP
dti-2660	39	79	the	the	DET
dti-2660	39	80	infection	infection	NOUN
dti-2660	39	81	,	,	PUNCT
dti-2660	39	82	the	the	DET
dti-2660	39	83	categorization	categorization	NOUN
dti-2660	39	84	of	of	ADP
dti-2660	39	85	risk	risk	NOUN
dti-2660	39	86	factors	factor	NOUN
dti-2660	39	87	,	,	PUNCT
dti-2660	39	88	the	the	DET
dti-2660	39	89	frequency	frequency	NOUN
dti-2660	39	90	of	of	ADP
dti-2660	39	91	occurrence	occurrence	NOUN
dti-2660	39	92	,	,	PUNCT
dti-2660	39	93	and	and	CCONJ
dti-2660	39	94	the	the	DET
dti-2660	39	95	availability	availability	NOUN
dti-2660	39	96	of	of	ADP
dti-2660	39	97	appropriate	appropriate	ADJ
dti-2660	39	98	antimicrobial	antimicrobial	ADJ
dti-2660	39	99	therapy	therapy	NOUN
dti-2660	39	100	(	(	PUNCT
dti-2660	39	101	10	10	NUM
dti-2660	39	102	)	)	PUNCT
dti-2660	39	103	.	.	PUNCT
dti-2660	40	1	for	for	ADP
dti-2660	40	2	example	example	NOUN
dti-2660	40	3	,	,	PUNCT
dti-2660	40	4	a	a	DET
dti-2660	40	5	young	young	ADJ
dti-2660	40	6	,	,	PUNCT
dti-2660	40	7	premenopausal	premenopausal	NOUN
dti-2660	40	8	,	,	PUNCT
dti-2660	40	9	nonpregnant	nonpregnant	ADJ
dti-2660	40	10	woman	woman	NOUN
dti-2660	40	11	with	with	ADP
dti-2660	40	12	no	no	DET
dti-2660	40	13	known	know	VERB
dti-2660	40	14	relevant	relevant	ADJ
dti-2660	40	15	anatomical	anatomical	ADJ
dti-2660	40	16	and	and	CCONJ
dti-2660	40	17	functional	functional	ADJ
dti-2660	40	18	abnormalities	abnormality	NOUN
dti-2660	40	19	within	within	ADP
dti-2660	40	20	the	the	DET
dti-2660	40	21	urinary	urinary	ADJ
dti-2660	40	22	tract	tract	NOUN
dti-2660	40	23	or	or	CCONJ
dti-2660	40	24	comorbidities	comorbiditie	NOUN
dti-2660	40	25	presenting	present	VERB
dti-2660	40	26	with	with	ADP
dti-2660	40	27	the	the	DET
dti-2660	40	28	typical	typical	ADJ
dti-2660	40	29	symptoms	symptom	NOUN
dti-2660	40	30	of	of	ADP
dti-2660	40	31	a	a	DET
dti-2660	40	32	uti	uti	PROPN
dti-2660	40	33	can	can	AUX
dti-2660	40	34	be	be	AUX
dti-2660	40	35	considered	consider	VERB
dti-2660	40	36	to	to	PART
dti-2660	40	37	have	have	VERB
dti-2660	40	38	an	an	DET
dti-2660	40	39	uncomplicated	uncomplicated	ADJ
dti-2660	40	40	uti	uti	PROPN
dti-2660	40	41	.	.	PUNCT
dti-2660	41	1	by	by	ADP
dti-2660	41	2	definition	definition	NOUN
dti-2660	41	3	,	,	PUNCT
dti-2660	41	4	all	all	DET
dti-2660	41	5	other	other	ADJ
dti-2660	41	6	utis	utis	NOUN
dti-2660	41	7	are	be	AUX
dti-2660	41	8	complicated	complicate	VERB
dti-2660	41	9	utis	utis	NOUN
dti-2660	41	10	,	,	PUNCT
dti-2660	41	11	with	with	ADP
dti-2660	41	12	a	a	DET
dti-2660	41	13	higher	high	ADJ
dti-2660	41	14	risk	risk	NOUN
dti-2660	41	15	of	of	ADP
dti-2660	41	16	developing	develop	VERB
dti-2660	41	17	a	a	DET
dti-2660	41	18	complicated	complicated	ADJ
dti-2660	41	19	course	course	NOUN
dti-2660	41	20	.	.	PUNCT
dti-2660	42	1	this	this	DET
dti-2660	42	2	classification	classification	NOUN
dti-2660	42	3	system	system	NOUN
dti-2660	42	4	for	for	ADP
dti-2660	42	5	utis	utis	NOUN
dti-2660	42	6	is	be	AUX
dti-2660	42	7	summarized	summarize	VERB
dti-2660	42	8	in	in	ADP
dti-2660	42	9	table	table	NOUN
dti-2660	42	10	i.	i.	NOUN
dti-2660	42	11	even	even	ADV
dti-2660	42	12	an	an	DET
dti-2660	42	13	uncomplicated	uncomplicated	ADJ
dti-2660	42	14	uti	uti	PROPN
dti-2660	42	15	is	be	AUX
dti-2660	42	16	not	not	PART
dti-2660	42	17	just	just	ADV
dti-2660	42	18	a	a	DET
dti-2660	42	19	simple	simple	ADJ
dti-2660	42	20	infection	infection	NOUN
dti-2660	42	21	,	,	PUNCT
dti-2660	42	22	as	as	SCONJ
dti-2660	42	23	it	it	PRON
dti-2660	42	24	involves	involve	VERB
dti-2660	42	25	symptoms	symptom	NOUN
dti-2660	42	26	and	and	CCONJ
dti-2660	42	27	restricted	restrict	VERB
dti-2660	42	28	activity	activity	NOUN
dti-2660	42	29	and	and	CCONJ
dti-2660	42	30	may	may	AUX
dti-2660	42	31	necessitate	necessitate	VERB
dti-2660	42	32	sick	sick	ADJ
dti-2660	42	33	leave	leave	NOUN
dti-2660	42	34	or	or	CCONJ
dti-2660	42	35	bed	bed	NOUN
dti-2660	42	36	rest	rest	NOUN
dti-2660	42	37	.	.	PUNCT
dti-2660	43	1	a	a	DET
dti-2660	43	2	uti	uti	PROPN
dti-2660	43	3	occurring	occur	VERB
dti-2660	43	4	at	at	ADV
dti-2660	43	5	least	least	ADV
dti-2660	43	6	three	three	NUM
dti-2660	43	7	times	time	NOUN
dti-2660	43	8	a	a	DET
dti-2660	43	9	year	year	NOUN
dti-2660	43	10	or	or	CCONJ
dti-2660	43	11	twice	twice	ADV
dti-2660	43	12	in	in	ADP
dti-2660	43	13	the	the	DET
dti-2660	43	14	previous	previous	ADJ
dti-2660	43	15	6	6	NUM
dti-2660	43	16	months	month	NOUN
dti-2660	43	17	is	be	AUX
dti-2660	43	18	defined	define	VERB
dti-2660	43	19	as	as	ADP
dti-2660	43	20	an	an	DET
dti-2660	43	21	ruti	ruti	PROPN
dti-2660	43	22	.	.	PUNCT
dti-2660	44	1	however	however	ADV
dti-2660	44	2	,	,	PUNCT
dti-2660	44	3	contrary	contrary	ADV
dti-2660	44	4	to	to	ADP
dti-2660	44	5	historical	historical	ADJ
dti-2660	44	6	practice	practice	NOUN
dti-2660	44	7	,	,	PUNCT
dti-2660	44	8	it	it	PRON
dti-2660	44	9	is	be	AUX
dti-2660	44	10	strongly	strongly	ADV
dti-2660	44	11	recommended	recommend	VERB
dti-2660	44	12	not	not	PART
dti-2660	44	13	to	to	PART
dti-2660	44	14	treat	treat	VERB
dti-2660	44	15	cases	case	NOUN
dti-2660	44	16	of	of	ADP
dti-2660	44	17	asymptomatic	asymptomatic	ADJ
dti-2660	44	18	bacteriuria	bacteriuria	NOUN
dti-2660	44	19	,	,	PUNCT
dti-2660	44	20	where	where	SCONJ
dti-2660	44	21	the	the	DET
dti-2660	44	22	presence	presence	NOUN
dti-2660	44	23	of	of	ADP
dti-2660	44	24	bacteria	bacteria	NOUN
dti-2660	44	25	is	be	AUX
dti-2660	44	26	found	find	VERB
dti-2660	44	27	in	in	ADP
dti-2660	44	28	a	a	DET
dti-2660	44	29	urine	urine	NOUN
dti-2660	44	30	culture	culture	NOUN
dti-2660	44	31	taken	take	VERB
dti-2660	44	32	as	as	ADP
dti-2660	44	33	part	part	NOUN
dti-2660	44	34	of	of	ADP
dti-2660	44	35	a	a	DET
dti-2660	44	36	routine	routine	ADJ
dti-2660	44	37	clinical	clinical	ADJ
dti-2660	44	38	visit	visit	NOUN
dti-2660	44	39	in	in	ADP
dti-2660	44	40	a	a	DET
dti-2660	44	41	patient	patient	NOUN
dti-2660	44	42	without	without	ADP
dti-2660	44	43	symptoms	symptom	NOUN
dti-2660	44	44	(	(	PUNCT
dti-2660	44	45	8)	8)	NUM
dti-2660	44	46	.	.	PUNCT
dti-2660	45	1	in	in	ADP
dti-2660	45	2	fact	fact	NOUN
dti-2660	45	3	,	,	PUNCT
dti-2660	45	4	there	there	PRON
dti-2660	45	5	is	be	VERB
dti-2660	45	6	evidence	evidence	NOUN
dti-2660	45	7	that	that	SCONJ
dti-2660	45	8	asymptomatic	asymptomatic	ADJ
dti-2660	45	9	bacteriuria	bacteriuria	NOUN
dti-2660	45	10	is	be	AUX
dti-2660	45	11	a	a	DET
dti-2660	45	12	common	common	ADJ
dti-2660	45	13	commensal	commensal	NOUN
dti-2660	45	14	colonization	colonization	NOUN
dti-2660	45	15	that	that	PRON
dti-2660	45	16	may	may	AUX
dti-2660	45	17	have	have	VERB
dti-2660	45	18	a	a	DET
dti-2660	45	19	protective	protective	ADJ
dti-2660	45	20	function	function	NOUN
dti-2660	45	21	against	against	ADP
dti-2660	45	22	superinfecting	superinfect	VERB
dti-2660	45	23	https://patients.uroweb.org/	https://patients.uroweb.org/	PRON
dti-2660	45	24	other	other	ADJ
dti-2660	45	25	-	-	PUNCT
dti-2660	45	26	diseases	disease	NOUN
dti-2660	45	27	/	/	SYM
dti-2660	45	28	urinary	urinary	NOUN
dti-2660	45	29	-	-	PUNCT
dti-2660	45	30	infections/	infections/	NOUN
dti-2660	45	31	utis	utis	NOUN
dti-2660	45	32	in	in	ADP
dti-2660	45	33	the	the	DET
dti-2660	45	34	era	era	NOUN
dti-2660	45	35	of	of	ADP
dti-2660	45	36	amr128	amr128	NOUN
dti-2660	45	37	©	©	PROPN
dti-2660	45	38	2023	2023	NUM
dti-2660	45	39	the	the	DET
dti-2660	45	40	authors	author	NOUN
dti-2660	45	41	.	.	PUNCT
dti-2660	46	1	drug	drug	NOUN
dti-2660	46	2	target	target	NOUN
dti-2660	46	3	insights	insight	NOUN
dti-2660	46	4	issn	issn	VERB
dti-2660	46	5	1177	1177	NUM
dti-2660	46	6	-	-	SYM
dti-2660	46	7	3928	3928	NUM
dti-2660	46	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2660	46	9	table	table	NOUN
dti-2660	46	10	i	i	PRON
dti-2660	46	11	the	the	DET
dti-2660	46	12	classification	classification	NOUN
dti-2660	46	13	of	of	ADP
dti-2660	46	14	urinary	urinary	ADJ
dti-2660	46	15	tract	tract	NOUN
dti-2660	46	16	infections	infection	NOUN
dti-2660	46	17	according	accord	VERB
dti-2660	46	18	to	to	ADP
dti-2660	46	19	the	the	DET
dti-2660	46	20	european	european	PROPN
dti-2660	46	21	association	association	PROPN
dti-2660	46	22	of	of	ADP
dti-2660	46	23	urology	urology	NOUN
dti-2660	46	24	(	(	PUNCT
dti-2660	46	25	eau	eau	PROPN
dti-2660	46	26	)	)	PUNCT
dti-2660	46	27	urological	urological	ADJ
dti-2660	46	28	infections	infection	NOUN
dti-2660	46	29	guidelines	guideline	NOUN
dti-2660	46	30	(	(	PUNCT
dti-2660	46	31	8)	8)	NUM
dti-2660	46	32	classification	classification	NOUN
dti-2660	46	33	uncomplicated	uncomplicated	ADJ
dti-2660	46	34	utis	utis	NOUN
dti-2660	46	35	acute	acute	NOUN
dti-2660	46	36	,	,	PUNCT
dti-2660	46	37	sporadic	sporadic	ADJ
dti-2660	46	38	,	,	PUNCT
dti-2660	46	39	or	or	CCONJ
dti-2660	46	40	recurrent	recurrent	VERB
dti-2660	46	41	lower	lower	ADV
dti-2660	46	42	(	(	PUNCT
dti-2660	46	43	uncomplicated	uncomplicated	ADJ
dti-2660	46	44	cystitis	cystitis	NOUN
dti-2660	46	45	)	)	PUNCT
dti-2660	46	46	and/or	and/or	CCONJ
dti-2660	46	47	upper	upper	ADJ
dti-2660	46	48	(	(	PUNCT
dti-2660	46	49	uncomplicated	uncomplicated	ADJ
dti-2660	46	50	pyelonephritis	pyelonephritis	PROPN
dti-2660	46	51	)	)	PUNCT
dti-2660	46	52	uti	uti	PROPN
dti-2660	46	53	,	,	PUNCT
dti-2660	46	54	limited	limit	VERB
dti-2660	46	55	to	to	PART
dti-2660	46	56	nonpregnant	nonpregnant	VERB
dti-2660	46	57	women	woman	NOUN
dti-2660	46	58	with	with	ADP
dti-2660	46	59	no	no	DET
dti-2660	46	60	known	know	VERB
dti-2660	46	61	relevant	relevant	ADJ
dti-2660	46	62	anatomical	anatomical	ADJ
dti-2660	46	63	and	and	CCONJ
dti-2660	46	64	functional	functional	ADJ
dti-2660	46	65	abnormalities	abnormality	NOUN
dti-2660	46	66	within	within	ADP
dti-2660	46	67	the	the	DET
dti-2660	46	68	urinary	urinary	ADJ
dti-2660	46	69	tract	tract	NOUN
dti-2660	46	70	or	or	CCONJ
dti-2660	46	71	comorbidities	comorbiditie	NOUN
dti-2660	46	72	.	.	PUNCT
dti-2660	47	1	complicated	complicate	VERB
dti-2660	47	2	utis	utis	NOUN
dti-2660	47	3	all	all	DET
dti-2660	47	4	utis	utis	NOUN
dti-2660	47	5	that	that	PRON
dti-2660	47	6	are	be	AUX
dti-2660	47	7	not	not	PART
dti-2660	47	8	defined	define	VERB
dti-2660	47	9	as	as	ADP
dti-2660	47	10	uncomplicated	uncomplicated	ADJ
dti-2660	47	11	,	,	PUNCT
dti-2660	47	12	meaning	mean	VERB
dti-2660	47	13	in	in	ADP
dti-2660	47	14	a	a	DET
dti-2660	47	15	narrower	narrow	ADJ
dti-2660	47	16	sense	sense	NOUN
dti-2660	47	17	utis	utis	NOUN
dti-2660	47	18	in	in	ADP
dti-2660	47	19	a	a	DET
dti-2660	47	20	patient	patient	NOUN
dti-2660	47	21	with	with	ADP
dti-2660	47	22	an	an	DET
dti-2660	47	23	increased	increase	VERB
dti-2660	47	24	chance	chance	NOUN
dti-2660	47	25	of	of	ADP
dti-2660	47	26	a	a	DET
dti-2660	47	27	complicated	complicated	ADJ
dti-2660	47	28	course	course	NOUN
dti-2660	47	29	,	,	PUNCT
dti-2660	47	30	that	that	ADV
dti-2660	47	31	is	is	ADV
dti-2660	47	32	,	,	PUNCT
dti-2660	47	33	all	all	DET
dti-2660	47	34	men	man	NOUN
dti-2660	47	35	,	,	PUNCT
dti-2660	47	36	pregnant	pregnant	ADJ
dti-2660	47	37	women	woman	NOUN
dti-2660	47	38	,	,	PUNCT
dti-2660	47	39	patients	patient	NOUN
dti-2660	47	40	with	with	ADP
dti-2660	47	41	relevant	relevant	ADJ
dti-2660	47	42	anatomical	anatomical	ADJ
dti-2660	47	43	or	or	CCONJ
dti-2660	47	44	functional	functional	ADJ
dti-2660	47	45	abnormalities	abnormality	NOUN
dti-2660	47	46	of	of	ADP
dti-2660	47	47	the	the	DET
dti-2660	47	48	urinary	urinary	ADJ
dti-2660	47	49	tract	tract	NOUN
dti-2660	47	50	,	,	PUNCT
dti-2660	47	51	indwelling	indwell	VERB
dti-2660	47	52	urinary	urinary	ADJ
dti-2660	47	53	catheters	catheter	NOUN
dti-2660	47	54	,	,	PUNCT
dti-2660	47	55	renal	renal	ADJ
dti-2660	47	56	diseases	disease	NOUN
dti-2660	47	57	,	,	PUNCT
dti-2660	47	58	and/or	and/or	CCONJ
dti-2660	47	59	with	with	ADP
dti-2660	47	60	other	other	ADJ
dti-2660	47	61	concomitant	concomitant	ADJ
dti-2660	47	62	immunocompromising	immunocompromise	VERB
dti-2660	47	63	diseases	disease	NOUN
dti-2660	47	64	,	,	PUNCT
dti-2660	47	65	for	for	ADP
dti-2660	47	66	example	example	NOUN
dti-2660	47	67	,	,	PUNCT
dti-2660	47	68	diabetes	diabetes	NOUN
dti-2660	47	69	.	.	PUNCT
dti-2660	48	1	recurrent	recurrent	ADJ
dti-2660	48	2	utis	utis	NOUN
dti-2660	48	3	recurrences	recurrence	NOUN
dti-2660	48	4	of	of	ADP
dti-2660	48	5	uncomplicated	uncomplicated	ADJ
dti-2660	48	6	and/or	and/or	CCONJ
dti-2660	48	7	complicated	complicated	ADJ
dti-2660	48	8	utis	utis	NOUN
dti-2660	48	9	,	,	PUNCT
dti-2660	48	10	with	with	ADP
dti-2660	48	11	a	a	DET
dti-2660	48	12	frequency	frequency	NOUN
dti-2660	48	13	of	of	ADP
dti-2660	48	14	at	at	ADV
dti-2660	48	15	least	least	ADV
dti-2660	48	16	three	three	NUM
dti-2660	48	17	utis	utis	ADJ
dti-2660	48	18	/	/	SYM
dti-2660	48	19	year	year	NOUN
dti-2660	48	20	or	or	CCONJ
dti-2660	48	21	two	two	NUM
dti-2660	48	22	utis	utis	NOUN
dti-2660	48	23	in	in	ADP
dti-2660	48	24	the	the	DET
dti-2660	48	25	last	last	ADJ
dti-2660	48	26	6	6	NUM
dti-2660	48	27	months	month	NOUN
dti-2660	48	28	.	.	PUNCT
dti-2660	49	1	catheter	catheter	NOUN
dti-2660	49	2	-	-	PUNCT
dti-2660	49	3	associated	associate	VERB
dti-2660	49	4	utis	utis	NOUN
dti-2660	49	5	catheter	catheter	NOUN
dti-2660	49	6	-	-	PUNCT
dti-2660	49	7	associated	associate	VERB
dti-2660	49	8	uti	uti	PROPN
dti-2660	49	9	(	(	PUNCT
dti-2660	49	10	ca	ca	NOUN
dti-2660	49	11	-	-	PUNCT
dti-2660	49	12	uti	uti	PROPN
dti-2660	49	13	)	)	PUNCT
dti-2660	49	14	refers	refer	VERB
dti-2660	49	15	to	to	ADP
dti-2660	49	16	utis	utis	NOUN
dti-2660	49	17	occurring	occurring	NOUN
dti-2660	49	18	in	in	ADP
dti-2660	49	19	a	a	DET
dti-2660	49	20	person	person	NOUN
dti-2660	49	21	whose	whose	DET
dti-2660	49	22	urinary	urinary	ADJ
dti-2660	49	23	tract	tract	NOUN
dti-2660	49	24	is	be	AUX
dti-2660	49	25	currently	currently	ADV
dti-2660	49	26	catheterized	catheterize	VERB
dti-2660	49	27	or	or	CCONJ
dti-2660	49	28	has	have	AUX
dti-2660	49	29	had	have	VERB
dti-2660	49	30	a	a	DET
dti-2660	49	31	catheter	catheter	NOUN
dti-2660	49	32	in	in	ADP
dti-2660	49	33	place	place	NOUN
dti-2660	49	34	within	within	ADP
dti-2660	49	35	the	the	DET
dti-2660	49	36	past	past	ADJ
dti-2660	49	37	48	48	NUM
dti-2660	49	38	hours	hour	NOUN
dti-2660	49	39	.	.	PUNCT
dti-2660	50	1	urosepsis	urosepsis	ADJ
dti-2660	50	2	urosepsis	urosepsis	NOUN
dti-2660	50	3	is	be	AUX
dti-2660	50	4	defined	define	VERB
dti-2660	50	5	as	as	ADP
dti-2660	50	6	life	life	NOUN
dti-2660	50	7	-	-	PUNCT
dti-2660	50	8	threatening	threaten	VERB
dti-2660	50	9	organ	organ	NOUN
dti-2660	50	10	dysfunction	dysfunction	NOUN
dti-2660	50	11	caused	cause	VERB
dti-2660	50	12	by	by	ADP
dti-2660	50	13	a	a	DET
dti-2660	50	14	dysregulated	dysregulated	ADJ
dti-2660	50	15	host	host	NOUN
dti-2660	50	16	response	response	NOUN
dti-2660	50	17	to	to	ADP
dti-2660	50	18	infection	infection	NOUN
dti-2660	50	19	originating	originating	NOUN
dti-2660	50	20	from	from	ADP
dti-2660	50	21	the	the	DET
dti-2660	50	22	urinary	urinary	ADJ
dti-2660	50	23	tract	tract	NOUN
dti-2660	50	24	and/or	and/or	CCONJ
dti-2660	50	25	male	male	ADJ
dti-2660	50	26	genital	genital	ADJ
dti-2660	50	27	organs	organ	NOUN
dti-2660	50	28	(	(	PUNCT
dti-2660	50	29	54	54	NUM
dti-2660	50	30	)	)	PUNCT
dti-2660	50	31	.	.	PUNCT
dti-2660	51	1	uti	uti	PROPN
dti-2660	51	2	=	=	PUNCT
dti-2660	52	1	urinary	urinary	ADJ
dti-2660	52	2	tract	tract	NOUN
dti-2660	52	3	infection	infection	NOUN
dti-2660	52	4	.	.	PUNCT
dti-2660	53	1	reproduced	reproduce	VERB
dti-2660	53	2	from	from	ADP
dti-2660	53	3	bonkat	bonkat	PROPN
dti-2660	53	4	g	g	PROPN
dti-2660	53	5	,	,	PUNCT
dti-2660	53	6	bartoletti	bartoletti	PROPN
dti-2660	53	7	r	r	NOUN
dti-2660	53	8	,	,	PUNCT
dti-2660	53	9	bruyere	bruyere	NOUN
dti-2660	53	10	f	f	PROPN
dti-2660	53	11	,	,	PUNCT
dti-2660	53	12	et	et	PROPN
dti-2660	53	13	al	al	PROPN
dti-2660	53	14	.	.	PUNCT
dti-2660	54	1	eau	eau	PROPN
dti-2660	54	2	guidelines	guideline	NOUN
dti-2660	54	3	on	on	ADP
dti-2660	54	4	urological	urological	ADJ
dti-2660	54	5	infections	infection	NOUN
dti-2660	54	6	.	.	PUNCT
dti-2660	55	1	edn	edn	NOUN
dti-2660	55	2	.	.	PUNCT
dti-2660	55	3	presented	present	VERB
dti-2660	55	4	at	at	ADP
dti-2660	55	5	the	the	DET
dti-2660	55	6	eau	eau	PROPN
dti-2660	55	7	annual	annual	ADJ
dti-2660	55	8	congress	congress	PROPN
dti-2660	55	9	,	,	PUNCT
dti-2660	55	10	milan	milan	PROPN
dti-2660	55	11	,	,	PUNCT
dti-2660	55	12	italy	italy	PROPN
dti-2660	55	13	,	,	PUNCT
dti-2660	55	14	2023	2023	NUM
dti-2660	55	15	.	.	PUNCT
dti-2660	56	1	isbn	isbn	ADJ
dti-2660	56	2	978	978	NUM
dti-2660	56	3	-	-	SYM
dti-2660	56	4	94	94	NUM
dti-2660	56	5	-	-	PUNCT
dti-2660	56	6	92671	92671	NUM
dti-2660	56	7	-	-	PUNCT
dti-2660	56	8	19	19	NUM
dti-2660	56	9	-	-	SYM
dti-2660	56	10	6	6	NUM
dti-2660	56	11	and	and	CCONJ
dti-2660	56	12	published	publish	VERB
dti-2660	56	13	by	by	ADP
dti-2660	56	14	uroweb.org	uroweb.org	NOUN
dti-2660	56	15	as	as	ADP
dti-2660	56	16	an	an	DET
dti-2660	56	17	open	open	ADJ
dti-2660	56	18	access	access	NOUN
dti-2660	56	19	article	article	NOUN
dti-2660	56	20	under	under	ADP
dti-2660	56	21	the	the	DET
dti-2660	56	22	cc	cc	NOUN
dti-2660	56	23	by	by	ADP
dti-2660	56	24	4.0	4.0	NUM
dti-2660	56	25	license	license	NOUN
dti-2660	56	26	.	.	PUNCT
dti-2660	57	1	symptomatic	symptomatic	ADJ
dti-2660	57	2	uti	uti	PROPN
dti-2660	57	3	,	,	PUNCT
dti-2660	57	4	and	and	CCONJ
dti-2660	57	5	treating	treat	VERB
dti-2660	57	6	it	it	PRON
dti-2660	57	7	may	may	AUX
dti-2660	57	8	be	be	AUX
dti-2660	57	9	harmful	harmful	ADJ
dti-2660	57	10	in	in	ADP
dti-2660	57	11	some	some	DET
dti-2660	57	12	cases	case	NOUN
dti-2660	57	13	(	(	PUNCT
dti-2660	57	14	8,11	8,11	NUM
dti-2660	57	15	)	)	PUNCT
dti-2660	57	16	.	.	PUNCT
dti-2660	58	1	uti	uti	PROPN
dti-2660	58	2	is	be	AUX
dti-2660	58	3	strongly	strongly	ADV
dti-2660	58	4	gender	gender	NOUN
dti-2660	58	5	biased	bias	VERB
dti-2660	58	6	,	,	PUNCT
dti-2660	58	7	exhibiting	exhibit	VERB
dti-2660	58	8	one	one	NUM
dti-2660	58	9	of	of	ADP
dti-2660	58	10	the	the	DET
dti-2660	58	11	most	most	ADV
dti-2660	58	12	prominent	prominent	ADJ
dti-2660	58	13	sex	sex	NOUN
dti-2660	58	14	disparities	disparity	NOUN
dti-2660	58	15	among	among	ADP
dti-2660	58	16	infectious	infectious	ADJ
dti-2660	58	17	diseases	disease	NOUN
dti-2660	58	18	.	.	PUNCT
dti-2660	59	1	premenopausal	premenopausal	NOUN
dti-2660	59	2	women	woman	NOUN
dti-2660	59	3	are	be	AUX
dti-2660	59	4	20	20	NUM
dti-2660	59	5	-	-	SYM
dti-2660	59	6	40	40	NUM
dti-2660	59	7	times	time	NOUN
dti-2660	59	8	more	more	ADV
dti-2660	59	9	likely	likely	ADJ
dti-2660	59	10	to	to	PART
dti-2660	59	11	have	have	VERB
dti-2660	59	12	a	a	DET
dti-2660	59	13	uti	uti	PROPN
dti-2660	59	14	than	than	ADP
dti-2660	59	15	men	man	NOUN
dti-2660	59	16	of	of	ADP
dti-2660	59	17	the	the	DET
dti-2660	59	18	same	same	ADJ
dti-2660	59	19	age	age	NOUN
dti-2660	59	20	(	(	PUNCT
dti-2660	59	21	12	12	NUM
dti-2660	59	22	-	-	SYM
dti-2660	59	23	15	15	NUM
dti-2660	59	24	)	)	PUNCT
dti-2660	59	25	.	.	PUNCT
dti-2660	60	1	anatomical	anatomical	ADJ
dti-2660	60	2	differences	difference	NOUN
dti-2660	60	3	may	may	AUX
dti-2660	60	4	account	account	VERB
dti-2660	60	5	for	for	ADP
dti-2660	60	6	some	some	PRON
dti-2660	60	7	of	of	ADP
dti-2660	60	8	this	this	DET
dti-2660	60	9	disparity	disparity	NOUN
dti-2660	60	10	.	.	PUNCT
dti-2660	61	1	for	for	ADP
dti-2660	61	2	instance	instance	NOUN
dti-2660	61	3	,	,	PUNCT
dti-2660	61	4	men	man	NOUN
dti-2660	61	5	have	have	VERB
dti-2660	61	6	a	a	DET
dti-2660	61	7	longer	long	ADJ
dti-2660	61	8	urethra	urethra	NOUN
dti-2660	61	9	,	,	PUNCT
dti-2660	61	10	and	and	CCONJ
dti-2660	61	11	the	the	DET
dti-2660	61	12	distance	distance	NOUN
dti-2660	61	13	between	between	ADP
dti-2660	61	14	the	the	DET
dti-2660	61	15	anus	anus	NOUN
dti-2660	61	16	and	and	CCONJ
dti-2660	61	17	urethral	urethral	ADJ
dti-2660	61	18	opening	opening	NOUN
dti-2660	61	19	is	be	AUX
dti-2660	61	20	shorter	short	ADJ
dti-2660	61	21	in	in	ADP
dti-2660	61	22	females	female	NOUN
dti-2660	61	23	.	.	PUNCT
dti-2660	62	1	however	however	ADV
dti-2660	62	2	,	,	PUNCT
dti-2660	62	3	anatomical	anatomical	ADJ
dti-2660	62	4	differences	difference	NOUN
dti-2660	62	5	do	do	AUX
dti-2660	62	6	not	not	PART
dti-2660	62	7	explain	explain	VERB
dti-2660	62	8	why	why	SCONJ
dti-2660	62	9	young	young	ADJ
dti-2660	62	10	males	male	NOUN
dti-2660	62	11	and	and	CCONJ
dti-2660	62	12	females	female	NOUN
dti-2660	62	13	fig	fig	NOUN
dti-2660	62	14	.	.	PUNCT
dti-2660	63	1	1	1	NUM
dti-2660	63	2	global	global	ADJ
dti-2660	63	3	deaths	death	NOUN
dti-2660	63	4	attributable	attributable	ADJ
dti-2660	63	5	to	to	ADP
dti-2660	63	6	or	or	CCONJ
dti-2660	63	7	associated	associate	VERB
dti-2660	63	8	with	with	ADP
dti-2660	63	9	antimicrobial	antimicrobial	ADJ
dti-2660	63	10	resistance	resistance	NOUN
dti-2660	63	11	by	by	ADP
dti-2660	63	12	pathogen	pathogen	NOUN
dti-2660	63	13	in	in	ADP
dti-2660	63	14	2019	2019	NUM
dti-2660	63	15	(	(	PUNCT
dti-2660	63	16	6	6	NUM
dti-2660	63	17	)	)	PUNCT
dti-2660	63	18	.	.	PUNCT
dti-2660	64	1	reproduced	reproduce	VERB
dti-2660	64	2	from	from	ADP
dti-2660	64	3	the	the	DET
dti-2660	64	4	lancet	lancet	NOUN
dti-2660	64	5	,	,	PUNCT
dti-2660	64	6	2022;399(10325	2022;399(10325	NUM
dti-2660	64	7	)	)	PUNCT
dti-2660	64	8	,	,	PUNCT
dti-2660	64	9	antimicrobial	antimicrobial	ADJ
dti-2660	64	10	resistance	resistance	NOUN
dti-2660	64	11	collaborators	collaborator	NOUN
dti-2660	64	12	.	.	PUNCT
dti-2660	65	1	global	global	ADJ
dti-2660	65	2	burden	burden	NOUN
dti-2660	65	3	of	of	ADP
dti-2660	65	4	bacterial	bacterial	ADJ
dti-2660	65	5	antimicrobial	antimicrobial	ADJ
dti-2660	65	6	resistance	resistance	NOUN
dti-2660	65	7	in	in	ADP
dti-2660	65	8	2019	2019	NUM
dti-2660	65	9	:	:	PUNCT
dti-2660	65	10	a	a	DET
dti-2660	65	11	systematic	systematic	ADJ
dti-2660	65	12	analysis	analysis	NOUN
dti-2660	65	13	.	.	PUNCT
dti-2660	66	1	pages	page	NOUN
dti-2660	66	2	629	629	NUM
dti-2660	66	3	-	-	SYM
dti-2660	66	4	655	655	NUM
dti-2660	66	5	,	,	PUNCT
dti-2660	66	6	published	publish	VERB
dti-2660	66	7	by	by	ADP
dti-2660	66	8	elsevier	elsevier	PROPN
dti-2660	66	9	ltd	ltd	PROPN
dti-2660	66	10	as	as	ADP
dti-2660	66	11	an	an	DET
dti-2660	66	12	open	open	ADJ
dti-2660	66	13	access	access	NOUN
dti-2660	66	14	article	article	NOUN
dti-2660	66	15	under	under	ADP
dti-2660	66	16	the	the	DET
dti-2660	66	17	cc	cc	NOUN
dti-2660	66	18	by	by	ADP
dti-2660	66	19	4.0	4.0	NUM
dti-2660	66	20	license	license	NOUN
dti-2660	66	21	.	.	PUNCT
dti-2660	67	1	have	have	VERB
dti-2660	67	2	similar	similar	ADJ
dti-2660	67	3	rates	rate	NOUN
dti-2660	67	4	of	of	ADP
dti-2660	67	5	rutis	rutis	NOUN
dti-2660	67	6	,	,	PUNCT
dti-2660	67	7	and	and	CCONJ
dti-2660	67	8	the	the	DET
dti-2660	67	9	rates	rate	NOUN
dti-2660	67	10	of	of	ADP
dti-2660	67	11	utis	utis	NOUN
dti-2660	67	12	in	in	ADP
dti-2660	67	13	males	male	NOUN
dti-2660	67	14	over	over	ADP
dti-2660	67	15	65	65	NUM
dti-2660	67	16	years	year	NOUN
dti-2660	67	17	increase	increase	VERB
dti-2660	67	18	substantially	substantially	ADV
dti-2660	67	19	until	until	SCONJ
dti-2660	67	20	they	they	PRON
dti-2660	67	21	are	be	AUX
dti-2660	67	22	nearly	nearly	ADV
dti-2660	67	23	equivalent	equivalent	ADJ
dti-2660	67	24	to	to	ADP
dti-2660	67	25	those	those	PRON
dti-2660	67	26	in	in	ADP
dti-2660	67	27	older	old	ADJ
dti-2660	67	28	women	woman	NOUN
dti-2660	67	29	(	(	PUNCT
dti-2660	67	30	12,16	12,16	NOUN
dti-2660	67	31	)	)	PUNCT
dti-2660	67	32	.	.	PUNCT
dti-2660	68	1	changes	change	NOUN
dti-2660	68	2	in	in	ADP
dti-2660	68	3	the	the	DET
dti-2660	68	4	incidence	incidence	NOUN
dti-2660	68	5	of	of	ADP
dti-2660	68	6	utis	utis	NOUN
dti-2660	68	7	in	in	ADP
dti-2660	68	8	older	old	ADJ
dti-2660	68	9	men	man	NOUN
dti-2660	68	10	may	may	AUX
dti-2660	68	11	,	,	PUNCT
dti-2660	68	12	instead	instead	ADV
dti-2660	68	13	,	,	PUNCT
dti-2660	68	14	be	be	AUX
dti-2660	68	15	due	due	ADJ
dti-2660	68	16	to	to	ADP
dti-2660	68	17	urodynamic	urodynamic	ADJ
dti-2660	68	18	changes	change	NOUN
dti-2660	68	19	such	such	ADJ
dti-2660	68	20	as	as	ADP
dti-2660	68	21	prostatic	prostatic	ADJ
dti-2660	68	22	hypertrophy	hypertrophy	NOUN
dti-2660	68	23	or	or	CCONJ
dti-2660	68	24	other	other	ADJ
dti-2660	68	25	factors	factor	NOUN
dti-2660	68	26	,	,	PUNCT
dti-2660	68	27	for	for	ADP
dti-2660	68	28	example	example	NOUN
dti-2660	68	29	,	,	PUNCT
dti-2660	68	30	biological	biological	ADJ
dti-2660	68	31	or	or	CCONJ
dti-2660	68	32	immunological	immunological	ADJ
dti-2660	68	33	changes	change	NOUN
dti-2660	68	34	occurring	occur	VERB
dti-2660	68	35	over	over	ADP
dti-2660	68	36	time	time	NOUN
dti-2660	68	37	(	(	PUNCT
dti-2660	68	38	16	16	NUM
dti-2660	68	39	-	-	SYM
dti-2660	68	40	19	19	NUM
dti-2660	68	41	)	)	PUNCT
dti-2660	68	42	.	.	PUNCT
dti-2660	69	1	indeed	indeed	ADV
dti-2660	69	2	,	,	PUNCT
dti-2660	69	3	the	the	DET
dti-2660	69	4	differences	difference	NOUN
dti-2660	69	5	in	in	ADP
dti-2660	69	6	uti	uti	PROPN
dti-2660	69	7	susceptibility	susceptibility	NOUN
dti-2660	69	8	by	by	ADP
dti-2660	69	9	gender	gender	NOUN
dti-2660	69	10	are	be	AUX
dti-2660	69	11	most	most	ADV
dti-2660	69	12	evident	evident	ADJ
dti-2660	69	13	in	in	ADP
dti-2660	69	14	postpubescent	postpubescent	ADJ
dti-2660	69	15	adults	adult	NOUN
dti-2660	69	16	younger	young	ADJ
dti-2660	69	17	than	than	ADP
dti-2660	69	18	50	50	NUM
dti-2660	69	19	years	year	NOUN
dti-2660	69	20	,	,	PUNCT
dti-2660	69	21	a	a	DET
dti-2660	69	22	time	time	NOUN
dti-2660	69	23	when	when	SCONJ
dti-2660	69	24	estrogen	estrogen	NOUN
dti-2660	69	25	and	and	CCONJ
dti-2660	69	26	testosterone	testosterone	NOUN
dti-2660	69	27	are	be	AUX
dti-2660	69	28	at	at	ADP
dti-2660	69	29	their	their	PRON
dti-2660	69	30	highest	high	ADJ
dti-2660	69	31	levels	level	NOUN
dti-2660	69	32	in	in	ADP
dti-2660	69	33	females	female	NOUN
dti-2660	69	34	and	and	CCONJ
dti-2660	69	35	males	male	NOUN
dti-2660	69	36	,	,	PUNCT
dti-2660	69	37	respectively	respectively	ADV
dti-2660	69	38	(	(	PUNCT
dti-2660	69	39	12,14	12,14	ADV
dti-2660	69	40	)	)	PUNCT
dti-2660	69	41	.	.	PUNCT
dti-2660	70	1	pothoven	pothoven	ADJ
dti-2660	70	2	drug	drug	NOUN
dti-2660	70	3	target	target	NOUN
dti-2660	70	4	insights	insight	NOUN
dti-2660	70	5	2023	2023	NUM
dti-2660	70	6	;	;	PUNCT
dti-2660	70	7	17	17	NUM
dti-2660	70	8	:	:	SYM
dti-2660	70	9	129	129	NUM
dti-2660	70	10	©	©	PROPN
dti-2660	70	11	2023	2023	NUM
dti-2660	70	12	the	the	DET
dti-2660	70	13	authors	author	NOUN
dti-2660	70	14	.	.	PUNCT
dti-2660	71	1	published	publish	VERB
dti-2660	71	2	by	by	ADP
dti-2660	71	3	aboutscience	aboutscience	NOUN
dti-2660	71	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2660	71	5	zychlinsky	zychlinsky	PROPN
dti-2660	71	6	scharff	scharff	VERB
dti-2660	71	7	and	and	CCONJ
dti-2660	71	8	colleagues	colleague	NOUN
dti-2660	71	9	hypothesized	hypothesize	VERB
dti-2660	71	10	that	that	SCONJ
dti-2660	71	11	sexbased	sexbase	VERB
dti-2660	71	12	differences	difference	NOUN
dti-2660	71	13	in	in	ADP
dti-2660	71	14	immunity	immunity	NOUN
dti-2660	71	15	influence	influence	NOUN
dti-2660	71	16	response	response	NOUN
dti-2660	71	17	to	to	ADP
dti-2660	71	18	uti	uti	PROPN
dti-2660	71	19	,	,	PUNCT
dti-2660	71	20	which	which	PRON
dti-2660	71	21	they	they	PRON
dti-2660	71	22	explored	explore	VERB
dti-2660	71	23	in	in	ADP
dti-2660	71	24	an	an	DET
dti-2660	71	25	animal	animal	NOUN
dti-2660	71	26	model	model	NOUN
dti-2660	71	27	designed	design	VERB
dti-2660	71	28	to	to	PART
dti-2660	71	29	bypass	bypass	VERB
dti-2660	71	30	anatomical	anatomical	ADJ
dti-2660	71	31	differences	difference	NOUN
dti-2660	71	32	,	,	PUNCT
dti-2660	71	33	enabling	enable	VERB
dti-2660	71	34	innate	innate	ADJ
dti-2660	71	35	and	and	CCONJ
dti-2660	71	36	adaptive	adaptive	ADJ
dti-2660	71	37	immune	immune	ADJ
dti-2660	71	38	responses	response	NOUN
dti-2660	71	39	in	in	ADP
dti-2660	71	40	infected	infected	ADJ
dti-2660	71	41	female	female	ADJ
dti-2660	71	42	and	and	CCONJ
dti-2660	71	43	male	male	ADJ
dti-2660	71	44	mice	mouse	NOUN
dti-2660	71	45	to	to	PART
dti-2660	71	46	be	be	AUX
dti-2660	71	47	directly	directly	ADV
dti-2660	71	48	compared	compare	VERB
dti-2660	71	49	(	(	PUNCT
dti-2660	71	50	19	19	NUM
dti-2660	71	51	)	)	PUNCT
dti-2660	71	52	.	.	PUNCT
dti-2660	72	1	they	they	PRON
dti-2660	72	2	identified	identify	VERB
dti-2660	72	3	a	a	DET
dti-2660	72	4	cytokine	cytokine	ADJ
dti-2660	72	5	pathway	pathway	NOUN
dti-2660	72	6	essential	essential	ADJ
dti-2660	72	7	for	for	ADP
dti-2660	72	8	bacterial	bacterial	ADJ
dti-2660	72	9	clearance	clearance	NOUN
dti-2660	72	10	after	after	ADP
dti-2660	72	11	infection	infection	NOUN
dti-2660	72	12	with	with	ADP
dti-2660	72	13	uropathogenic	uropathogenic	ADJ
dti-2660	72	14	e.	e.	PROPN
dti-2660	72	15	coli	coli	PROPN
dti-2660	72	16	(	(	PUNCT
dti-2660	72	17	upec	upec	NOUN
dti-2660	72	18	)	)	PUNCT
dti-2660	72	19	,	,	PUNCT
dti-2660	72	20	demonstrating	demonstrate	VERB
dti-2660	72	21	that	that	SCONJ
dti-2660	72	22	interleukin	interleukin	NOUN
dti-2660	72	23	17	17	NUM
dti-2660	72	24	(	(	PUNCT
dti-2660	72	25	il-17	il-17	NUM
dti-2660	72	26	)	)	PUNCT
dti-2660	72	27	specifically	specifically	ADV
dti-2660	72	28	influenced	influence	VERB
dti-2660	72	29	the	the	DET
dti-2660	72	30	innate	innate	ADJ
dti-2660	72	31	immune	immune	ADJ
dti-2660	72	32	response	response	NOUN
dti-2660	72	33	to	to	ADP
dti-2660	72	34	bacterial	bacterial	ADJ
dti-2660	72	35	infection	infection	NOUN
dti-2660	72	36	in	in	ADP
dti-2660	72	37	a	a	DET
dti-2660	72	38	sex	sex	NOUN
dti-2660	72	39	-	-	PUNCT
dti-2660	72	40	dependent	dependent	ADJ
dti-2660	72	41	manner	manner	NOUN
dti-2660	72	42	(	(	PUNCT
dti-2660	72	43	19	19	NUM
dti-2660	72	44	)	)	PUNCT
dti-2660	72	45	.	.	PUNCT
dti-2660	73	1	whether	whether	SCONJ
dti-2660	73	2	this	this	DET
dti-2660	73	3	finding	finding	NOUN
dti-2660	73	4	is	be	AUX
dti-2660	73	5	directly	directly	ADV
dti-2660	73	6	relatable	relatable	ADJ
dti-2660	73	7	to	to	ADP
dti-2660	73	8	human	human	ADJ
dti-2660	73	9	infection	infection	NOUN
dti-2660	73	10	outcomes	outcome	NOUN
dti-2660	73	11	remains	remain	VERB
dti-2660	73	12	to	to	PART
dti-2660	73	13	be	be	AUX
dti-2660	73	14	demonstrated	demonstrate	VERB
dti-2660	73	15	.	.	PUNCT
dti-2660	74	1	however	however	ADV
dti-2660	74	2	,	,	PUNCT
dti-2660	74	3	it	it	PRON
dti-2660	74	4	provides	provide	VERB
dti-2660	74	5	a	a	DET
dti-2660	74	6	possible	possible	ADJ
dti-2660	74	7	explanation	explanation	NOUN
dti-2660	74	8	for	for	ADP
dti-2660	74	9	the	the	DET
dti-2660	74	10	similarly	similarly	ADV
dti-2660	74	11	high	high	ADJ
dti-2660	74	12	frequency	frequency	NOUN
dti-2660	74	13	of	of	ADP
dti-2660	74	14	infection	infection	NOUN
dti-2660	74	15	in	in	ADP
dti-2660	74	16	older	old	ADJ
dti-2660	74	17	men	man	NOUN
dti-2660	74	18	and	and	CCONJ
dti-2660	74	19	women	woman	NOUN
dti-2660	74	20	and	and	CCONJ
dti-2660	74	21	the	the	DET
dti-2660	74	22	increased	increase	VERB
dti-2660	74	23	severity	severity	NOUN
dti-2660	74	24	associated	associate	VERB
dti-2660	74	25	with	with	ADP
dti-2660	74	26	uti	uti	PROPN
dti-2660	74	27	in	in	ADP
dti-2660	74	28	men	man	NOUN
dti-2660	74	29	,	,	PUNCT
dti-2660	74	30	suggesting	suggest	VERB
dti-2660	74	31	hormone	hormone	NOUN
dti-2660	74	32	-	-	PUNCT
dti-2660	74	33	mediated	mediate	VERB
dti-2660	74	34	suppression	suppression	NOUN
dti-2660	74	35	of	of	ADP
dti-2660	74	36	the	the	DET
dti-2660	74	37	innate	innate	ADJ
dti-2660	74	38	immune	immune	ADJ
dti-2660	74	39	response	response	NOUN
dti-2660	74	40	.	.	PUNCT
dti-2660	75	1	this	this	PRON
dti-2660	75	2	is	be	AUX
dti-2660	75	3	supported	support	VERB
dti-2660	75	4	by	by	ADP
dti-2660	75	5	significant	significant	ADJ
dti-2660	75	6	sex	sex	NOUN
dti-2660	75	7	differences	difference	NOUN
dti-2660	75	8	in	in	ADP
dti-2660	75	9	the	the	DET
dti-2660	75	10	expression	expression	NOUN
dti-2660	75	11	of	of	ADP
dti-2660	75	12	immune	immune	NOUN
dti-2660	75	13	-	-	PUNCT
dti-2660	75	14	mediating	mediate	VERB
dti-2660	75	15	genes	gene	NOUN
dti-2660	75	16	induced	induce	VERB
dti-2660	75	17	during	during	ADP
dti-2660	75	18	uti	uti	PROPN
dti-2660	75	19	,	,	PUNCT
dti-2660	75	20	including	include	VERB
dti-2660	75	21	in	in	ADP
dti-2660	75	22	the	the	DET
dti-2660	75	23	il-17	il-17	PRON
dti-2660	75	24	/	/	SYM
dti-2660	75	25	il-33	il-33	ADJ
dti-2660	75	26	axis	axis	NOUN
dti-2660	75	27	(	(	PUNCT
dti-2660	75	28	19	19	NUM
dti-2660	75	29	)	)	PUNCT
dti-2660	75	30	.	.	PUNCT
dti-2660	76	1	the	the	DET
dti-2660	76	2	authors	author	NOUN
dti-2660	76	3	concluded	conclude	VERB
dti-2660	76	4	that	that	SCONJ
dti-2660	76	5	a	a	DET
dti-2660	76	6	better	well	ADJ
dti-2660	76	7	understanding	understanding	NOUN
dti-2660	76	8	of	of	ADP
dti-2660	76	9	the	the	DET
dti-2660	76	10	immune	immune	ADJ
dti-2660	76	11	system	system	NOUN
dti-2660	76	12	’s	’s	PART
dti-2660	76	13	role	role	NOUN
dti-2660	76	14	in	in	ADP
dti-2660	76	15	utis	utis	NOUN
dti-2660	76	16	might	might	AUX
dti-2660	76	17	contribute	contribute	VERB
dti-2660	76	18	to	to	ADP
dti-2660	76	19	developing	develop	VERB
dti-2660	76	20	nonantibiotic	nonantibiotic	NOUN
dti-2660	76	21	-	-	PUNCT
dti-2660	76	22	based	base	VERB
dti-2660	76	23	stratified	stratified	ADJ
dti-2660	76	24	therapies	therapy	NOUN
dti-2660	76	25	targeting	target	VERB
dti-2660	76	26	sex	sex	NOUN
dti-2660	76	27	-	-	PUNCT
dti-2660	76	28	specific	specific	ADJ
dti-2660	76	29	immune	immune	ADJ
dti-2660	76	30	pathways	pathway	NOUN
dti-2660	76	31	in	in	ADP
dti-2660	76	32	managing	manage	VERB
dti-2660	76	33	women	woman	NOUN
dti-2660	76	34	and	and	CCONJ
dti-2660	76	35	men	man	NOUN
dti-2660	76	36	(	(	PUNCT
dti-2660	76	37	19	19	NUM
dti-2660	76	38	)	)	PUNCT
dti-2660	76	39	.	.	PUNCT
dti-2660	77	1	in	in	ADP
dti-2660	77	2	conclusion	conclusion	NOUN
dti-2660	77	3	,	,	PUNCT
dti-2660	77	4	while	while	SCONJ
dti-2660	77	5	multiple	multiple	ADJ
dti-2660	77	6	factors	factor	NOUN
dti-2660	77	7	,	,	PUNCT
dti-2660	77	8	including	include	VERB
dti-2660	77	9	genetics	genetic	NOUN
dti-2660	77	10	,	,	PUNCT
dti-2660	77	11	age	age	NOUN
dti-2660	77	12	,	,	PUNCT
dti-2660	77	13	and	and	CCONJ
dti-2660	77	14	access	access	NOUN
dti-2660	77	15	to	to	ADP
dti-2660	77	16	care	care	NOUN
dti-2660	77	17	,	,	PUNCT
dti-2660	77	18	contribute	contribute	VERB
dti-2660	77	19	to	to	ADP
dti-2660	77	20	the	the	DET
dti-2660	77	21	gender	gender	NOUN
dti-2660	77	22	differences	difference	NOUN
dti-2660	77	23	in	in	ADP
dti-2660	77	24	the	the	DET
dti-2660	77	25	incidence	incidence	NOUN
dti-2660	77	26	of	of	ADP
dti-2660	77	27	utis	utis	NOUN
dti-2660	77	28	,	,	PUNCT
dti-2660	77	29	sex	sex	NOUN
dti-2660	77	30	hormones	hormone	NOUN
dti-2660	77	31	have	have	VERB
dti-2660	77	32	a	a	DET
dti-2660	77	33	powerful	powerful	ADJ
dti-2660	77	34	influence	influence	NOUN
dti-2660	77	35	on	on	ADP
dti-2660	77	36	the	the	DET
dti-2660	77	37	onset	onset	NOUN
dti-2660	77	38	,	,	PUNCT
dti-2660	77	39	severity	severity	NOUN
dti-2660	77	40	,	,	PUNCT
dti-2660	77	41	and	and	CCONJ
dti-2660	77	42	patient	patient	ADJ
dti-2660	77	43	outcomes	outcome	NOUN
dti-2660	77	44	(	(	PUNCT
dti-2660	77	45	12,14	12,14	ADV
dti-2660	77	46	)	)	PUNCT
dti-2660	77	47	.	.	PUNCT
dti-2660	78	1	uti	uti	PROPN
dti-2660	78	2	is	be	AUX
dti-2660	78	3	a	a	DET
dti-2660	78	4	syndrome	syndrome	NOUN
dti-2660	78	5	.	.	PUNCT
dti-2660	79	1	the	the	DET
dti-2660	79	2	symptoms	symptom	NOUN
dti-2660	79	3	of	of	ADP
dti-2660	79	4	urgency	urgency	NOUN
dti-2660	79	5	,	,	PUNCT
dti-2660	79	6	frequency	frequency	NOUN
dti-2660	79	7	,	,	PUNCT
dti-2660	79	8	fever	fever	NOUN
dti-2660	79	9	,	,	PUNCT
dti-2660	79	10	suprapubic	suprapubic	ADJ
dti-2660	79	11	pain	pain	NOUN
dti-2660	79	12	,	,	PUNCT
dti-2660	79	13	or	or	CCONJ
dti-2660	79	14	dysuria	dysuria	PROPN
dti-2660	79	15	,	,	PUNCT
dti-2660	79	16	combined	combine	VERB
dti-2660	79	17	with	with	ADP
dti-2660	79	18	the	the	DET
dti-2660	79	19	presence	presence	NOUN
dti-2660	79	20	of	of	ADP
dti-2660	79	21	bacteria	bacteria	NOUN
dti-2660	79	22	in	in	ADP
dti-2660	79	23	the	the	DET
dti-2660	79	24	urine	urine	NOUN
dti-2660	79	25	,	,	PUNCT
dti-2660	79	26	constitute	constitute	VERB
dti-2660	79	27	a	a	DET
dti-2660	79	28	uti	uti	PROPN
dti-2660	79	29	.	.	PUNCT
dti-2660	80	1	when	when	SCONJ
dti-2660	80	2	a	a	DET
dti-2660	80	3	patient	patient	NOUN
dti-2660	80	4	has	have	VERB
dti-2660	80	5	symptoms	symptom	NOUN
dti-2660	80	6	without	without	ADP
dti-2660	80	7	bacteriuria	bacteriuria	PROPN
dti-2660	80	8	,	,	PUNCT
dti-2660	80	9	other	other	ADJ
dti-2660	80	10	syndromes	syndrome	NOUN
dti-2660	80	11	should	should	AUX
dti-2660	80	12	be	be	AUX
dti-2660	80	13	considered	consider	VERB
dti-2660	80	14	,	,	PUNCT
dti-2660	80	15	such	such	ADJ
dti-2660	80	16	as	as	ADP
dti-2660	80	17	overactive	overactive	ADJ
dti-2660	80	18	bladder	bladder	NOUN
dti-2660	80	19	(	(	PUNCT
dti-2660	80	20	oab	oab	PROPN
dti-2660	80	21	)	)	PUNCT
dti-2660	80	22	syndrome	syndrome	NOUN
dti-2660	80	23	or	or	CCONJ
dti-2660	80	24	interstitial	interstitial	ADJ
dti-2660	80	25	cystitis	cystitis	NOUN
dti-2660	80	26	/	/	SYM
dti-2660	80	27	bladder	bladder	NOUN
dti-2660	80	28	pain	pain	NOUN
dti-2660	80	29	syndrome	syndrome	NOUN
dti-2660	80	30	(	(	PUNCT
dti-2660	80	31	ic	ic	PROPN
dti-2660	80	32	/	/	SYM
dti-2660	80	33	bps	bps	NOUN
dti-2660	80	34	)	)	PUNCT
dti-2660	80	35	,	,	PUNCT
dti-2660	80	36	which	which	PRON
dti-2660	80	37	should	should	AUX
dti-2660	80	38	not	not	PART
dti-2660	80	39	routinely	routinely	ADV
dti-2660	80	40	be	be	AUX
dti-2660	80	41	treated	treat	VERB
dti-2660	80	42	with	with	ADP
dti-2660	80	43	antibiotics	antibiotic	NOUN
dti-2660	80	44	(	(	PUNCT
dti-2660	80	45	20,21	20,21	NUM
dti-2660	80	46	)	)	PUNCT
dti-2660	80	47	.	.	PUNCT
dti-2660	81	1	point	point	NOUN
dti-2660	81	2	-	-	PUNCT
dti-2660	81	3	of	of	ADP
dti-2660	81	4	-	-	PUNCT
dti-2660	81	5	care	care	NOUN
dti-2660	81	6	testing	testing	NOUN
dti-2660	81	7	by	by	ADP
dti-2660	81	8	dipstick	dipstick	NOUN
dti-2660	81	9	may	may	AUX
dti-2660	81	10	help	help	VERB
dti-2660	81	11	to	to	PART
dti-2660	81	12	clarify	clarify	VERB
dti-2660	81	13	a	a	DET
dti-2660	81	14	diagnosis	diagnosis	NOUN
dti-2660	81	15	,	,	PUNCT
dti-2660	81	16	but	but	CCONJ
dti-2660	81	17	such	such	ADJ
dti-2660	81	18	analysis	analysis	NOUN
dti-2660	81	19	has	have	VERB
dti-2660	81	20	drawbacks	drawback	NOUN
dti-2660	81	21	,	,	PUNCT
dti-2660	81	22	and	and	CCONJ
dti-2660	81	23	the	the	DET
dti-2660	81	24	characteristic	characteristic	ADJ
dti-2660	81	25	clinical	clinical	ADJ
dti-2660	81	26	presentation	presentation	NOUN
dti-2660	81	27	is	be	AUX
dti-2660	81	28	reliable	reliable	ADJ
dti-2660	81	29	for	for	ADP
dti-2660	81	30	the	the	DET
dti-2660	81	31	diagnosis	diagnosis	NOUN
dti-2660	81	32	.	.	PUNCT
dti-2660	82	1	a	a	DET
dti-2660	82	2	complete	complete	ADJ
dti-2660	82	3	medical	medical	ADJ
dti-2660	82	4	history	history	NOUN
dti-2660	82	5	and	and	CCONJ
dti-2660	82	6	a	a	DET
dti-2660	82	7	short	short	ADJ
dti-2660	82	8	physical	physical	ADJ
dti-2660	82	9	examination	examination	NOUN
dti-2660	82	10	should	should	AUX
dti-2660	82	11	still	still	ADV
dti-2660	82	12	be	be	AUX
dti-2660	82	13	taken	take	VERB
dti-2660	82	14	.	.	PUNCT
dti-2660	83	1	however	however	ADV
dti-2660	83	2	,	,	PUNCT
dti-2660	83	3	the	the	DET
dti-2660	83	4	diagnosis	diagnosis	NOUN
dti-2660	83	5	of	of	ADP
dti-2660	83	6	a	a	DET
dti-2660	83	7	first	first	ADJ
dti-2660	83	8	episode	episode	NOUN
dti-2660	83	9	of	of	ADP
dti-2660	83	10	uncomplicated	uncomplicated	ADJ
dti-2660	83	11	uti	uti	PROPN
dti-2660	83	12	can	can	AUX
dti-2660	83	13	be	be	AUX
dti-2660	83	14	symptom	symptom	NOUN
dti-2660	83	15	based	base	VERB
dti-2660	83	16	,	,	PUNCT
dti-2660	83	17	and	and	CCONJ
dti-2660	83	18	there	there	PRON
dti-2660	83	19	is	be	VERB
dti-2660	83	20	usually	usually	ADV
dti-2660	83	21	no	no	DET
dti-2660	83	22	requirement	requirement	NOUN
dti-2660	83	23	for	for	ADP
dti-2660	83	24	further	further	ADJ
dti-2660	83	25	diagnostic	diagnostic	ADJ
dti-2660	83	26	workup	workup	NOUN
dti-2660	83	27	in	in	ADP
dti-2660	83	28	women	woman	NOUN
dti-2660	83	29	under	under	ADP
dti-2660	83	30	40	40	NUM
dti-2660	83	31	without	without	ADP
dti-2660	83	32	other	other	ADJ
dti-2660	83	33	risk	risk	NOUN
dti-2660	83	34	factors	factor	NOUN
dti-2660	83	35	.	.	PUNCT
dti-2660	84	1	taking	take	VERB
dti-2660	84	2	a	a	DET
dti-2660	84	3	urine	urine	NOUN
dti-2660	84	4	culture	culture	NOUN
dti-2660	84	5	is	be	AUX
dti-2660	84	6	not	not	PART
dti-2660	84	7	recommended	recommend	VERB
dti-2660	84	8	for	for	ADP
dti-2660	84	9	the	the	DET
dti-2660	84	10	first	first	ADJ
dti-2660	84	11	episode	episode	NOUN
dti-2660	84	12	but	but	CCONJ
dti-2660	84	13	should	should	AUX
dti-2660	84	14	be	be	AUX
dti-2660	84	15	considered	consider	VERB
dti-2660	84	16	if	if	SCONJ
dti-2660	84	17	presenting	present	VERB
dti-2660	84	18	symptoms	symptom	NOUN
dti-2660	84	19	are	be	AUX
dti-2660	84	20	not	not	PART
dti-2660	84	21	characteristic	characteristic	ADJ
dti-2660	84	22	or	or	CCONJ
dti-2660	84	23	when	when	SCONJ
dti-2660	84	24	there	there	PRON
dti-2660	84	25	is	be	VERB
dti-2660	84	26	a	a	DET
dti-2660	84	27	failure	failure	NOUN
dti-2660	84	28	to	to	PART
dti-2660	84	29	respond	respond	VERB
dti-2660	84	30	to	to	ADP
dti-2660	84	31	antibiotics	antibiotic	NOUN
dti-2660	84	32	or	or	CCONJ
dti-2660	84	33	the	the	DET
dti-2660	84	34	infection	infection	NOUN
dti-2660	84	35	recurs	recur	NOUN
dti-2660	84	36	within	within	ADP
dti-2660	84	37	1	1	NUM
dti-2660	84	38	month	month	NOUN
dti-2660	84	39	of	of	ADP
dti-2660	84	40	antimicrobial	antimicrobial	ADJ
dti-2660	84	41	therapy	therapy	NOUN
dti-2660	84	42	(	(	PUNCT
dti-2660	84	43	8)	8)	NUM
dti-2660	84	44	.	.	PUNCT
dti-2660	85	1	a	a	DET
dti-2660	85	2	voided	void	VERB
dti-2660	85	3	urine	urine	NOUN
dti-2660	85	4	specimen	speciman	NOUN
dti-2660	85	5	,	,	PUNCT
dti-2660	85	6	collected	collect	VERB
dti-2660	85	7	using	use	VERB
dti-2660	85	8	a	a	DET
dti-2660	85	9	method	method	NOUN
dti-2660	85	10	to	to	PART
dti-2660	85	11	minimize	minimize	VERB
dti-2660	85	12	contamination	contamination	NOUN
dti-2660	85	13	,	,	PUNCT
dti-2660	85	14	is	be	AUX
dti-2660	85	15	usually	usually	ADV
dti-2660	85	16	appropriate	appropriate	ADJ
dti-2660	85	17	.	.	PUNCT
dti-2660	86	1	an	an	DET
dti-2660	86	2	in	in	ADP
dti-2660	86	3	-	-	PUNCT
dti-2660	86	4	and	and	CCONJ
dti-2660	86	5	-	-	PUNCT
dti-2660	86	6	out	out	NOUN
dti-2660	86	7	catheter	catheter	NOUN
dti-2660	86	8	specimen	speciman	NOUN
dti-2660	86	9	is	be	AUX
dti-2660	86	10	recommended	recommend	VERB
dti-2660	86	11	if	if	SCONJ
dti-2660	86	12	a	a	DET
dti-2660	86	13	voided	void	VERB
dti-2660	86	14	specimen	speciman	NOUN
dti-2660	86	15	can	can	AUX
dti-2660	86	16	not	not	PART
dti-2660	86	17	be	be	AUX
dti-2660	86	18	obtained	obtain	VERB
dti-2660	86	19	.	.	PUNCT
dti-2660	87	1	any	any	DET
dti-2660	87	2	gram	gram	NOUN
dti-2660	87	3	-	-	PUNCT
dti-2660	87	4	negative	negative	ADJ
dti-2660	87	5	organism	organism	NOUN
dti-2660	87	6	isolated	isolate	VERB
dti-2660	87	7	in	in	ADP
dti-2660	87	8	counts	count	VERB
dti-2660	87	9	≥102	≥102	AUX
dti-2660	87	10	colony	colony	NOUN
dti-2660	87	11	-	-	PUNCT
dti-2660	87	12	forming	form	VERB
dti-2660	87	13	units	unit	NOUN
dti-2660	87	14	(	(	PUNCT
dti-2660	87	15	cfu)/ml	cfu)/ml	VERB
dti-2660	87	16	is	be	AUX
dti-2660	87	17	considered	consider	VERB
dti-2660	87	18	relevant	relevant	ADJ
dti-2660	87	19	for	for	ADP
dti-2660	87	20	this	this	DET
dti-2660	87	21	presentation	presentation	NOUN
dti-2660	87	22	in	in	ADP
dti-2660	87	23	these	these	DET
dti-2660	87	24	patients	patient	NOUN
dti-2660	87	25	.	.	PUNCT
dti-2660	88	1	of	of	ADP
dti-2660	88	2	note	note	NOUN
dti-2660	88	3	,	,	PUNCT
dti-2660	88	4	true	true	ADJ
dti-2660	88	5	bacteriuria	bacteriuria	NOUN
dti-2660	88	6	is	be	AUX
dti-2660	88	7	considered	consider	VERB
dti-2660	88	8	to	to	PART
dti-2660	88	9	be	be	AUX
dti-2660	88	10	a	a	DET
dti-2660	88	11	count	count	NOUN
dti-2660	88	12	>	>	X
dti-2660	88	13	10⁵	10⁵	NUM
dti-2660	88	14	cfu	cfu	NOUN
dti-2660	88	15	/	/	SYM
dti-2660	88	16	ml	ml	NOUN
dti-2660	88	17	,	,	PUNCT
dti-2660	88	18	both	both	PRON
dti-2660	88	19	for	for	ADP
dti-2660	88	20	pyelonephritis	pyelonephritis	NOUN
dti-2660	88	21	and	and	CCONJ
dti-2660	88	22	cystitis	cystitis	NOUN
dti-2660	88	23	,	,	PUNCT
dti-2660	88	24	and	and	CCONJ
dti-2660	88	25	the	the	DET
dti-2660	88	26	cut	cut	NOUN
dti-2660	88	27	-	-	PUNCT
dti-2660	88	28	off	off	NOUN
dti-2660	88	29	of	of	ADP
dti-2660	88	30	105	105	NUM
dti-2660	88	31	bacteria	bacteria	NOUN
dti-2660	88	32	/	/	SYM
dti-2660	88	33	ml	ml	X
dti-2660	88	34	remains	remain	VERB
dti-2660	88	35	the	the	DET
dti-2660	88	36	benchmark	benchmark	NOUN
dti-2660	88	37	in	in	ADP
dti-2660	88	38	many	many	ADJ
dti-2660	88	39	laboratories	laboratory	NOUN
dti-2660	88	40	.	.	PUNCT
dti-2660	89	1	data	datum	NOUN
dti-2660	89	2	from	from	ADP
dti-2660	89	3	international	international	ADJ
dti-2660	89	4	surveillance	surveillance	NOUN
dti-2660	89	5	studies	study	NOUN
dti-2660	89	6	suggest	suggest	VERB
dti-2660	89	7	that	that	SCONJ
dti-2660	89	8	the	the	DET
dti-2660	89	9	most	most	ADV
dti-2660	89	10	common	common	ADJ
dti-2660	89	11	pathogens	pathogen	NOUN
dti-2660	89	12	associated	associate	VERB
dti-2660	89	13	with	with	ADP
dti-2660	89	14	uncomplicated	uncomplicated	ADJ
dti-2660	89	15	uti	uti	PROPN
dti-2660	89	16	are	be	AUX
dti-2660	89	17	upec	upec	NOUN
dti-2660	89	18	,	,	PUNCT
dti-2660	89	19	which	which	PRON
dti-2660	89	20	accounted	account	VERB
dti-2660	89	21	for	for	ADP
dti-2660	89	22	76.7	76.7	NUM
dti-2660	89	23	%	%	NOUN
dti-2660	89	24	of	of	ADP
dti-2660	89	25	uncomplicated	uncomplicated	ADJ
dti-2660	89	26	cystitis	cystitis	NOUN
dti-2660	89	27	,	,	PUNCT
dti-2660	89	28	enterococcus	enterococcus	NOUN
dti-2660	89	29	faecalis	faecalis	NOUN
dti-2660	89	30	(	(	PUNCT
dti-2660	89	31	4.0	4.0	NUM
dti-2660	89	32	%	%	NOUN
dti-2660	89	33	)	)	PUNCT
dti-2660	89	34	,	,	PUNCT
dti-2660	89	35	staphylococcus	staphylococcus	NOUN
dti-2660	89	36	saprophyticus	saprophyticus	NOUN
dti-2660	89	37	(	(	PUNCT
dti-2660	89	38	3.6	3.6	NUM
dti-2660	89	39	%	%	NOUN
dti-2660	89	40	)	)	PUNCT
dti-2660	89	41	,	,	PUNCT
dti-2660	89	42	klebsiella	klebsiella	NOUN
dti-2660	89	43	pneumoniae	pneumoniae	ADJ
dti-2660	89	44	(	(	PUNCT
dti-2660	89	45	3.5	3.5	NUM
dti-2660	89	46	%	%	NOUN
dti-2660	89	47	)	)	PUNCT
dti-2660	89	48	,	,	PUNCT
dti-2660	89	49	proteus	proteus	NOUN
dti-2660	89	50	mirabilis	mirabilis	PROPN
dti-2660	89	51	(	(	PUNCT
dti-2660	89	52	3.5	3.5	NUM
dti-2660	89	53	%	%	NOUN
dti-2660	89	54	)	)	PUNCT
dti-2660	89	55	,	,	PUNCT
dti-2660	89	56	and	and	CCONJ
dti-2660	89	57	other	other	ADJ
dti-2660	89	58	bacteria	bacteria	NOUN
dti-2660	89	59	(	(	PUNCT
dti-2660	89	60	8.7	8.7	NUM
dti-2660	89	61	%	%	NOUN
dti-2660	89	62	)	)	PUNCT
dti-2660	89	63	(	(	PUNCT
dti-2660	89	64	22,23	22,23	NOUN
dti-2660	89	65	)	)	PUNCT
dti-2660	89	66	.	.	PUNCT
dti-2660	90	1	upec	upec	NOUN
dti-2660	90	2	is	be	AUX
dti-2660	90	3	also	also	ADV
dti-2660	90	4	the	the	DET
dti-2660	90	5	most	most	ADV
dti-2660	90	6	prevalent	prevalent	ADJ
dti-2660	90	7	pathogen	pathogen	NOUN
dti-2660	90	8	identified	identify	VERB
dti-2660	90	9	in	in	ADP
dti-2660	90	10	complicated	complicated	ADJ
dti-2660	90	11	cystitis	cystitis	NOUN
dti-2660	90	12	(	(	PUNCT
dti-2660	90	13	43	43	NUM
dti-2660	90	14	%	%	NOUN
dti-2660	90	15	)	)	PUNCT
dti-2660	90	16	,	,	PUNCT
dti-2660	90	17	but	but	CCONJ
dti-2660	90	18	to	to	ADP
dti-2660	90	19	a	a	DET
dti-2660	90	20	much	much	ADV
dti-2660	90	21	smaller	small	ADJ
dti-2660	90	22	extent	extent	NOUN
dti-2660	90	23	than	than	ADP
dti-2660	90	24	in	in	ADP
dti-2660	90	25	uncomplicated	uncomplicated	ADJ
dti-2660	90	26	uti	uti	PROPN
dti-2660	90	27	,	,	PUNCT
dti-2660	90	28	and	and	CCONJ
dti-2660	90	29	many	many	ADJ
dti-2660	90	30	other	other	ADJ
dti-2660	90	31	pathogens	pathogen	NOUN
dti-2660	90	32	,	,	PUNCT
dti-2660	90	33	including	include	VERB
dti-2660	90	34	klebsiella	klebsiella	PROPN
dti-2660	90	35	spp	spp	PROPN
dti-2660	90	36	.	.	PUNCT
dti-2660	91	1	(	(	PUNCT
dti-2660	91	2	13	13	NUM
dti-2660	91	3	%	%	NOUN
dti-2660	91	4	)	)	PUNCT
dti-2660	91	5	,	,	PUNCT
dti-2660	91	6	enterococcus	enterococcus	NOUN
dti-2660	91	7	spp	spp	NOUN
dti-2660	91	8	.	.	PUNCT
dti-2660	92	1	(	(	PUNCT
dti-2660	92	2	10	10	NUM
dti-2660	92	3	%	%	NOUN
dti-2660	92	4	)	)	PUNCT
dti-2660	92	5	,	,	PUNCT
dti-2660	92	6	pseudomonas	pseudomona	VERB
dti-2660	92	7	aeruginosa	aeruginosa	NOUN
dti-2660	92	8	(	(	PUNCT
dti-2660	92	9	9	9	NUM
dti-2660	92	10	%	%	NOUN
dti-2660	92	11	)	)	PUNCT
dti-2660	92	12	,	,	PUNCT
dti-2660	92	13	enterobacter	enterobacter	ADJ
dti-2660	92	14	spp	spp	NOUN
dti-2660	92	15	.	.	PUNCT
dti-2660	93	1	(	(	PUNCT
dti-2660	93	2	7	7	NUM
dti-2660	93	3	%	%	NOUN
dti-2660	93	4	)	)	PUNCT
dti-2660	93	5	,	,	PUNCT
dti-2660	93	6	proteus	proteus	PROPN
dti-2660	93	7	spp	spp	NOUN
dti-2660	93	8	.	.	PUNCT
dti-2660	94	1	(	(	PUNCT
dti-2660	94	2	6	6	NUM
dti-2660	94	3	%	%	NOUN
dti-2660	94	4	)	)	PUNCT
dti-2660	94	5	,	,	PUNCT
dti-2660	94	6	s.	s.	PROPN
dti-2660	94	7	aureus	aureus	PROPN
dti-2660	94	8	(	(	PUNCT
dti-2660	94	9	3	3	NUM
dti-2660	94	10	%	%	NOUN
dti-2660	94	11	)	)	PUNCT
dti-2660	94	12	,	,	PUNCT
dti-2660	94	13	fungi	fungus	NOUN
dti-2660	94	14	(	(	PUNCT
dti-2660	94	15	1	1	NUM
dti-2660	94	16	%	%	NOUN
dti-2660	94	17	)	)	PUNCT
dti-2660	94	18	,	,	PUNCT
dti-2660	94	19	and	and	CCONJ
dti-2660	94	20	other	other	ADJ
dti-2660	94	21	bacteria	bacteria	NOUN
dti-2660	94	22	,	,	PUNCT
dti-2660	94	23	become	become	VERB
dti-2660	94	24	important	important	ADJ
dti-2660	94	25	,	,	PUNCT
dti-2660	94	26	as	as	SCONJ
dti-2660	94	27	does	do	VERB
dti-2660	94	28	the	the	DET
dti-2660	94	29	issue	issue	NOUN
dti-2660	94	30	of	of	ADP
dti-2660	94	31	amr	amr	PROPN
dti-2660	94	32	(	(	PUNCT
dti-2660	94	33	22,24	22,24	NUM
dti-2660	94	34	)	)	PUNCT
dti-2660	94	35	.	.	PUNCT
dti-2660	95	1	treatment	treatment	NOUN
dti-2660	95	2	strategies	strategy	NOUN
dti-2660	95	3	there	there	PRON
dti-2660	95	4	are	be	VERB
dti-2660	95	5	a	a	DET
dti-2660	95	6	variety	variety	NOUN
dti-2660	95	7	of	of	ADP
dti-2660	95	8	antibiotic	antibiotic	ADJ
dti-2660	95	9	strategies	strategy	NOUN
dti-2660	95	10	and	and	CCONJ
dti-2660	95	11	antibioticsparing	antibioticsparing	NOUN
dti-2660	95	12	approaches	approach	NOUN
dti-2660	95	13	to	to	ADP
dti-2660	95	14	treating	treat	VERB
dti-2660	95	15	an	an	DET
dti-2660	95	16	episode	episode	NOUN
dti-2660	95	17	of	of	ADP
dti-2660	95	18	uncomplicated	uncomplicated	ADJ
dti-2660	95	19	uti	uti	PROPN
dti-2660	95	20	(	(	PUNCT
dti-2660	95	21	fig	fig	NOUN
dti-2660	95	22	.	.	PUNCT
dti-2660	96	1	2a	2a	NUM
dti-2660	96	2	)	)	PUNCT
dti-2660	96	3	.	.	PUNCT
dti-2660	97	1	a	a	DET
dti-2660	97	2	recent	recent	ADJ
dti-2660	97	3	systematic	systematic	ADJ
dti-2660	97	4	review	review	NOUN
dti-2660	97	5	of	of	ADP
dti-2660	97	6	randomized	randomized	ADJ
dti-2660	97	7	controlled	control	VERB
dti-2660	97	8	trials	trial	NOUN
dti-2660	97	9	of	of	ADP
dti-2660	97	10	analgesics	analgesic	NOUN
dti-2660	97	11	(	(	PUNCT
dti-2660	97	12	nonsteroidal	nonsteroidal	NOUN
dti-2660	97	13	anti	anti	ADJ
dti-2660	97	14	-	-	ADJ
dti-2660	97	15	inflammatory	inflammatory	ADJ
dti-2660	97	16	drugs	drug	NOUN
dti-2660	97	17	[	[	X
dti-2660	97	18	nsaids]/nonsteroidal	nsaids]/nonsteroidal	ADJ
dti-2660	97	19	antirheumatic	antirheumatic	ADJ
dti-2660	97	20	drugs	drug	NOUN
dti-2660	97	21	[	[	X
dti-2660	97	22	nsars	nsar	NOUN
dti-2660	97	23	]	]	PUNCT
dti-2660	97	24	)	)	PUNCT
dti-2660	97	25	,	,	PUNCT
dti-2660	97	26	herbal	herbal	ADJ
dti-2660	97	27	formulations	formulation	NOUN
dti-2660	97	28	,	,	PUNCT
dti-2660	97	29	delayed	delay	VERB
dti-2660	97	30	prescription	prescription	NOUN
dti-2660	97	31	of	of	ADP
dti-2660	97	32	antibiotics	antibiotic	NOUN
dti-2660	97	33	,	,	PUNCT
dti-2660	97	34	and	and	CCONJ
dti-2660	97	35	placebo	placebo	NOUN
dti-2660	97	36	therapy	therapy	NOUN
dti-2660	97	37	to	to	PART
dti-2660	97	38	prevent	prevent	VERB
dti-2660	97	39	the	the	DET
dti-2660	97	40	overuse	overuse	NOUN
dti-2660	97	41	of	of	ADP
dti-2660	97	42	antibiotics	antibiotic	NOUN
dti-2660	97	43	in	in	ADP
dti-2660	97	44	women	woman	NOUN
dti-2660	97	45	with	with	ADP
dti-2660	97	46	uncomplicated	uncomplicated	ADJ
dti-2660	97	47	utis	utis	NOUN
dti-2660	97	48	found	find	VERB
dti-2660	97	49	that	that	SCONJ
dti-2660	97	50	antibiotic	antibiotic	ADJ
dti-2660	97	51	-	-	PUNCT
dti-2660	97	52	sparing	spare	VERB
dti-2660	97	53	strategies	strategy	NOUN
dti-2660	97	54	can	can	AUX
dti-2660	97	55	reduce	reduce	VERB
dti-2660	97	56	antibiotic	antibiotic	ADJ
dti-2660	97	57	use	use	NOUN
dti-2660	97	58	by	by	ADP
dti-2660	97	59	60	60	NUM
dti-2660	97	60	-	-	SYM
dti-2660	97	61	70	70	NUM
dti-2660	97	62	%	%	NOUN
dti-2660	97	63	(	(	PUNCT
dti-2660	97	64	25	25	NUM
dti-2660	97	65	)	)	PUNCT
dti-2660	97	66	.	.	PUNCT
dti-2660	98	1	however	however	ADV
dti-2660	98	2	,	,	PUNCT
dti-2660	98	3	they	they	PRON
dti-2660	98	4	may	may	AUX
dti-2660	98	5	result	result	VERB
dti-2660	98	6	in	in	ADP
dti-2660	98	7	higher	high	ADJ
dti-2660	98	8	rates	rate	NOUN
dti-2660	98	9	of	of	ADP
dti-2660	98	10	incomplete	incomplete	ADJ
dti-2660	98	11	recovery	recovery	NOUN
dti-2660	98	12	or	or	CCONJ
dti-2660	98	13	therapy	therapy	NOUN
dti-2660	98	14	failure	failure	NOUN
dti-2660	98	15	compared	compare	VERB
dti-2660	98	16	with	with	ADP
dti-2660	98	17	immediate	immediate	ADJ
dti-2660	98	18	antibiotic	antibiotic	ADJ
dti-2660	98	19	use	use	NOUN
dti-2660	98	20	,	,	PUNCT
dti-2660	98	21	and	and	CCONJ
dti-2660	98	22	a	a	DET
dti-2660	98	23	higher	high	ADJ
dti-2660	98	24	incidence	incidence	NOUN
dti-2660	98	25	of	of	ADP
dti-2660	98	26	secondary	secondary	ADJ
dti-2660	98	27	outcomes	outcome	NOUN
dti-2660	98	28	,	,	PUNCT
dti-2660	98	29	such	such	ADJ
dti-2660	98	30	as	as	ADP
dti-2660	98	31	pyelonephritis	pyelonephritis	NOUN
dti-2660	98	32	or	or	CCONJ
dti-2660	98	33	febrile	febrile	NOUN
dti-2660	98	34	uti	uti	PROPN
dti-2660	98	35	(	(	PUNCT
dti-2660	98	36	25	25	NUM
dti-2660	98	37	-	-	SYM
dti-2660	98	38	27	27	NUM
dti-2660	98	39	)	)	PUNCT
dti-2660	98	40	.	.	PUNCT
dti-2660	99	1	the	the	DET
dti-2660	99	2	use	use	NOUN
dti-2660	99	3	of	of	ADP
dti-2660	99	4	antibiotic	antibiotic	NOUN
dti-2660	99	5	-	-	PUNCT
dti-2660	99	6	sparing	sparing	NOUN
dti-2660	99	7	and	and	CCONJ
dti-2660	99	8	other	other	ADJ
dti-2660	99	9	strategies	strategy	NOUN
dti-2660	99	10	in	in	ADP
dti-2660	99	11	the	the	DET
dti-2660	99	12	treatment	treatment	NOUN
dti-2660	99	13	and	and	CCONJ
dti-2660	99	14	prevention	prevention	NOUN
dti-2660	99	15	of	of	ADP
dti-2660	99	16	rutis	rutis	NOUN
dti-2660	99	17	will	will	AUX
dti-2660	99	18	be	be	AUX
dti-2660	99	19	developed	develop	VERB
dti-2660	99	20	in	in	ADP
dti-2660	99	21	the	the	DET
dti-2660	99	22	following	follow	VERB
dti-2660	99	23	sections	section	NOUN
dti-2660	99	24	.	.	PUNCT
dti-2660	100	1	the	the	DET
dti-2660	100	2	eau	eau	PROPN
dti-2660	100	3	guidelines	guideline	NOUN
dti-2660	100	4	for	for	ADP
dti-2660	100	5	antimicrobial	antimicrobial	ADJ
dti-2660	100	6	therapy	therapy	NOUN
dti-2660	100	7	in	in	ADP
dti-2660	100	8	uncomplicated	uncomplicated	ADJ
dti-2660	100	9	uti	uti	PROPN
dti-2660	100	10	recommend	recommend	VERB
dti-2660	100	11	first	first	ADJ
dti-2660	100	12	-	-	PUNCT
dti-2660	100	13	line	line	NOUN
dti-2660	100	14	therapy	therapy	NOUN
dti-2660	100	15	with	with	ADP
dti-2660	100	16	fosfomycin	fosfomycin	PROPN
dti-2660	100	17	trometamol	trometamol	PROPN
dti-2660	100	18	,	,	PUNCT
dti-2660	100	19	different	different	ADJ
dti-2660	100	20	formulations	formulation	NOUN
dti-2660	100	21	of	of	ADP
dti-2660	100	22	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	100	23	,	,	PUNCT
dti-2660	100	24	or	or	CCONJ
dti-2660	100	25	pivmecillinam	pivmecillinam	PROPN
dti-2660	100	26	.	.	PUNCT
dti-2660	101	1	table	table	NOUN
dti-2660	101	2	ii	ii	PROPN
dti-2660	101	3	summarizes	summarize	VERB
dti-2660	101	4	the	the	DET
dti-2660	101	5	regimens	regimen	NOUN
dti-2660	101	6	and	and	CCONJ
dti-2660	101	7	details	detail	NOUN
dti-2660	101	8	the	the	DET
dti-2660	101	9	doses	dose	NOUN
dti-2660	101	10	and	and	CCONJ
dti-2660	101	11	duration	duration	NOUN
dti-2660	101	12	of	of	ADP
dti-2660	101	13	therapy	therapy	NOUN
dti-2660	101	14	.	.	PUNCT
dti-2660	102	1	of	of	ADP
dti-2660	102	2	note	note	NOUN
dti-2660	102	3	,	,	PUNCT
dti-2660	102	4	fluoroquinolone	fluoroquinolone	NOUN
dti-2660	102	5	and	and	CCONJ
dti-2660	102	6	quinolone	quinolone	NOUN
dti-2660	102	7	antibiotics	antibiotic	NOUN
dti-2660	102	8	are	be	AUX
dti-2660	102	9	no	no	ADV
dti-2660	102	10	longer	long	ADV
dti-2660	102	11	included	include	VERB
dti-2660	102	12	in	in	ADP
dti-2660	102	13	the	the	DET
dti-2660	102	14	treatment	treatment	NOUN
dti-2660	102	15	of	of	ADP
dti-2660	102	16	uncomplicated	uncomplicated	ADJ
dti-2660	102	17	utis	utis	NOUN
dti-2660	102	18	,	,	PUNCT
dti-2660	102	19	having	having	AUX
dti-2660	102	20	been	be	AUX
dti-2660	102	21	banned	ban	VERB
dti-2660	102	22	from	from	ADP
dti-2660	102	23	use	use	NOUN
dti-2660	102	24	by	by	ADP
dti-2660	102	25	the	the	DET
dti-2660	102	26	european	european	PROPN
dti-2660	102	27	commission	commission	PROPN
dti-2660	102	28	from	from	ADP
dti-2660	102	29	2019	2019	NUM
dti-2660	102	30	because	because	SCONJ
dti-2660	102	31	of	of	ADP
dti-2660	102	32	serious	serious	ADJ
dti-2660	102	33	disabling	disabling	NOUN
dti-2660	102	34	and	and	CCONJ
dti-2660	102	35	potentially	potentially	ADV
dti-2660	102	36	permanent	permanent	ADJ
dti-2660	102	37	side	side	NOUN
dti-2660	102	38	effects	effect	NOUN
dti-2660	102	39	(	(	PUNCT
dti-2660	102	40	28	28	NUM
dti-2660	102	41	)	)	PUNCT
dti-2660	102	42	.	.	PUNCT
dti-2660	103	1	to	to	PART
dti-2660	103	2	guide	guide	VERB
dti-2660	103	3	the	the	DET
dti-2660	103	4	choice	choice	NOUN
dti-2660	103	5	of	of	ADP
dti-2660	103	6	antibiotic	antibiotic	NOUN
dti-2660	103	7	for	for	ADP
dti-2660	103	8	uncomplicated	uncomplicated	ADJ
dti-2660	103	9	uti	uti	PROPN
dti-2660	103	10	,	,	PUNCT
dti-2660	103	11	it	it	PRON
dti-2660	103	12	is	be	AUX
dti-2660	103	13	important	important	ADJ
dti-2660	103	14	to	to	PART
dti-2660	103	15	be	be	AUX
dti-2660	103	16	aware	aware	ADJ
dti-2660	103	17	of	of	ADP
dti-2660	103	18	the	the	DET
dti-2660	103	19	local	local	ADJ
dti-2660	103	20	resistance	resistance	NOUN
dti-2660	103	21	data	datum	NOUN
dti-2660	103	22	.	.	PUNCT
dti-2660	104	1	for	for	ADP
dti-2660	104	2	example	example	NOUN
dti-2660	104	3	,	,	PUNCT
dti-2660	104	4	surveillance	surveillance	NOUN
dti-2660	104	5	study	study	NOUN
dti-2660	104	6	conducted	conduct	VERB
dti-2660	104	7	in	in	ADP
dti-2660	104	8	europe	europe	PROPN
dti-2660	104	9	and	and	CCONJ
dti-2660	104	10	brazil	brazil	PROPN
dti-2660	104	11	in	in	ADP
dti-2660	104	12	the	the	DET
dti-2660	104	13	antimicrobial	antimicrobial	ADJ
dti-2660	104	14	resistance	resistance	NOUN
dti-2660	104	15	epidemiology	epidemiology	NOUN
dti-2660	104	16	in	in	ADP
dti-2660	104	17	females	female	NOUN
dti-2660	104	18	with	with	ADP
dti-2660	104	19	cystitis	cystitis	NOUN
dti-2660	104	20	(	(	PUNCT
dti-2660	104	21	aresc	aresc	NOUN
dti-2660	104	22	)	)	PUNCT
dti-2660	104	23	study	study	NOUN
dti-2660	104	24	identified	identify	VERB
dti-2660	104	25	e.	e.	PROPN
dti-2660	104	26	coli	coli	NOUN
dti-2660	104	27	as	as	ADP
dti-2660	104	28	by	by	ADP
dti-2660	104	29	far	far	ADV
dti-2660	104	30	the	the	DET
dti-2660	104	31	most	most	ADV
dti-2660	104	32	frequent	frequent	ADJ
dti-2660	104	33	uropathogen	uropathogen	NOUN
dti-2660	104	34	identified	identify	VERB
dti-2660	104	35	,	,	PUNCT
dti-2660	104	36	present	present	ADJ
dti-2660	104	37	in	in	ADP
dti-2660	104	38	74.6	74.6	NUM
dti-2660	104	39	%	%	NOUN
dti-2660	104	40	of	of	ADP
dti-2660	104	41	urine	urine	NOUN
dti-2660	104	42	cultures	culture	NOUN
dti-2660	104	43	,	,	PUNCT
dti-2660	104	44	followed	follow	VERB
dti-2660	104	45	by	by	ADP
dti-2660	104	46	e.	e.	PROPN
dti-2660	104	47	faecalis	faecalis	PROPN
dti-2660	104	48	,	,	PUNCT
dti-2660	104	49	s.	s.	PROPN
dti-2660	104	50	saprophyticus	saprophyticus	PROPN
dti-2660	104	51	,	,	PUNCT
dti-2660	104	52	k.	k.	PROPN
dti-2660	104	53	pneumoniae	pneumoniae	PROPN
dti-2660	104	54	,	,	PUNCT
dti-2660	104	55	and	and	CCONJ
dti-2660	104	56	p.	p.	PROPN
dti-2660	104	57	mirabilis	mirabilis	PROPN
dti-2660	104	58	,	,	PUNCT
dti-2660	104	59	all	all	PRON
dti-2660	104	60	at	at	ADP
dti-2660	104	61	less	less	ADJ
dti-2660	104	62	than	than	ADP
dti-2660	104	63	5	5	NUM
dti-2660	104	64	%	%	NOUN
dti-2660	104	65	and	and	CCONJ
dti-2660	104	66	found	find	VERB
dti-2660	104	67	that	that	SCONJ
dti-2660	104	68	,	,	PUNCT
dti-2660	104	69	although	although	SCONJ
dti-2660	104	70	susceptibility	susceptibility	NOUN
dti-2660	104	71	rates	rate	NOUN
dti-2660	104	72	varied	vary	VERB
dti-2660	104	73	considerably	considerably	ADV
dti-2660	104	74	from	from	ADP
dti-2660	104	75	country	country	NOUN
dti-2660	104	76	to	to	ADP
dti-2660	104	77	country	country	NOUN
dti-2660	104	78	,	,	PUNCT
dti-2660	104	79	rates	rate	NOUN
dti-2660	104	80	for	for	ADP
dti-2660	104	81	fosfomycin	fosfomycin	PROPN
dti-2660	104	82	,	,	PUNCT
dti-2660	104	83	pivmecillinam	pivmecillinam	PROPN
dti-2660	104	84	,	,	PUNCT
dti-2660	104	85	and	and	CCONJ
dti-2660	104	86	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	104	87	approached	approach	VERB
dti-2660	104	88	100	100	NUM
dti-2660	104	89	%	%	NOUN
dti-2660	104	90	overall	overall	ADJ
dti-2660	104	91	(	(	PUNCT
dti-2660	104	92	98.1	98.1	NUM
dti-2660	104	93	%	%	NOUN
dti-2660	104	94	,	,	PUNCT
dti-2660	104	95	95.8	95.8	NUM
dti-2660	104	96	%	%	NOUN
dti-2660	104	97	,	,	PUNCT
dti-2660	104	98	and	and	CCONJ
dti-2660	104	99	95.2	95.2	NUM
dti-2660	104	100	%	%	NOUN
dti-2660	104	101	,	,	PUNCT
dti-2660	104	102	respectively	respectively	ADV
dti-2660	104	103	)	)	PUNCT
dti-2660	104	104	(	(	PUNCT
dti-2660	104	105	23	23	NUM
dti-2660	104	106	)	)	PUNCT
dti-2660	104	107	.	.	PUNCT
dti-2660	105	1	susceptibility	susceptibility	NOUN
dti-2660	105	2	to	to	ADP
dti-2660	105	3	cotrimoxazole	cotrimoxazole	NOUN
dti-2660	105	4	was	be	AUX
dti-2660	105	5	lower	low	ADJ
dti-2660	105	6	(	(	PUNCT
dti-2660	105	7	70.5	70.5	NUM
dti-2660	105	8	%	%	NOUN
dti-2660	105	9	)	)	PUNCT
dti-2660	105	10	,	,	PUNCT
dti-2660	105	11	which	which	PRON
dti-2660	105	12	is	be	AUX
dti-2660	105	13	why	why	SCONJ
dti-2660	105	14	cotrimoxazole	cotrimoxazole	NOUN
dti-2660	105	15	is	be	AUX
dti-2660	105	16	not	not	PART
dti-2660	105	17	recommended	recommend	VERB
dti-2660	105	18	as	as	ADP
dti-2660	105	19	a	a	DET
dti-2660	105	20	first	first	ADJ
dti-2660	105	21	-	-	PUNCT
dti-2660	105	22	line	line	NOUN
dti-2660	105	23	treatment	treatment	NOUN
dti-2660	105	24	in	in	ADP
dti-2660	105	25	uncomplicated	uncomplicated	ADJ
dti-2660	105	26	uti	uti	PROPN
dti-2660	105	27	.	.	PUNCT
dti-2660	106	1	in	in	ADP
dti-2660	106	2	contrast	contrast	NOUN
dti-2660	106	3	,	,	PUNCT
dti-2660	106	4	a	a	DET
dti-2660	106	5	recent	recent	ADJ
dti-2660	106	6	study	study	NOUN
dti-2660	106	7	of	of	ADP
dti-2660	106	8	the	the	DET
dti-2660	106	9	prevalence	prevalence	NOUN
dti-2660	106	10	and	and	CCONJ
dti-2660	106	11	resistance	resistance	NOUN
dti-2660	106	12	patterns	pattern	NOUN
dti-2660	106	13	of	of	ADP
dti-2660	106	14	uropathogens	uropathogen	NOUN
dti-2660	106	15	in	in	ADP
dti-2660	106	16	different	different	ADJ
dti-2660	106	17	regions	region	NOUN
dti-2660	106	18	of	of	ADP
dti-2660	106	19	india	india	PROPN
dti-2660	106	20	found	find	VERB
dti-2660	106	21	that	that	SCONJ
dti-2660	106	22	,	,	PUNCT
dti-2660	106	23	while	while	SCONJ
dti-2660	106	24	e.	e.	PROPN
dti-2660	106	25	coli	coli	PROPN
dti-2660	106	26	was	be	AUX
dti-2660	106	27	still	still	ADV
dti-2660	106	28	the	the	DET
dti-2660	106	29	most	most	ADV
dti-2660	106	30	prevalent	prevalent	ADJ
dti-2660	106	31	pathogen	pathogen	NOUN
dti-2660	106	32	identified	identify	VERB
dti-2660	106	33	(	(	PUNCT
dti-2660	106	34	68.3	68.3	NUM
dti-2660	106	35	%	%	NOUN
dti-2660	106	36	overall	overall	ADJ
dti-2660	106	37	)	)	PUNCT
dti-2660	106	38	,	,	PUNCT
dti-2660	106	39	there	there	PRON
dti-2660	106	40	was	be	VERB
dti-2660	106	41	a	a	DET
dti-2660	106	42	much	much	ADV
dti-2660	106	43	higher	high	ADJ
dti-2660	106	44	prevalence	prevalence	NOUN
dti-2660	106	45	of	of	ADP
dti-2660	106	46	k.	k.	PROPN
dti-2660	106	47	pneumoniae	pneumoniae	PROPN
dti-2660	106	48	(	(	PUNCT
dti-2660	106	49	17.7	17.7	NUM
dti-2660	106	50	%	%	NOUN
dti-2660	106	51	)	)	PUNCT
dti-2660	106	52	than	than	ADP
dti-2660	106	53	in	in	ADP
dti-2660	106	54	europe	europe	PROPN
dti-2660	106	55	,	,	PUNCT
dti-2660	106	56	and	and	CCONJ
dti-2660	106	57	resistance	resistance	NOUN
dti-2660	106	58	to	to	ADP
dti-2660	106	59	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	106	60	was	be	AUX
dti-2660	106	61	higher	high	ADJ
dti-2660	106	62	for	for	ADP
dti-2660	106	63	both	both	DET
dti-2660	106	64	pathogens	pathogen	NOUN
dti-2660	106	65	(	(	PUNCT
dti-2660	106	66	5.8	5.8	NUM
dti-2660	106	67	%	%	NOUN
dti-2660	106	68	and	and	CCONJ
dti-2660	106	69	45.4	45.4	NUM
dti-2660	106	70	%	%	NOUN
dti-2660	106	71	,	,	PUNCT
dti-2660	106	72	respectively	respectively	ADV
dti-2660	106	73	)	)	PUNCT
dti-2660	106	74	(	(	PUNCT
dti-2660	106	75	29	29	NUM
dti-2660	106	76	)	)	PUNCT
dti-2660	106	77	.	.	PUNCT
dti-2660	107	1	of	of	ADP
dti-2660	107	2	note	note	NOUN
dti-2660	107	3	,	,	PUNCT
dti-2660	107	4	none	none	NOUN
dti-2660	107	5	of	of	ADP
dti-2660	107	6	the	the	DET
dti-2660	107	7	upec	upec	NOUN
dti-2660	107	8	were	be	AUX
dti-2660	107	9	resistant	resistant	ADJ
dti-2660	107	10	to	to	ADP
dti-2660	107	11	fosfomycin	fosfomycin	PROPN
dti-2660	107	12	.	.	PUNCT
dti-2660	108	1	these	these	DET
dti-2660	108	2	differences	difference	NOUN
dti-2660	108	3	emphasize	emphasize	VERB
dti-2660	108	4	utis	utis	NOUN
dti-2660	108	5	in	in	ADP
dti-2660	108	6	the	the	DET
dti-2660	108	7	era	era	NOUN
dti-2660	108	8	of	of	ADP
dti-2660	108	9	amr130	amr130	PROPN
dti-2660	108	10	©	©	PROPN
dti-2660	108	11	2023	2023	NUM
dti-2660	108	12	the	the	DET
dti-2660	108	13	authors	author	NOUN
dti-2660	108	14	.	.	PUNCT
dti-2660	109	1	drug	drug	NOUN
dti-2660	109	2	target	target	NOUN
dti-2660	109	3	insights	insight	NOUN
dti-2660	109	4	issn	issn	VERB
dti-2660	109	5	1177	1177	NUM
dti-2660	109	6	-	-	SYM
dti-2660	109	7	3928	3928	NUM
dti-2660	109	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2660	109	9	table	table	NOUN
dti-2660	109	10	ii	ii	PROPN
dti-2660	109	11	suggested	suggest	VERB
dti-2660	109	12	regimens	regimen	NOUN
dti-2660	109	13	for	for	ADP
dti-2660	109	14	antimicrobial	antimicrobial	ADJ
dti-2660	109	15	therapy	therapy	NOUN
dti-2660	109	16	in	in	ADP
dti-2660	109	17	uncomplicated	uncomplicated	ADJ
dti-2660	109	18	cystitis	cystitis	NOUN
dti-2660	109	19	.	.	PUNCT
dti-2660	110	1	recommendations	recommendation	NOUN
dti-2660	110	2	of	of	ADP
dti-2660	110	3	the	the	DET
dti-2660	110	4	european	european	PROPN
dti-2660	110	5	association	association	PROPN
dti-2660	110	6	of	of	ADP
dti-2660	110	7	urology	urology	NOUN
dti-2660	110	8	(	(	PUNCT
dti-2660	110	9	eau	eau	PROPN
dti-2660	110	10	)	)	PUNCT
dti-2660	110	11	(	(	PUNCT
dti-2660	110	12	8)	8)	NUM
dti-2660	110	13	antimicrobial	antimicrobial	ADJ
dti-2660	110	14	daily	daily	ADJ
dti-2660	110	15	dose	dose	NOUN
dti-2660	110	16	duration	duration	NOUN
dti-2660	110	17	of	of	ADP
dti-2660	110	18	therapy	therapy	NOUN
dti-2660	110	19	comments	comment	VERB
dti-2660	110	20	first	first	ADJ
dti-2660	110	21	-	-	PUNCT
dti-2660	110	22	line	line	NOUN
dti-2660	110	23	women	woman	NOUN
dti-2660	110	24	fosfomycin	fosfomycin	VERB
dti-2660	110	25	trometamol	trometamol	VERB
dti-2660	110	26	3	3	NUM
dti-2660	110	27	g	g	NOUN
dti-2660	110	28	sd	sd	ADP
dti-2660	110	29	1	1	NUM
dti-2660	110	30	day	day	NOUN
dti-2660	110	31	recommended	recommend	VERB
dti-2660	110	32	only	only	ADV
dti-2660	110	33	in	in	ADP
dti-2660	110	34	women	woman	NOUN
dti-2660	110	35	with	with	ADP
dti-2660	110	36	uncomplicated	uncomplicated	ADJ
dti-2660	110	37	cystitis	cystitis	NOUN
dti-2660	110	38	.	.	PUNCT
dti-2660	111	1	nitrofurantoin	nitrofurantoin	PROPN
dti-2660	111	2	macrocrystal	macrocrystal	ADJ
dti-2660	111	3	50	50	NUM
dti-2660	111	4	-	-	SYM
dti-2660	111	5	100	100	NUM
dti-2660	111	6	mg	mg	NUM
dti-2660	111	7	four	four	NUM
dti-2660	111	8	times	time	NOUN
dti-2660	111	9	a	a	DET
dti-2660	111	10	day	day	NOUN
dti-2660	111	11	5	5	NUM
dti-2660	111	12	days	day	NOUN
dti-2660	111	13	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	111	14	monohydrate	monohydrate	NOUN
dti-2660	111	15	/	/	SYM
dti-2660	111	16	macrocrystals	macrocrystal	NOUN
dti-2660	111	17	100	100	NUM
dti-2660	111	18	mg	mg	NOUN
dti-2660	111	19	b.i.d	b.i.d	PROPN
dti-2660	111	20	.	.	PUNCT
dti-2660	112	1	5	5	NUM
dti-2660	112	2	days	day	NOUN
dti-2660	112	3	nitrofurantoin	nitrofurantoin	X
dti-2660	112	4	macrocrystal	macrocrystal	ADJ
dti-2660	112	5	prolonged	prolong	VERB
dti-2660	112	6	release	release	NOUN
dti-2660	112	7	100	100	NUM
dti-2660	112	8	mg	mg	NOUN
dti-2660	112	9	b.i.d	b.i.d	PROPN
dti-2660	112	10	.	.	PUNCT
dti-2660	113	1	5	5	NUM
dti-2660	113	2	days	day	NOUN
dti-2660	113	3	pivmecillinam	pivmecillinam	PROPN
dti-2660	113	4	400	400	NUM
dti-2660	113	5	mg	mg	PROPN
dti-2660	113	6	t.i.d	t.i.d	PROPN
dti-2660	113	7	.	.	PUNCT
dti-2660	114	1	3	3	NUM
dti-2660	114	2	-	-	SYM
dti-2660	114	3	5	5	NUM
dti-2660	114	4	days	day	NOUN
dti-2660	114	5	alternatives	alternative	NOUN
dti-2660	114	6	cephalosporins	cephalosporin	NOUN
dti-2660	114	7	(	(	PUNCT
dti-2660	114	8	e.g.	e.g.	ADV
dti-2660	114	9	,	,	PUNCT
dti-2660	114	10	cefadroxil	cefadroxil	NOUN
dti-2660	114	11	)	)	PUNCT
dti-2660	114	12	500	500	NUM
dti-2660	114	13	mg	mg	NOUN
dti-2660	114	14	b.i.d	b.i.d	PROPN
dti-2660	114	15	.	.	PUNCT
dti-2660	115	1	3	3	NUM
dti-2660	115	2	days	day	NOUN
dti-2660	115	3	or	or	CCONJ
dti-2660	115	4	comparable	comparable	ADJ
dti-2660	115	5	if	if	SCONJ
dti-2660	115	6	the	the	DET
dti-2660	115	7	local	local	ADJ
dti-2660	115	8	resistance	resistance	NOUN
dti-2660	115	9	pattern	pattern	NOUN
dti-2660	115	10	for	for	ADP
dti-2660	115	11	escherichia	escherichia	NOUN
dti-2660	115	12	coli	coli	NOUN
dti-2660	115	13	is	be	AUX
dti-2660	115	14	<	<	X
dti-2660	115	15	20	20	NUM
dti-2660	115	16	%	%	NOUN
dti-2660	115	17	trimethoprim	trimethoprim	NOUN
dti-2660	115	18	200	200	NUM
dti-2660	115	19	mg	mg	NOUN
dti-2660	115	20	b.i.d	b.i.d	PROPN
dti-2660	115	21	.	.	PUNCT
dti-2660	116	1	5	5	NUM
dti-2660	116	2	days	day	NOUN
dti-2660	116	3	not	not	PART
dti-2660	116	4	in	in	ADP
dti-2660	116	5	the	the	DET
dti-2660	116	6	first	first	ADJ
dti-2660	116	7	trimester	trimester	NOUN
dti-2660	116	8	of	of	ADP
dti-2660	116	9	pregnancy	pregnancy	NOUN
dti-2660	116	10	trimethoprim	trimethoprim	ADJ
dti-2660	116	11	-	-	PUNCT
dti-2660	116	12	sulfamethoxazole	sulfamethoxazole	NOUN
dti-2660	116	13	160/800	160/800	PROPN
dti-2660	116	14	mg	mg	NOUN
dti-2660	116	15	b.i.d	b.i.d	PROPN
dti-2660	116	16	.	.	PUNCT
dti-2660	117	1	3	3	NUM
dti-2660	117	2	days	day	NOUN
dti-2660	117	3	not	not	PART
dti-2660	117	4	in	in	ADP
dti-2660	117	5	the	the	DET
dti-2660	117	6	last	last	ADJ
dti-2660	117	7	trimester	trimester	NOUN
dti-2660	117	8	of	of	ADP
dti-2660	117	9	pregnancy	pregnancy	NOUN
dti-2660	117	10	treatment	treatment	NOUN
dti-2660	117	11	in	in	ADP
dti-2660	117	12	men	man	NOUN
dti-2660	117	13	trimethoprim	trimethoprim	ADJ
dti-2660	117	14	-	-	PUNCT
dti-2660	117	15	sulfamethoxazole	sulfamethoxazole	NOUN
dti-2660	117	16	160/800	160/800	PROPN
dti-2660	117	17	mg	mg	NOUN
dti-2660	117	18	b.i.d	b.i.d	PROPN
dti-2660	117	19	.	.	PUNCT
dti-2660	118	1	7	7	NUM
dti-2660	118	2	days	day	NOUN
dti-2660	118	3	restricted	restrict	VERB
dti-2660	118	4	to	to	ADP
dti-2660	118	5	men	man	NOUN
dti-2660	118	6	.	.	PUNCT
dti-2660	119	1	fluoroquinolones	fluoroquinolone	NOUN
dti-2660	119	2	can	can	AUX
dti-2660	119	3	also	also	ADV
dti-2660	119	4	be	be	AUX
dti-2660	119	5	prescribed	prescribe	VERB
dti-2660	119	6	in	in	ADP
dti-2660	119	7	accordance	accordance	NOUN
dti-2660	119	8	with	with	ADP
dti-2660	119	9	local	local	ADJ
dti-2660	119	10	susceptibility	susceptibility	NOUN
dti-2660	119	11	testing	testing	NOUN
dti-2660	119	12	.	.	PUNCT
dti-2660	120	1	b.i.d	b.i.d	INTJ
dti-2660	120	2	.	.	PUNCT
dti-2660	121	1	=	=	PUNCT
dti-2660	121	2	twice	twice	ADV
dti-2660	121	3	daily	daily	ADV
dti-2660	121	4	;	;	PUNCT
dti-2660	121	5	sd	sd	ADP
dti-2660	121	6	=	=	PUNCT
dti-2660	121	7	single	single	ADJ
dti-2660	121	8	dose	dose	NOUN
dti-2660	121	9	;	;	PUNCT
dti-2660	121	10	t.i.d	t.i.d	PROPN
dti-2660	121	11	.	.	PUNCT
dti-2660	122	1	=	=	PUNCT
dti-2660	122	2	three	three	NUM
dti-2660	122	3	times	time	NOUN
dti-2660	122	4	daily	daily	ADV
dti-2660	122	5	.	.	PUNCT
dti-2660	123	1	reproduced	reproduce	VERB
dti-2660	123	2	from	from	ADP
dti-2660	123	3	bonkat	bonkat	PROPN
dti-2660	123	4	g	g	PROPN
dti-2660	123	5	,	,	PUNCT
dti-2660	123	6	bartoletti	bartoletti	PROPN
dti-2660	123	7	r	r	NOUN
dti-2660	123	8	,	,	PUNCT
dti-2660	123	9	bruyere	bruyere	NOUN
dti-2660	123	10	f	f	PROPN
dti-2660	123	11	,	,	PUNCT
dti-2660	123	12	et	et	PROPN
dti-2660	123	13	al	al	PROPN
dti-2660	123	14	.	.	PUNCT
dti-2660	124	1	eau	eau	PROPN
dti-2660	124	2	guidelines	guideline	NOUN
dti-2660	124	3	on	on	ADP
dti-2660	124	4	urological	urological	ADJ
dti-2660	124	5	infections	infection	NOUN
dti-2660	124	6	.	.	PUNCT
dti-2660	125	1	edn	edn	NOUN
dti-2660	125	2	.	.	PUNCT
dti-2660	125	3	presented	present	VERB
dti-2660	125	4	at	at	ADP
dti-2660	125	5	the	the	DET
dti-2660	125	6	eau	eau	PROPN
dti-2660	125	7	annual	annual	ADJ
dti-2660	125	8	congress	congress	PROPN
dti-2660	125	9	,	,	PUNCT
dti-2660	125	10	milan	milan	PROPN
dti-2660	125	11	,	,	PUNCT
dti-2660	125	12	italy	italy	PROPN
dti-2660	125	13	,	,	PUNCT
dti-2660	125	14	2023	2023	NUM
dti-2660	125	15	.	.	PUNCT
dti-2660	126	1	isbn	isbn	ADJ
dti-2660	126	2	978	978	NUM
dti-2660	126	3	-	-	SYM
dti-2660	126	4	94	94	NUM
dti-2660	126	5	-	-	PUNCT
dti-2660	126	6	92671	92671	NUM
dti-2660	126	7	-	-	PUNCT
dti-2660	126	8	19	19	NUM
dti-2660	126	9	-	-	SYM
dti-2660	126	10	6	6	NUM
dti-2660	126	11	and	and	CCONJ
dti-2660	126	12	published	publish	VERB
dti-2660	126	13	by	by	ADP
dti-2660	126	14	uroweb.org	uroweb.org	NOUN
dti-2660	126	15	as	as	ADP
dti-2660	126	16	an	an	DET
dti-2660	126	17	open	open	ADJ
dti-2660	126	18	access	access	NOUN
dti-2660	126	19	article	article	NOUN
dti-2660	126	20	under	under	ADP
dti-2660	126	21	the	the	DET
dti-2660	126	22	cc	cc	NOUN
dti-2660	126	23	by	by	ADP
dti-2660	126	24	4.0	4.0	NUM
dti-2660	126	25	license	license	NOUN
dti-2660	126	26	.	.	PUNCT
dti-2660	127	1	fig	fig	NOUN
dti-2660	127	2	.	.	PUNCT
dti-2660	128	1	2	2	NUM
dti-2660	128	2	treatment	treatment	NOUN
dti-2660	128	3	options	option	NOUN
dti-2660	128	4	for	for	ADP
dti-2660	128	5	a	a	DET
dti-2660	128	6	)	)	PUNCT
dti-2660	128	7	uncomplicated	uncomplicated	ADJ
dti-2660	128	8	urinary	urinary	ADJ
dti-2660	128	9	tract	tract	NOUN
dti-2660	128	10	infections	infection	NOUN
dti-2660	128	11	(	(	PUNCT
dti-2660	128	12	utis	utis	NOUN
dti-2660	128	13	)	)	PUNCT
dti-2660	128	14	and	and	CCONJ
dti-2660	128	15	b	b	X
dti-2660	128	16	)	)	PUNCT
dti-2660	128	17	recurrent	recurrent	ADJ
dti-2660	128	18	urinary	urinary	ADJ
dti-2660	128	19	tract	tract	NOUN
dti-2660	128	20	infections	infection	NOUN
dti-2660	128	21	(	(	PUNCT
dti-2660	128	22	rutis	rutis	NOUN
dti-2660	128	23	)	)	PUNCT
dti-2660	128	24	.	.	PUNCT
dti-2660	129	1	pothoven	pothoven	ADJ
dti-2660	129	2	drug	drug	NOUN
dti-2660	129	3	target	target	NOUN
dti-2660	129	4	insights	insight	NOUN
dti-2660	129	5	2023	2023	NUM
dti-2660	129	6	;	;	PUNCT
dti-2660	129	7	17	17	NUM
dti-2660	129	8	:	:	SYM
dti-2660	129	9	131	131	NUM
dti-2660	129	10	©	©	PROPN
dti-2660	129	11	2023	2023	NUM
dti-2660	129	12	the	the	DET
dti-2660	129	13	authors	author	NOUN
dti-2660	129	14	.	.	PUNCT
dti-2660	130	1	published	publish	VERB
dti-2660	130	2	by	by	ADP
dti-2660	130	3	aboutscience	aboutscience	NOUN
dti-2660	130	4	www.aboutscience.eu	www.aboutscience.eu	VERB
dti-2660	130	5	the	the	DET
dti-2660	130	6	importance	importance	NOUN
dti-2660	130	7	of	of	ADP
dti-2660	130	8	local	local	ADJ
dti-2660	130	9	prevalence	prevalence	NOUN
dti-2660	130	10	and	and	CCONJ
dti-2660	130	11	resistance	resistance	NOUN
dti-2660	130	12	patterns	pattern	NOUN
dti-2660	130	13	to	to	PART
dti-2660	130	14	guide	guide	VERB
dti-2660	130	15	the	the	DET
dti-2660	130	16	choice	choice	NOUN
dti-2660	130	17	of	of	ADP
dti-2660	130	18	antibiotic	antibiotic	ADJ
dti-2660	130	19	.	.	PUNCT
dti-2660	131	1	prevention	prevention	NOUN
dti-2660	131	2	of	of	ADP
dti-2660	131	3	recurrent	recurrent	ADJ
dti-2660	131	4	cystitis	cystitis	NOUN
dti-2660	131	5	:	:	PUNCT
dti-2660	131	6	current	current	ADJ
dti-2660	131	7	state	state	NOUN
dti-2660	131	8	of	of	ADP
dti-2660	131	9	the	the	DET
dti-2660	131	10	art	art	NOUN
dti-2660	131	11	as	as	SCONJ
dti-2660	131	12	noted	note	VERB
dti-2660	131	13	,	,	PUNCT
dti-2660	131	14	an	an	DET
dti-2660	131	15	ruti	ruti	PROPN
dti-2660	131	16	is	be	AUX
dti-2660	131	17	defined	define	VERB
dti-2660	131	18	as	as	ADP
dti-2660	131	19	an	an	DET
dti-2660	131	20	uti	uti	PROPN
dti-2660	131	21	occurring	occur	VERB
dti-2660	131	22	at	at	ADV
dti-2660	131	23	least	least	ADV
dti-2660	131	24	three	three	NUM
dti-2660	131	25	times	time	NOUN
dti-2660	131	26	a	a	DET
dti-2660	131	27	year	year	NOUN
dti-2660	131	28	or	or	CCONJ
dti-2660	131	29	twice	twice	ADV
dti-2660	131	30	in	in	ADP
dti-2660	131	31	the	the	DET
dti-2660	131	32	previous	previous	ADJ
dti-2660	131	33	6	6	NUM
dti-2660	131	34	months	month	NOUN
dti-2660	131	35	.	.	PUNCT
dti-2660	132	1	however	however	ADV
dti-2660	132	2	,	,	PUNCT
dti-2660	132	3	in	in	ADP
dti-2660	132	4	real	real	ADJ
dti-2660	132	5	-	-	PUNCT
dti-2660	132	6	world	world	NOUN
dti-2660	132	7	practice	practice	NOUN
dti-2660	132	8	,	,	PUNCT
dti-2660	132	9	only	only	ADV
dti-2660	132	10	about	about	ADV
dti-2660	132	11	20	20	NUM
dti-2660	132	12	%	%	NOUN
dti-2660	132	13	of	of	ADP
dti-2660	132	14	episodes	episode	NOUN
dti-2660	132	15	occur	occur	VERB
dti-2660	132	16	twice	twice	ADV
dti-2660	132	17	in	in	ADP
dti-2660	132	18	6	6	NUM
dti-2660	132	19	months	month	NOUN
dti-2660	132	20	or	or	CCONJ
dti-2660	132	21	three	three	NUM
dti-2660	132	22	times	time	NOUN
dti-2660	132	23	a	a	DET
dti-2660	132	24	year	year	NOUN
dti-2660	132	25	;	;	PUNCT
dti-2660	132	26	in	in	ADP
dti-2660	132	27	a	a	DET
dti-2660	132	28	recent	recent	ADJ
dti-2660	132	29	european	european	ADJ
dti-2660	132	30	study	study	NOUN
dti-2660	132	31	(	(	PUNCT
dti-2660	132	32	gesprit	gesprit	PROPN
dti-2660	132	33	)	)	PUNCT
dti-2660	132	34	,	,	PUNCT
dti-2660	132	35	47.4	47.4	NUM
dti-2660	132	36	%	%	NOUN
dti-2660	132	37	of	of	ADP
dti-2660	132	38	women	woman	NOUN
dti-2660	132	39	had	have	VERB
dti-2660	132	40	at	at	ADV
dti-2660	132	41	least	least	ADJ
dti-2660	132	42	six	six	NUM
dti-2660	132	43	utis	utis	NOUN
dti-2660	132	44	per	per	ADP
dti-2660	132	45	year	year	NOUN
dti-2660	132	46	,	,	PUNCT
dti-2660	132	47	and	and	CCONJ
dti-2660	132	48	14.4	14.4	NUM
dti-2660	132	49	%	%	NOUN
dti-2660	132	50	had	have	VERB
dti-2660	132	51	over	over	ADP
dti-2660	132	52	12	12	NUM
dti-2660	132	53	infections	infection	NOUN
dti-2660	132	54	per	per	ADP
dti-2660	132	55	year	year	NOUN
dti-2660	132	56	(	(	PUNCT
dti-2660	132	57	30	30	NUM
dti-2660	132	58	)	)	PUNCT
dti-2660	132	59	.	.	PUNCT
dti-2660	133	1	in	in	ADP
dti-2660	133	2	fact	fact	NOUN
dti-2660	133	3	,	,	PUNCT
dti-2660	133	4	before	before	SCONJ
dti-2660	133	5	preventive	preventive	ADJ
dti-2660	133	6	measures	measure	NOUN
dti-2660	133	7	were	be	AUX
dti-2660	133	8	started	start	VERB
dti-2660	133	9	,	,	PUNCT
dti-2660	133	10	almost	almost	ADV
dti-2660	133	11	a	a	DET
dti-2660	133	12	third	third	NOUN
dti-2660	133	13	of	of	ADP
dti-2660	133	14	women	woman	NOUN
dti-2660	133	15	experienced	experience	VERB
dti-2660	133	16	at	at	ADP
dti-2660	133	17	least	least	ADV
dti-2660	133	18	ten	ten	NUM
dti-2660	133	19	episodes	episode	NOUN
dti-2660	133	20	per	per	ADP
dti-2660	133	21	year	year	NOUN
dti-2660	133	22	.	.	PUNCT
dti-2660	134	1	the	the	DET
dti-2660	134	2	health	health	NOUN
dti-2660	134	3	and	and	CCONJ
dti-2660	134	4	economic	economic	ADJ
dti-2660	134	5	burden	burden	NOUN
dti-2660	134	6	caused	cause	VERB
dti-2660	134	7	by	by	ADP
dti-2660	134	8	rutis	rutis	NOUN
dti-2660	134	9	is	be	AUX
dti-2660	134	10	significant	significant	ADJ
dti-2660	134	11	;	;	PUNCT
dti-2660	134	12	rutis	rutis	NOUN
dti-2660	134	13	impact	impact	NOUN
dti-2660	134	14	patients	patient	NOUN
dti-2660	134	15	’	'	PUNCT
dti-2660	134	16	daily	daily	ADJ
dti-2660	134	17	activities	activity	NOUN
dti-2660	134	18	and	and	CCONJ
dti-2660	134	19	mental	mental	ADJ
dti-2660	134	20	health	health	NOUN
dti-2660	134	21	,	,	PUNCT
dti-2660	134	22	leading	lead	VERB
dti-2660	134	23	to	to	ADP
dti-2660	134	24	high	high	ADJ
dti-2660	134	25	levels	level	NOUN
dti-2660	134	26	of	of	ADP
dti-2660	134	27	frustration	frustration	NOUN
dti-2660	134	28	,	,	PUNCT
dti-2660	134	29	anger	anger	NOUN
dti-2660	134	30	,	,	PUNCT
dti-2660	134	31	and	and	CCONJ
dti-2660	134	32	dissatisfaction	dissatisfaction	NOUN
dti-2660	134	33	(	(	PUNCT
dti-2660	134	34	30	30	NUM
dti-2660	134	35	)	)	PUNCT
dti-2660	134	36	.	.	PUNCT
dti-2660	135	1	women	woman	NOUN
dti-2660	135	2	may	may	AUX
dti-2660	135	3	need	need	VERB
dti-2660	135	4	bed	bed	NOUN
dti-2660	135	5	rest	rest	NOUN
dti-2660	135	6	,	,	PUNCT
dti-2660	135	7	be	be	AUX
dti-2660	135	8	absent	absent	ADJ
dti-2660	135	9	from	from	ADP
dti-2660	135	10	work	work	NOUN
dti-2660	135	11	,	,	PUNCT
dti-2660	135	12	and	and	CCONJ
dti-2660	135	13	require	require	VERB
dti-2660	135	14	doctor	doctor	NOUN
dti-2660	135	15	visits	visit	NOUN
dti-2660	135	16	and	and	CCONJ
dti-2660	135	17	prescriptions	prescription	NOUN
dti-2660	135	18	for	for	ADP
dti-2660	135	19	antibiotics	antibiotic	NOUN
dti-2660	135	20	.	.	PUNCT
dti-2660	136	1	there	there	PRON
dti-2660	136	2	are	be	VERB
dti-2660	136	3	many	many	ADJ
dti-2660	136	4	strategies	strategy	NOUN
dti-2660	136	5	for	for	ADP
dti-2660	136	6	preventing	prevent	VERB
dti-2660	136	7	the	the	DET
dti-2660	136	8	recurrence	recurrence	NOUN
dti-2660	136	9	of	of	ADP
dti-2660	136	10	utis	utis	NOUN
dti-2660	136	11	,	,	PUNCT
dti-2660	136	12	which	which	PRON
dti-2660	136	13	can	can	AUX
dti-2660	136	14	be	be	AUX
dti-2660	136	15	summarized	summarize	VERB
dti-2660	136	16	as	as	ADP
dti-2660	136	17	antibiotic	antibiotic	ADJ
dti-2660	136	18	-	-	PUNCT
dti-2660	136	19	sparing	spare	VERB
dti-2660	136	20	strategies	strategy	NOUN
dti-2660	136	21	,	,	PUNCT
dti-2660	136	22	antibiotic	antibiotic	ADJ
dti-2660	136	23	prophylaxis	prophylaxis	NOUN
dti-2660	136	24	,	,	PUNCT
dti-2660	136	25	and	and	CCONJ
dti-2660	136	26	experimental	experimental	ADJ
dti-2660	136	27	strategies	strategy	NOUN
dti-2660	136	28	(	(	PUNCT
dti-2660	136	29	fig	fig	NOUN
dti-2660	136	30	.	.	PUNCT
dti-2660	136	31	2b	2b	NUM
dti-2660	136	32	)	)	PUNCT
dti-2660	136	33	.	.	PUNCT
dti-2660	137	1	non	non	ADJ
dti-2660	137	2	-	-	ADJ
dti-2660	137	3	antimicrobial	antimicrobial	ADJ
dti-2660	137	4	prophylaxis	prophylaxis	NOUN
dti-2660	137	5	in	in	ADP
dti-2660	137	6	following	follow	VERB
dti-2660	137	7	a	a	DET
dti-2660	137	8	step	step	NOUN
dti-2660	137	9	-	-	PUNCT
dti-2660	137	10	by	by	ADP
dti-2660	137	11	-	-	PUNCT
dti-2660	137	12	step	step	NOUN
dti-2660	137	13	approach	approach	NOUN
dti-2660	137	14	to	to	ADP
dti-2660	137	15	prophylaxis	prophylaxis	NOUN
dti-2660	137	16	for	for	ADP
dti-2660	137	17	rutis	rutis	NOUN
dti-2660	137	18	,	,	PUNCT
dti-2660	137	19	avoidance	avoidance	NOUN
dti-2660	137	20	of	of	ADP
dti-2660	137	21	risk	risk	NOUN
dti-2660	137	22	factors	factor	NOUN
dti-2660	137	23	and	and	CCONJ
dti-2660	137	24	behavioral	behavioral	ADJ
dti-2660	137	25	modifications	modification	NOUN
dti-2660	137	26	(	(	PUNCT
dti-2660	137	27	increasing	increase	VERB
dti-2660	137	28	fluid	fluid	ADJ
dti-2660	137	29	intake	intake	NOUN
dti-2660	137	30	,	,	PUNCT
dti-2660	137	31	preor	preor	NOUN
dti-2660	137	32	postcoital	postcoital	ADJ
dti-2660	137	33	urination	urination	NOUN
dti-2660	137	34	,	,	PUNCT
dti-2660	137	35	and	and	CCONJ
dti-2660	137	36	hygiene	hygiene	NOUN
dti-2660	137	37	procedures	procedure	NOUN
dti-2660	137	38	)	)	PUNCT
dti-2660	137	39	can	can	AUX
dti-2660	137	40	be	be	AUX
dti-2660	137	41	considered	consider	VERB
dti-2660	137	42	the	the	DET
dti-2660	137	43	first	first	ADJ
dti-2660	137	44	step	step	NOUN
dti-2660	137	45	.	.	PUNCT
dti-2660	138	1	however	however	ADV
dti-2660	138	2	,	,	PUNCT
dti-2660	138	3	evidence	evidence	NOUN
dti-2660	138	4	for	for	ADP
dti-2660	138	5	their	their	PRON
dti-2660	138	6	benefits	benefit	NOUN
dti-2660	138	7	in	in	ADP
dti-2660	138	8	reducing	reduce	VERB
dti-2660	138	9	episodes	episode	NOUN
dti-2660	138	10	of	of	ADP
dti-2660	138	11	ruti	ruti	PROPN
dti-2660	138	12	is	be	AUX
dti-2660	138	13	limited	limited	ADJ
dti-2660	138	14	.	.	PUNCT
dti-2660	139	1	a	a	DET
dti-2660	139	2	recent	recent	ADJ
dti-2660	139	3	study	study	NOUN
dti-2660	139	4	showed	show	VERB
dti-2660	139	5	that	that	SCONJ
dti-2660	139	6	increasing	increase	VERB
dti-2660	139	7	the	the	DET
dti-2660	139	8	daily	daily	ADJ
dti-2660	139	9	water	water	NOUN
dti-2660	139	10	intake	intake	NOUN
dti-2660	139	11	by	by	ADP
dti-2660	139	12	about	about	ADV
dti-2660	139	13	1.5	1.5	NUM
dti-2660	139	14	l	l	NOUN
dti-2660	139	15	reduced	reduce	VERB
dti-2660	139	16	cystitis	cystitis	NOUN
dti-2660	139	17	episodes	episode	NOUN
dti-2660	139	18	and	and	CCONJ
dti-2660	139	19	antibiotic	antibiotic	ADJ
dti-2660	139	20	usage	usage	NOUN
dti-2660	139	21	in	in	ADP
dti-2660	139	22	premenopausal	premenopausal	ADJ
dti-2660	139	23	women	woman	NOUN
dti-2660	139	24	with	with	ADP
dti-2660	139	25	rutis	rutis	NOUN
dti-2660	139	26	(	(	PUNCT
dti-2660	139	27	31	31	NUM
dti-2660	139	28	)	)	PUNCT
dti-2660	139	29	.	.	PUNCT
dti-2660	140	1	during	during	ADP
dti-2660	140	2	12	12	NUM
dti-2660	140	3	months	month	NOUN
dti-2660	140	4	of	of	ADP
dti-2660	140	5	follow	follow	NOUN
dti-2660	140	6	-	-	PUNCT
dti-2660	140	7	up	up	NOUN
dti-2660	140	8	,	,	PUNCT
dti-2660	140	9	the	the	DET
dti-2660	140	10	mean	mean	ADJ
dti-2660	140	11	number	number	NOUN
dti-2660	140	12	of	of	ADP
dti-2660	140	13	cystitis	cystitis	NOUN
dti-2660	140	14	episodes	episode	NOUN
dti-2660	140	15	in	in	ADP
dti-2660	140	16	the	the	DET
dti-2660	140	17	70	70	NUM
dti-2660	140	18	women	woman	NOUN
dti-2660	140	19	randomized	randomize	VERB
dti-2660	140	20	to	to	ADP
dti-2660	140	21	the	the	DET
dti-2660	140	22	increased	increase	VERB
dti-2660	140	23	water	water	NOUN
dti-2660	140	24	intake	intake	NOUN
dti-2660	140	25	group	group	NOUN
dti-2660	140	26	was	be	AUX
dti-2660	140	27	1.7	1.7	NUM
dti-2660	140	28	(	(	PUNCT
dti-2660	140	29	95	95	NUM
dti-2660	140	30	%	%	NOUN
dti-2660	140	31	confidence	confidence	NOUN
dti-2660	140	32	interval	interval	NOUN
dti-2660	141	1	[	[	X
dti-2660	141	2	ci	ci	X
dti-2660	141	3	]	]	X
dti-2660	141	4	,	,	PUNCT
dti-2660	141	5	1.5	1.5	NUM
dti-2660	141	6	to	to	PART
dti-2660	141	7	1.8	1.8	NUM
dti-2660	141	8	)	)	PUNCT
dti-2660	141	9	vs	vs	ADP
dti-2660	141	10	3.2	3.2	NUM
dti-2660	141	11	(	(	PUNCT
dti-2660	141	12	95	95	NUM
dti-2660	141	13	%	%	NOUN
dti-2660	141	14	ci	ci	NOUN
dti-2660	141	15	,	,	PUNCT
dti-2660	141	16	3.0	3.0	NUM
dti-2660	141	17	to	to	PART
dti-2660	141	18	3.4	3.4	NUM
dti-2660	141	19	)	)	PUNCT
dti-2660	141	20	in	in	ADP
dti-2660	141	21	the	the	DET
dti-2660	141	22	70	70	NUM
dti-2660	141	23	women	woman	NOUN
dti-2660	141	24	in	in	ADP
dti-2660	141	25	the	the	DET
dti-2660	141	26	control	control	NOUN
dti-2660	141	27	group	group	NOUN
dti-2660	141	28	who	who	PRON
dti-2660	141	29	did	do	AUX
dti-2660	141	30	not	not	PART
dti-2660	141	31	increase	increase	VERB
dti-2660	141	32	their	their	PRON
dti-2660	141	33	usual	usual	ADJ
dti-2660	141	34	water	water	NOUN
dti-2660	141	35	intake	intake	NOUN
dti-2660	141	36	,	,	PUNCT
dti-2660	141	37	a	a	DET
dti-2660	141	38	difference	difference	NOUN
dti-2660	141	39	in	in	ADP
dti-2660	141	40	means	mean	NOUN
dti-2660	141	41	of	of	ADP
dti-2660	141	42	1.5	1.5	NUM
dti-2660	141	43	(	(	PUNCT
dti-2660	141	44	95	95	NUM
dti-2660	141	45	%	%	NOUN
dti-2660	141	46	ci	ci	NOUN
dti-2660	141	47	,	,	PUNCT
dti-2660	141	48	1.2	1.2	NUM
dti-2660	141	49	to	to	ADP
dti-2660	141	50	1.8	1.8	NUM
dti-2660	141	51	;	;	PUNCT
dti-2660	141	52	p	p	X
dti-2660	141	53	<	<	X
dti-2660	141	54	0.001	0.001	NUM
dti-2660	141	55	)	)	PUNCT
dti-2660	141	56	.	.	PUNCT
dti-2660	142	1	over	over	ADP
dti-2660	142	2	that	that	DET
dti-2660	142	3	time	time	NOUN
dti-2660	142	4	,	,	PUNCT
dti-2660	142	5	the	the	DET
dti-2660	142	6	mean	mean	ADJ
dti-2660	142	7	number	number	NOUN
dti-2660	142	8	of	of	ADP
dti-2660	142	9	antibiotic	antibiotic	ADJ
dti-2660	142	10	regimens	regimen	NOUN
dti-2660	142	11	required	require	VERB
dti-2660	142	12	to	to	PART
dti-2660	142	13	treat	treat	VERB
dti-2660	142	14	cystitis	cystitis	NOUN
dti-2660	142	15	episodes	episode	NOUN
dti-2660	142	16	was	be	AUX
dti-2660	142	17	1.9	1.9	NUM
dti-2660	142	18	vs	vs	ADP
dti-2660	142	19	3.6	3.6	NUM
dti-2660	142	20	,	,	PUNCT
dti-2660	142	21	respectively	respectively	ADV
dti-2660	142	22	(	(	PUNCT
dti-2660	142	23	p	p	X
dti-2660	142	24	<	<	X
dti-2660	142	25	0.001	0.001	NUM
dti-2660	142	26	)	)	PUNCT
dti-2660	142	27	(	(	PUNCT
dti-2660	142	28	31	31	NUM
dti-2660	142	29	)	)	PUNCT
dti-2660	142	30	.	.	PUNCT
dti-2660	143	1	non	non	ADJ
dti-2660	143	2	-	-	ADJ
dti-2660	143	3	antimicrobial	antimicrobial	ADJ
dti-2660	143	4	strategies	strategy	NOUN
dti-2660	143	5	avoid	avoid	VERB
dti-2660	143	6	the	the	DET
dti-2660	143	7	risk	risk	NOUN
dti-2660	143	8	of	of	ADP
dti-2660	143	9	amr	amr	PROPN
dti-2660	143	10	and	and	CCONJ
dti-2660	143	11	are	be	AUX
dti-2660	143	12	the	the	DET
dti-2660	143	13	next	next	ADJ
dti-2660	143	14	step	step	NOUN
dti-2660	143	15	to	to	PART
dti-2660	143	16	consider	consider	VERB
dti-2660	143	17	before	before	SCONJ
dti-2660	143	18	antimicrobial	antimicrobial	ADJ
dti-2660	143	19	therapy	therapy	NOUN
dti-2660	143	20	is	be	AUX
dti-2660	143	21	used	use	VERB
dti-2660	143	22	.	.	PUNCT
dti-2660	144	1	these	these	DET
dti-2660	144	2	strategies	strategy	NOUN
dti-2660	144	3	include	include	VERB
dti-2660	144	4	hormonal	hormonal	ADJ
dti-2660	144	5	replacement	replacement	NOUN
dti-2660	144	6	therapy	therapy	NOUN
dti-2660	144	7	,	,	PUNCT
dti-2660	144	8	immunoactive	immunoactive	ADJ
dti-2660	144	9	prophylaxis	prophylaxis	NOUN
dti-2660	144	10	,	,	PUNCT
dti-2660	144	11	probiotics	probiotic	NOUN
dti-2660	144	12	,	,	PUNCT
dti-2660	144	13	cranberry	cranberry	NOUN
dti-2660	144	14	,	,	PUNCT
dti-2660	144	15	d	d	NOUN
dti-2660	144	16	-	-	PUNCT
dti-2660	144	17	mannose	mannose	NOUN
dti-2660	144	18	,	,	PUNCT
dti-2660	144	19	methenamine	methenamine	NOUN
dti-2660	144	20	hippurate	hippurate	NOUN
dti-2660	144	21	,	,	PUNCT
dti-2660	144	22	and	and	CCONJ
dti-2660	144	23	intravesical	intravesical	ADJ
dti-2660	144	24	instillations	instillation	NOUN
dti-2660	144	25	of	of	ADP
dti-2660	144	26	gags	gag	NOUN
dti-2660	144	27	(	(	PUNCT
dti-2660	144	28	8,32	8,32	NUM
dti-2660	144	29	-	-	SYM
dti-2660	144	30	34	34	NUM
dti-2660	144	31	)	)	PUNCT
dti-2660	144	32	.	.	PUNCT
dti-2660	145	1	hormonal	hormonal	ADJ
dti-2660	145	2	replacement	replacement	NOUN
dti-2660	145	3	using	use	VERB
dti-2660	145	4	topical	topical	ADJ
dti-2660	145	5	(	(	PUNCT
dti-2660	145	6	but	but	CCONJ
dti-2660	145	7	not	not	PART
dti-2660	145	8	oral	oral	ADJ
dti-2660	145	9	)	)	PUNCT
dti-2660	145	10	estrogen	estrogen	NOUN
dti-2660	145	11	therapy	therapy	NOUN
dti-2660	145	12	in	in	ADP
dti-2660	145	13	postmenopausal	postmenopausal	ADJ
dti-2660	145	14	women	woman	NOUN
dti-2660	145	15	,	,	PUNCT
dti-2660	145	16	intended	intend	VERB
dti-2660	145	17	to	to	PART
dti-2660	145	18	enhance	enhance	VERB
dti-2660	145	19	vaginal	vaginal	ADJ
dti-2660	145	20	and	and	CCONJ
dti-2660	145	21	urethral	urethral	ADJ
dti-2660	145	22	flora	flora	NOUN
dti-2660	145	23	,	,	PUNCT
dti-2660	145	24	has	have	AUX
dti-2660	145	25	been	be	AUX
dti-2660	145	26	shown	show	VERB
dti-2660	145	27	to	to	PART
dti-2660	145	28	have	have	VERB
dti-2660	145	29	some	some	DET
dti-2660	145	30	beneficial	beneficial	ADJ
dti-2660	145	31	effects	effect	NOUN
dti-2660	145	32	in	in	ADP
dti-2660	145	33	reducing	reduce	VERB
dti-2660	145	34	rutis	rutis	NOUN
dti-2660	145	35	without	without	ADP
dti-2660	145	36	systematic	systematic	ADJ
dti-2660	145	37	side	side	NOUN
dti-2660	145	38	effects	effect	NOUN
dti-2660	145	39	,	,	PUNCT
dti-2660	145	40	although	although	SCONJ
dti-2660	145	41	local	local	ADJ
dti-2660	145	42	irritation	irritation	NOUN
dti-2660	145	43	and	and	CCONJ
dti-2660	145	44	minor	minor	ADJ
dti-2660	145	45	bleeding	bleeding	NOUN
dti-2660	145	46	can	can	AUX
dti-2660	145	47	occur	occur	VERB
dti-2660	145	48	(	(	PUNCT
dti-2660	145	49	8,34	8,34	NUM
dti-2660	145	50	-	-	SYM
dti-2660	145	51	36	36	NUM
dti-2660	145	52	)	)	PUNCT
dti-2660	145	53	.	.	PUNCT
dti-2660	146	1	topical	topical	ADJ
dti-2660	146	2	estrogen	estrogen	NOUN
dti-2660	146	3	administration	administration	NOUN
dti-2660	146	4	by	by	ADP
dti-2660	146	5	vaginal	vaginal	ADJ
dti-2660	146	6	cream	cream	NOUN
dti-2660	146	7	or	or	CCONJ
dti-2660	146	8	pessary	pessary	NOUN
dti-2660	146	9	is	be	AUX
dti-2660	146	10	more	more	ADV
dti-2660	146	11	effective	effective	ADJ
dti-2660	146	12	than	than	ADP
dti-2660	146	13	placebo	placebo	NOUN
dti-2660	146	14	but	but	CCONJ
dti-2660	146	15	less	less	ADV
dti-2660	146	16	effective	effective	ADJ
dti-2660	146	17	than	than	ADP
dti-2660	146	18	antimicrobial	antimicrobial	ADJ
dti-2660	146	19	prophylaxis	prophylaxis	NOUN
dti-2660	146	20	.	.	PUNCT
dti-2660	147	1	a	a	DET
dti-2660	147	2	number	number	NOUN
dti-2660	147	3	of	of	ADP
dti-2660	147	4	different	different	ADJ
dti-2660	147	5	immune	immune	ADJ
dti-2660	147	6	cells	cell	NOUN
dti-2660	147	7	are	be	AUX
dti-2660	147	8	present	present	ADJ
dti-2660	147	9	in	in	ADP
dti-2660	147	10	the	the	DET
dti-2660	147	11	bladder	bladder	NOUN
dti-2660	147	12	,	,	PUNCT
dti-2660	147	13	including	include	VERB
dti-2660	147	14	macrophages	macrophage	NOUN
dti-2660	147	15	,	,	PUNCT
dti-2660	147	16	dendritic	dendritic	ADJ
dti-2660	147	17	cells	cell	NOUN
dti-2660	147	18	,	,	PUNCT
dti-2660	147	19	lymphocytes	lymphocyte	NOUN
dti-2660	147	20	,	,	PUNCT
dti-2660	147	21	monocytes	monocyte	NOUN
dti-2660	147	22	,	,	PUNCT
dti-2660	147	23	neutrophils	neutrophil	NOUN
dti-2660	147	24	,	,	PUNCT
dti-2660	147	25	and	and	CCONJ
dti-2660	147	26	eosinophils	eosinophil	VERB
dti-2660	147	27	,	,	PUNCT
dti-2660	147	28	suggesting	suggest	VERB
dti-2660	147	29	a	a	DET
dti-2660	147	30	role	role	NOUN
dti-2660	147	31	for	for	ADP
dti-2660	147	32	prophylaxis	prophylaxis	NOUN
dti-2660	147	33	with	with	ADP
dti-2660	147	34	immunoactive	immunoactive	ADJ
dti-2660	147	35	agents	agent	NOUN
dti-2660	147	36	in	in	ADP
dti-2660	147	37	utis	utis	PROPN
dti-2660	147	38	(	(	PUNCT
dti-2660	147	39	8,34	8,34	NUM
dti-2660	147	40	)	)	PUNCT
dti-2660	147	41	.	.	PUNCT
dti-2660	148	1	immunoactive	immunoactive	ADJ
dti-2660	148	2	agents	agent	NOUN
dti-2660	148	3	are	be	AUX
dti-2660	148	4	understood	understand	VERB
dti-2660	148	5	to	to	PART
dti-2660	148	6	stimulate	stimulate	VERB
dti-2660	148	7	both	both	CCONJ
dti-2660	148	8	the	the	DET
dti-2660	148	9	innate	innate	ADJ
dti-2660	148	10	and	and	CCONJ
dti-2660	148	11	adaptive	adaptive	ADJ
dti-2660	148	12	immune	immune	ADJ
dti-2660	148	13	systems	system	NOUN
dti-2660	148	14	to	to	PART
dti-2660	148	15	increase	increase	VERB
dti-2660	148	16	the	the	DET
dti-2660	148	17	production	production	NOUN
dti-2660	148	18	of	of	ADP
dti-2660	148	19	bacteria	bacteria	NOUN
dti-2660	148	20	-	-	PUNCT
dti-2660	148	21	specific	specific	ADJ
dti-2660	148	22	antibodies	antibody	NOUN
dti-2660	148	23	.	.	PUNCT
dti-2660	149	1	om-89	om-89	PUNCT
dti-2660	149	2	(	(	PUNCT
dti-2660	149	3	uro	uro	PROPN
dti-2660	149	4	-	-	PUNCT
dti-2660	149	5	vaxom	vaxom	PROPN
dti-2660	149	6	)	)	PUNCT
dti-2660	149	7	is	be	AUX
dti-2660	149	8	perhaps	perhaps	ADV
dti-2660	149	9	the	the	DET
dti-2660	149	10	most	most	ADV
dti-2660	149	11	widely	widely	ADV
dti-2660	149	12	studied	study	VERB
dti-2660	149	13	immunostimulant	immunostimulant	NOUN
dti-2660	149	14	,	,	PUNCT
dti-2660	149	15	consisting	consist	VERB
dti-2660	149	16	of	of	ADP
dti-2660	149	17	an	an	DET
dti-2660	149	18	extract	extract	NOUN
dti-2660	149	19	for	for	ADP
dti-2660	149	20	oral	oral	ADJ
dti-2660	149	21	administration	administration	NOUN
dti-2660	149	22	of	of	ADP
dti-2660	149	23	18	18	NUM
dti-2660	149	24	strains	strain	NOUN
dti-2660	149	25	of	of	ADP
dti-2660	149	26	heat	heat	NOUN
dti-2660	149	27	-	-	PUNCT
dti-2660	149	28	killed	kill	VERB
dti-2660	149	29	upec	upec	NOUN
dti-2660	149	30	.	.	PUNCT
dti-2660	150	1	om-89	om-89	NUM
dti-2660	150	2	-	-	PUNCT
dti-2660	150	3	s	s	NOUN
dti-2660	150	4	is	be	AUX
dti-2660	150	5	a	a	DET
dti-2660	150	6	newer	new	ADJ
dti-2660	150	7	formulation	formulation	NOUN
dti-2660	150	8	prepared	prepare	VERB
dti-2660	150	9	by	by	ADP
dti-2660	150	10	a	a	DET
dti-2660	150	11	different	different	ADJ
dti-2660	150	12	lysis	lysis	NOUN
dti-2660	150	13	process	process	NOUN
dti-2660	150	14	.	.	PUNCT
dti-2660	151	1	om-89	om-89	PUNCT
dti-2660	152	1	(	(	PUNCT
dti-2660	152	2	but	but	CCONJ
dti-2660	152	3	not	not	PART
dti-2660	152	4	om-89s	om-89s	NUM
dti-2660	152	5	)	)	PUNCT
dti-2660	152	6	has	have	AUX
dti-2660	152	7	shown	show	VERB
dti-2660	152	8	significant	significant	ADJ
dti-2660	152	9	efficacy	efficacy	NOUN
dti-2660	152	10	in	in	ADP
dti-2660	152	11	the	the	DET
dti-2660	152	12	prophylaxis	prophylaxis	NOUN
dti-2660	152	13	of	of	ADP
dti-2660	152	14	rutis	rutis	NOUN
dti-2660	152	15	and	and	CCONJ
dti-2660	152	16	is	be	AUX
dti-2660	152	17	included	include	VERB
dti-2660	152	18	in	in	ADP
dti-2660	152	19	the	the	DET
dti-2660	152	20	eau	eau	PROPN
dti-2660	152	21	guidelines	guideline	NOUN
dti-2660	152	22	as	as	ADP
dti-2660	152	23	an	an	DET
dti-2660	152	24	option	option	NOUN
dti-2660	152	25	with	with	ADP
dti-2660	152	26	a	a	DET
dti-2660	152	27	high	high	ADJ
dti-2660	152	28	level	level	NOUN
dti-2660	152	29	of	of	ADP
dti-2660	152	30	evidence	evidence	NOUN
dti-2660	152	31	for	for	ADP
dti-2660	152	32	preventing	prevent	VERB
dti-2660	152	33	ruti	ruti	PROPN
dti-2660	152	34	in	in	ADP
dti-2660	152	35	women	woman	NOUN
dti-2660	152	36	(	(	PUNCT
dti-2660	152	37	8,33,34,37,38	8,33,34,37,38	NOUN
dti-2660	152	38	)	)	PUNCT
dti-2660	152	39	.	.	PUNCT
dti-2660	153	1	a	a	DET
dti-2660	153	2	systematic	systematic	ADJ
dti-2660	153	3	review	review	NOUN
dti-2660	153	4	of	of	ADP
dti-2660	153	5	the	the	DET
dti-2660	153	6	role	role	NOUN
dti-2660	153	7	of	of	ADP
dti-2660	153	8	vaccines	vaccine	NOUN
dti-2660	153	9	in	in	ADP
dti-2660	153	10	the	the	DET
dti-2660	153	11	treatment	treatment	NOUN
dti-2660	153	12	of	of	ADP
dti-2660	153	13	rutis	rutis	NOUN
dti-2660	153	14	concluded	conclude	VERB
dti-2660	153	15	that	that	SCONJ
dti-2660	153	16	om-89	om-89	PUNCT
dti-2660	153	17	(	(	PUNCT
dti-2660	153	18	usually	usually	ADV
dti-2660	153	19	at	at	ADP
dti-2660	153	20	a	a	DET
dti-2660	153	21	dose	dose	NOUN
dti-2660	153	22	of	of	ADP
dti-2660	153	23	one	one	NUM
dti-2660	153	24	oral	oral	ADJ
dti-2660	153	25	tablet	tablet	NOUN
dti-2660	153	26	once	once	ADV
dti-2660	153	27	daily	daily	ADV
dti-2660	153	28	for	for	ADP
dti-2660	153	29	3	3	NUM
dti-2660	153	30	months	month	NOUN
dti-2660	153	31	,	,	PUNCT
dti-2660	153	32	and/or	and/or	CCONJ
dti-2660	153	33	a	a	DET
dti-2660	153	34	booster	booster	NOUN
dti-2660	153	35	of	of	ADP
dti-2660	153	36	one	one	NUM
dti-2660	153	37	tablet	tablet	NOUN
dti-2660	153	38	daily	daily	ADV
dti-2660	153	39	for	for	ADP
dti-2660	153	40	the	the	DET
dti-2660	153	41	first	first	ADJ
dti-2660	153	42	10	10	NUM
dti-2660	153	43	days	day	NOUN
dti-2660	153	44	of	of	ADP
dti-2660	153	45	months	month	NOUN
dti-2660	153	46	6	6	NUM
dti-2660	153	47	-	-	SYM
dti-2660	153	48	9	9	NUM
dti-2660	153	49	)	)	PUNCT
dti-2660	153	50	had	have	VERB
dti-2660	153	51	a	a	DET
dti-2660	153	52	short	short	ADJ
dti-2660	153	53	-	-	PUNCT
dti-2660	153	54	term	term	NOUN
dti-2660	153	55	role	role	NOUN
dti-2660	153	56	in	in	ADP
dti-2660	153	57	preventing	prevent	VERB
dti-2660	153	58	rutis	rutis	NOUN
dti-2660	153	59	,	,	PUNCT
dti-2660	153	60	significantly	significantly	ADV
dti-2660	153	61	reducing	reduce	VERB
dti-2660	153	62	the	the	DET
dti-2660	153	63	risk	risk	NOUN
dti-2660	153	64	of	of	ADP
dti-2660	153	65	recurrence	recurrence	NOUN
dti-2660	153	66	compared	compare	VERB
dti-2660	153	67	with	with	ADP
dti-2660	153	68	placebo	placebo	NOUN
dti-2660	153	69	,	,	PUNCT
dti-2660	153	70	with	with	ADP
dti-2660	153	71	only	only	ADJ
dti-2660	153	72	mild	mild	ADJ
dti-2660	153	73	side	side	NOUN
dti-2660	153	74	effects	effect	NOUN
dti-2660	153	75	(	(	PUNCT
dti-2660	153	76	33	33	NUM
dti-2660	153	77	)	)	PUNCT
dti-2660	153	78	.	.	PUNCT
dti-2660	154	1	however	however	ADV
dti-2660	154	2	,	,	PUNCT
dti-2660	154	3	vaccination	vaccination	NOUN
dti-2660	154	4	therapies	therapy	NOUN
dti-2660	154	5	remain	remain	VERB
dti-2660	154	6	under	under	ADV
dti-2660	154	7	-	-	PUNCT
dti-2660	154	8	reviewed	review	VERB
dti-2660	154	9	,	,	PUNCT
dti-2660	154	10	and	and	CCONJ
dti-2660	154	11	further	further	ADJ
dti-2660	154	12	research	research	NOUN
dti-2660	154	13	is	be	AUX
dti-2660	154	14	needed	need	VERB
dti-2660	154	15	.	.	PUNCT
dti-2660	155	1	when	when	SCONJ
dti-2660	155	2	the	the	DET
dti-2660	155	3	balanced	balanced	ADJ
dti-2660	155	4	ecosystem	ecosystem	NOUN
dti-2660	155	5	of	of	ADP
dti-2660	155	6	normal	normal	ADJ
dti-2660	155	7	flora	flora	NOUN
dti-2660	155	8	in	in	ADP
dti-2660	155	9	the	the	DET
dti-2660	155	10	vagina	vagina	NOUN
dti-2660	155	11	is	be	AUX
dti-2660	155	12	disturbed	disturb	VERB
dti-2660	155	13	through	through	ADP
dti-2660	155	14	repeated	repeat	VERB
dti-2660	155	15	antibiotic	antibiotic	ADJ
dti-2660	155	16	use	use	NOUN
dti-2660	155	17	,	,	PUNCT
dti-2660	155	18	spermicide	spermicide	NOUN
dti-2660	155	19	use	use	NOUN
dti-2660	155	20	,	,	PUNCT
dti-2660	155	21	or	or	CCONJ
dti-2660	155	22	in	in	ADP
dti-2660	155	23	postmenopausal	postmenopausal	ADJ
dti-2660	155	24	women	woman	NOUN
dti-2660	155	25	,	,	PUNCT
dti-2660	155	26	the	the	DET
dti-2660	155	27	vagina	vagina	NOUN
dti-2660	155	28	may	may	AUX
dti-2660	155	29	become	become	VERB
dti-2660	155	30	a	a	DET
dti-2660	155	31	reservoir	reservoir	NOUN
dti-2660	155	32	for	for	ADP
dti-2660	155	33	uropathogenic	uropathogenic	ADJ
dti-2660	155	34	bacteria	bacteria	NOUN
dti-2660	155	35	(	(	PUNCT
dti-2660	155	36	12,34,39	12,34,39	NUM
dti-2660	155	37	)	)	PUNCT
dti-2660	155	38	.	.	PUNCT
dti-2660	156	1	probiotics	probiotic	NOUN
dti-2660	156	2	may	may	AUX
dti-2660	156	3	help	help	VERB
dti-2660	156	4	to	to	PART
dti-2660	156	5	prevent	prevent	VERB
dti-2660	156	6	rutis	rutis	NOUN
dti-2660	156	7	through	through	ADP
dti-2660	156	8	many	many	ADJ
dti-2660	156	9	mechanisms	mechanism	NOUN
dti-2660	156	10	,	,	PUNCT
dti-2660	156	11	including	include	VERB
dti-2660	156	12	restoration	restoration	NOUN
dti-2660	156	13	of	of	ADP
dti-2660	156	14	the	the	DET
dti-2660	156	15	natural	natural	ADJ
dti-2660	156	16	vaginal	vaginal	ADJ
dti-2660	156	17	microbiota	microbiota	NOUN
dti-2660	156	18	by	by	ADP
dti-2660	156	19	increasing	increase	VERB
dti-2660	156	20	the	the	DET
dti-2660	156	21	level	level	NOUN
dti-2660	156	22	of	of	ADP
dti-2660	156	23	protective	protective	ADJ
dti-2660	156	24	lactobacillus	lactobacillus	NOUN
dti-2660	156	25	species	specie	NOUN
dti-2660	156	26	,	,	PUNCT
dti-2660	156	27	altering	alter	VERB
dti-2660	156	28	the	the	DET
dti-2660	156	29	ph	ph	NOUN
dti-2660	156	30	of	of	ADP
dti-2660	156	31	the	the	DET
dti-2660	156	32	vagina	vagina	NOUN
dti-2660	156	33	,	,	PUNCT
dti-2660	156	34	inhibiting	inhibit	VERB
dti-2660	156	35	bacterial	bacterial	ADJ
dti-2660	156	36	biofilm	biofilm	NOUN
dti-2660	156	37	formation	formation	NOUN
dti-2660	156	38	,	,	PUNCT
dti-2660	156	39	downregulating	downregulate	VERB
dti-2660	156	40	inflammatory	inflammatory	ADJ
dti-2660	156	41	cytokines	cytokine	NOUN
dti-2660	156	42	,	,	PUNCT
dti-2660	156	43	and	and	CCONJ
dti-2660	156	44	inhibiting	inhibit	VERB
dti-2660	156	45	the	the	DET
dti-2660	156	46	uptake	uptake	NOUN
dti-2660	156	47	of	of	ADP
dti-2660	156	48	e.	e.	PROPN
dti-2660	156	49	coli	coli	NOUN
dti-2660	156	50	by	by	ADP
dti-2660	156	51	vaginal	vaginal	ADJ
dti-2660	156	52	epithelial	epithelial	ADJ
dti-2660	156	53	receptors	receptor	NOUN
dti-2660	156	54	.	.	PUNCT
dti-2660	157	1	while	while	SCONJ
dti-2660	157	2	there	there	PRON
dti-2660	157	3	are	be	VERB
dti-2660	157	4	some	some	DET
dti-2660	157	5	contradictory	contradictory	ADJ
dti-2660	157	6	findings	finding	NOUN
dti-2660	157	7	,	,	PUNCT
dti-2660	157	8	oral	oral	ADJ
dti-2660	157	9	or	or	CCONJ
dti-2660	157	10	vaginal	vaginal	ADJ
dti-2660	157	11	administration	administration	NOUN
dti-2660	157	12	of	of	ADP
dti-2660	157	13	the	the	DET
dti-2660	157	14	lactobacillus	lactobacillus	NOUN
dti-2660	157	15	strains	strain	VERB
dti-2660	157	16	l.	l.	PROPN
dti-2660	157	17	rhamnosus	rhamnosus	PROPN
dti-2660	157	18	gr-1	gr-1	PROPN
dti-2660	157	19	,	,	PUNCT
dti-2660	157	20	l.	l.	PROPN
dti-2660	157	21	reuteri	reuteri	PROPN
dti-2660	157	22	b-54	b-54	PROPN
dti-2660	157	23	and	and	CCONJ
dti-2660	157	24	rc-14	rc-14	ADV
dti-2660	157	25	,	,	PUNCT
dti-2660	157	26	l.	l.	PROPN
dti-2660	157	27	casei	casei	PROPN
dti-2660	157	28	shirota	shirota	NOUN
dti-2660	157	29	,	,	PUNCT
dti-2660	157	30	or	or	CCONJ
dti-2660	157	31	l.	l.	PROPN
dti-2660	157	32	crispatus	crispatus	PROPN
dti-2660	157	33	ctv-05	ctv-05	PROPN
dti-2660	157	34	have	have	AUX
dti-2660	157	35	been	be	AUX
dti-2660	157	36	shown	show	VERB
dti-2660	157	37	to	to	PART
dti-2660	157	38	be	be	AUX
dti-2660	157	39	effective	effective	ADJ
dti-2660	157	40	for	for	ADP
dti-2660	157	41	vaginal	vaginal	ADJ
dti-2660	157	42	flora	flora	NOUN
dti-2660	157	43	restoration	restoration	NOUN
dti-2660	157	44	and	and	CCONJ
dti-2660	157	45	a	a	DET
dti-2660	157	46	beneficial	beneficial	ADJ
dti-2660	157	47	effect	effect	NOUN
dti-2660	157	48	in	in	ADP
dti-2660	157	49	preventing	prevent	VERB
dti-2660	157	50	rutis	rutis	NOUN
dti-2660	157	51	(	(	PUNCT
dti-2660	157	52	8,12,34,36,39,40	8,12,34,36,39,40	NUM
dti-2660	157	53	)	)	PUNCT
dti-2660	157	54	.	.	PUNCT
dti-2660	158	1	however	however	ADV
dti-2660	158	2	,	,	PUNCT
dti-2660	158	3	the	the	DET
dti-2660	158	4	level	level	NOUN
dti-2660	158	5	of	of	ADP
dti-2660	158	6	evidence	evidence	NOUN
dti-2660	158	7	is	be	AUX
dti-2660	158	8	insufficient	insufficient	ADJ
dti-2660	158	9	to	to	PART
dti-2660	158	10	allow	allow	VERB
dti-2660	158	11	definitive	definitive	ADJ
dti-2660	158	12	recommendations	recommendation	NOUN
dti-2660	158	13	on	on	ADP
dti-2660	158	14	the	the	DET
dti-2660	158	15	route	route	NOUN
dti-2660	158	16	of	of	ADP
dti-2660	158	17	admission	admission	NOUN
dti-2660	158	18	,	,	PUNCT
dti-2660	158	19	optimal	optimal	ADJ
dti-2660	158	20	dosage	dosage	NOUN
dti-2660	158	21	,	,	PUNCT
dti-2660	158	22	or	or	CCONJ
dti-2660	158	23	treatment	treatment	NOUN
dti-2660	158	24	duration	duration	NOUN
dti-2660	158	25	(	(	PUNCT
dti-2660	158	26	8,35	8,35	NUM
dti-2660	158	27	)	)	PUNCT
dti-2660	158	28	.	.	PUNCT
dti-2660	159	1	a	a	DET
dti-2660	159	2	number	number	NOUN
dti-2660	159	3	of	of	ADP
dti-2660	159	4	meta	meta	ADJ
dti-2660	159	5	-	-	PUNCT
dti-2660	159	6	analyses	analysis	NOUN
dti-2660	159	7	and	and	CCONJ
dti-2660	159	8	systematic	systematic	ADJ
dti-2660	159	9	reviews	review	NOUN
dti-2660	159	10	that	that	PRON
dti-2660	159	11	have	have	AUX
dti-2660	159	12	investigated	investigate	VERB
dti-2660	159	13	the	the	DET
dti-2660	159	14	efficacy	efficacy	NOUN
dti-2660	159	15	of	of	ADP
dti-2660	159	16	cranberry	cranberry	NOUN
dti-2660	159	17	-	-	PUNCT
dti-2660	159	18	containing	contain	VERB
dti-2660	159	19	products	product	NOUN
dti-2660	159	20	have	have	AUX
dti-2660	159	21	found	find	VERB
dti-2660	159	22	a	a	DET
dti-2660	159	23	favorable	favorable	ADJ
dti-2660	159	24	benefit	benefit	NOUN
dti-2660	159	25	-	-	PUNCT
dti-2660	159	26	to	to	ADP
dti-2660	159	27	-	-	PUNCT
dti-2660	159	28	harm	harm	NOUN
dti-2660	159	29	ratio	ratio	NOUN
dti-2660	159	30	but	but	CCONJ
dti-2660	159	31	limited	limited	ADJ
dti-2660	159	32	evidence	evidence	NOUN
dti-2660	159	33	for	for	ADP
dti-2660	159	34	their	their	PRON
dti-2660	159	35	efficacy	efficacy	NOUN
dti-2660	159	36	in	in	ADP
dti-2660	159	37	protection	protection	NOUN
dti-2660	159	38	against	against	ADP
dti-2660	159	39	utis	utis	NOUN
dti-2660	159	40	.	.	PUNCT
dti-2660	160	1	however	however	ADV
dti-2660	160	2	,	,	PUNCT
dti-2660	160	3	a	a	DET
dti-2660	160	4	recent	recent	ADJ
dti-2660	160	5	cochrane	cochrane	NOUN
dti-2660	160	6	database	database	NOUN
dti-2660	160	7	systematic	systematic	PROPN
dti-2660	160	8	review	review	NOUN
dti-2660	160	9	of	of	ADP
dti-2660	160	10	50	50	NUM
dti-2660	160	11	randomized	randomized	ADJ
dti-2660	160	12	or	or	CCONJ
dti-2660	160	13	quasi	quasi	ADJ
dti-2660	160	14	-	-	ADJ
dti-2660	160	15	randomized	randomized	ADJ
dti-2660	160	16	controlled	control	VERB
dti-2660	160	17	trials	trial	NOUN
dti-2660	160	18	(	(	PUNCT
dti-2660	160	19	8,857	8,857	NUM
dti-2660	160	20	patients	patient	NOUN
dti-2660	160	21	)	)	PUNCT
dti-2660	160	22	of	of	ADP
dti-2660	160	23	cranberry	cranberry	NOUN
dti-2660	160	24	products	product	NOUN
dti-2660	160	25	vs	vs	ADP
dti-2660	160	26	placebo	placebo	NOUN
dti-2660	160	27	,	,	PUNCT
dti-2660	160	28	no	no	DET
dti-2660	160	29	specific	specific	ADJ
dti-2660	160	30	treatment	treatment	NOUN
dti-2660	160	31	,	,	PUNCT
dti-2660	160	32	or	or	CCONJ
dti-2660	160	33	other	other	ADJ
dti-2660	160	34	interventions	intervention	NOUN
dti-2660	160	35	for	for	ADP
dti-2660	160	36	the	the	DET
dti-2660	160	37	prevention	prevention	NOUN
dti-2660	160	38	of	of	ADP
dti-2660	160	39	utis	utis	NOUN
dti-2660	160	40	supports	support	VERB
dti-2660	160	41	their	their	PRON
dti-2660	160	42	use	use	NOUN
dti-2660	160	43	to	to	PART
dti-2660	160	44	reduce	reduce	VERB
dti-2660	160	45	the	the	DET
dti-2660	160	46	risk	risk	NOUN
dti-2660	160	47	of	of	ADP
dti-2660	160	48	symptomatic	symptomatic	ADJ
dti-2660	160	49	,	,	PUNCT
dti-2660	160	50	cultureverified	cultureverifie	VERB
dti-2660	160	51	utis	utis	NOUN
dti-2660	160	52	in	in	ADP
dti-2660	160	53	women	woman	NOUN
dti-2660	160	54	with	with	ADP
dti-2660	160	55	rutis	rutis	NOUN
dti-2660	160	56	,	,	PUNCT
dti-2660	160	57	children	child	NOUN
dti-2660	160	58	,	,	PUNCT
dti-2660	160	59	and	and	CCONJ
dti-2660	160	60	people	people	NOUN
dti-2660	160	61	susceptible	susceptible	ADJ
dti-2660	160	62	to	to	ADP
dti-2660	160	63	utis	utis	NOUN
dti-2660	160	64	following	follow	VERB
dti-2660	160	65	interventions	intervention	NOUN
dti-2660	160	66	(	(	PUNCT
dti-2660	160	67	41	41	NUM
dti-2660	160	68	)	)	PUNCT
dti-2660	160	69	.	.	PUNCT
dti-2660	161	1	currently	currently	ADV
dti-2660	161	2	,	,	PUNCT
dti-2660	161	3	the	the	DET
dti-2660	161	4	level	level	NOUN
dti-2660	161	5	of	of	ADP
dti-2660	161	6	evidence	evidence	NOUN
dti-2660	161	7	for	for	ADP
dti-2660	161	8	cranberry	cranberry	NOUN
dti-2660	161	9	products	product	NOUN
dti-2660	161	10	compared	compare	VERB
dti-2660	161	11	to	to	ADP
dti-2660	161	12	antibiotics	antibiotic	NOUN
dti-2660	161	13	or	or	CCONJ
dti-2660	161	14	probiotics	probiotic	NOUN
dti-2660	161	15	alone	alone	ADV
dti-2660	161	16	is	be	AUX
dti-2660	161	17	very	very	ADV
dti-2660	161	18	low	low	ADJ
dti-2660	161	19	,	,	PUNCT
dti-2660	161	20	and	and	CCONJ
dti-2660	161	21	the	the	DET
dti-2660	161	22	available	available	ADJ
dti-2660	161	23	evidence	evidence	NOUN
dti-2660	161	24	does	do	AUX
dti-2660	161	25	not	not	PART
dti-2660	161	26	support	support	VERB
dti-2660	161	27	their	their	PRON
dti-2660	161	28	use	use	NOUN
dti-2660	161	29	in	in	ADP
dti-2660	161	30	older	old	ADJ
dti-2660	161	31	patients	patient	NOUN
dti-2660	161	32	,	,	PUNCT
dti-2660	161	33	patients	patient	NOUN
dti-2660	161	34	with	with	ADP
dti-2660	161	35	bladder	bladder	NOUN
dti-2660	161	36	emptying	empty	VERB
dti-2660	161	37	problems	problem	NOUN
dti-2660	161	38	,	,	PUNCT
dti-2660	161	39	or	or	CCONJ
dti-2660	161	40	pregnant	pregnant	ADJ
dti-2660	161	41	women	woman	NOUN
dti-2660	161	42	.	.	PUNCT
dti-2660	162	1	the	the	DET
dti-2660	162	2	monosaccharide	monosaccharide	NOUN
dti-2660	162	3	isomer	isomer	NOUN
dti-2660	162	4	of	of	ADP
dti-2660	162	5	glucose	glucose	NOUN
dti-2660	162	6	,	,	PUNCT
dti-2660	162	7	d	d	X
dti-2660	162	8	-	-	PUNCT
dti-2660	162	9	mannose	mannose	NOUN
dti-2660	162	10	,	,	PUNCT
dti-2660	162	11	is	be	AUX
dti-2660	162	12	thought	think	VERB
dti-2660	162	13	to	to	PART
dti-2660	162	14	act	act	VERB
dti-2660	162	15	in	in	ADP
dti-2660	162	16	the	the	DET
dti-2660	162	17	bladder	bladder	NOUN
dti-2660	162	18	by	by	ADP
dti-2660	162	19	inhibiting	inhibit	VERB
dti-2660	162	20	the	the	DET
dti-2660	162	21	adhesion	adhesion	NOUN
dti-2660	162	22	of	of	ADP
dti-2660	162	23	upec	upec	NOUN
dti-2660	162	24	to	to	ADP
dti-2660	162	25	uroepithelial	uroepithelial	ADJ
dti-2660	162	26	cells	cell	NOUN
dti-2660	162	27	(	(	PUNCT
dti-2660	162	28	34,36	34,36	NUM
dti-2660	162	29	)	)	PUNCT
dti-2660	162	30	.	.	PUNCT
dti-2660	163	1	again	again	ADV
dti-2660	163	2	,	,	PUNCT
dti-2660	163	3	the	the	DET
dti-2660	163	4	overall	overall	ADJ
dti-2660	163	5	level	level	NOUN
dti-2660	163	6	of	of	ADP
dti-2660	163	7	evidence	evidence	NOUN
dti-2660	163	8	for	for	ADP
dti-2660	163	9	efficacy	efficacy	NOUN
dti-2660	163	10	in	in	ADP
dti-2660	163	11	the	the	DET
dti-2660	163	12	prevention	prevention	NOUN
dti-2660	163	13	of	of	ADP
dti-2660	163	14	ruti	ruti	PROPN
dti-2660	163	15	is	be	AUX
dti-2660	163	16	weak	weak	ADJ
dti-2660	163	17	and	and	CCONJ
dti-2660	163	18	contradictory	contradictory	ADJ
dti-2660	163	19	,	,	PUNCT
dti-2660	163	20	and	and	CCONJ
dti-2660	163	21	,	,	PUNCT
dti-2660	163	22	as	as	ADP
dti-2660	163	23	with	with	ADP
dti-2660	163	24	cranberry	cranberry	NOUN
dti-2660	163	25	products	product	NOUN
dti-2660	163	26	,	,	PUNCT
dti-2660	163	27	a	a	DET
dti-2660	163	28	good	good	ADJ
dti-2660	163	29	patient	patient	ADJ
dti-2660	163	30	history	history	NOUN
dti-2660	163	31	to	to	PART
dti-2660	163	32	identify	identify	VERB
dti-2660	163	33	what	what	PRON
dti-2660	163	34	has	have	AUX
dti-2660	163	35	already	already	ADV
dti-2660	163	36	been	be	AUX
dti-2660	163	37	tried	try	VERB
dti-2660	163	38	and	and	CCONJ
dti-2660	163	39	to	to	PART
dti-2660	163	40	determine	determine	VERB
dti-2660	163	41	what	what	PRON
dti-2660	163	42	triggers	trigger	NOUN
dti-2660	163	43	the	the	DET
dti-2660	163	44	uti	uti	PROPN
dti-2660	163	45	should	should	AUX
dti-2660	163	46	first	first	ADV
dti-2660	163	47	be	be	AUX
dti-2660	163	48	taken	take	VERB
dti-2660	163	49	.	.	PUNCT
dti-2660	164	1	the	the	DET
dti-2660	164	2	patient	patient	NOUN
dti-2660	164	3	should	should	AUX
dti-2660	164	4	be	be	AUX
dti-2660	164	5	informed	inform	VERB
dti-2660	164	6	that	that	SCONJ
dti-2660	164	7	further	further	ADJ
dti-2660	164	8	studies	study	NOUN
dti-2660	164	9	are	be	AUX
dti-2660	164	10	utis	utis	NOUN
dti-2660	164	11	in	in	ADP
dti-2660	164	12	the	the	DET
dti-2660	164	13	era	era	NOUN
dti-2660	164	14	of	of	ADP
dti-2660	164	15	amr132	amr132	PROPN
dti-2660	164	16	©	©	PROPN
dti-2660	164	17	2023	2023	NUM
dti-2660	164	18	the	the	DET
dti-2660	164	19	authors	author	NOUN
dti-2660	164	20	.	.	PUNCT
dti-2660	165	1	drug	drug	NOUN
dti-2660	165	2	target	target	NOUN
dti-2660	165	3	insights	insight	NOUN
dti-2660	165	4	issn	issn	VERB
dti-2660	165	5	1177	1177	NUM
dti-2660	165	6	-	-	SYM
dti-2660	165	7	3928	3928	NUM
dti-2660	165	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2660	165	9	needed	need	VERB
dti-2660	165	10	before	before	SCONJ
dti-2660	165	11	d	d	NOUN
dti-2660	165	12	-	-	PUNCT
dti-2660	165	13	mannose	mannose	NOUN
dti-2660	165	14	can	can	AUX
dti-2660	165	15	be	be	AUX
dti-2660	165	16	fully	fully	ADV
dti-2660	165	17	recommended	recommend	VERB
dti-2660	165	18	(	(	PUNCT
dti-2660	165	19	8)	8)	NUM
dti-2660	165	20	.	.	PUNCT
dti-2660	166	1	a	a	DET
dti-2660	166	2	recent	recent	ADJ
dti-2660	166	3	cochrane	cochrane	NOUN
dti-2660	166	4	systematic	systematic	ADJ
dti-2660	166	5	review	review	NOUN
dti-2660	166	6	of	of	ADP
dti-2660	166	7	randomized	randomized	ADJ
dti-2660	166	8	controlled	control	VERB
dti-2660	166	9	trials	trial	NOUN
dti-2660	166	10	also	also	ADV
dti-2660	166	11	concluded	conclude	VERB
dti-2660	166	12	that	that	SCONJ
dti-2660	166	13	there	there	PRON
dti-2660	166	14	is	be	VERB
dti-2660	166	15	currently	currently	ADV
dti-2660	166	16	little	little	ADJ
dti-2660	166	17	to	to	ADP
dti-2660	166	18	no	no	DET
dti-2660	166	19	evidence	evidence	NOUN
dti-2660	166	20	for	for	ADP
dti-2660	166	21	or	or	CCONJ
dti-2660	166	22	against	against	ADP
dti-2660	166	23	d	d	NOUN
dti-2660	166	24	-	-	PUNCT
dti-2660	166	25	mannose	mannose	ADJ
dti-2660	166	26	use	use	NOUN
dti-2660	166	27	in	in	ADP
dti-2660	166	28	preventing	prevent	VERB
dti-2660	166	29	rutis	rutis	NOUN
dti-2660	166	30	(	(	PUNCT
dti-2660	166	31	42	42	NUM
dti-2660	166	32	)	)	PUNCT
dti-2660	166	33	.	.	PUNCT
dti-2660	167	1	the	the	DET
dti-2660	167	2	urinary	urinary	ADJ
dti-2660	167	3	antiseptic	antiseptic	ADJ
dti-2660	167	4	methenamine	methenamine	NOUN
dti-2660	167	5	hippurate	hippurate	NOUN
dti-2660	167	6	(	(	PUNCT
dti-2660	167	7	hexamine	hexamine	NOUN
dti-2660	167	8	hippurate	hippurate	PROPN
dti-2660	167	9	)	)	PUNCT
dti-2660	167	10	has	have	VERB
dti-2660	167	11	bacteriostatic	bacteriostatic	ADJ
dti-2660	167	12	activity	activity	NOUN
dti-2660	167	13	via	via	ADP
dti-2660	167	14	the	the	DET
dti-2660	167	15	production	production	NOUN
dti-2660	167	16	of	of	ADP
dti-2660	167	17	formaldehyde	formaldehyde	NOUN
dti-2660	167	18	from	from	ADP
dti-2660	167	19	hexamine	hexamine	NOUN
dti-2660	167	20	in	in	ADP
dti-2660	167	21	an	an	DET
dti-2660	167	22	acid	acid	ADJ
dti-2660	167	23	environment	environment	NOUN
dti-2660	167	24	(	(	PUNCT
dti-2660	167	25	34,36	34,36	NUM
dti-2660	167	26	)	)	PUNCT
dti-2660	167	27	.	.	PUNCT
dti-2660	168	1	the	the	DET
dti-2660	168	2	most	most	ADV
dti-2660	168	3	recent	recent	ADJ
dti-2660	168	4	cochrane	cochrane	NOUN
dti-2660	168	5	review	review	NOUN
dti-2660	168	6	of	of	ADP
dti-2660	168	7	methenamine	methenamine	PROPN
dti-2660	168	8	hippurate	hippurate	NOUN
dti-2660	168	9	for	for	ADP
dti-2660	168	10	preventing	prevent	VERB
dti-2660	168	11	utis	utis	NOUN
dti-2660	168	12	dates	date	NOUN
dti-2660	168	13	back	back	ADV
dti-2660	168	14	to	to	ADP
dti-2660	168	15	2012	2012	NUM
dti-2660	168	16	when	when	SCONJ
dti-2660	168	17	it	it	PRON
dti-2660	168	18	was	be	AUX
dti-2660	168	19	concluded	conclude	VERB
dti-2660	168	20	that	that	SCONJ
dti-2660	168	21	methenamine	methenamine	PROPN
dti-2660	168	22	hippurate	hippurate	NOUN
dti-2660	168	23	might	might	AUX
dti-2660	168	24	be	be	AUX
dti-2660	168	25	effective	effective	ADJ
dti-2660	168	26	short	short	ADJ
dti-2660	168	27	-	-	PUNCT
dti-2660	168	28	term	term	NOUN
dti-2660	168	29	prophylaxis	prophylaxis	NOUN
dti-2660	168	30	in	in	ADP
dti-2660	168	31	patients	patient	NOUN
dti-2660	168	32	without	without	ADP
dti-2660	168	33	renal	renal	ADJ
dti-2660	168	34	tract	tract	NOUN
dti-2660	168	35	abnormalities	abnormality	NOUN
dti-2660	168	36	(	(	PUNCT
dti-2660	168	37	43	43	NUM
dti-2660	168	38	)	)	PUNCT
dti-2660	168	39	.	.	PUNCT
dti-2660	169	1	there	there	PRON
dti-2660	169	2	was	be	VERB
dti-2660	169	3	a	a	DET
dti-2660	169	4	76	76	NUM
dti-2660	169	5	%	%	NOUN
dti-2660	169	6	reduction	reduction	NOUN
dti-2660	169	7	in	in	ADP
dti-2660	169	8	the	the	DET
dti-2660	169	9	incidence	incidence	NOUN
dti-2660	169	10	of	of	ADP
dti-2660	169	11	utis	utis	NOUN
dti-2660	169	12	(	(	PUNCT
dti-2660	169	13	risk	risk	NOUN
dti-2660	169	14	ratio	ratio	NOUN
dti-2660	169	15	0.24	0.24	NUM
dti-2660	169	16	;	;	PUNCT
dti-2660	169	17	95	95	NUM
dti-2660	169	18	%	%	NOUN
dti-2660	169	19	ci	ci	NOUN
dti-2660	169	20	,	,	PUNCT
dti-2660	169	21	0.07	0.07	NUM
dti-2660	169	22	to	to	ADP
dti-2660	169	23	0.89	0.89	NUM
dti-2660	169	24	)	)	PUNCT
dti-2660	169	25	,	,	PUNCT
dti-2660	169	26	comparable	comparable	ADJ
dti-2660	169	27	to	to	ADP
dti-2660	169	28	antibiotic	antibiotic	ADJ
dti-2660	169	29	prophylaxis	prophylaxis	NOUN
dti-2660	169	30	,	,	PUNCT
dti-2660	169	31	but	but	CCONJ
dti-2660	169	32	the	the	DET
dti-2660	169	33	quality	quality	NOUN
dti-2660	169	34	of	of	ADP
dti-2660	169	35	studies	study	NOUN
dti-2660	169	36	included	include	VERB
dti-2660	169	37	in	in	ADP
dti-2660	169	38	the	the	DET
dti-2660	169	39	analysis	analysis	NOUN
dti-2660	169	40	was	be	AUX
dti-2660	169	41	mixed	mixed	ADJ
dti-2660	169	42	,	,	PUNCT
dti-2660	169	43	and	and	CCONJ
dti-2660	169	44	the	the	DET
dti-2660	169	45	data	datum	NOUN
dti-2660	169	46	were	be	AUX
dti-2660	169	47	heterogeneous	heterogeneous	ADJ
dti-2660	169	48	.	.	PUNCT
dti-2660	170	1	more	more	ADJ
dti-2660	170	2	recent	recent	ADJ
dti-2660	170	3	studies	study	NOUN
dti-2660	170	4	have	have	AUX
dti-2660	170	5	shown	show	VERB
dti-2660	170	6	that	that	SCONJ
dti-2660	170	7	long	long	ADJ
dti-2660	170	8	-	-	PUNCT
dti-2660	170	9	term	term	NOUN
dti-2660	170	10	(	(	PUNCT
dti-2660	170	11	6	6	NUM
dti-2660	170	12	-	-	SYM
dti-2660	170	13	12	12	NUM
dti-2660	170	14	months	month	NOUN
dti-2660	170	15	)	)	PUNCT
dti-2660	171	1	methenamine	methenamine	NOUN
dti-2660	171	2	hippurate	hippurate	NOUN
dti-2660	171	3	is	be	AUX
dti-2660	171	4	not	not	PART
dti-2660	171	5	inferior	inferior	ADJ
dti-2660	171	6	to	to	ADP
dti-2660	171	7	daily	daily	ADJ
dti-2660	171	8	low	low	ADJ
dti-2660	171	9	-	-	PUNCT
dti-2660	171	10	dose	dose	NOUN
dti-2660	171	11	antibiotics	antibiotic	NOUN
dti-2660	171	12	to	to	PART
dti-2660	171	13	prevent	prevent	VERB
dti-2660	171	14	ruti	ruti	PROPN
dti-2660	171	15	(	(	PUNCT
dti-2660	171	16	26,44	26,44	NUM
dti-2660	171	17	)	)	PUNCT
dti-2660	171	18	.	.	PUNCT
dti-2660	172	1	in	in	ADP
dti-2660	172	2	a	a	DET
dti-2660	172	3	study	study	NOUN
dti-2660	172	4	conducted	conduct	VERB
dti-2660	172	5	at	at	ADP
dti-2660	172	6	eight	eight	NUM
dti-2660	172	7	centers	center	NOUN
dti-2660	172	8	in	in	ADP
dti-2660	172	9	the	the	DET
dti-2660	172	10	united	united	ADJ
dti-2660	172	11	kingdom	kingdom	PROPN
dti-2660	172	12	,	,	PUNCT
dti-2660	172	13	240	240	NUM
dti-2660	172	14	women	woman	NOUN
dti-2660	172	15	with	with	ADP
dti-2660	172	16	rutis	rutis	NOUN
dti-2660	172	17	were	be	AUX
dti-2660	172	18	randomized	randomize	VERB
dti-2660	172	19	to	to	PART
dti-2660	172	20	methenamine	methenamine	VERB
dti-2660	172	21	hippurate	hippurate	NOUN
dti-2660	172	22	twice	twice	ADV
dti-2660	172	23	daily	daily	ADV
dti-2660	172	24	(	(	PUNCT
dti-2660	172	25	n	n	NOUN
dti-2660	172	26	=	=	SYM
dti-2660	172	27	120	120	NUM
dti-2660	172	28	)	)	PUNCT
dti-2660	172	29	or	or	CCONJ
dti-2660	172	30	daily	daily	ADJ
dti-2660	172	31	lowdose	lowdose	VERB
dti-2660	172	32	antibiotics	antibiotic	NOUN
dti-2660	172	33	(	(	PUNCT
dti-2660	172	34	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	172	35	,	,	PUNCT
dti-2660	172	36	trimethoprim	trimethoprim	NOUN
dti-2660	172	37	,	,	PUNCT
dti-2660	172	38	or	or	CCONJ
dti-2660	172	39	cefalexin	cefalexin	NOUN
dti-2660	172	40	;	;	PUNCT
dti-2660	172	41	n	n	NOUN
dti-2660	172	42	=	=	SYM
dti-2660	172	43	120	120	NUM
dti-2660	172	44	)	)	PUNCT
dti-2660	172	45	for	for	ADP
dti-2660	172	46	12	12	NUM
dti-2660	172	47	months	month	NOUN
dti-2660	172	48	(	(	PUNCT
dti-2660	172	49	26	26	NUM
dti-2660	172	50	)	)	PUNCT
dti-2660	172	51	.	.	PUNCT
dti-2660	173	1	during	during	ADP
dti-2660	173	2	the	the	DET
dti-2660	173	3	12	12	NUM
dti-2660	173	4	-	-	PUNCT
dti-2660	173	5	month	month	NOUN
dti-2660	173	6	treatment	treatment	NOUN
dti-2660	173	7	period	period	NOUN
dti-2660	173	8	,	,	PUNCT
dti-2660	173	9	the	the	DET
dti-2660	173	10	incidence	incidence	NOUN
dti-2660	173	11	of	of	ADP
dti-2660	173	12	utis	utis	NOUN
dti-2660	173	13	requiring	require	VERB
dti-2660	173	14	antibiotic	antibiotic	ADJ
dti-2660	173	15	treatment	treatment	NOUN
dti-2660	173	16	was	be	AUX
dti-2660	173	17	1.38	1.38	NUM
dti-2660	173	18	(	(	PUNCT
dti-2660	173	19	95	95	NUM
dti-2660	173	20	%	%	NOUN
dti-2660	173	21	ci	ci	NOUN
dti-2660	173	22	,	,	PUNCT
dti-2660	173	23	1.05	1.05	NUM
dti-2660	173	24	to	to	PART
dti-2660	173	25	1.72	1.72	NUM
dti-2660	173	26	)	)	PUNCT
dti-2660	173	27	episodes	episode	NOUN
dti-2660	173	28	per	per	ADP
dti-2660	173	29	person	person	NOUN
dti-2660	173	30	-	-	PUNCT
dti-2660	173	31	year	year	NOUN
dti-2660	173	32	in	in	ADP
dti-2660	173	33	the	the	DET
dti-2660	173	34	methenamine	methenamine	NOUN
dti-2660	173	35	hippurate	hippurate	PROPN
dti-2660	173	36	group	group	NOUN
dti-2660	173	37	and	and	CCONJ
dti-2660	173	38	0.89	0.89	NUM
dti-2660	173	39	(	(	PUNCT
dti-2660	173	40	95	95	NUM
dti-2660	173	41	%	%	NOUN
dti-2660	173	42	ci	ci	NOUN
dti-2660	173	43	,	,	PUNCT
dti-2660	173	44	0.65	0.65	NUM
dti-2660	173	45	to	to	ADP
dti-2660	173	46	1.12	1.12	NUM
dti-2660	173	47	)	)	PUNCT
dti-2660	173	48	in	in	ADP
dti-2660	173	49	the	the	DET
dti-2660	173	50	antibiotics	antibiotic	NOUN
dti-2660	173	51	group	group	NOUN
dti-2660	173	52	.	.	PUNCT
dti-2660	174	1	the	the	DET
dti-2660	174	2	absolute	absolute	ADJ
dti-2660	174	3	difference	difference	NOUN
dti-2660	174	4	of	of	ADP
dti-2660	174	5	0.49	0.49	NUM
dti-2660	174	6	(	(	PUNCT
dti-2660	174	7	90	90	NUM
dti-2660	174	8	%	%	NOUN
dti-2660	174	9	ci	ci	NOUN
dti-2660	174	10	,	,	PUNCT
dti-2660	174	11	0.15	0.15	NUM
dti-2660	174	12	to	to	PART
dti-2660	174	13	0.84	0.84	NUM
dti-2660	174	14	)	)	PUNCT
dti-2660	174	15	indicated	indicate	VERB
dti-2660	174	16	noninferiority	noninferiority	NOUN
dti-2660	174	17	between	between	ADP
dti-2660	174	18	the	the	DET
dti-2660	174	19	two	two	NUM
dti-2660	174	20	strategies	strategy	NOUN
dti-2660	174	21	.	.	PUNCT
dti-2660	175	1	therefore	therefore	ADV
dti-2660	175	2	,	,	PUNCT
dti-2660	175	3	the	the	DET
dti-2660	175	4	current	current	ADJ
dti-2660	175	5	recommendations	recommendation	NOUN
dti-2660	175	6	support	support	VERB
dti-2660	175	7	using	use	VERB
dti-2660	175	8	methenamine	methenamine	NOUN
dti-2660	175	9	hippurate	hippurate	NOUN
dti-2660	175	10	to	to	PART
dti-2660	175	11	prevent	prevent	VERB
dti-2660	175	12	rutis	rutis	NOUN
dti-2660	175	13	in	in	ADP
dti-2660	175	14	women	woman	NOUN
dti-2660	175	15	without	without	ADP
dti-2660	175	16	urinary	urinary	ADJ
dti-2660	175	17	tract	tract	NOUN
dti-2660	175	18	abnormalities	abnormality	NOUN
dti-2660	175	19	(	(	PUNCT
dti-2660	175	20	8)	8)	NUM
dti-2660	175	21	.	.	PUNCT
dti-2660	176	1	as	as	ADP
dti-2660	176	2	disruption	disruption	NOUN
dti-2660	176	3	of	of	ADP
dti-2660	176	4	the	the	DET
dti-2660	176	5	bladder	bladder	NOUN
dti-2660	176	6	lining	lining	NOUN
dti-2660	176	7	(	(	PUNCT
dti-2660	176	8	urothelium	urothelium	NOUN
dti-2660	176	9	)	)	PUNCT
dti-2660	177	1	and	and	CCONJ
dti-2660	177	2	resultant	resultant	VERB
dti-2660	177	3	loss	loss	NOUN
dti-2660	177	4	of	of	ADP
dti-2660	177	5	the	the	DET
dti-2660	177	6	protective	protective	ADJ
dti-2660	177	7	gag	gag	NOUN
dti-2660	177	8	layer	layer	NOUN
dti-2660	177	9	is	be	AUX
dti-2660	177	10	considered	consider	VERB
dti-2660	177	11	to	to	PART
dti-2660	177	12	be	be	AUX
dti-2660	177	13	a	a	DET
dti-2660	177	14	key	key	ADJ
dti-2660	177	15	factor	factor	NOUN
dti-2660	177	16	promoting	promote	VERB
dti-2660	177	17	rutis	rutis	NOUN
dti-2660	177	18	,	,	PUNCT
dti-2660	177	19	gag	gag	NOUN
dti-2660	177	20	therapy	therapy	NOUN
dti-2660	177	21	with	with	ADP
dti-2660	177	22	intravesical	intravesical	ADJ
dti-2660	177	23	instillations	instillation	NOUN
dti-2660	177	24	of	of	ADP
dti-2660	177	25	hyaluronic	hyaluronic	ADJ
dti-2660	177	26	acid	acid	NOUN
dti-2660	177	27	(	(	PUNCT
dti-2660	177	28	ha	ha	INTJ
dti-2660	177	29	)	)	PUNCT
dti-2660	177	30	or	or	CCONJ
dti-2660	177	31	ha	ha	INTJ
dti-2660	177	32	in	in	ADP
dti-2660	177	33	combination	combination	NOUN
dti-2660	177	34	with	with	ADP
dti-2660	177	35	chondroitin	chondroitin	NOUN
dti-2660	177	36	sulfate	sulfate	NOUN
dti-2660	177	37	(	(	PUNCT
dti-2660	177	38	cs	cs	PROPN
dti-2660	177	39	)	)	PUNCT
dti-2660	177	40	has	have	AUX
dti-2660	177	41	been	be	AUX
dti-2660	177	42	suggested	suggest	VERB
dti-2660	177	43	as	as	ADP
dti-2660	177	44	an	an	DET
dti-2660	177	45	option	option	NOUN
dti-2660	177	46	to	to	PART
dti-2660	177	47	prevent	prevent	VERB
dti-2660	177	48	rutis	rutis	NOUN
dti-2660	177	49	,	,	PUNCT
dti-2660	177	50	particularly	particularly	ADV
dti-2660	177	51	in	in	ADP
dti-2660	177	52	patients	patient	NOUN
dti-2660	177	53	where	where	SCONJ
dti-2660	177	54	less	less	ADV
dti-2660	177	55	invasive	invasive	ADJ
dti-2660	177	56	preventive	preventive	ADJ
dti-2660	177	57	approaches	approach	NOUN
dti-2660	177	58	have	have	AUX
dti-2660	177	59	been	be	AUX
dti-2660	177	60	unsuccessful	unsuccessful	ADJ
dti-2660	177	61	(	(	PUNCT
dti-2660	177	62	8)	8)	NUM
dti-2660	177	63	.	.	PUNCT
dti-2660	178	1	the	the	DET
dti-2660	178	2	quality	quality	NOUN
dti-2660	178	3	of	of	ADP
dti-2660	178	4	evidence	evidence	NOUN
dti-2660	178	5	for	for	ADP
dti-2660	178	6	the	the	DET
dti-2660	178	7	benefits	benefit	NOUN
dti-2660	178	8	of	of	ADP
dti-2660	178	9	combination	combination	NOUN
dti-2660	178	10	therapy	therapy	NOUN
dti-2660	178	11	is	be	AUX
dti-2660	178	12	highest	high	ADJ
dti-2660	178	13	,	,	PUNCT
dti-2660	178	14	as	as	SCONJ
dti-2660	178	15	randomized	randomize	VERB
dti-2660	178	16	controlled	control	VERB
dti-2660	178	17	trials	trial	NOUN
dti-2660	178	18	of	of	ADP
dti-2660	178	19	the	the	DET
dti-2660	178	20	instillation	instillation	NOUN
dti-2660	178	21	of	of	ADP
dti-2660	178	22	single	single	ADJ
dti-2660	178	23	-	-	PUNCT
dti-2660	178	24	agent	agent	NOUN
dti-2660	178	25	ha	ha	INTJ
dti-2660	178	26	or	or	CCONJ
dti-2660	178	27	cs	cs	PROPN
dti-2660	178	28	are	be	AUX
dti-2660	178	29	lacking	lack	VERB
dti-2660	178	30	.	.	PUNCT
dti-2660	179	1	in	in	ADP
dti-2660	179	2	a	a	DET
dti-2660	179	3	randomized	randomized	ADJ
dti-2660	179	4	trial	trial	NOUN
dti-2660	179	5	in	in	ADP
dti-2660	179	6	57	57	NUM
dti-2660	179	7	women	woman	NOUN
dti-2660	179	8	with	with	ADP
dti-2660	179	9	ruti	ruti	PROPN
dti-2660	179	10	,	,	PUNCT
dti-2660	179	11	intravesical	intravesical	ADJ
dti-2660	179	12	administration	administration	NOUN
dti-2660	179	13	of	of	ADP
dti-2660	179	14	50	50	NUM
dti-2660	179	15	ml	ml	NOUN
dti-2660	179	16	of	of	ADP
dti-2660	179	17	ha	ha	INTJ
dti-2660	179	18	1.6	1.6	NUM
dti-2660	179	19	%	%	NOUN
dti-2660	179	20	plus	plus	CCONJ
dti-2660	179	21	cs	cs	PROPN
dti-2660	179	22	2.0	2.0	NUM
dti-2660	179	23	%	%	NOUN
dti-2660	179	24	(	(	PUNCT
dti-2660	179	25	ialuril	ialuril	PROPN
dti-2660	179	26	®	®	PROPN
dti-2660	179	27	,	,	PUNCT
dti-2660	179	28	ibsa	ibsa	NOUN
dti-2660	179	29	)	)	PUNCT
dti-2660	179	30	for	for	ADP
dti-2660	179	31	6	6	NUM
dti-2660	179	32	months	month	NOUN
dti-2660	179	33	,	,	PUNCT
dti-2660	179	34	the	the	DET
dti-2660	179	35	decrease	decrease	NOUN
dti-2660	179	36	in	in	ADP
dti-2660	179	37	mean	mean	VERB
dti-2660	179	38	uti	uti	PROPN
dti-2660	179	39	rate	rate	NOUN
dti-2660	179	40	per	per	ADP
dti-2660	179	41	patient	patient	NOUN
dti-2660	179	42	-	-	PUNCT
dti-2660	179	43	year	year	NOUN
dti-2660	179	44	at	at	ADP
dti-2660	179	45	the	the	DET
dti-2660	179	46	end	end	NOUN
dti-2660	179	47	of	of	ADP
dti-2660	179	48	the	the	DET
dti-2660	179	49	12	12	NUM
dti-2660	179	50	-	-	PUNCT
dti-2660	179	51	month	month	NOUN
dti-2660	179	52	study	study	NOUN
dti-2660	179	53	was	be	AUX
dti-2660	179	54	86.6	86.6	NUM
dti-2660	179	55	%	%	NOUN
dti-2660	179	56	±	±	NUM
dti-2660	179	57	47.6	47.6	NUM
dti-2660	179	58	compared	compare	VERB
dti-2660	179	59	with	with	ADP
dti-2660	179	60	9.6	9.6	NUM
dti-2660	179	61	%	%	NOUN
dti-2660	179	62	±	±	NUM
dti-2660	179	63	24.6	24.6	NUM
dti-2660	179	64	for	for	ADP
dti-2660	179	65	placebo	placebo	NOUN
dti-2660	179	66	(	(	PUNCT
dti-2660	179	67	intravesical	intravesical	ADJ
dti-2660	179	68	saline	saline	NOUN
dti-2660	179	69	)	)	PUNCT
dti-2660	179	70	,	,	PUNCT
dti-2660	179	71	a	a	DET
dti-2660	179	72	mean	mean	ADJ
dti-2660	179	73	difference	difference	NOUN
dti-2660	179	74	of	of	ADP
dti-2660	179	75	77	77	NUM
dti-2660	179	76	%	%	NOUN
dti-2660	179	77	(	(	PUNCT
dti-2660	179	78	95	95	NUM
dti-2660	179	79	%	%	NOUN
dti-2660	179	80	ci	ci	NOUN
dti-2660	179	81	,	,	PUNCT
dti-2660	179	82	72.3	72.3	NUM
dti-2660	179	83	to	to	ADP
dti-2660	179	84	80.8	80.8	NUM
dti-2660	179	85	,	,	PUNCT
dti-2660	179	86	p	p	PROPN
dti-2660	179	87	=	=	NOUN
dti-2660	179	88	0.0002	0.0002	NUM
dti-2660	179	89	)	)	PUNCT
dti-2660	179	90	(	(	PUNCT
dti-2660	179	91	45	45	NUM
dti-2660	179	92	)	)	PUNCT
dti-2660	179	93	.	.	PUNCT
dti-2660	180	1	the	the	DET
dti-2660	180	2	mean	mean	ADJ
dti-2660	180	3	time	time	NOUN
dti-2660	180	4	to	to	ADP
dti-2660	180	5	uti	uti	PROPN
dti-2660	180	6	recurrence	recurrence	NOUN
dti-2660	180	7	was	be	AUX
dti-2660	180	8	also	also	ADV
dti-2660	180	9	significantly	significantly	ADV
dti-2660	180	10	shorter	short	ADJ
dti-2660	180	11	in	in	ADP
dti-2660	180	12	the	the	DET
dti-2660	180	13	placebo	placebo	NOUN
dti-2660	180	14	group	group	NOUN
dti-2660	180	15	.	.	PUNCT
dti-2660	181	1	given	give	VERB
dti-2660	181	2	the	the	DET
dti-2660	181	3	issue	issue	NOUN
dti-2660	181	4	of	of	ADP
dti-2660	181	5	antibiotic	antibiotic	ADJ
dti-2660	181	6	resistance	resistance	NOUN
dti-2660	181	7	,	,	PUNCT
dti-2660	181	8	the	the	DET
dti-2660	181	9	instillation	instillation	NOUN
dti-2660	181	10	of	of	ADP
dti-2660	181	11	gags	gag	NOUN
dti-2660	181	12	may	may	AUX
dti-2660	181	13	become	become	VERB
dti-2660	181	14	a	a	DET
dti-2660	181	15	recommended	recommend	VERB
dti-2660	181	16	prophylactic	prophylactic	ADJ
dti-2660	181	17	option	option	NOUN
dti-2660	181	18	to	to	ADP
dti-2660	181	19	antibiotic	antibiotic	ADJ
dti-2660	181	20	prophylaxis	prophylaxis	NOUN
dti-2660	181	21	when	when	SCONJ
dti-2660	181	22	more	more	ADJ
dti-2660	181	23	data	datum	NOUN
dti-2660	181	24	are	be	AUX
dti-2660	181	25	available	available	ADJ
dti-2660	181	26	.	.	PUNCT
dti-2660	182	1	another	another	DET
dti-2660	182	2	,	,	PUNCT
dti-2660	182	3	retrospective	retrospective	ADJ
dti-2660	182	4	,	,	PUNCT
dti-2660	182	5	case	case	NOUN
dti-2660	182	6	-	-	PUNCT
dti-2660	182	7	control	control	NOUN
dti-2660	182	8	study	study	NOUN
dti-2660	182	9	in	in	ADP
dti-2660	182	10	276	276	NUM
dti-2660	182	11	women	woman	NOUN
dti-2660	182	12	treated	treat	VERB
dti-2660	182	13	for	for	ADP
dti-2660	182	14	rutis	rutis	NOUN
dti-2660	182	15	at	at	ADP
dti-2660	182	16	seven	seven	NUM
dti-2660	182	17	european	european	ADJ
dti-2660	182	18	centers	center	NOUN
dti-2660	182	19	compared	compare	VERB
dti-2660	182	20	intravesical	intravesical	ADJ
dti-2660	182	21	administration	administration	NOUN
dti-2660	182	22	of	of	ADP
dti-2660	182	23	combination	combination	NOUN
dti-2660	182	24	ha+cs	ha+cs	NOUN
dti-2660	182	25	with	with	ADP
dti-2660	182	26	eaurecommended	eaurecommended	ADJ
dti-2660	182	27	standard	standard	NOUN
dti-2660	182	28	of	of	ADP
dti-2660	182	29	care	care	NOUN
dti-2660	182	30	(	(	PUNCT
dti-2660	182	31	continuous	continuous	ADJ
dti-2660	182	32	or	or	CCONJ
dti-2660	182	33	postcoital	postcoital	ADJ
dti-2660	182	34	antimicrobial	antimicrobial	ADJ
dti-2660	182	35	prophylaxis	prophylaxis	NOUN
dti-2660	182	36	,	,	PUNCT
dti-2660	182	37	immunoactive	immunoactive	ADJ
dti-2660	182	38	prophylaxis	prophylaxis	NOUN
dti-2660	182	39	,	,	PUNCT
dti-2660	182	40	prophylaxis	prophylaxis	ADJ
dti-2660	182	41	with	with	ADP
dti-2660	182	42	probiotics	probiotic	NOUN
dti-2660	182	43	or	or	CCONJ
dti-2660	182	44	cranberry	cranberry	NOUN
dti-2660	182	45	,	,	PUNCT
dti-2660	182	46	or	or	CCONJ
dti-2660	182	47	a	a	DET
dti-2660	182	48	combination	combination	NOUN
dti-2660	182	49	of	of	ADP
dti-2660	182	50	these	these	PRON
dti-2660	182	51	)	)	PUNCT
dti-2660	182	52	(	(	PUNCT
dti-2660	182	53	46	46	NUM
dti-2660	182	54	)	)	PUNCT
dti-2660	182	55	.	.	PUNCT
dti-2660	183	1	in	in	ADP
dti-2660	183	2	this	this	DET
dti-2660	183	3	real	real	ADJ
dti-2660	183	4	-	-	PUNCT
dti-2660	183	5	world	world	NOUN
dti-2660	183	6	setting	setting	NOUN
dti-2660	183	7	,	,	PUNCT
dti-2660	183	8	bladder	bladder	NOUN
dti-2660	183	9	instillation	instillation	NOUN
dti-2660	183	10	of	of	ADP
dti-2660	183	11	combined	combined	ADJ
dti-2660	183	12	ha	ha	INTJ
dti-2660	183	13	and	and	CCONJ
dti-2660	183	14	cs	cs	PROPN
dti-2660	183	15	reduced	reduce	VERB
dti-2660	183	16	the	the	DET
dti-2660	183	17	risk	risk	NOUN
dti-2660	183	18	of	of	ADP
dti-2660	183	19	uti	uti	PROPN
dti-2660	183	20	recurrences	recurrence	NOUN
dti-2660	183	21	,	,	PUNCT
dti-2660	183	22	compared	compare	VERB
dti-2660	183	23	with	with	ADP
dti-2660	183	24	standard	standard	ADJ
dti-2660	183	25	management	management	NOUN
dti-2660	183	26	(	(	PUNCT
dti-2660	183	27	55.7	55.7	NUM
dti-2660	183	28	%	%	NOUN
dti-2660	183	29	vs	vs	ADP
dti-2660	183	30	62.1	62.1	NUM
dti-2660	183	31	%	%	NOUN
dti-2660	183	32	,	,	PUNCT
dti-2660	183	33	respectively	respectively	ADV
dti-2660	183	34	)	)	PUNCT
dti-2660	183	35	,	,	PUNCT
dti-2660	183	36	although	although	SCONJ
dti-2660	183	37	the	the	DET
dti-2660	183	38	difference	difference	NOUN
dti-2660	183	39	did	do	AUX
dti-2660	183	40	not	not	PART
dti-2660	183	41	reach	reach	VERB
dti-2660	183	42	statistical	statistical	ADJ
dti-2660	183	43	significance	significance	NOUN
dti-2660	183	44	(	(	PUNCT
dti-2660	183	45	p	p	NOUN
dti-2660	183	46	=	=	NOUN
dti-2660	183	47	0.313	0.313	NUM
dti-2660	183	48	)	)	PUNCT
dti-2660	183	49	.	.	PUNCT
dti-2660	184	1	however	however	ADV
dti-2660	184	2	,	,	PUNCT
dti-2660	184	3	when	when	SCONJ
dti-2660	184	4	the	the	DET
dti-2660	184	5	adjusted	adjust	VERB
dti-2660	184	6	odds	odd	NOUN
dti-2660	184	7	ratio	ratio	NOUN
dti-2660	184	8	(	(	PUNCT
dti-2660	184	9	or	or	CCONJ
dti-2660	184	10	)	)	PUNCT
dti-2660	184	11	for	for	ADP
dti-2660	184	12	developing	develop	VERB
dti-2660	184	13	a	a	DET
dti-2660	184	14	bacteriologically	bacteriologically	ADV
dti-2660	184	15	confirmed	confirm	VERB
dti-2660	184	16	ruti	ruti	PROPN
dti-2660	184	17	within	within	ADP
dti-2660	184	18	12	12	NUM
dti-2660	184	19	months	month	NOUN
dti-2660	184	20	was	be	AUX
dti-2660	184	21	calculated	calculate	VERB
dti-2660	184	22	,	,	PUNCT
dti-2660	184	23	there	there	PRON
dti-2660	184	24	was	be	VERB
dti-2660	184	25	a	a	DET
dti-2660	184	26	49	49	NUM
dti-2660	184	27	%	%	NOUN
dti-2660	184	28	reduced	reduce	VERB
dti-2660	184	29	risk	risk	NOUN
dti-2660	184	30	of	of	ADP
dti-2660	184	31	developing	develop	VERB
dti-2660	184	32	a	a	DET
dti-2660	184	33	recurrence	recurrence	NOUN
dti-2660	184	34	in	in	ADP
dti-2660	184	35	women	woman	NOUN
dti-2660	184	36	treated	treat	VERB
dti-2660	184	37	with	with	ADP
dti-2660	184	38	ha+cs	ha+c	NOUN
dti-2660	184	39	compared	compare	VERB
dti-2660	184	40	with	with	ADP
dti-2660	184	41	standard	standard	ADJ
dti-2660	184	42	care	care	NOUN
dti-2660	184	43	(	(	PUNCT
dti-2660	184	44	or	or	CCONJ
dti-2660	184	45	0.51	0.51	NUM
dti-2660	184	46	,	,	PUNCT
dti-2660	184	47	95	95	NUM
dti-2660	184	48	%	%	NOUN
dti-2660	184	49	ci	ci	NOUN
dti-2660	184	50	,	,	PUNCT
dti-2660	184	51	0.27	0.27	NUM
dti-2660	184	52	to	to	ADP
dti-2660	184	53	0.96	0.96	NUM
dti-2660	184	54	)	)	PUNCT
dti-2660	184	55	(	(	PUNCT
dti-2660	184	56	46	46	NUM
dti-2660	184	57	)	)	PUNCT
dti-2660	184	58	.	.	PUNCT
dti-2660	185	1	treatment	treatment	NOUN
dti-2660	185	2	adherence	adherence	NOUN
dti-2660	185	3	(	(	PUNCT
dti-2660	185	4	≥5	≥5	NUM
dti-2660	185	5	instillations	instillation	NOUN
dti-2660	185	6	)	)	PUNCT
dti-2660	185	7	was	be	AUX
dti-2660	185	8	associated	associate	VERB
dti-2660	185	9	with	with	ADP
dti-2660	185	10	improved	improved	ADJ
dti-2660	185	11	benefits	benefit	NOUN
dti-2660	185	12	of	of	ADP
dti-2660	185	13	ha+cs	ha+cs	NOUN
dti-2660	185	14	therapy	therapy	NOUN
dti-2660	185	15	.	.	PUNCT
dti-2660	186	1	data	datum	NOUN
dti-2660	186	2	from	from	ADP
dti-2660	186	3	a	a	DET
dti-2660	186	4	systematic	systematic	ADJ
dti-2660	186	5	review	review	NOUN
dti-2660	186	6	and	and	CCONJ
dti-2660	186	7	meta	meta	NOUN
dti-2660	186	8	-	-	PUNCT
dti-2660	186	9	analysis	analysis	NOUN
dti-2660	186	10	of	of	ADP
dti-2660	186	11	randomized	randomized	ADJ
dti-2660	186	12	and	and	CCONJ
dti-2660	186	13	nonrandomized	nonrandomize	VERB
dti-2660	186	14	trials	trial	NOUN
dti-2660	186	15	found	find	VERB
dti-2660	186	16	that	that	SCONJ
dti-2660	186	17	ha	ha	INTJ
dti-2660	186	18	plus	plus	CCONJ
dti-2660	186	19	cs	cs	PROPN
dti-2660	186	20	decreased	decrease	VERB
dti-2660	186	21	the	the	DET
dti-2660	186	22	rate	rate	NOUN
dti-2660	186	23	of	of	ADP
dti-2660	186	24	ruti	ruti	PROPN
dti-2660	186	25	per	per	ADP
dti-2660	186	26	patient	patient	NOUN
dti-2660	186	27	-	-	PUNCT
dti-2660	186	28	year	year	NOUN
dti-2660	186	29	by	by	ADP
dti-2660	186	30	a	a	DET
dti-2660	186	31	pooled	pool	VERB
dti-2660	186	32	mean	mean	ADJ
dti-2660	186	33	difference	difference	NOUN
dti-2660	186	34	of	of	ADP
dti-2660	186	35	2.56	2.56	NUM
dti-2660	186	36	compared	compare	VERB
dti-2660	186	37	with	with	ADP
dti-2660	186	38	controls	control	NOUN
dti-2660	186	39	(	(	PUNCT
dti-2660	186	40	95	95	NUM
dti-2660	186	41	%	%	NOUN
dti-2660	186	42	ci	ci	NOUN
dti-2660	186	43	,	,	PUNCT
dti-2660	186	44	3.86	3.86	NUM
dti-2660	186	45	,	,	PUNCT
dti-2660	186	46	−1.26	−1.26	X
dti-2660	186	47	,	,	PUNCT
dti-2660	186	48	p	p	X
dti-2660	186	49	<	<	X
dti-2660	186	50	0.001	0.001	NUM
dti-2660	186	51	)	)	PUNCT
dti-2660	186	52	(	(	PUNCT
dti-2660	186	53	47	47	NUM
dti-2660	186	54	)	)	PUNCT
dti-2660	186	55	.	.	PUNCT
dti-2660	187	1	the	the	DET
dti-2660	187	2	time	time	NOUN
dti-2660	187	3	to	to	ADP
dti-2660	187	4	a	a	DET
dti-2660	187	5	first	first	ADJ
dti-2660	187	6	recurrence	recurrence	NOUN
dti-2660	187	7	of	of	ADP
dti-2660	187	8	a	a	DET
dti-2660	187	9	uti	uti	PROPN
dti-2660	187	10	was	be	AUX
dti-2660	187	11	also	also	ADV
dti-2660	187	12	increased	increase	VERB
dti-2660	187	13	by	by	ADP
dti-2660	187	14	a	a	DET
dti-2660	187	15	mean	mean	NOUN
dti-2660	187	16	of	of	ADP
dti-2660	187	17	130.05	130.05	NUM
dti-2660	187	18	days	day	NOUN
dti-2660	187	19	.	.	PUNCT
dti-2660	188	1	however	however	ADV
dti-2660	188	2	,	,	PUNCT
dti-2660	188	3	patients	patient	NOUN
dti-2660	188	4	should	should	AUX
dti-2660	188	5	be	be	AUX
dti-2660	188	6	informed	inform	VERB
dti-2660	188	7	that	that	SCONJ
dti-2660	188	8	further	further	ADJ
dti-2660	188	9	studies	study	NOUN
dti-2660	188	10	are	be	AUX
dti-2660	188	11	needed	need	VERB
dti-2660	188	12	to	to	PART
dti-2660	188	13	confirm	confirm	VERB
dti-2660	188	14	the	the	DET
dti-2660	188	15	results	result	NOUN
dti-2660	188	16	of	of	ADP
dti-2660	188	17	existing	exist	VERB
dti-2660	188	18	trials	trial	NOUN
dti-2660	188	19	(	(	PUNCT
dti-2660	188	20	8)	8)	NUM
dti-2660	188	21	.	.	PUNCT
dti-2660	189	1	an	an	DET
dti-2660	189	2	oral	oral	ADJ
dti-2660	189	3	formulation	formulation	NOUN
dti-2660	189	4	of	of	ADP
dti-2660	189	5	ha	ha	INTJ
dti-2660	189	6	,	,	PUNCT
dti-2660	189	7	cs	cs	ADJ
dti-2660	189	8	,	,	PUNCT
dti-2660	189	9	quercetin	quercetin	NOUN
dti-2660	189	10	,	,	PUNCT
dti-2660	189	11	and	and	CCONJ
dti-2660	189	12	curcumin	curcumin	NOUN
dti-2660	189	13	(	(	PUNCT
dti-2660	189	14	ialuril	ialuril	NOUN
dti-2660	189	15	®	®	NOUN
dti-2660	189	16	soft	soft	ADJ
dti-2660	189	17	gels	gel	NOUN
dti-2660	189	18	,	,	PUNCT
dti-2660	189	19	ibsa	ibsa	NOUN
dti-2660	189	20	)	)	PUNCT
dti-2660	189	21	is	be	AUX
dti-2660	189	22	available	available	ADJ
dti-2660	189	23	and	and	CCONJ
dti-2660	189	24	may	may	AUX
dti-2660	189	25	be	be	AUX
dti-2660	189	26	appropriate	appropriate	ADJ
dti-2660	189	27	in	in	ADP
dti-2660	189	28	patients	patient	NOUN
dti-2660	189	29	with	with	ADP
dti-2660	189	30	pelvic	pelvic	ADJ
dti-2660	189	31	pain	pain	NOUN
dti-2660	189	32	,	,	PUNCT
dti-2660	189	33	although	although	SCONJ
dti-2660	189	34	hard	hard	ADJ
dti-2660	189	35	data	datum	NOUN
dti-2660	189	36	on	on	ADP
dti-2660	189	37	usefulness	usefulness	NOUN
dti-2660	189	38	in	in	ADP
dti-2660	189	39	the	the	DET
dti-2660	189	40	prevention	prevention	NOUN
dti-2660	189	41	of	of	ADP
dti-2660	189	42	rutis	rutis	NOUN
dti-2660	189	43	are	be	AUX
dti-2660	189	44	limited	limited	ADJ
dti-2660	189	45	.	.	PUNCT
dti-2660	190	1	many	many	ADJ
dti-2660	190	2	other	other	ADJ
dti-2660	190	3	non	non	ADJ
dti-2660	190	4	-	-	ADJ
dti-2660	190	5	antimicrobial	antimicrobial	ADJ
dti-2660	190	6	options	option	NOUN
dti-2660	190	7	have	have	AUX
dti-2660	190	8	been	be	AUX
dti-2660	190	9	investigated	investigate	VERB
dti-2660	190	10	or	or	CCONJ
dti-2660	190	11	are	be	AUX
dti-2660	190	12	already	already	ADV
dti-2660	190	13	in	in	ADP
dti-2660	190	14	use	use	NOUN
dti-2660	190	15	as	as	ADP
dti-2660	190	16	strategies	strategy	NOUN
dti-2660	190	17	to	to	PART
dti-2660	190	18	prevent	prevent	VERB
dti-2660	190	19	rutis	rutis	NOUN
dti-2660	190	20	.	.	PUNCT
dti-2660	191	1	a	a	DET
dti-2660	191	2	detailed	detailed	ADJ
dti-2660	191	3	review	review	NOUN
dti-2660	191	4	of	of	ADP
dti-2660	191	5	these	these	DET
dti-2660	191	6	approaches	approach	NOUN
dti-2660	191	7	is	be	AUX
dti-2660	191	8	beyond	beyond	ADP
dti-2660	191	9	the	the	DET
dti-2660	191	10	scope	scope	NOUN
dti-2660	191	11	of	of	ADP
dti-2660	191	12	this	this	DET
dti-2660	191	13	article	article	NOUN
dti-2660	191	14	.	.	PUNCT
dti-2660	192	1	however	however	ADV
dti-2660	192	2	,	,	PUNCT
dti-2660	192	3	a	a	DET
dti-2660	192	4	comprehensive	comprehensive	ADJ
dti-2660	192	5	review	review	NOUN
dti-2660	192	6	by	by	ADP
dti-2660	192	7	paul	paul	PROPN
dti-2660	192	8	loubet	loubet	PROPN
dti-2660	192	9	and	and	CCONJ
dti-2660	192	10	colleagues	colleague	NOUN
dti-2660	192	11	provides	provide	VERB
dti-2660	192	12	a	a	DET
dti-2660	192	13	useful	useful	ADJ
dti-2660	192	14	overview	overview	NOUN
dti-2660	192	15	of	of	ADP
dti-2660	192	16	alternative	alternative	ADJ
dti-2660	192	17	therapeutic	therapeutic	ADJ
dti-2660	192	18	options	option	NOUN
dti-2660	192	19	to	to	ADP
dti-2660	192	20	antibiotics	antibiotic	NOUN
dti-2660	192	21	(	(	PUNCT
dti-2660	192	22	40	40	NUM
dti-2660	192	23	)	)	PUNCT
dti-2660	192	24	.	.	PUNCT
dti-2660	193	1	among	among	ADP
dti-2660	193	2	the	the	DET
dti-2660	193	3	approaches	approach	NOUN
dti-2660	193	4	are	be	AUX
dti-2660	193	5	small	small	ADJ
dti-2660	193	6	compounds	compound	NOUN
dti-2660	193	7	,	,	PUNCT
dti-2660	193	8	often	often	ADV
dti-2660	193	9	molecules	molecule	NOUN
dti-2660	193	10	that	that	PRON
dti-2660	193	11	are	be	AUX
dti-2660	193	12	by	by	ADP
dti-2660	193	13	-	-	PUNCT
dti-2660	193	14	products	product	NOUN
dti-2660	193	15	of	of	ADP
dti-2660	193	16	or	or	CCONJ
dti-2660	193	17	mimic	mimic	VERB
dti-2660	193	18	bacterial	bacterial	ADJ
dti-2660	193	19	substrates	substrate	NOUN
dti-2660	193	20	,	,	PUNCT
dti-2660	193	21	designed	design	VERB
dti-2660	193	22	to	to	PART
dti-2660	193	23	occupy	occupy	VERB
dti-2660	193	24	binding	bind	VERB
dti-2660	193	25	sites	site	NOUN
dti-2660	193	26	to	to	PART
dti-2660	193	27	prevent	prevent	VERB
dti-2660	193	28	adherence	adherence	NOUN
dti-2660	193	29	of	of	ADP
dti-2660	193	30	pathogens	pathogen	NOUN
dti-2660	193	31	to	to	ADP
dti-2660	193	32	the	the	DET
dti-2660	193	33	uroepithelium	uroepithelium	NOUN
dti-2660	193	34	,	,	PUNCT
dti-2660	193	35	directly	directly	ADV
dti-2660	193	36	target	target	VERB
dti-2660	193	37	the	the	DET
dti-2660	193	38	protective	protective	ADJ
dti-2660	193	39	capsule	capsule	NOUN
dti-2660	193	40	of	of	ADP
dti-2660	193	41	bacteria	bacteria	NOUN
dti-2660	193	42	,	,	PUNCT
dti-2660	193	43	inhibit	inhibit	VERB
dti-2660	193	44	enzymes	enzyme	NOUN
dti-2660	193	45	essential	essential	ADJ
dti-2660	193	46	to	to	ADP
dti-2660	193	47	upec	upec	NOUN
dti-2660	193	48	,	,	PUNCT
dti-2660	193	49	or	or	CCONJ
dti-2660	193	50	reduce	reduce	VERB
dti-2660	193	51	biofilm	biofilm	NOUN
dti-2660	193	52	formation	formation	NOUN
dti-2660	193	53	(	(	PUNCT
dti-2660	193	54	40	40	NUM
dti-2660	193	55	)	)	PUNCT
dti-2660	193	56	.	.	PUNCT
dti-2660	194	1	the	the	DET
dti-2660	194	2	formation	formation	NOUN
dti-2660	194	3	of	of	ADP
dti-2660	194	4	biofilms	biofilm	NOUN
dti-2660	194	5	,	,	PUNCT
dti-2660	194	6	either	either	CCONJ
dti-2660	194	7	directly	directly	ADV
dti-2660	194	8	on	on	ADP
dti-2660	194	9	the	the	DET
dti-2660	194	10	urothelial	urothelial	ADJ
dti-2660	194	11	surface	surface	NOUN
dti-2660	194	12	or	or	CCONJ
dti-2660	194	13	formed	form	VERB
dti-2660	194	14	around	around	ADP
dti-2660	194	15	indwelling	indwell	VERB
dti-2660	194	16	catheters	catheter	NOUN
dti-2660	194	17	,	,	PUNCT
dti-2660	194	18	is	be	AUX
dti-2660	194	19	a	a	DET
dti-2660	194	20	common	common	ADJ
dti-2660	194	21	strategy	strategy	NOUN
dti-2660	194	22	adopted	adopt	VERB
dti-2660	194	23	by	by	ADP
dti-2660	194	24	upec	upec	NOUN
dti-2660	194	25	,	,	PUNCT
dti-2660	194	26	providing	provide	VERB
dti-2660	194	27	a	a	DET
dti-2660	194	28	favorable	favorable	ADJ
dti-2660	194	29	environment	environment	NOUN
dti-2660	194	30	for	for	ADP
dti-2660	194	31	bacterial	bacterial	ADJ
dti-2660	194	32	colonization	colonization	NOUN
dti-2660	194	33	and	and	CCONJ
dti-2660	194	34	a	a	DET
dti-2660	194	35	persistent	persistent	ADJ
dti-2660	194	36	source	source	NOUN
dti-2660	194	37	for	for	ADP
dti-2660	194	38	bacterial	bacterial	ADJ
dti-2660	194	39	access	access	NOUN
dti-2660	194	40	to	to	ADP
dti-2660	194	41	the	the	DET
dti-2660	194	42	urinary	urinary	ADJ
dti-2660	194	43	tract	tract	NOUN
dti-2660	194	44	,	,	PUNCT
dti-2660	194	45	thus	thus	ADV
dti-2660	194	46	facilitating	facilitate	VERB
dti-2660	194	47	rutis	rutis	NOUN
dti-2660	194	48	(	(	PUNCT
dti-2660	194	49	16,22	16,22	NOUN
dti-2660	194	50	)	)	PUNCT
dti-2660	194	51	.	.	PUNCT
dti-2660	195	1	vitamin	vitamin	NOUN
dti-2660	195	2	c	c	PROPN
dti-2660	195	3	,	,	PUNCT
dti-2660	195	4	chinese	chinese	ADJ
dti-2660	195	5	medical	medical	ADJ
dti-2660	195	6	herbs	herb	NOUN
dti-2660	195	7	,	,	PUNCT
dti-2660	195	8	and	and	CCONJ
dti-2660	195	9	various	various	ADJ
dti-2660	195	10	vaccine	vaccine	NOUN
dti-2660	195	11	approaches	approach	VERB
dti-2660	195	12	that	that	PRON
dti-2660	195	13	target	target	VERB
dti-2660	195	14	microbial	microbial	ADJ
dti-2660	195	15	adhesion	adhesion	NOUN
dti-2660	195	16	,	,	PUNCT
dti-2660	195	17	the	the	DET
dti-2660	195	18	bacterial	bacterial	ADJ
dti-2660	195	19	capsule	capsule	NOUN
dti-2660	195	20	,	,	PUNCT
dti-2660	195	21	toxins	toxin	NOUN
dti-2660	195	22	secreted	secrete	VERB
dti-2660	195	23	by	by	ADP
dti-2660	195	24	upec	upec	NOUN
dti-2660	195	25	that	that	PRON
dti-2660	195	26	act	act	VERB
dti-2660	195	27	as	as	ADP
dti-2660	195	28	virulence	virulence	NOUN
dti-2660	195	29	factors	factor	NOUN
dti-2660	195	30	,	,	PUNCT
dti-2660	195	31	or	or	CCONJ
dti-2660	195	32	iron	iron	NOUN
dti-2660	195	33	metabolism	metabolism	NOUN
dti-2660	195	34	processes	process	NOUN
dti-2660	195	35	essential	essential	ADJ
dti-2660	195	36	for	for	ADP
dti-2660	195	37	bacterial	bacterial	ADJ
dti-2660	195	38	growth	growth	NOUN
dti-2660	195	39	and	and	CCONJ
dti-2660	195	40	colonization	colonization	NOUN
dti-2660	195	41	are	be	AUX
dti-2660	195	42	also	also	ADV
dti-2660	195	43	alternative	alternative	ADJ
dti-2660	195	44	nonantibiotic	nonantibiotic	ADJ
dti-2660	195	45	therapeutic	therapeutic	ADJ
dti-2660	195	46	options	option	NOUN
dti-2660	195	47	for	for	ADP
dti-2660	195	48	utis	utis	NOUN
dti-2660	195	49	(	(	PUNCT
dti-2660	195	50	34,40	34,40	NUM
dti-2660	195	51	)	)	PUNCT
dti-2660	195	52	.	.	PUNCT
dti-2660	196	1	finally	finally	ADV
dti-2660	196	2	,	,	PUNCT
dti-2660	196	3	although	although	SCONJ
dti-2660	196	4	not	not	PART
dti-2660	196	5	commonly	commonly	ADV
dti-2660	196	6	utilized	utilize	VERB
dti-2660	196	7	in	in	ADP
dti-2660	196	8	the	the	DET
dti-2660	196	9	west	west	NOUN
dti-2660	196	10	,	,	PUNCT
dti-2660	196	11	bacteriophages	bacteriophage	NOUN
dti-2660	196	12	,	,	PUNCT
dti-2660	196	13	viruses	virus	NOUN
dti-2660	196	14	that	that	PRON
dti-2660	196	15	cause	cause	VERB
dti-2660	196	16	lysis	lysis	NOUN
dti-2660	196	17	of	of	ADP
dti-2660	196	18	bacterial	bacterial	ADJ
dti-2660	196	19	cells	cell	NOUN
dti-2660	196	20	,	,	PUNCT
dti-2660	196	21	including	include	VERB
dti-2660	196	22	antibiotic	antibiotic	ADJ
dti-2660	196	23	-	-	PUNCT
dti-2660	196	24	resistant	resistant	ADJ
dti-2660	196	25	upec	upec	NOUN
dti-2660	196	26	,	,	PUNCT
dti-2660	196	27	have	have	AUX
dti-2660	196	28	been	be	AUX
dti-2660	196	29	used	use	VERB
dti-2660	196	30	in	in	ADP
dti-2660	196	31	eastern	eastern	ADJ
dti-2660	196	32	european	european	ADJ
dti-2660	196	33	countries	country	NOUN
dti-2660	196	34	for	for	ADP
dti-2660	196	35	decades	decade	NOUN
dti-2660	196	36	(	(	PUNCT
dti-2660	196	37	36	36	NUM
dti-2660	196	38	)	)	PUNCT
dti-2660	196	39	.	.	PUNCT
dti-2660	197	1	antibiotic	antibiotic	ADJ
dti-2660	197	2	prophylaxis	prophylaxis	NOUN
dti-2660	197	3	when	when	SCONJ
dti-2660	197	4	non	non	ADJ
dti-2660	197	5	-	-	ADJ
dti-2660	197	6	antimicrobial	antimicrobial	ADJ
dti-2660	197	7	interventions	intervention	NOUN
dti-2660	197	8	have	have	AUX
dti-2660	197	9	failed	fail	VERB
dti-2660	197	10	,	,	PUNCT
dti-2660	197	11	continuous	continuous	ADJ
dti-2660	197	12	low	low	ADJ
dti-2660	197	13	-	-	PUNCT
dti-2660	197	14	dose	dose	NOUN
dti-2660	197	15	antimicrobials	antimicrobial	NOUN
dti-2660	197	16	and	and	CCONJ
dti-2660	197	17	postcoital	postcoital	ADJ
dti-2660	197	18	antimicrobial	antimicrobial	ADJ
dti-2660	197	19	prophylaxis	prophylaxis	NOUN
dti-2660	197	20	have	have	AUX
dti-2660	197	21	been	be	AUX
dti-2660	197	22	shown	show	VERB
dti-2660	197	23	to	to	PART
dti-2660	197	24	reduce	reduce	VERB
dti-2660	197	25	the	the	DET
dti-2660	197	26	rate	rate	NOUN
dti-2660	197	27	of	of	ADP
dti-2660	197	28	rutis	rutis	NOUN
dti-2660	197	29	(	(	PUNCT
dti-2660	197	30	8,36	8,36	NUM
dti-2660	197	31	)	)	PUNCT
dti-2660	197	32	and	and	CCONJ
dti-2660	197	33	are	be	AUX
dti-2660	197	34	recommended	recommend	VERB
dti-2660	197	35	for	for	ADP
dti-2660	197	36	use	use	NOUN
dti-2660	197	37	(	(	PUNCT
dti-2660	197	38	8)	8)	NUM
dti-2660	197	39	.	.	PUNCT
dti-2660	198	1	there	there	PRON
dti-2660	198	2	is	be	VERB
dti-2660	198	3	no	no	DET
dti-2660	198	4	significant	significant	ADJ
dti-2660	198	5	difference	difference	NOUN
dti-2660	198	6	between	between	ADP
dti-2660	198	7	the	the	DET
dti-2660	198	8	two	two	NUM
dti-2660	198	9	strategies	strategy	NOUN
dti-2660	198	10	.	.	PUNCT
dti-2660	199	1	in	in	ADP
dti-2660	199	2	both	both	DET
dti-2660	199	3	approaches	approach	NOUN
dti-2660	199	4	,	,	PUNCT
dti-2660	199	5	patients	patient	NOUN
dti-2660	199	6	should	should	AUX
dti-2660	199	7	be	be	AUX
dti-2660	199	8	counseled	counsel	VERB
dti-2660	199	9	on	on	ADP
dti-2660	199	10	possible	possible	ADJ
dti-2660	199	11	side	side	NOUN
dti-2660	199	12	effects	effect	NOUN
dti-2660	199	13	.	.	PUNCT
dti-2660	200	1	the	the	DET
dti-2660	200	2	optimal	optimal	ADJ
dti-2660	200	3	duration	duration	NOUN
dti-2660	200	4	of	of	ADP
dti-2660	200	5	continuous	continuous	ADJ
dti-2660	200	6	antimicrobial	antimicrobial	ADJ
dti-2660	200	7	prophylaxis	prophylaxis	NOUN
dti-2660	200	8	is	be	AUX
dti-2660	200	9	uncertain	uncertain	ADJ
dti-2660	200	10	,	,	PUNCT
dti-2660	200	11	with	with	ADP
dti-2660	200	12	studies	study	NOUN
dti-2660	200	13	reporting	report	VERB
dti-2660	200	14	durations	duration	NOUN
dti-2660	200	15	of	of	ADP
dti-2660	200	16	from	from	ADP
dti-2660	200	17	3	3	NUM
dti-2660	200	18	to	to	ADP
dti-2660	200	19	as	as	ADV
dti-2660	200	20	long	long	ADJ
dti-2660	200	21	as	as	ADP
dti-2660	200	22	12	12	NUM
dti-2660	200	23	months	month	NOUN
dti-2660	200	24	;	;	PUNCT
dti-2660	200	25	between	between	SCONJ
dti-2660	200	26	3	3	NUM
dti-2660	200	27	and	and	CCONJ
dti-2660	200	28	6	6	NUM
dti-2660	200	29	months	month	NOUN
dti-2660	200	30	is	be	AUX
dti-2660	200	31	typical	typical	ADJ
dti-2660	200	32	(	(	PUNCT
dti-2660	200	33	8)	8)	NUM
dti-2660	200	34	.	.	PUNCT
dti-2660	200	35	intermittent	intermittent	ADJ
dti-2660	200	36	self	self	NOUN
dti-2660	200	37	-	-	PUNCT
dti-2660	200	38	start	start	NOUN
dti-2660	200	39	treatment	treatment	NOUN
dti-2660	200	40	(	(	PUNCT
dti-2660	200	41	self	self	NOUN
dti-2660	200	42	-	-	PUNCT
dti-2660	200	43	diagnosis	diagnosis	NOUN
dti-2660	200	44	and	and	CCONJ
dti-2660	200	45	selftreatment	selftreatment	NOUN
dti-2660	200	46	)	)	PUNCT
dti-2660	200	47	with	with	ADP
dti-2660	200	48	a	a	DET
dti-2660	200	49	short	short	ADJ
dti-2660	200	50	course	course	NOUN
dti-2660	200	51	of	of	ADP
dti-2660	200	52	antibiotic	antibiotic	ADJ
dti-2660	200	53	therapy	therapy	NOUN
dti-2660	200	54	is	be	AUX
dti-2660	200	55	also	also	ADV
dti-2660	200	56	pothoven	pothoven	ADJ
dti-2660	200	57	drug	drug	NOUN
dti-2660	200	58	target	target	NOUN
dti-2660	200	59	insights	insight	NOUN
dti-2660	200	60	2023	2023	NUM
dti-2660	200	61	;	;	PUNCT
dti-2660	200	62	17	17	NUM
dti-2660	200	63	:	:	SYM
dti-2660	200	64	133	133	NUM
dti-2660	200	65	©	©	PROPN
dti-2660	200	66	2023	2023	NUM
dti-2660	200	67	the	the	DET
dti-2660	200	68	authors	author	NOUN
dti-2660	200	69	.	.	PUNCT
dti-2660	201	1	published	publish	VERB
dti-2660	201	2	by	by	ADP
dti-2660	201	3	aboutscience	aboutscience	NOUN
dti-2660	201	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2660	201	5	effective	effective	ADJ
dti-2660	201	6	and	and	CCONJ
dti-2660	201	7	safe	safe	ADJ
dti-2660	201	8	in	in	ADP
dti-2660	201	9	women	woman	NOUN
dti-2660	201	10	with	with	ADP
dti-2660	201	11	rutis	rutis	NOUN
dti-2660	201	12	who	who	PRON
dti-2660	201	13	have	have	AUX
dti-2660	201	14	shown	show	VERB
dti-2660	201	15	good	good	ADJ
dti-2660	201	16	compliance	compliance	NOUN
dti-2660	201	17	and	and	CCONJ
dti-2660	201	18	motivation	motivation	NOUN
dti-2660	201	19	and	and	CCONJ
dti-2660	201	20	can	can	AUX
dti-2660	201	21	be	be	AUX
dti-2660	201	22	an	an	DET
dti-2660	201	23	economical	economical	ADJ
dti-2660	201	24	approach	approach	NOUN
dti-2660	201	25	to	to	ADP
dti-2660	201	26	preventing	prevent	VERB
dti-2660	201	27	rutis	rutis	NOUN
dti-2660	201	28	(	(	PUNCT
dti-2660	201	29	8,36	8,36	NUM
dti-2660	201	30	)	)	PUNCT
dti-2660	201	31	.	.	PUNCT
dti-2660	202	1	the	the	DET
dti-2660	202	2	choice	choice	NOUN
dti-2660	202	3	of	of	ADP
dti-2660	202	4	antimicrobial	antimicrobial	ADJ
dti-2660	202	5	agent	agent	NOUN
dti-2660	202	6	is	be	AUX
dti-2660	202	7	the	the	DET
dti-2660	202	8	same	same	ADJ
dti-2660	202	9	as	as	ADP
dti-2660	202	10	that	that	PRON
dti-2660	202	11	for	for	ADP
dti-2660	202	12	acute	acute	ADJ
dti-2660	202	13	uncomplicated	uncomplicated	ADJ
dti-2660	202	14	uti	uti	PROPN
dti-2660	202	15	and	and	CCONJ
dti-2660	202	16	should	should	AUX
dti-2660	202	17	be	be	AUX
dti-2660	202	18	based	base	VERB
dti-2660	202	19	on	on	ADP
dti-2660	202	20	local	local	ADJ
dti-2660	202	21	resistance	resistance	NOUN
dti-2660	202	22	patterns	pattern	NOUN
dti-2660	202	23	.	.	PUNCT
dti-2660	203	1	patients	patient	NOUN
dti-2660	203	2	on	on	ADP
dti-2660	203	3	antimicrobial	antimicrobial	ADJ
dti-2660	203	4	prophylaxis	prophylaxis	NOUN
dti-2660	203	5	may	may	AUX
dti-2660	203	6	have	have	AUX
dti-2660	203	7	been	be	AUX
dti-2660	203	8	advised	advise	VERB
dti-2660	203	9	to	to	PART
dti-2660	203	10	increase	increase	VERB
dti-2660	203	11	the	the	DET
dti-2660	203	12	dose	dose	NOUN
dti-2660	203	13	of	of	ADP
dti-2660	203	14	the	the	DET
dti-2660	203	15	same	same	ADJ
dti-2660	203	16	antibiotic	antibiotic	NOUN
dti-2660	203	17	if	if	SCONJ
dti-2660	203	18	they	they	PRON
dti-2660	203	19	have	have	VERB
dti-2660	203	20	a	a	DET
dti-2660	203	21	breakthrough	breakthrough	ADJ
dti-2660	203	22	infection	infection	NOUN
dti-2660	203	23	.	.	PUNCT
dti-2660	204	1	however	however	ADV
dti-2660	204	2	,	,	PUNCT
dti-2660	204	3	a	a	DET
dti-2660	204	4	more	more	ADV
dti-2660	204	5	appropriate	appropriate	ADJ
dti-2660	204	6	course	course	NOUN
dti-2660	204	7	of	of	ADP
dti-2660	204	8	action	action	NOUN
dti-2660	204	9	would	would	AUX
dti-2660	204	10	be	be	AUX
dti-2660	204	11	for	for	SCONJ
dti-2660	204	12	a	a	DET
dti-2660	204	13	culture	culture	NOUN
dti-2660	204	14	to	to	PART
dti-2660	204	15	be	be	AUX
dti-2660	204	16	taken	take	VERB
dti-2660	204	17	to	to	PART
dti-2660	204	18	determine	determine	VERB
dti-2660	204	19	if	if	SCONJ
dti-2660	204	20	switching	switch	VERB
dti-2660	204	21	to	to	ADP
dti-2660	204	22	an	an	DET
dti-2660	204	23	antibiotic	antibiotic	ADJ
dti-2660	204	24	more	more	ADV
dti-2660	204	25	helpful	helpful	ADJ
dti-2660	204	26	in	in	ADP
dti-2660	204	27	the	the	DET
dti-2660	204	28	setting	setting	NOUN
dti-2660	204	29	is	be	AUX
dti-2660	204	30	indicated	indicate	VERB
dti-2660	204	31	.	.	PUNCT
dti-2660	205	1	if	if	SCONJ
dti-2660	205	2	the	the	DET
dti-2660	205	3	patient	patient	NOUN
dti-2660	205	4	has	have	VERB
dti-2660	205	5	severe	severe	ADJ
dti-2660	205	6	symptoms	symptom	NOUN
dti-2660	205	7	and	and	CCONJ
dti-2660	205	8	wishes	wish	VERB
dti-2660	205	9	to	to	PART
dti-2660	205	10	start	start	VERB
dti-2660	205	11	empirical	empirical	ADJ
dti-2660	205	12	treatment	treatment	NOUN
dti-2660	205	13	immediately	immediately	ADV
dti-2660	205	14	,	,	PUNCT
dti-2660	205	15	the	the	DET
dti-2660	205	16	recommended	recommend	VERB
dti-2660	205	17	first	first	ADJ
dti-2660	205	18	-	-	PUNCT
dti-2660	205	19	line	line	NOUN
dti-2660	205	20	antibiotics	antibiotic	NOUN
dti-2660	205	21	(	(	PUNCT
dti-2660	205	22	i.e.	i.e.	X
dti-2660	205	23	,	,	PUNCT
dti-2660	205	24	fosfomycin	fosfomycin	PROPN
dti-2660	205	25	trometamol	trometamol	PROPN
dti-2660	205	26	,	,	PUNCT
dti-2660	205	27	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	205	28	,	,	PUNCT
dti-2660	205	29	or	or	CCONJ
dti-2660	205	30	pivmecillinam	pivmecillinam	PROPN
dti-2660	205	31	)	)	PUNCT
dti-2660	205	32	should	should	AUX
dti-2660	205	33	be	be	AUX
dti-2660	205	34	chosen	choose	VERB
dti-2660	205	35	(	(	PUNCT
dti-2660	205	36	8)	8)	NUM
dti-2660	205	37	.	.	PUNCT
dti-2660	205	38	managing	manage	VERB
dti-2660	205	39	patients	patient	NOUN
dti-2660	205	40	with	with	ADP
dti-2660	205	41	utis	utis	NOUN
dti-2660	205	42	in	in	ADP
dti-2660	205	43	daily	daily	ADJ
dti-2660	205	44	practice	practice	NOUN
dti-2660	205	45	:	:	PUNCT
dti-2660	205	46	the	the	DET
dti-2660	205	47	nurse	nurse	NOUN
dti-2660	205	48	’s	’s	PART
dti-2660	205	49	perspective	perspective	NOUN
dti-2660	205	50	managing	manage	VERB
dti-2660	205	51	utis	utis	NOUN
dti-2660	205	52	is	be	AUX
dti-2660	205	53	a	a	DET
dti-2660	205	54	major	major	ADJ
dti-2660	205	55	problem	problem	NOUN
dti-2660	205	56	for	for	ADP
dti-2660	205	57	patients	patient	NOUN
dti-2660	205	58	,	,	PUNCT
dti-2660	205	59	caregivers	caregiver	NOUN
dti-2660	205	60	,	,	PUNCT
dti-2660	205	61	and	and	CCONJ
dti-2660	205	62	the	the	DET
dti-2660	205	63	physicians	physician	NOUN
dti-2660	205	64	and	and	CCONJ
dti-2660	205	65	specialist	specialist	NOUN
dti-2660	205	66	nurses	nurse	NOUN
dti-2660	205	67	involved	involve	VERB
dti-2660	205	68	in	in	ADP
dti-2660	205	69	daily	daily	ADJ
dti-2660	205	70	clinical	clinical	ADJ
dti-2660	205	71	practice	practice	NOUN
dti-2660	205	72	.	.	PUNCT
dti-2660	206	1	as	as	ADV
dti-2660	206	2	well	well	ADV
dti-2660	206	3	as	as	ADP
dti-2660	206	4	the	the	DET
dti-2660	206	5	economic	economic	ADJ
dti-2660	206	6	cost	cost	NOUN
dti-2660	206	7	,	,	PUNCT
dti-2660	206	8	utis	utis	NOUN
dti-2660	206	9	impose	impose	VERB
dti-2660	206	10	a	a	DET
dti-2660	206	11	considerable	considerable	ADJ
dti-2660	206	12	loss	loss	NOUN
dti-2660	206	13	of	of	ADP
dti-2660	206	14	quality	quality	NOUN
dti-2660	206	15	of	of	ADP
dti-2660	206	16	life	life	NOUN
dti-2660	206	17	for	for	ADP
dti-2660	206	18	the	the	DET
dti-2660	206	19	patient	patient	NOUN
dti-2660	206	20	(	(	PUNCT
dti-2660	206	21	1,2,30,48	1,2,30,48	PROPN
dti-2660	206	22	)	)	PUNCT
dti-2660	206	23	.	.	PUNCT
dti-2660	207	1	increasingly	increasingly	ADV
dti-2660	207	2	,	,	PUNCT
dti-2660	207	3	public	public	ADJ
dti-2660	207	4	health	health	NOUN
dti-2660	207	5	policy	policy	NOUN
dti-2660	207	6	is	be	AUX
dti-2660	207	7	to	to	PART
dti-2660	207	8	keep	keep	VERB
dti-2660	207	9	older	old	ADJ
dti-2660	207	10	people	people	NOUN
dti-2660	207	11	in	in	ADP
dti-2660	207	12	their	their	PRON
dti-2660	207	13	homes	home	NOUN
dti-2660	207	14	for	for	ADP
dti-2660	207	15	as	as	ADV
dti-2660	207	16	long	long	ADV
dti-2660	207	17	as	as	ADP
dti-2660	207	18	possible	possible	ADJ
dti-2660	207	19	,	,	PUNCT
dti-2660	207	20	promoting	promote	VERB
dti-2660	207	21	self	self	NOUN
dti-2660	207	22	-	-	PUNCT
dti-2660	207	23	care	care	NOUN
dti-2660	207	24	for	for	ADP
dti-2660	207	25	everyone	everyone	PRON
dti-2660	207	26	and	and	CCONJ
dti-2660	207	27	providing	provide	VERB
dti-2660	207	28	home	home	NOUN
dti-2660	207	29	care	care	NOUN
dti-2660	207	30	services	service	NOUN
dti-2660	207	31	where	where	SCONJ
dti-2660	207	32	necessary	necessary	ADJ
dti-2660	207	33	.	.	PUNCT
dti-2660	208	1	for	for	ADP
dti-2660	208	2	patients	patient	NOUN
dti-2660	208	3	with	with	ADP
dti-2660	208	4	utis	utis	NOUN
dti-2660	208	5	,	,	PUNCT
dti-2660	208	6	there	there	PRON
dti-2660	208	7	is	be	VERB
dti-2660	208	8	likely	likely	ADJ
dti-2660	208	9	to	to	PART
dti-2660	208	10	be	be	AUX
dti-2660	208	11	a	a	DET
dti-2660	208	12	preference	preference	NOUN
dti-2660	208	13	for	for	ADP
dti-2660	208	14	selfinstilling	selfinstille	VERB
dti-2660	208	15	bladder	bladder	NOUN
dti-2660	208	16	compounds	compound	NOUN
dti-2660	208	17	at	at	ADP
dti-2660	208	18	home	home	NOUN
dti-2660	208	19	,	,	PUNCT
dti-2660	208	20	and	and	CCONJ
dti-2660	208	21	visiting	visit	VERB
dti-2660	208	22	specialist	specialist	NOUN
dti-2660	208	23	nurses	nurse	NOUN
dti-2660	208	24	will	will	AUX
dti-2660	208	25	teach	teach	VERB
dti-2660	208	26	self	self	NOUN
dti-2660	208	27	-	-	PUNCT
dti-2660	208	28	catheterization	catheterization	NOUN
dti-2660	208	29	and	and	CCONJ
dti-2660	208	30	self	self	NOUN
dti-2660	208	31	-	-	PUNCT
dti-2660	208	32	instillation	instillation	NOUN
dti-2660	208	33	procedures	procedure	NOUN
dti-2660	208	34	.	.	PUNCT
dti-2660	209	1	a	a	DET
dti-2660	209	2	specialized	specialized	ADJ
dti-2660	209	3	urological	urological	ADJ
dti-2660	209	4	team	team	NOUN
dti-2660	209	5	that	that	PRON
dti-2660	209	6	can	can	AUX
dti-2660	209	7	provide	provide	VERB
dti-2660	209	8	almost	almost	ADV
dti-2660	209	9	all	all	PRON
dti-2660	209	10	urological	urological	ADJ
dti-2660	209	11	care	care	NOUN
dti-2660	209	12	in	in	ADP
dti-2660	209	13	the	the	DET
dti-2660	209	14	home	home	NOUN
dti-2660	209	15	,	,	PUNCT
dti-2660	209	16	including	include	VERB
dti-2660	209	17	managing	manage	VERB
dti-2660	209	18	utis	utis	NOUN
dti-2660	209	19	,	,	PUNCT
dti-2660	209	20	is	be	AUX
dti-2660	209	21	effective	effective	ADJ
dti-2660	209	22	in	in	ADP
dti-2660	209	23	freeing	free	VERB
dti-2660	209	24	up	up	ADP
dti-2660	209	25	hospital	hospital	NOUN
dti-2660	209	26	care	care	NOUN
dti-2660	209	27	.	.	PUNCT
dti-2660	210	1	in	in	ADP
dti-2660	210	2	the	the	DET
dti-2660	210	3	absence	absence	NOUN
dti-2660	210	4	of	of	ADP
dti-2660	210	5	specialized	specialized	ADJ
dti-2660	210	6	inhome	inhome	NOUN
dti-2660	210	7	care	care	NOUN
dti-2660	210	8	,	,	PUNCT
dti-2660	210	9	solutions	solution	NOUN
dti-2660	210	10	must	must	AUX
dti-2660	210	11	be	be	AUX
dti-2660	210	12	found	find	VERB
dti-2660	210	13	in	in	ADP
dti-2660	210	14	the	the	DET
dti-2660	210	15	outpatient	outpatient	NOUN
dti-2660	210	16	setting	setting	NOUN
dti-2660	210	17	.	.	PUNCT
dti-2660	211	1	ideally	ideally	ADV
dti-2660	211	2	,	,	PUNCT
dti-2660	211	3	seeing	see	VERB
dti-2660	211	4	patients	patient	NOUN
dti-2660	211	5	in	in	ADP
dti-2660	211	6	their	their	PRON
dti-2660	211	7	homes	home	NOUN
dti-2660	211	8	provides	provide	VERB
dti-2660	211	9	an	an	DET
dti-2660	211	10	insight	insight	NOUN
dti-2660	211	11	into	into	ADP
dti-2660	211	12	the	the	DET
dti-2660	211	13	most	most	ADV
dti-2660	211	14	helpful	helpful	ADJ
dti-2660	211	15	approach	approach	NOUN
dti-2660	211	16	to	to	ADP
dti-2660	211	17	patient	patient	NOUN
dti-2660	211	18	needs	need	NOUN
dti-2660	211	19	.	.	PUNCT
dti-2660	212	1	utis	utis	NOUN
dti-2660	212	2	often	often	ADV
dti-2660	212	3	contribute	contribute	VERB
dti-2660	212	4	to	to	ADP
dti-2660	212	5	delirium	delirium	NOUN
dti-2660	212	6	,	,	PUNCT
dti-2660	212	7	falls	fall	VERB
dti-2660	212	8	,	,	PUNCT
dti-2660	212	9	and	and	CCONJ
dti-2660	212	10	confusion	confusion	NOUN
dti-2660	212	11	in	in	ADP
dti-2660	212	12	vulnerable	vulnerable	ADJ
dti-2660	212	13	older	old	ADJ
dti-2660	212	14	patients	patient	NOUN
dti-2660	212	15	,	,	PUNCT
dti-2660	212	16	even	even	ADV
dti-2660	212	17	before	before	SCONJ
dti-2660	212	18	a	a	DET
dti-2660	212	19	uti	uti	PROPN
dti-2660	212	20	is	be	AUX
dti-2660	212	21	diagnosed	diagnose	VERB
dti-2660	212	22	(	(	PUNCT
dti-2660	212	23	49,50	49,50	NOUN
dti-2660	212	24	)	)	PUNCT
dti-2660	212	25	.	.	PUNCT
dti-2660	213	1	therefore	therefore	ADV
dti-2660	213	2	,	,	PUNCT
dti-2660	213	3	prevention	prevention	NOUN
dti-2660	213	4	is	be	AUX
dti-2660	213	5	the	the	DET
dti-2660	213	6	best	good	ADJ
dti-2660	213	7	solution	solution	NOUN
dti-2660	213	8	;	;	PUNCT
dti-2660	213	9	the	the	DET
dti-2660	213	10	challenge	challenge	NOUN
dti-2660	213	11	is	be	AUX
dti-2660	213	12	achieving	achieve	VERB
dti-2660	213	13	this	this	PRON
dti-2660	213	14	.	.	PUNCT
dti-2660	214	1	close	close	ADJ
dti-2660	214	2	cooperation	cooperation	NOUN
dti-2660	214	3	involving	involve	VERB
dti-2660	214	4	the	the	DET
dti-2660	214	5	nurse	nurse	NOUN
dti-2660	214	6	,	,	PUNCT
dti-2660	214	7	physician	physician	NOUN
dti-2660	214	8	,	,	PUNCT
dti-2660	214	9	patient	patient	NOUN
dti-2660	214	10	,	,	PUNCT
dti-2660	214	11	caregivers	caregiver	NOUN
dti-2660	214	12	,	,	PUNCT
dti-2660	214	13	and	and	CCONJ
dti-2660	214	14	even	even	ADV
dti-2660	214	15	neighbors	neighbor	NOUN
dti-2660	214	16	is	be	AUX
dti-2660	214	17	fundamental	fundamental	ADJ
dti-2660	214	18	.	.	PUNCT
dti-2660	215	1	knowledge	knowledge	NOUN
dti-2660	215	2	and	and	CCONJ
dti-2660	215	3	understanding	understanding	NOUN
dti-2660	215	4	of	of	ADP
dti-2660	215	5	the	the	DET
dti-2660	215	6	relevant	relevant	ADJ
dti-2660	215	7	clinical	clinical	ADJ
dti-2660	215	8	guidelines	guideline	NOUN
dti-2660	215	9	for	for	ADP
dti-2660	215	10	urological	urological	ADJ
dti-2660	215	11	infections	infection	NOUN
dti-2660	215	12	should	should	AUX
dti-2660	215	13	be	be	AUX
dti-2660	215	14	shared	share	VERB
dti-2660	215	15	,	,	PUNCT
dti-2660	215	16	and	and	CCONJ
dti-2660	215	17	agreement	agreement	NOUN
dti-2660	215	18	on	on	ADP
dti-2660	215	19	the	the	DET
dti-2660	215	20	relative	relative	ADJ
dti-2660	215	21	roles	role	NOUN
dti-2660	215	22	and	and	CCONJ
dti-2660	215	23	time	time	NOUN
dti-2660	215	24	points	point	NOUN
dti-2660	215	25	for	for	ADP
dti-2660	215	26	interventions	intervention	NOUN
dti-2660	215	27	should	should	AUX
dti-2660	215	28	be	be	AUX
dti-2660	215	29	established	establish	VERB
dti-2660	215	30	.	.	PUNCT
dti-2660	216	1	an	an	DET
dti-2660	216	2	open	open	ADJ
dti-2660	216	3	and	and	CCONJ
dti-2660	216	4	proactive	proactive	ADJ
dti-2660	216	5	multidisciplinary	multidisciplinary	ADJ
dti-2660	216	6	approach	approach	NOUN
dti-2660	216	7	should	should	AUX
dti-2660	216	8	be	be	AUX
dti-2660	216	9	adopted	adopt	VERB
dti-2660	216	10	,	,	PUNCT
dti-2660	216	11	sharing	share	VERB
dti-2660	216	12	knowledge	knowledge	NOUN
dti-2660	216	13	about	about	ADP
dti-2660	216	14	patients	patient	NOUN
dti-2660	216	15	and	and	CCONJ
dti-2660	216	16	bringing	bring	VERB
dti-2660	216	17	the	the	DET
dti-2660	216	18	individual	individual	ADJ
dti-2660	216	19	members	member	NOUN
dti-2660	216	20	’	’	PART
dti-2660	216	21	experience	experience	NOUN
dti-2660	216	22	and	and	CCONJ
dti-2660	216	23	expertise	expertise	NOUN
dti-2660	216	24	to	to	PART
dti-2660	216	25	bear	bear	VERB
dti-2660	216	26	on	on	ADP
dti-2660	216	27	the	the	DET
dti-2660	216	28	issue	issue	NOUN
dti-2660	216	29	.	.	PUNCT
dti-2660	217	1	the	the	DET
dti-2660	217	2	patient	patient	NOUN
dti-2660	217	3	and	and	CCONJ
dti-2660	217	4	caregivers	caregiver	NOUN
dti-2660	217	5	will	will	AUX
dti-2660	217	6	benefit	benefit	VERB
dti-2660	217	7	from	from	ADP
dti-2660	217	8	being	be	AUX
dti-2660	217	9	educated	educate	VERB
dti-2660	217	10	by	by	ADP
dti-2660	217	11	the	the	DET
dti-2660	217	12	urologic	urologic	ADJ
dti-2660	217	13	nurse	nurse	NOUN
dti-2660	217	14	on	on	ADP
dti-2660	217	15	prevention	prevention	NOUN
dti-2660	217	16	strategies	strategy	NOUN
dti-2660	217	17	.	.	PUNCT
dti-2660	218	1	these	these	PRON
dti-2660	218	2	include	include	VERB
dti-2660	218	3	drinking	drink	VERB
dti-2660	218	4	enough	enough	ADJ
dti-2660	218	5	water	water	NOUN
dti-2660	218	6	,	,	PUNCT
dti-2660	218	7	following	follow	VERB
dti-2660	218	8	an	an	DET
dti-2660	218	9	adequate	adequate	ADJ
dti-2660	218	10	diet	diet	NOUN
dti-2660	218	11	(	(	PUNCT
dti-2660	218	12	e.g.	e.g.	ADV
dti-2660	218	13	,	,	PUNCT
dti-2660	218	14	limiting	limit	VERB
dti-2660	218	15	the	the	DET
dti-2660	218	16	amount	amount	NOUN
dti-2660	218	17	of	of	ADP
dti-2660	218	18	sugar	sugar	NOUN
dti-2660	218	19	,	,	PUNCT
dti-2660	218	20	a	a	DET
dti-2660	218	21	substrate	substrate	NOUN
dti-2660	218	22	for	for	ADP
dti-2660	218	23	bacteria	bacteria	NOUN
dti-2660	218	24	,	,	PUNCT
dti-2660	218	25	in	in	ADP
dti-2660	218	26	the	the	DET
dti-2660	218	27	diet	diet	NOUN
dti-2660	218	28	for	for	ADP
dti-2660	218	29	diabetic	diabetic	ADJ
dti-2660	218	30	patients	patient	NOUN
dti-2660	218	31	)	)	PUNCT
dti-2660	218	32	,	,	PUNCT
dti-2660	218	33	good	good	ADJ
dti-2660	218	34	hygiene	hygiene	NOUN
dti-2660	218	35	procedures	procedure	NOUN
dti-2660	218	36	daily	daily	ADV
dti-2660	218	37	and	and	CCONJ
dti-2660	218	38	after	after	ADP
dti-2660	218	39	sex	sex	NOUN
dti-2660	218	40	,	,	PUNCT
dti-2660	218	41	solving	solve	VERB
dti-2660	218	42	any	any	DET
dti-2660	218	43	issues	issue	NOUN
dti-2660	218	44	of	of	ADP
dti-2660	218	45	incontinence	incontinence	NOUN
dti-2660	218	46	as	as	ADV
dti-2660	218	47	best	good	ADJ
dti-2660	218	48	as	as	ADP
dti-2660	218	49	possible	possible	ADJ
dti-2660	218	50	,	,	PUNCT
dti-2660	218	51	encouraging	encourage	VERB
dti-2660	218	52	patients	patient	NOUN
dti-2660	218	53	to	to	PART
dti-2660	218	54	keep	keep	VERB
dti-2660	218	55	active	active	ADJ
dti-2660	218	56	and	and	CCONJ
dti-2660	218	57	moving	move	VERB
dti-2660	218	58	,	,	PUNCT
dti-2660	218	59	and	and	CCONJ
dti-2660	218	60	,	,	PUNCT
dti-2660	218	61	where	where	SCONJ
dti-2660	218	62	appropriate	appropriate	ADJ
dti-2660	218	63	,	,	PUNCT
dti-2660	218	64	good	good	ADJ
dti-2660	218	65	catheter	catheter	NOUN
dti-2660	218	66	management	management	NOUN
dti-2660	218	67	(	(	PUNCT
dti-2660	218	68	8,30,51,52	8,30,51,52	NUM
dti-2660	218	69	)	)	PUNCT
dti-2660	218	70	.	.	PUNCT
dti-2660	219	1	this	this	PRON
dti-2660	219	2	can	can	AUX
dti-2660	219	3	be	be	AUX
dti-2660	219	4	a	a	DET
dti-2660	219	5	big	big	ADJ
dti-2660	219	6	challenge	challenge	NOUN
dti-2660	219	7	with	with	ADP
dti-2660	219	8	elderly	elderly	ADJ
dti-2660	219	9	and	and	CCONJ
dti-2660	219	10	vulnerable	vulnerable	ADJ
dti-2660	219	11	people	people	NOUN
dti-2660	219	12	,	,	PUNCT
dti-2660	219	13	particularly	particularly	ADV
dti-2660	219	14	where	where	SCONJ
dti-2660	219	15	dementia	dementia	NOUN
dti-2660	219	16	,	,	PUNCT
dti-2660	219	17	depression	depression	NOUN
dti-2660	219	18	,	,	PUNCT
dti-2660	219	19	refusal	refusal	NOUN
dti-2660	219	20	of	of	ADP
dti-2660	219	21	care	care	NOUN
dti-2660	219	22	,	,	PUNCT
dti-2660	219	23	or	or	CCONJ
dti-2660	219	24	living	live	VERB
dti-2660	219	25	alone	alone	ADJ
dti-2660	219	26	without	without	ADP
dti-2660	219	27	support	support	NOUN
dti-2660	219	28	are	be	AUX
dti-2660	219	29	issues	issue	NOUN
dti-2660	219	30	.	.	PUNCT
dti-2660	220	1	the	the	DET
dti-2660	220	2	problem	problem	NOUN
dti-2660	220	3	can	can	AUX
dti-2660	220	4	be	be	AUX
dti-2660	220	5	different	different	ADJ
dti-2660	220	6	in	in	ADP
dti-2660	220	7	every	every	DET
dti-2660	220	8	situation	situation	NOUN
dti-2660	220	9	,	,	PUNCT
dti-2660	220	10	and	and	CCONJ
dti-2660	220	11	if	if	SCONJ
dti-2660	220	12	a	a	DET
dti-2660	220	13	meaningful	meaningful	ADJ
dti-2660	220	14	difference	difference	NOUN
dti-2660	220	15	is	be	AUX
dti-2660	220	16	to	to	PART
dti-2660	220	17	be	be	AUX
dti-2660	220	18	achieved	achieve	VERB
dti-2660	220	19	,	,	PUNCT
dti-2660	220	20	it	it	PRON
dti-2660	220	21	is	be	AUX
dti-2660	220	22	essential	essential	ADJ
dti-2660	220	23	to	to	PART
dti-2660	220	24	know	know	VERB
dti-2660	220	25	what	what	PRON
dti-2660	220	26	is	be	AUX
dti-2660	220	27	acceptable	acceptable	ADJ
dti-2660	220	28	to	to	ADP
dti-2660	220	29	the	the	DET
dti-2660	220	30	patient	patient	NOUN
dti-2660	220	31	and	and	CCONJ
dti-2660	220	32	their	their	PRON
dti-2660	220	33	level	level	NOUN
dti-2660	220	34	of	of	ADP
dti-2660	220	35	compliance	compliance	NOUN
dti-2660	220	36	.	.	PUNCT
dti-2660	221	1	searching	search	VERB
dti-2660	221	2	to	to	PART
dti-2660	221	3	find	find	VERB
dti-2660	221	4	the	the	DET
dti-2660	221	5	best	good	ADJ
dti-2660	221	6	solution	solution	NOUN
dti-2660	221	7	should	should	AUX
dti-2660	221	8	always	always	ADV
dti-2660	221	9	be	be	AUX
dti-2660	221	10	the	the	DET
dti-2660	221	11	goal	goal	NOUN
dti-2660	221	12	.	.	PUNCT
dti-2660	222	1	in	in	ADP
dti-2660	222	2	daily	daily	ADJ
dti-2660	222	3	practice	practice	NOUN
dti-2660	222	4	,	,	PUNCT
dti-2660	222	5	a	a	DET
dti-2660	222	6	cautious	cautious	ADJ
dti-2660	222	7	approach	approach	NOUN
dti-2660	222	8	to	to	ADP
dti-2660	222	9	antibiotics	antibiotic	NOUN
dti-2660	222	10	is	be	AUX
dti-2660	222	11	appropriate	appropriate	ADJ
dti-2660	222	12	,	,	PUNCT
dti-2660	222	13	and	and	CCONJ
dti-2660	222	14	their	their	PRON
dti-2660	222	15	use	use	NOUN
dti-2660	222	16	is	be	AUX
dti-2660	222	17	reserved	reserve	VERB
dti-2660	222	18	only	only	ADV
dti-2660	222	19	in	in	ADP
dti-2660	222	20	case	case	NOUN
dti-2660	222	21	of	of	ADP
dti-2660	222	22	infection	infection	NOUN
dti-2660	222	23	after	after	ADP
dti-2660	222	24	performing	perform	VERB
dti-2660	222	25	the	the	DET
dti-2660	222	26	necessary	necessary	ADJ
dti-2660	222	27	analysis	analysis	NOUN
dti-2660	222	28	.	.	PUNCT
dti-2660	223	1	antibiotics	antibiotic	NOUN
dti-2660	223	2	may	may	AUX
dti-2660	223	3	initially	initially	ADV
dti-2660	223	4	be	be	AUX
dti-2660	223	5	used	use	VERB
dti-2660	223	6	if	if	SCONJ
dti-2660	223	7	cystoscopy	cystoscopy	NOUN
dti-2660	223	8	imaging	imaging	NOUN
dti-2660	223	9	shows	show	VERB
dti-2660	223	10	the	the	DET
dti-2660	223	11	bladder	bladder	NOUN
dti-2660	223	12	to	to	PART
dti-2660	223	13	be	be	AUX
dti-2660	223	14	very	very	ADV
dti-2660	223	15	infected	infect	VERB
dti-2660	223	16	,	,	PUNCT
dti-2660	223	17	with	with	ADP
dti-2660	223	18	alternative	alternative	ADJ
dti-2660	223	19	treatments	treatment	NOUN
dti-2660	223	20	to	to	ADP
dti-2660	223	21	antibiotic	antibiotic	ADJ
dti-2660	223	22	prophylaxis	prophylaxis	NOUN
dti-2660	223	23	considered	consider	VERB
dti-2660	223	24	at	at	ADP
dti-2660	223	25	a	a	DET
dti-2660	223	26	later	later	ADJ
dti-2660	223	27	time	time	NOUN
dti-2660	223	28	where	where	SCONJ
dti-2660	223	29	appropriate	appropriate	ADJ
dti-2660	223	30	,	,	PUNCT
dti-2660	223	31	perhaps	perhaps	ADV
dti-2660	223	32	3	3	NUM
dti-2660	223	33	-	-	SYM
dti-2660	223	34	4	4	NUM
dti-2660	223	35	months	month	NOUN
dti-2660	223	36	after	after	ADP
dti-2660	223	37	initial	initial	ADJ
dti-2660	223	38	antibiotic	antibiotic	ADJ
dti-2660	223	39	therapy	therapy	NOUN
dti-2660	223	40	.	.	PUNCT
dti-2660	224	1	despite	despite	SCONJ
dti-2660	224	2	reservations	reservation	NOUN
dti-2660	224	3	about	about	ADP
dti-2660	224	4	its	its	PRON
dti-2660	224	5	effectiveness	effectiveness	NOUN
dti-2660	224	6	,	,	PUNCT
dti-2660	224	7	d	d	X
dti-2660	224	8	-	-	PUNCT
dti-2660	224	9	mannose	mannose	NOUN
dti-2660	224	10	may	may	AUX
dti-2660	224	11	be	be	AUX
dti-2660	224	12	appropriate	appropriate	ADJ
dti-2660	224	13	to	to	PART
dti-2660	224	14	help	help	VERB
dti-2660	224	15	reduce	reduce	VERB
dti-2660	224	16	ruti	ruti	PROPN
dti-2660	224	17	episodes	episode	NOUN
dti-2660	224	18	in	in	ADP
dti-2660	224	19	some	some	DET
dti-2660	224	20	patients	patient	NOUN
dti-2660	224	21	,	,	PUNCT
dti-2660	224	22	topical	topical	ADJ
dti-2660	224	23	estrogens	estrogen	NOUN
dti-2660	224	24	can	can	AUX
dti-2660	224	25	be	be	AUX
dti-2660	224	26	beneficial	beneficial	ADJ
dti-2660	224	27	in	in	ADP
dti-2660	224	28	postmenopausal	postmenopausal	ADJ
dti-2660	224	29	women	woman	NOUN
dti-2660	224	30	,	,	PUNCT
dti-2660	224	31	and	and	CCONJ
dti-2660	224	32	probiotics	probiotic	NOUN
dti-2660	224	33	or	or	CCONJ
dti-2660	224	34	gag	gag	NOUN
dti-2660	224	35	therapy	therapy	NOUN
dti-2660	224	36	may	may	AUX
dti-2660	224	37	also	also	ADV
dti-2660	224	38	be	be	AUX
dti-2660	224	39	considered	consider	VERB
dti-2660	224	40	to	to	PART
dti-2660	224	41	help	help	VERB
dti-2660	224	42	prevent	prevent	VERB
dti-2660	224	43	rutis	rutis	NOUN
dti-2660	224	44	(	(	PUNCT
dti-2660	224	45	8)	8)	NUM
dti-2660	224	46	.	.	PUNCT
dti-2660	225	1	if	if	SCONJ
dti-2660	225	2	intravesical	intravesical	ADJ
dti-2660	225	3	instillation	instillation	NOUN
dti-2660	225	4	of	of	ADP
dti-2660	225	5	gags	gag	NOUN
dti-2660	225	6	is	be	AUX
dti-2660	225	7	applicable	applicable	ADJ
dti-2660	225	8	,	,	PUNCT
dti-2660	225	9	high	high	ADJ
dti-2660	225	10	-	-	PUNCT
dti-2660	225	11	dose	dose	NOUN
dti-2660	225	12	ha	ha	INTJ
dti-2660	225	13	and	and	CCONJ
dti-2660	225	14	cs	cs	PROPN
dti-2660	225	15	are	be	AUX
dti-2660	225	16	preferred	prefer	VERB
dti-2660	225	17	(	(	PUNCT
dti-2660	225	18	8)	8)	NUM
dti-2660	225	19	,	,	PUNCT
dti-2660	225	20	and	and	CCONJ
dti-2660	225	21	training	training	NOUN
dti-2660	225	22	on	on	ADP
dti-2660	225	23	self	self	NOUN
dti-2660	225	24	-	-	PUNCT
dti-2660	225	25	instillation	instillation	NOUN
dti-2660	225	26	should	should	AUX
dti-2660	225	27	be	be	AUX
dti-2660	225	28	given	give	VERB
dti-2660	225	29	.	.	PUNCT
dti-2660	226	1	seven	seven	NUM
dti-2660	226	2	instillations	instillation	NOUN
dti-2660	226	3	are	be	AUX
dti-2660	226	4	typically	typically	ADV
dti-2660	226	5	used	use	VERB
dti-2660	226	6	,	,	PUNCT
dti-2660	226	7	the	the	DET
dti-2660	226	8	first	first	ADJ
dti-2660	226	9	four	four	NUM
dti-2660	226	10	at	at	ADP
dti-2660	226	11	weekly	weekly	ADJ
dti-2660	226	12	intervals	interval	NOUN
dti-2660	226	13	,	,	PUNCT
dti-2660	226	14	then	then	ADV
dti-2660	226	15	two	two	NUM
dti-2660	226	16	at	at	ADP
dti-2660	226	17	2	2	NUM
dti-2660	226	18	weeks	week	NOUN
dti-2660	226	19	apart	apart	ADV
dti-2660	226	20	,	,	PUNCT
dti-2660	226	21	and	and	CCONJ
dti-2660	226	22	one	one	NUM
dti-2660	226	23	a	a	DET
dti-2660	226	24	month	month	NOUN
dti-2660	226	25	later	later	ADV
dti-2660	226	26	.	.	PUNCT
dti-2660	227	1	however	however	ADV
dti-2660	227	2	,	,	PUNCT
dti-2660	227	3	if	if	SCONJ
dti-2660	227	4	patients	patient	NOUN
dti-2660	227	5	find	find	VERB
dti-2660	227	6	pain	pain	NOUN
dti-2660	227	7	relief	relief	NOUN
dti-2660	227	8	from	from	ADP
dti-2660	227	9	the	the	DET
dti-2660	227	10	treatment	treatment	NOUN
dti-2660	227	11	,	,	PUNCT
dti-2660	227	12	it	it	PRON
dti-2660	227	13	may	may	AUX
dti-2660	227	14	be	be	AUX
dti-2660	227	15	extended	extend	VERB
dti-2660	227	16	empirically	empirically	ADV
dti-2660	227	17	in	in	ADP
dti-2660	227	18	consultation	consultation	NOUN
dti-2660	227	19	with	with	ADP
dti-2660	227	20	their	their	PRON
dti-2660	227	21	needs	need	NOUN
dti-2660	227	22	.	.	PUNCT
dti-2660	228	1	a	a	DET
dti-2660	228	2	number	number	NOUN
dti-2660	228	3	of	of	ADP
dti-2660	228	4	issues	issue	NOUN
dti-2660	228	5	should	should	AUX
dti-2660	228	6	be	be	AUX
dti-2660	228	7	addressed	address	VERB
dti-2660	228	8	to	to	PART
dti-2660	228	9	improve	improve	VERB
dti-2660	228	10	catheter	catheter	NOUN
dti-2660	228	11	management	management	NOUN
dti-2660	228	12	in	in	ADP
dti-2660	228	13	rutis	rutis	NOUN
dti-2660	228	14	.	.	PUNCT
dti-2660	229	1	it	it	PRON
dti-2660	229	2	should	should	AUX
dti-2660	229	3	be	be	AUX
dti-2660	229	4	considered	consider	VERB
dti-2660	229	5	if	if	SCONJ
dti-2660	229	6	catheterization	catheterization	NOUN
dti-2660	229	7	is	be	AUX
dti-2660	229	8	necessary	necessary	ADJ
dti-2660	229	9	,	,	PUNCT
dti-2660	229	10	the	the	DET
dti-2660	229	11	risk	risk	NOUN
dti-2660	229	12	of	of	ADP
dti-2660	229	13	potential	potential	ADJ
dti-2660	229	14	infections	infection	NOUN
dti-2660	229	15	,	,	PUNCT
dti-2660	229	16	how	how	SCONJ
dti-2660	229	17	accepting	accept	VERB
dti-2660	229	18	the	the	DET
dti-2660	229	19	patient	patient	NOUN
dti-2660	229	20	is	be	AUX
dti-2660	229	21	of	of	ADP
dti-2660	229	22	the	the	DET
dti-2660	229	23	procedure	procedure	NOUN
dti-2660	229	24	,	,	PUNCT
dti-2660	229	25	issues	issue	NOUN
dti-2660	229	26	of	of	ADP
dti-2660	229	27	pain	pain	NOUN
dti-2660	229	28	or	or	CCONJ
dti-2660	229	29	blocking	blocking	NOUN
dti-2660	229	30	of	of	ADP
dti-2660	229	31	catheter	catheter	NOUN
dti-2660	229	32	insertion	insertion	NOUN
dti-2660	229	33	,	,	PUNCT
dti-2660	229	34	and	and	CCONJ
dti-2660	229	35	the	the	DET
dti-2660	229	36	choice	choice	NOUN
dti-2660	229	37	of	of	ADP
dti-2660	229	38	catheterization	catheterization	NOUN
dti-2660	229	39	methods	method	NOUN
dti-2660	229	40	.	.	PUNCT
dti-2660	230	1	in	in	ADP
dti-2660	230	2	all	all	DET
dti-2660	230	3	instances	instance	NOUN
dti-2660	230	4	,	,	PUNCT
dti-2660	230	5	the	the	DET
dti-2660	230	6	aim	aim	NOUN
dti-2660	230	7	should	should	AUX
dti-2660	230	8	be	be	AUX
dti-2660	230	9	to	to	PART
dti-2660	230	10	find	find	VERB
dti-2660	230	11	the	the	DET
dti-2660	230	12	best	good	ADJ
dti-2660	230	13	solution	solution	NOUN
dti-2660	230	14	for	for	ADP
dti-2660	230	15	the	the	DET
dti-2660	230	16	individual	individual	ADJ
dti-2660	230	17	patient	patient	NOUN
dti-2660	230	18	.	.	PUNCT
dti-2660	231	1	in	in	ADP
dti-2660	231	2	seeking	seek	VERB
dti-2660	231	3	alternative	alternative	ADJ
dti-2660	231	4	methods	method	NOUN
dti-2660	231	5	to	to	ADP
dti-2660	231	6	standard	standard	ADJ
dti-2660	231	7	catheterization	catheterization	NOUN
dti-2660	231	8	,	,	PUNCT
dti-2660	231	9	the	the	DET
dti-2660	231	10	ialuadapter	ialuadapter	NOUN
dti-2660	231	11	®	®	NOUN
dti-2660	231	12	device	device	NOUN
dti-2660	231	13	has	have	AUX
dti-2660	231	14	been	be	AUX
dti-2660	231	15	developed	develop	VERB
dti-2660	231	16	for	for	ADP
dti-2660	231	17	instillation	instillation	NOUN
dti-2660	231	18	into	into	ADP
dti-2660	231	19	the	the	DET
dti-2660	231	20	bladder	bladder	NOUN
dti-2660	231	21	(	(	PUNCT
dti-2660	231	22	fig	fig	NOUN
dti-2660	231	23	.	.	PUNCT
dti-2660	232	1	3	3	NUM
dti-2660	232	2	)	)	PUNCT
dti-2660	232	3	.	.	PUNCT
dti-2660	233	1	it	it	PRON
dti-2660	233	2	can	can	AUX
dti-2660	233	3	be	be	AUX
dti-2660	233	4	attached	attach	VERB
dti-2660	233	5	to	to	ADP
dti-2660	233	6	luer	luer	NOUN
dti-2660	233	7	lock	lock	NOUN
dti-2660	233	8	or	or	CCONJ
dti-2660	233	9	luer	luer	NOUN
dti-2660	233	10	slip	slip	NOUN
dti-2660	233	11	syringes	syrinx	NOUN
dti-2660	233	12	and	and	CCONJ
dti-2660	233	13	offers	offer	VERB
dti-2660	233	14	an	an	DET
dti-2660	233	15	efficient	efficient	ADJ
dti-2660	233	16	method	method	NOUN
dti-2660	233	17	of	of	ADP
dti-2660	233	18	administering	administer	VERB
dti-2660	233	19	medicine	medicine	NOUN
dti-2660	233	20	into	into	ADP
dti-2660	233	21	the	the	DET
dti-2660	233	22	bladder	bladder	NOUN
dti-2660	233	23	without	without	ADP
dti-2660	233	24	needing	need	VERB
dti-2660	233	25	a	a	DET
dti-2660	233	26	catheter	catheter	NOUN
dti-2660	233	27	.	.	PUNCT
dti-2660	234	1	the	the	DET
dti-2660	234	2	adapter	adapter	NOUN
dti-2660	234	3	tip	tip	NOUN
dti-2660	234	4	can	can	AUX
dti-2660	234	5	be	be	AUX
dti-2660	234	6	guided	guide	VERB
dti-2660	234	7	into	into	ADP
dti-2660	234	8	the	the	DET
dti-2660	234	9	urethral	urethral	ADJ
dti-2660	234	10	orifice	orifice	NOUN
dti-2660	234	11	of	of	ADP
dti-2660	234	12	female	female	ADJ
dti-2660	234	13	and	and	CCONJ
dti-2660	234	14	male	male	ADJ
dti-2660	234	15	patients	patient	NOUN
dti-2660	234	16	with	with	ADP
dti-2660	234	17	minimal	minimal	ADJ
dti-2660	234	18	risk	risk	NOUN
dti-2660	234	19	of	of	ADP
dti-2660	234	20	pain	pain	NOUN
dti-2660	234	21	or	or	CCONJ
dti-2660	234	22	other	other	ADJ
dti-2660	234	23	complications	complication	NOUN
dti-2660	234	24	(	(	PUNCT
dti-2660	234	25	53	53	NUM
dti-2660	234	26	)	)	PUNCT
dti-2660	234	27	.	.	PUNCT
dti-2660	235	1	fig	fig	NOUN
dti-2660	235	2	.	.	PUNCT
dti-2660	236	1	3	3	NUM
dti-2660	236	2	the	the	DET
dti-2660	236	3	ialuadapter	ialuadapter	NOUN
dti-2660	236	4	®	®	NOUN
dti-2660	236	5	device	device	NOUN
dti-2660	236	6	for	for	ADP
dti-2660	236	7	use	use	NOUN
dti-2660	236	8	with	with	ADP
dti-2660	236	9	a	a	DET
dti-2660	236	10	luer	luer	NOUN
dti-2660	236	11	lock	lock	NOUN
dti-2660	236	12	or	or	CCONJ
dti-2660	236	13	luer	luer	NOUN
dti-2660	236	14	slip	slip	NOUN
dti-2660	236	15	syringe	syringe	NOUN
dti-2660	236	16	as	as	ADP
dti-2660	236	17	an	an	DET
dti-2660	236	18	alternative	alternative	NOUN
dti-2660	236	19	to	to	ADP
dti-2660	236	20	intravesical	intravesical	ADJ
dti-2660	236	21	instillation	instillation	NOUN
dti-2660	236	22	by	by	ADP
dti-2660	236	23	standard	standard	ADJ
dti-2660	236	24	catheterization	catheterization	NOUN
dti-2660	236	25	.	.	PUNCT
dti-2660	237	1	figure	figure	VERB
dti-2660	237	2	the	the	DET
dti-2660	237	3	property	property	NOUN
dti-2660	237	4	of	of	ADP
dti-2660	237	5	institut	institut	PROPN
dti-2660	237	6	biochimique	biochimique	PROPN
dti-2660	237	7	sa	sa	PROPN
dti-2660	237	8	(	(	PUNCT
dti-2660	237	9	ibsa	ibsa	NOUN
dti-2660	237	10	)	)	PUNCT
dti-2660	237	11	.	.	PUNCT
dti-2660	238	1	after	after	ADP
dti-2660	238	2	an	an	DET
dti-2660	238	3	initial	initial	ADJ
dti-2660	238	4	learning	learning	NOUN
dti-2660	238	5	curve	curve	NOUN
dti-2660	238	6	involving	involve	VERB
dti-2660	238	7	some	some	DET
dti-2660	238	8	practice	practice	NOUN
dti-2660	238	9	with	with	ADP
dti-2660	238	10	the	the	DET
dti-2660	238	11	ialuadapter	ialuadapter	PROPN
dti-2660	238	12	®	®	PROPN
dti-2660	238	13	,	,	PUNCT
dti-2660	238	14	the	the	DET
dti-2660	238	15	use	use	NOUN
dti-2660	238	16	of	of	ADP
dti-2660	238	17	the	the	DET
dti-2660	238	18	device	device	NOUN
dti-2660	238	19	for	for	ADP
dti-2660	238	20	the	the	DET
dti-2660	238	21	instillation	instillation	NOUN
dti-2660	238	22	of	of	ADP
dti-2660	238	23	ha	ha	INTJ
dti-2660	238	24	and	and	CCONJ
dti-2660	238	25	cs	cs	PROPN
dti-2660	238	26	is	be	AUX
dti-2660	238	27	a	a	DET
dti-2660	238	28	pain	pain	NOUN
dti-2660	238	29	-	-	PUNCT
dti-2660	238	30	free	free	ADJ
dti-2660	238	31	alternative	alternative	NOUN
dti-2660	238	32	to	to	ADP
dti-2660	238	33	standard	standard	ADJ
dti-2660	238	34	catheterization	catheterization	NOUN
dti-2660	238	35	in	in	ADP
dti-2660	238	36	both	both	DET
dti-2660	238	37	men	man	NOUN
dti-2660	238	38	and	and	CCONJ
dti-2660	238	39	women	woman	NOUN
dti-2660	238	40	,	,	PUNCT
dti-2660	238	41	associated	associate	VERB
dti-2660	238	42	with	with	ADP
dti-2660	238	43	fewer	few	ADJ
dti-2660	238	44	infections	infection	NOUN
dti-2660	238	45	while	while	SCONJ
dti-2660	238	46	providing	provide	VERB
dti-2660	238	47	simultaneous	simultaneous	ADJ
dti-2660	238	48	treatment	treatment	NOUN
dti-2660	238	49	of	of	ADP
dti-2660	238	50	the	the	DET
dti-2660	238	51	bladder	bladder	NOUN
dti-2660	238	52	and	and	CCONJ
dti-2660	238	53	the	the	DET
dti-2660	238	54	urethra	urethra	NOUN
dti-2660	238	55	.	.	PUNCT
dti-2660	239	1	the	the	DET
dti-2660	239	2	method	method	NOUN
dti-2660	239	3	is	be	AUX
dti-2660	239	4	also	also	ADV
dti-2660	239	5	more	more	ADV
dti-2660	239	6	effective	effective	ADJ
dti-2660	239	7	and	and	CCONJ
dti-2660	239	8	gives	give	VERB
dti-2660	239	9	faster	fast	ADJ
dti-2660	239	10	results	result	NOUN
dti-2660	239	11	in	in	ADP
dti-2660	239	12	patients	patient	NOUN
dti-2660	239	13	with	with	ADP
dti-2660	239	14	bladder	bladder	NOUN
dti-2660	239	15	pain	pain	NOUN
dti-2660	239	16	and	and	CCONJ
dti-2660	239	17	urethritis	urethritis	NOUN
dti-2660	239	18	.	.	PUNCT
dti-2660	240	1	although	although	SCONJ
dti-2660	240	2	a	a	DET
dti-2660	240	3	residual	residual	ADJ
dti-2660	240	4	urine	urine	NOUN
dti-2660	240	5	volume	volume	NOUN
dti-2660	240	6	of	of	ADP
dti-2660	240	7	50	50	NUM
dti-2660	240	8	ml	ml	NOUN
dti-2660	240	9	is	be	AUX
dti-2660	240	10	acceptable	acceptable	ADJ
dti-2660	240	11	,	,	PUNCT
dti-2660	240	12	the	the	DET
dti-2660	240	13	patient	patient	NOUN
dti-2660	240	14	should	should	AUX
dti-2660	240	15	ideally	ideally	ADV
dti-2660	240	16	have	have	VERB
dti-2660	240	17	an	an	DET
dti-2660	240	18	empty	empty	ADJ
dti-2660	240	19	bladder	bladder	NOUN
dti-2660	240	20	before	before	ADP
dti-2660	240	21	use	use	NOUN
dti-2660	240	22	.	.	PUNCT
dti-2660	241	1	utis	utis	NOUN
dti-2660	241	2	in	in	ADP
dti-2660	241	3	the	the	DET
dti-2660	241	4	era	era	NOUN
dti-2660	241	5	of	of	ADP
dti-2660	241	6	amr134	amr134	NOUN
dti-2660	241	7	©	©	PROPN
dti-2660	241	8	2023	2023	NUM
dti-2660	241	9	the	the	DET
dti-2660	241	10	authors	author	NOUN
dti-2660	241	11	.	.	PUNCT
dti-2660	242	1	drug	drug	NOUN
dti-2660	242	2	target	target	NOUN
dti-2660	242	3	insights	insight	NOUN
dti-2660	242	4	issn	issn	VERB
dti-2660	242	5	1177	1177	NUM
dti-2660	242	6	-	-	SYM
dti-2660	242	7	3928	3928	NUM
dti-2660	242	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2660	242	9	in	in	ADP
dti-2660	242	10	a	a	DET
dti-2660	242	11	6	6	NUM
dti-2660	242	12	-	-	PUNCT
dti-2660	242	13	month	month	NOUN
dti-2660	242	14	study	study	NOUN
dti-2660	242	15	in	in	ADP
dti-2660	242	16	the	the	DET
dti-2660	242	17	andros	andros	PROPN
dti-2660	242	18	clinic	clinic	PROPN
dti-2660	242	19	in	in	ADP
dti-2660	242	20	rijswijk	rijswijk	NOUN
dti-2660	242	21	,	,	PUNCT
dti-2660	242	22	around	around	ADV
dti-2660	242	23	170	170	NUM
dti-2660	242	24	instillations	instillation	NOUN
dti-2660	242	25	were	be	AUX
dti-2660	242	26	performed	perform	VERB
dti-2660	242	27	with	with	ADP
dti-2660	242	28	the	the	DET
dti-2660	242	29	device	device	NOUN
dti-2660	242	30	in	in	ADP
dti-2660	242	31	80	80	NUM
dti-2660	242	32	patients	patient	NOUN
dti-2660	242	33	,	,	PUNCT
dti-2660	242	34	predominantly	predominantly	ADV
dti-2660	242	35	in	in	ADP
dti-2660	242	36	women	woman	NOUN
dti-2660	242	37	with	with	ADP
dti-2660	242	38	bps	bps	PROPN
dti-2660	242	39	/	/	SYM
dti-2660	242	40	ic	ic	PROPN
dti-2660	242	41	(	(	PUNCT
dti-2660	242	42	80.2	80.2	NUM
dti-2660	242	43	%	%	NOUN
dti-2660	242	44	)	)	PUNCT
dti-2660	242	45	,	,	PUNCT
dti-2660	242	46	although	although	SCONJ
dti-2660	242	47	17.4	17.4	NUM
dti-2660	242	48	%	%	NOUN
dti-2660	242	49	of	of	ADP
dti-2660	242	50	patients	patient	NOUN
dti-2660	242	51	had	have	VERB
dti-2660	242	52	rutis	rutis	NOUN
dti-2660	242	53	and	and	CCONJ
dti-2660	242	54	2.3	2.3	NUM
dti-2660	242	55	%	%	NOUN
dti-2660	242	56	oab	oab	PROPN
dti-2660	242	57	syndrome	syndrome	PROPN
dti-2660	242	58	(	(	PUNCT
dti-2660	242	59	tab	tab	PROPN
dti-2660	242	60	.	.	PUNCT
dti-2660	242	61	iii	iii	PROPN
dti-2660	242	62	)	)	PUNCT
dti-2660	242	63	(	(	PUNCT
dti-2660	242	64	r	r	NOUN
dti-2660	242	65	pothoven	pothoven	NOUN
dti-2660	242	66	,	,	PUNCT
dti-2660	242	67	data	datum	NOUN
dti-2660	242	68	on	on	ADP
dti-2660	242	69	file	file	NOUN
dti-2660	242	70	)	)	PUNCT
dti-2660	242	71	.	.	PUNCT
dti-2660	243	1	the	the	DET
dti-2660	243	2	majority	majority	NOUN
dti-2660	243	3	(	(	PUNCT
dti-2660	243	4	62.5	62.5	NUM
dti-2660	243	5	%	%	NOUN
dti-2660	243	6	)	)	PUNCT
dti-2660	243	7	of	of	ADP
dti-2660	243	8	patients	patient	NOUN
dti-2660	243	9	were	be	AUX
dti-2660	243	10	aged	age	VERB
dti-2660	243	11	over	over	ADP
dti-2660	243	12	50	50	NUM
dti-2660	243	13	,	,	PUNCT
dti-2660	243	14	and	and	CCONJ
dti-2660	243	15	only	only	ADV
dti-2660	243	16	two	two	NUM
dti-2660	243	17	men	man	NOUN
dti-2660	243	18	were	be	AUX
dti-2660	243	19	included	include	VERB
dti-2660	243	20	in	in	ADP
dti-2660	243	21	the	the	DET
dti-2660	243	22	study	study	NOUN
dti-2660	243	23	.	.	PUNCT
dti-2660	244	1	the	the	DET
dti-2660	244	2	main	main	ADJ
dti-2660	244	3	reason	reason	NOUN
dti-2660	244	4	patients	patient	NOUN
dti-2660	244	5	tried	try	VERB
dti-2660	244	6	the	the	DET
dti-2660	244	7	ialuadapter	ialuadapter	NOUN
dti-2660	244	8	®	®	NOUN
dti-2660	244	9	as	as	ADP
dti-2660	244	10	an	an	DET
dti-2660	244	11	alternative	alternative	NOUN
dti-2660	244	12	to	to	ADP
dti-2660	244	13	standard	standard	ADJ
dti-2660	244	14	catheterization	catheterization	NOUN
dti-2660	244	15	was	be	AUX
dti-2660	244	16	an	an	DET
dti-2660	244	17	expectation	expectation	NOUN
dti-2660	244	18	of	of	ADP
dti-2660	244	19	experiencing	experience	VERB
dti-2660	244	20	less	less	ADJ
dti-2660	244	21	pain	pain	NOUN
dti-2660	244	22	during	during	ADP
dti-2660	244	23	the	the	DET
dti-2660	244	24	procedure	procedure	NOUN
dti-2660	244	25	(	(	PUNCT
dti-2660	244	26	40.8	40.8	NUM
dti-2660	244	27	%	%	NOUN
dti-2660	244	28	of	of	ADP
dti-2660	244	29	patients	patient	NOUN
dti-2660	244	30	)	)	PUNCT
dti-2660	244	31	(	(	PUNCT
dti-2660	244	32	fig	fig	NOUN
dti-2660	244	33	.	.	PUNCT
dti-2660	244	34	4	4	NUM
dti-2660	244	35	)	)	PUNCT
dti-2660	244	36	.	.	PUNCT
dti-2660	245	1	ease	ease	NOUN
dti-2660	245	2	of	of	ADP
dti-2660	245	3	use	use	NOUN
dti-2660	245	4	and	and	CCONJ
dti-2660	245	5	anticipation	anticipation	NOUN
dti-2660	245	6	of	of	ADP
dti-2660	245	7	fewer	few	ADJ
dti-2660	245	8	infections	infection	NOUN
dti-2660	245	9	were	be	AUX
dti-2660	245	10	each	each	PRON
dti-2660	245	11	given	give	VERB
dti-2660	245	12	as	as	ADP
dti-2660	245	13	reasons	reason	NOUN
dti-2660	245	14	by	by	ADP
dti-2660	245	15	around	around	ADP
dti-2660	245	16	a	a	DET
dti-2660	245	17	quarter	quarter	NOUN
dti-2660	245	18	of	of	ADP
dti-2660	245	19	patients	patient	NOUN
dti-2660	245	20	,	,	PUNCT
dti-2660	245	21	while	while	SCONJ
dti-2660	245	22	1.9	1.9	NUM
dti-2660	245	23	%	%	NOUN
dti-2660	245	24	of	of	ADP
dti-2660	245	25	patients	patient	NOUN
dti-2660	245	26	had	have	VERB
dti-2660	245	27	a	a	DET
dti-2660	245	28	fear	fear	NOUN
dti-2660	245	29	of	of	ADP
dti-2660	245	30	standard	standard	ADJ
dti-2660	245	31	catheterization	catheterization	NOUN
dti-2660	245	32	.	.	PUNCT
dti-2660	246	1	other	other	ADJ
dti-2660	246	2	reasons	reason	NOUN
dti-2660	246	3	(	(	PUNCT
dti-2660	246	4	fewer	few	ADJ
dti-2660	246	5	complications	complication	NOUN
dti-2660	246	6	,	,	PUNCT
dti-2660	246	7	less	less	ADJ
dti-2660	246	8	pain	pain	NOUN
dti-2660	246	9	after	after	ADP
dti-2660	246	10	instillation	instillation	NOUN
dti-2660	246	11	,	,	PUNCT
dti-2660	246	12	more	more	ADV
dti-2660	246	13	comfortable	comfortable	ADJ
dti-2660	246	14	,	,	PUNCT
dti-2660	246	15	lower	low	ADJ
dti-2660	246	16	volume	volume	NOUN
dti-2660	246	17	of	of	ADP
dti-2660	246	18	fluid	fluid	NOUN
dti-2660	246	19	to	to	PART
dti-2660	246	20	be	be	AUX
dti-2660	246	21	given	give	VERB
dti-2660	246	22	,	,	PUNCT
dti-2660	246	23	and	and	CCONJ
dti-2660	246	24	greater	great	ADJ
dti-2660	246	25	effect	effect	NOUN
dti-2660	246	26	)	)	PUNCT
dti-2660	246	27	were	be	AUX
dti-2660	246	28	expressed	express	VERB
dti-2660	246	29	by	by	ADP
dti-2660	246	30	5.8	5.8	NUM
dti-2660	246	31	%	%	NOUN
dti-2660	246	32	of	of	ADP
dti-2660	246	33	patients	patient	NOUN
dti-2660	246	34	.	.	PUNCT
dti-2660	247	1	eighty	eighty	NUM
dti-2660	247	2	-	-	PUNCT
dti-2660	247	3	two	two	NUM
dti-2660	247	4	percent	percent	NOUN
dti-2660	247	5	of	of	ADP
dti-2660	247	6	patients	patient	NOUN
dti-2660	247	7	over	over	ADP
dti-2660	247	8	50	50	NUM
dti-2660	247	9	and	and	CCONJ
dti-2660	247	10	63.3	63.3	NUM
dti-2660	247	11	%	%	NOUN
dti-2660	247	12	of	of	ADP
dti-2660	247	13	those	those	PRON
dti-2660	247	14	under	under	ADP
dti-2660	247	15	50	50	NUM
dti-2660	247	16	wanted	want	VERB
dti-2660	247	17	to	to	PART
dti-2660	247	18	continue	continue	VERB
dti-2660	247	19	using	use	VERB
dti-2660	247	20	the	the	DET
dti-2660	247	21	ialuadapter	ialuadapter	NOUN
dti-2660	247	22	®	®	NOUN
dti-2660	247	23	(	(	PUNCT
dti-2660	247	24	fig	fig	NOUN
dti-2660	247	25	.	.	PUNCT
dti-2660	248	1	5	5	NUM
dti-2660	248	2	)	)	PUNCT
dti-2660	248	3	,	,	PUNCT
dti-2660	248	4	mainly	mainly	ADV
dti-2660	248	5	because	because	SCONJ
dti-2660	248	6	of	of	ADP
dti-2660	248	7	less	less	ADJ
dti-2660	248	8	pain	pain	NOUN
dti-2660	248	9	(	(	PUNCT
dti-2660	248	10	50.1	50.1	NUM
dti-2660	248	11	%	%	NOUN
dti-2660	248	12	of	of	ADP
dti-2660	248	13	patients	patient	NOUN
dti-2660	248	14	overall	overall	ADJ
dti-2660	248	15	)	)	PUNCT
dti-2660	248	16	.	.	PUNCT
dti-2660	249	1	other	other	ADJ
dti-2660	249	2	reasons	reason	NOUN
dti-2660	249	3	were	be	AUX
dti-2660	249	4	that	that	SCONJ
dti-2660	249	5	the	the	DET
dti-2660	249	6	device	device	NOUN
dti-2660	249	7	was	be	AUX
dti-2660	249	8	easier	easy	ADJ
dti-2660	249	9	to	to	PART
dti-2660	249	10	use	use	VERB
dti-2660	249	11	than	than	ADP
dti-2660	249	12	a	a	DET
dti-2660	249	13	catheter	catheter	NOUN
dti-2660	249	14	(	(	PUNCT
dti-2660	249	15	20.9	20.9	NUM
dti-2660	249	16	%	%	NOUN
dti-2660	249	17	)	)	PUNCT
dti-2660	249	18	and	and	CCONJ
dti-2660	249	19	could	could	AUX
dti-2660	249	20	be	be	AUX
dti-2660	249	21	done	do	VERB
dti-2660	249	22	at	at	ADP
dti-2660	249	23	home	home	NOUN
dti-2660	249	24	(	(	PUNCT
dti-2660	249	25	10.5	10.5	NUM
dti-2660	249	26	%	%	NOUN
dti-2660	249	27	)	)	PUNCT
dti-2660	249	28	.	.	PUNCT
dti-2660	250	1	it	it	PRON
dti-2660	250	2	was	be	AUX
dti-2660	250	3	thought	think	VERB
dti-2660	250	4	that	that	SCONJ
dti-2660	250	5	a	a	DET
dti-2660	250	6	greater	great	ADJ
dti-2660	250	7	proportion	proportion	NOUN
dti-2660	250	8	of	of	ADP
dti-2660	250	9	the	the	DET
dti-2660	250	10	younger	young	ADJ
dti-2660	250	11	patients	patient	NOUN
dti-2660	250	12	were	be	AUX
dti-2660	250	13	too	too	ADV
dti-2660	250	14	tense	tense	ADJ
dti-2660	250	15	and	and	CCONJ
dti-2660	250	16	less	less	ADV
dti-2660	250	17	able	able	ADJ
dti-2660	250	18	to	to	PART
dti-2660	250	19	relax	relax	VERB
dti-2660	250	20	than	than	ADP
dti-2660	250	21	those	those	DET
dti-2660	250	22	over	over	ADP
dti-2660	250	23	50	50	NUM
dti-2660	250	24	,	,	PUNCT
dti-2660	250	25	leading	lead	VERB
dti-2660	250	26	to	to	ADP
dti-2660	250	27	a	a	DET
dti-2660	250	28	higher	high	ADJ
dti-2660	250	29	rate	rate	NOUN
dti-2660	250	30	of	of	ADP
dti-2660	250	31	leakage	leakage	NOUN
dti-2660	250	32	after	after	ADP
dti-2660	250	33	instillation	instillation	NOUN
dti-2660	250	34	,	,	PUNCT
dti-2660	250	35	probably	probably	ADV
dti-2660	250	36	contributing	contribute	VERB
dti-2660	250	37	to	to	ADP
dti-2660	250	38	the	the	DET
dti-2660	250	39	lower	low	ADJ
dti-2660	250	40	percentage	percentage	NOUN
dti-2660	250	41	of	of	ADP
dti-2660	250	42	patients	patient	NOUN
dti-2660	250	43	under	under	ADP
dti-2660	250	44	50	50	NUM
dti-2660	250	45	wishing	wish	VERB
dti-2660	250	46	to	to	PART
dti-2660	250	47	continue	continue	VERB
dti-2660	250	48	to	to	PART
dti-2660	250	49	use	use	VERB
dti-2660	250	50	the	the	DET
dti-2660	250	51	device	device	NOUN
dti-2660	250	52	.	.	PUNCT
dti-2660	251	1	of	of	ADP
dti-2660	251	2	the	the	DET
dti-2660	251	3	59	59	NUM
dti-2660	251	4	patients	patient	NOUN
dti-2660	251	5	who	who	PRON
dti-2660	251	6	continued	continue	VERB
dti-2660	251	7	using	use	VERB
dti-2660	251	8	the	the	DET
dti-2660	251	9	ialuadapter	ialuadapter	PROPN
dti-2660	251	10	®	®	NOUN
dti-2660	251	11	,	,	PUNCT
dti-2660	251	12	none	none	NOUN
dti-2660	251	13	experienced	experience	VERB
dti-2660	251	14	an	an	DET
dti-2660	251	15	ruti	ruti	PROPN
dti-2660	251	16	.	.	PUNCT
dti-2660	252	1	research	research	NOUN
dti-2660	252	2	is	be	AUX
dti-2660	252	3	ongoing	ongoing	ADJ
dti-2660	252	4	to	to	PART
dti-2660	252	5	identify	identify	VERB
dti-2660	252	6	the	the	DET
dti-2660	252	7	patients	patient	NOUN
dti-2660	252	8	best	well	ADV
dti-2660	252	9	suited	suit	VERB
dti-2660	252	10	for	for	ADP
dti-2660	252	11	instillation	instillation	NOUN
dti-2660	252	12	therapy	therapy	NOUN
dti-2660	252	13	.	.	PUNCT
dti-2660	253	1	discussion	discussion	NOUN
dti-2660	253	2	and	and	CCONJ
dti-2660	253	3	conclusions	conclusion	NOUN
dti-2660	253	4	utis	utis	PROPN
dti-2660	253	5	impose	impose	VERB
dti-2660	253	6	a	a	DET
dti-2660	253	7	sizable	sizable	ADJ
dti-2660	253	8	personal	personal	ADJ
dti-2660	253	9	and	and	CCONJ
dti-2660	253	10	economic	economic	ADJ
dti-2660	253	11	burden	burden	NOUN
dti-2660	253	12	on	on	ADP
dti-2660	253	13	individuals	individual	NOUN
dti-2660	253	14	and	and	CCONJ
dti-2660	253	15	health	health	NOUN
dti-2660	253	16	resources	resource	NOUN
dti-2660	253	17	worldwide	worldwide	ADV
dti-2660	253	18	(	(	PUNCT
dti-2660	253	19	1	1	NUM
dti-2660	253	20	-	-	SYM
dti-2660	253	21	4	4	NUM
dti-2660	253	22	)	)	PUNCT
dti-2660	253	23	,	,	PUNCT
dti-2660	253	24	and	and	CCONJ
dti-2660	253	25	effectively	effectively	ADV
dti-2660	253	26	managing	manage	VERB
dti-2660	253	27	utis	utis	NOUN
dti-2660	253	28	is	be	AUX
dti-2660	253	29	a	a	DET
dti-2660	253	30	major	major	ADJ
dti-2660	253	31	challenge	challenge	NOUN
dti-2660	253	32	faced	face	VERB
dti-2660	253	33	not	not	PART
dti-2660	253	34	only	only	ADV
dti-2660	253	35	by	by	ADP
dti-2660	253	36	physicians	physician	NOUN
dti-2660	253	37	and	and	CCONJ
dti-2660	253	38	specialist	specialist	NOUN
dti-2660	253	39	nurses	nurse	NOUN
dti-2660	253	40	in	in	ADP
dti-2660	253	41	their	their	PRON
dti-2660	253	42	daily	daily	ADJ
dti-2660	253	43	clinical	clinical	ADJ
dti-2660	253	44	practices	practice	NOUN
dti-2660	253	45	but	but	CCONJ
dti-2660	253	46	also	also	ADV
dti-2660	253	47	by	by	ADP
dti-2660	253	48	patients	patient	NOUN
dti-2660	253	49	and	and	CCONJ
dti-2660	253	50	their	their	PRON
dti-2660	253	51	caregivers	caregiver	NOUN
dti-2660	253	52	in	in	ADP
dti-2660	253	53	the	the	DET
dti-2660	253	54	community	community	NOUN
dti-2660	253	55	.	.	PUNCT
dti-2660	254	1	while	while	SCONJ
dti-2660	254	2	antibiotic	antibiotic	ADJ
dti-2660	254	3	treatment	treatment	NOUN
dti-2660	254	4	of	of	ADP
dti-2660	254	5	symptoms	symptom	NOUN
dti-2660	254	6	suggestive	suggestive	ADJ
dti-2660	254	7	of	of	ADP
dti-2660	254	8	utis	utis	NOUN
dti-2660	254	9	and	and	CCONJ
dti-2660	254	10	rutis	rutis	NOUN
dti-2660	254	11	has	have	VERB
dti-2660	254	12	clear	clear	ADJ
dti-2660	254	13	benefits	benefit	NOUN
dti-2660	254	14	to	to	ADP
dti-2660	254	15	patients	patient	NOUN
dti-2660	254	16	,	,	PUNCT
dti-2660	254	17	overuse	overuse	NOUN
dti-2660	254	18	and	and	CCONJ
dti-2660	254	19	inappropriate	inappropriate	ADJ
dti-2660	254	20	use	use	NOUN
dti-2660	254	21	have	have	AUX
dti-2660	254	22	led	lead	VERB
dti-2660	254	23	to	to	ADP
dti-2660	254	24	a	a	DET
dti-2660	254	25	worldwide	worldwide	ADJ
dti-2660	254	26	problem	problem	NOUN
dti-2660	254	27	of	of	ADP
dti-2660	254	28	amr	amr	NOUN
dti-2660	254	29	that	that	PRON
dti-2660	254	30	has	have	AUX
dti-2660	254	31	become	become	VERB
dti-2660	254	32	an	an	DET
dti-2660	254	33	increasing	increase	VERB
dti-2660	254	34	threat	threat	NOUN
dti-2660	254	35	to	to	ADP
dti-2660	254	36	public	public	ADJ
dti-2660	254	37	health	health	NOUN
dti-2660	254	38	.	.	PUNCT
dti-2660	255	1	programs	program	NOUN
dti-2660	255	2	of	of	ADP
dti-2660	255	3	antimicrobial	antimicrobial	ADJ
dti-2660	255	4	stewardship	stewardship	NOUN
dti-2660	255	5	that	that	PRON
dti-2660	255	6	aim	aim	VERB
dti-2660	255	7	to	to	PART
dti-2660	255	8	optimize	optimize	VERB
dti-2660	255	9	clinical	clinical	ADJ
dti-2660	255	10	outcomes	outcome	NOUN
dti-2660	255	11	while	while	SCONJ
dti-2660	255	12	reducing	reduce	VERB
dti-2660	255	13	inappropriate	inappropriate	ADJ
dti-2660	255	14	antibiotic	antibiotic	ADJ
dti-2660	255	15	use	use	NOUN
dti-2660	255	16	have	have	AUX
dti-2660	255	17	been	be	AUX
dti-2660	255	18	developed	develop	VERB
dti-2660	255	19	to	to	PART
dti-2660	255	20	provide	provide	VERB
dti-2660	255	21	guidance	guidance	NOUN
dti-2660	255	22	encouraging	encouraging	ADJ
dti-2660	255	23	prudent	prudent	ADJ
dti-2660	255	24	and	and	CCONJ
dti-2660	255	25	appropriate	appropriate	ADJ
dti-2660	255	26	antibiotic	antibiotic	ADJ
dti-2660	255	27	prescribing	prescribing	NOUN
dti-2660	255	28	that	that	PRON
dti-2660	255	29	minimizes	minimize	VERB
dti-2660	255	30	the	the	DET
dti-2660	255	31	unintended	unintended	ADJ
dti-2660	255	32	consequences	consequence	NOUN
dti-2660	255	33	of	of	ADP
dti-2660	255	34	antibiotic	antibiotic	ADJ
dti-2660	255	35	overuse	overuse	NOUN
dti-2660	255	36	,	,	PUNCT
dti-2660	255	37	including	include	VERB
dti-2660	255	38	antibiotic	antibiotic	NOUN
dti-2660	255	39	-	-	PUNCT
dti-2660	255	40	related	relate	VERB
dti-2660	255	41	adverse	adverse	ADJ
dti-2660	255	42	events	event	NOUN
dti-2660	255	43	and	and	CCONJ
dti-2660	255	44	the	the	DET
dti-2660	255	45	emergence	emergence	NOUN
dti-2660	255	46	of	of	ADP
dti-2660	255	47	resistant	resistant	ADJ
dti-2660	255	48	bacterial	bacterial	ADJ
dti-2660	255	49	strains	strain	NOUN
dti-2660	255	50	(	(	PUNCT
dti-2660	255	51	5,8	5,8	NUM
dti-2660	255	52	)	)	PUNCT
dti-2660	255	53	.	.	PUNCT
dti-2660	256	1	when	when	SCONJ
dti-2660	256	2	antibiotic	antibiotic	ADJ
dti-2660	256	3	therapy	therapy	NOUN
dti-2660	256	4	is	be	AUX
dti-2660	256	5	indicated	indicate	VERB
dti-2660	256	6	for	for	ADP
dti-2660	256	7	treating	treat	VERB
dti-2660	256	8	utis	utis	NOUN
dti-2660	256	9	or	or	CCONJ
dti-2660	256	10	rutis	rutis	NOUN
dti-2660	256	11	,	,	PUNCT
dti-2660	256	12	choosing	choose	VERB
dti-2660	256	13	an	an	DET
dti-2660	256	14	appropriate	appropriate	ADJ
dti-2660	256	15	antibiotic	antibiotic	NOUN
dti-2660	256	16	based	base	VERB
dti-2660	256	17	on	on	ADP
dti-2660	256	18	local	local	ADJ
dti-2660	256	19	resistance	resistance	NOUN
dti-2660	256	20	and	and	CCONJ
dti-2660	256	21	susceptibility	susceptibility	NOUN
dti-2660	256	22	patterns	pattern	NOUN
dti-2660	256	23	is	be	AUX
dti-2660	256	24	essential	essential	ADJ
dti-2660	256	25	,	,	PUNCT
dti-2660	256	26	guided	guide	VERB
dti-2660	256	27	by	by	ADP
dti-2660	256	28	evidence	evidence	NOUN
dti-2660	256	29	-	-	PUNCT
dti-2660	256	30	based	base	VERB
dti-2660	256	31	clinical	clinical	ADJ
dti-2660	256	32	guidelines	guideline	NOUN
dti-2660	256	33	such	such	ADJ
dti-2660	256	34	as	as	ADP
dti-2660	256	35	those	those	PRON
dti-2660	256	36	compiled	compile	VERB
dti-2660	256	37	by	by	ADP
dti-2660	256	38	the	the	DET
dti-2660	256	39	eau	eau	PROPN
dti-2660	256	40	,	,	PUNCT
dti-2660	256	41	which	which	PRON
dti-2660	256	42	fig	fig	NOUN
dti-2660	256	43	.	.	PUNCT
dti-2660	257	1	4	4	NUM
dti-2660	257	2	reasons	reason	NOUN
dti-2660	257	3	for	for	ADP
dti-2660	257	4	trying	try	VERB
dti-2660	257	5	the	the	DET
dti-2660	257	6	ialuadapter	ialuadapter	NOUN
dti-2660	257	7	®	®	NOUN
dti-2660	257	8	as	as	ADP
dti-2660	257	9	an	an	DET
dti-2660	257	10	alternative	alternative	NOUN
dti-2660	257	11	to	to	ADP
dti-2660	257	12	standard	standard	ADJ
dti-2660	257	13	catheterization	catheterization	NOUN
dti-2660	257	14	(	(	PUNCT
dti-2660	257	15	n	n	NOUN
dti-2660	257	16	=	=	NUM
dti-2660	257	17	80	80	NUM
dti-2660	257	18	)	)	PUNCT
dti-2660	257	19	.	.	PUNCT
dti-2660	258	1	data	data	VERB
dti-2660	258	2	the	the	DET
dti-2660	258	3	property	property	NOUN
dti-2660	258	4	of	of	ADP
dti-2660	258	5	the	the	DET
dti-2660	258	6	author	author	NOUN
dti-2660	258	7	.	.	PUNCT
dti-2660	259	1	table	table	NOUN
dti-2660	259	2	iii	iii	NOUN
dti-2660	259	3	use	use	NOUN
dti-2660	259	4	of	of	ADP
dti-2660	259	5	the	the	DET
dti-2660	259	6	ialuadapter	ialuadapter	NOUN
dti-2660	259	7	®	®	NOUN
dti-2660	259	8	in	in	ADP
dti-2660	259	9	patients	patient	NOUN
dti-2660	259	10	with	with	ADP
dti-2660	259	11	urological	urological	ADJ
dti-2660	259	12	conditions	condition	NOUN
dti-2660	259	13	(	(	PUNCT
dti-2660	259	14	n	n	NOUN
dti-2660	259	15	=	=	NUM
dti-2660	259	16	80	80	NUM
dti-2660	259	17	)	)	PUNCT
dti-2660	259	18	parameter	parameter	NOUN
dti-2660	259	19	n	n	PROPN
dti-2660	259	20	(	(	PUNCT
dti-2660	259	21	%	%	INTJ
dti-2660	259	22	)	)	PUNCT
dti-2660	259	23	gender	gender	NOUN
dti-2660	259	24	female	female	NOUN
dti-2660	259	25	78	78	NUM
dti-2660	259	26	(	(	PUNCT
dti-2660	259	27	97.5	97.5	NUM
dti-2660	259	28	)	)	PUNCT
dti-2660	259	29	male	male	NOUN
dti-2660	259	30	2	2	NUM
dti-2660	259	31	(	(	PUNCT
dti-2660	259	32	2.5	2.5	NUM
dti-2660	259	33	)	)	PUNCT
dti-2660	259	34	age	age	NOUN
dti-2660	259	35	of	of	ADP
dti-2660	259	36	participants	participant	NOUN
dti-2660	259	37	≥50	≥50	ADP
dti-2660	259	38	years	year	NOUN
dti-2660	259	39	50	50	NUM
dti-2660	259	40	(	(	PUNCT
dti-2660	259	41	62.5	62.5	NUM
dti-2660	259	42	)	)	PUNCT
dti-2660	259	43	<	<	X
dti-2660	259	44	50	50	NUM
dti-2660	259	45	years	year	NOUN
dti-2660	259	46	30	30	NUM
dti-2660	259	47	(	(	PUNCT
dti-2660	259	48	37.5	37.5	NUM
dti-2660	259	49	)	)	PUNCT
dti-2660	259	50	urological	urological	ADJ
dti-2660	259	51	indication	indication	NOUN
dti-2660	259	52	bps	bps	PROPN
dti-2660	259	53	/	/	SYM
dti-2660	259	54	ic	ic	PROPN
dti-2660	259	55	64	64	NUM
dti-2660	259	56	(	(	PUNCT
dti-2660	259	57	80.2	80.2	NUM
dti-2660	259	58	)	)	PUNCT
dti-2660	259	59	rutis	rutis	NOUN
dti-2660	259	60	14	14	NUM
dti-2660	259	61	(	(	PUNCT
dti-2660	259	62	17.4	17.4	NUM
dti-2660	259	63	)	)	PUNCT
dti-2660	259	64	oab	oab	PROPN
dti-2660	259	65	syndrome	syndrome	NOUN
dti-2660	259	66	2	2	NUM
dti-2660	259	67	(	(	PUNCT
dti-2660	259	68	2.3	2.3	NUM
dti-2660	259	69	)	)	PUNCT
dti-2660	259	70	bps	bps	NOUN
dti-2660	259	71	/	/	SYM
dti-2660	259	72	ic	ic	NOUN
dti-2660	259	73	=	=	NOUN
dti-2660	259	74	bladder	bladder	NOUN
dti-2660	259	75	pain	pain	NOUN
dti-2660	259	76	syndrome	syndrome	NOUN
dti-2660	259	77	/	/	SYM
dti-2660	259	78	interstitial	interstitial	ADJ
dti-2660	259	79	cystitis	cystitis	NOUN
dti-2660	259	80	;	;	PUNCT
dti-2660	259	81	oab	oab	PROPN
dti-2660	259	82	=	=	PUNCT
dti-2660	259	83	overactive	overactive	ADJ
dti-2660	259	84	bladder	bladder	NOUN
dti-2660	259	85	;	;	PUNCT
dti-2660	260	1	ruti	ruti	PROPN
dti-2660	260	2	=	=	PUNCT
dti-2660	260	3	recurrent	recurrent	ADJ
dti-2660	260	4	urinary	urinary	ADJ
dti-2660	260	5	tract	tract	NOUN
dti-2660	260	6	infection	infection	NOUN
dti-2660	260	7	.	.	PUNCT
dti-2660	261	1	pothoven	pothoven	ADJ
dti-2660	261	2	drug	drug	NOUN
dti-2660	261	3	target	target	NOUN
dti-2660	261	4	insights	insight	NOUN
dti-2660	261	5	2023	2023	NUM
dti-2660	261	6	;	;	PUNCT
dti-2660	261	7	17	17	NUM
dti-2660	261	8	:	:	SYM
dti-2660	261	9	135	135	NUM
dti-2660	261	10	©	©	PROPN
dti-2660	261	11	2023	2023	NUM
dti-2660	261	12	the	the	DET
dti-2660	261	13	authors	author	NOUN
dti-2660	261	14	.	.	PUNCT
dti-2660	262	1	published	publish	VERB
dti-2660	262	2	by	by	ADP
dti-2660	262	3	aboutscience	aboutscience	NOUN
dti-2660	262	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2660	262	5	recommends	recommend	VERB
dti-2660	262	6	first	first	ADJ
dti-2660	262	7	-	-	PUNCT
dti-2660	262	8	line	line	NOUN
dti-2660	262	9	therapy	therapy	NOUN
dti-2660	262	10	with	with	ADP
dti-2660	262	11	fosfomycin	fosfomycin	PROPN
dti-2660	262	12	trometamol	trometamol	PROPN
dti-2660	262	13	,	,	PUNCT
dti-2660	262	14	nitrofurantoin	nitrofurantoin	NOUN
dti-2660	262	15	,	,	PUNCT
dti-2660	262	16	or	or	CCONJ
dti-2660	262	17	pivmecillinam	pivmecillinam	PROPN
dti-2660	262	18	as	as	ADP
dti-2660	262	19	first	first	ADJ
dti-2660	262	20	-	-	PUNCT
dti-2660	262	21	line	line	NOUN
dti-2660	262	22	antimicrobial	antimicrobial	ADJ
dti-2660	262	23	therapy	therapy	NOUN
dti-2660	262	24	for	for	ADP
dti-2660	262	25	uncomplicated	uncomplicated	ADJ
dti-2660	262	26	utis	utis	NOUN
dti-2660	262	27	(	(	PUNCT
dti-2660	262	28	8)	8)	NUM
dti-2660	262	29	.	.	PUNCT
dti-2660	263	1	appropriate	appropriate	ADJ
dti-2660	263	2	non	non	ADJ
dti-2660	263	3	-	-	ADJ
dti-2660	263	4	antimicrobial	antimicrobial	ADJ
dti-2660	263	5	strategies	strategy	NOUN
dti-2660	263	6	aimed	aim	VERB
dti-2660	263	7	at	at	ADP
dti-2660	263	8	reducing	reduce	VERB
dti-2660	263	9	the	the	DET
dti-2660	263	10	incidence	incidence	NOUN
dti-2660	263	11	of	of	ADP
dti-2660	263	12	rutis	rutis	NOUN
dti-2660	263	13	should	should	AUX
dti-2660	263	14	also	also	ADV
dti-2660	263	15	be	be	AUX
dti-2660	263	16	considered	consider	VERB
dti-2660	263	17	.	.	PUNCT
dti-2660	264	1	indeed	indeed	ADV
dti-2660	264	2	,	,	PUNCT
dti-2660	264	3	the	the	DET
dti-2660	264	4	increasing	increase	VERB
dti-2660	264	5	global	global	ADJ
dti-2660	264	6	burden	burden	NOUN
dti-2660	264	7	of	of	ADP
dti-2660	264	8	drug	drug	NOUN
dti-2660	264	9	-	-	PUNCT
dti-2660	264	10	resistant	resistant	ADJ
dti-2660	264	11	pathogens	pathogen	NOUN
dti-2660	264	12	makes	make	VERB
dti-2660	264	13	identifying	identify	VERB
dti-2660	264	14	effective	effective	ADJ
dti-2660	264	15	non	non	ADJ
dti-2660	264	16	-	-	ADJ
dti-2660	264	17	antimicrobial	antimicrobial	ADJ
dti-2660	264	18	strategies	strategy	NOUN
dti-2660	264	19	to	to	PART
dti-2660	264	20	reduce	reduce	VERB
dti-2660	264	21	the	the	DET
dti-2660	264	22	burden	burden	NOUN
dti-2660	264	23	of	of	ADP
dti-2660	264	24	bacterial	bacterial	ADJ
dti-2660	264	25	amr	amr	NOUN
dti-2660	264	26	an	an	DET
dti-2660	264	27	urgent	urgent	ADJ
dti-2660	264	28	priority	priority	NOUN
dti-2660	264	29	(	(	PUNCT
dti-2660	264	30	6	6	NUM
dti-2660	264	31	)	)	PUNCT
dti-2660	264	32	.	.	PUNCT
dti-2660	265	1	strategies	strategy	NOUN
dti-2660	265	2	are	be	AUX
dti-2660	265	3	available	available	ADJ
dti-2660	265	4	to	to	PART
dti-2660	265	5	reduce	reduce	VERB
dti-2660	265	6	the	the	DET
dti-2660	265	7	dependence	dependence	NOUN
dti-2660	265	8	on	on	ADP
dti-2660	265	9	antimicrobial	antimicrobial	ADJ
dti-2660	265	10	use	use	NOUN
dti-2660	265	11	in	in	ADP
dti-2660	265	12	uncomplicated	uncomplicated	ADJ
dti-2660	265	13	utis	utis	NOUN
dti-2660	265	14	,	,	PUNCT
dti-2660	265	15	including	include	VERB
dti-2660	265	16	methenamine	methenamine	NOUN
dti-2660	265	17	hippurate	hippurate	PROPN
dti-2660	265	18	,	,	PUNCT
dti-2660	265	19	cranberry	cranberry	NOUN
dti-2660	265	20	extract	extract	NOUN
dti-2660	265	21	,	,	PUNCT
dti-2660	265	22	d	d	NOUN
dti-2660	265	23	-	-	PUNCT
dti-2660	265	24	mannose	mannose	NOUN
dti-2660	265	25	,	,	PUNCT
dti-2660	265	26	probiotics	probiotic	NOUN
dti-2660	265	27	,	,	PUNCT
dti-2660	265	28	intravesical	intravesical	ADJ
dti-2660	265	29	gag	gag	NOUN
dti-2660	265	30	therapy	therapy	NOUN
dti-2660	265	31	,	,	PUNCT
dti-2660	265	32	and	and	CCONJ
dti-2660	265	33	prophylactic	prophylactic	ADJ
dti-2660	265	34	vaccination	vaccination	NOUN
dti-2660	265	35	.	.	PUNCT
dti-2660	266	1	regardless	regardless	ADV
dti-2660	266	2	of	of	ADP
dti-2660	266	3	whether	whether	SCONJ
dti-2660	266	4	an	an	DET
dti-2660	266	5	antimicrobial	antimicrobial	ADJ
dti-2660	266	6	or	or	CCONJ
dti-2660	266	7	non	non	ADJ
dti-2660	266	8	-	-	ADJ
dti-2660	266	9	antimicrobial	antimicrobial	ADJ
dti-2660	266	10	approach	approach	NOUN
dti-2660	266	11	is	be	AUX
dti-2660	266	12	taken	take	VERB
dti-2660	266	13	,	,	PUNCT
dti-2660	266	14	counseling	counsel	VERB
dti-2660	266	15	patients	patient	NOUN
dti-2660	266	16	about	about	ADP
dti-2660	266	17	avoidance	avoidance	NOUN
dti-2660	266	18	of	of	ADP
dti-2660	266	19	risk	risk	NOUN
dti-2660	266	20	factors	factor	NOUN
dti-2660	266	21	and	and	CCONJ
dti-2660	266	22	behavioral	behavioral	ADJ
dti-2660	266	23	modifications	modification	NOUN
dti-2660	266	24	can	can	AUX
dti-2660	266	25	be	be	AUX
dti-2660	266	26	a	a	DET
dti-2660	266	27	first	first	ADJ
dti-2660	266	28	step	step	NOUN
dti-2660	266	29	toward	toward	ADP
dti-2660	266	30	prophylaxis	prophylaxis	NOUN
dti-2660	266	31	of	of	ADP
dti-2660	266	32	rutis	rutis	NOUN
dti-2660	266	33	.	.	PUNCT
dti-2660	267	1	furthermore	furthermore	ADV
dti-2660	267	2	,	,	PUNCT
dti-2660	267	3	the	the	DET
dti-2660	267	4	use	use	NOUN
dti-2660	267	5	of	of	ADP
dti-2660	267	6	nonantimicrobial	nonantimicrobial	ADJ
dti-2660	267	7	strategies	strategy	NOUN
dti-2660	267	8	should	should	AUX
dti-2660	267	9	be	be	AUX
dti-2660	267	10	based	base	VERB
dti-2660	267	11	on	on	ADP
dti-2660	267	12	physician	physician	NOUN
dti-2660	267	13	expertise	expertise	NOUN
dti-2660	267	14	supported	support	VERB
dti-2660	267	15	by	by	ADP
dti-2660	267	16	clinical	clinical	ADJ
dti-2660	267	17	evidence	evidence	NOUN
dti-2660	267	18	,	,	PUNCT
dti-2660	267	19	as	as	ADP
dti-2660	267	20	reducing	reduce	VERB
dti-2660	267	21	the	the	DET
dti-2660	267	22	overall	overall	ADJ
dti-2660	267	23	use	use	NOUN
dti-2660	267	24	of	of	ADP
dti-2660	267	25	antibiotics	antibiotic	NOUN
dti-2660	267	26	should	should	AUX
dti-2660	267	27	not	not	PART
dti-2660	267	28	be	be	AUX
dti-2660	267	29	at	at	ADP
dti-2660	267	30	the	the	DET
dti-2660	267	31	expense	expense	NOUN
dti-2660	267	32	of	of	ADP
dti-2660	267	33	compromising	compromise	VERB
dti-2660	267	34	clinical	clinical	ADJ
dti-2660	267	35	outcomes	outcome	NOUN
dti-2660	267	36	.	.	PUNCT
dti-2660	268	1	further	far	ADV
dti-2660	268	2	well	well	ADV
dti-2660	268	3	-	-	PUNCT
dti-2660	268	4	designed	design	VERB
dti-2660	268	5	studies	study	NOUN
dti-2660	268	6	evaluating	evaluate	VERB
dti-2660	268	7	non	non	ADJ
dti-2660	268	8	-	-	ADJ
dti-2660	268	9	antimicrobial	antimicrobial	ADJ
dti-2660	268	10	prophylaxis	prophylaxis	NOUN
dti-2660	268	11	of	of	ADP
dti-2660	268	12	rutis	rutis	NOUN
dti-2660	268	13	is	be	AUX
dti-2660	268	14	needed	need	VERB
dti-2660	268	15	to	to	PART
dti-2660	268	16	extend	extend	VERB
dti-2660	268	17	the	the	DET
dti-2660	268	18	level	level	NOUN
dti-2660	268	19	of	of	ADP
dti-2660	268	20	evidence	evidence	NOUN
dti-2660	268	21	and	and	CCONJ
dti-2660	268	22	fully	fully	ADV
dti-2660	268	23	define	define	VERB
dti-2660	268	24	the	the	DET
dti-2660	268	25	place	place	NOUN
dti-2660	268	26	of	of	ADP
dti-2660	268	27	non	non	ADJ
dti-2660	268	28	-	-	ADJ
dti-2660	268	29	antimicrobial	antimicrobial	ADJ
dti-2660	268	30	strategies	strategy	NOUN
dti-2660	268	31	in	in	ADP
dti-2660	268	32	routine	routine	ADJ
dti-2660	268	33	clinical	clinical	ADJ
dti-2660	268	34	practice	practice	NOUN
dti-2660	268	35	.	.	PUNCT
dti-2660	269	1	also	also	ADV
dti-2660	269	2	important	important	ADJ
dti-2660	269	3	is	be	AUX
dti-2660	269	4	the	the	DET
dti-2660	269	5	need	need	NOUN
dti-2660	269	6	to	to	PART
dti-2660	269	7	identify	identify	VERB
dti-2660	269	8	which	which	PRON
dti-2660	269	9	patients	patient	NOUN
dti-2660	269	10	might	might	AUX
dti-2660	269	11	benefit	benefit	VERB
dti-2660	269	12	most	most	ADV
dti-2660	269	13	from	from	ADP
dti-2660	269	14	nonantimicrobial	nonantimicrobial	ADJ
dti-2660	269	15	treatment	treatment	NOUN
dti-2660	269	16	for	for	ADP
dti-2660	269	17	acute	acute	ADJ
dti-2660	269	18	utis	utis	NOUN
dti-2660	269	19	or	or	CCONJ
dti-2660	269	20	non	non	ADJ
dti-2660	269	21	-	-	ADJ
dti-2660	269	22	antimicrobial	antimicrobial	ADJ
dti-2660	269	23	prophylaxis	prophylaxis	NOUN
dti-2660	269	24	for	for	ADP
dti-2660	269	25	rutis	rutis	NOUN
dti-2660	269	26	.	.	PUNCT
dti-2660	270	1	acknowledgments	acknowledgment	NOUN
dti-2660	270	2	the	the	DET
dti-2660	270	3	authors	author	NOUN
dti-2660	270	4	thank	thank	VERB
dti-2660	270	5	ray	ray	PROPN
dti-2660	270	6	hill	hill	PROPN
dti-2660	270	7	,	,	PUNCT
dti-2660	270	8	an	an	DET
dti-2660	270	9	independent	independent	ADJ
dti-2660	270	10	medical	medical	ADJ
dti-2660	270	11	writer	writer	NOUN
dti-2660	270	12	who	who	PRON
dti-2660	270	13	provided	provide	VERB
dti-2660	270	14	technical	technical	ADJ
dti-2660	270	15	writing	writing	NOUN
dti-2660	270	16	support	support	NOUN
dti-2660	270	17	funded	fund	VERB
dti-2660	270	18	by	by	ADP
dti-2660	270	19	ibsa	ibsa	NOUN
dti-2660	270	20	institut	institut	PROPN
dti-2660	270	21	biochimique	biochimique	PROPN
dti-2660	270	22	sa	sa	PROPN
dti-2660	270	23	(	(	PUNCT
dti-2660	270	24	lugano	lugano	PROPN
dti-2660	270	25	,	,	PUNCT
dti-2660	270	26	switzerland	switzerland	PROPN
dti-2660	270	27	)	)	PUNCT
dti-2660	270	28	.	.	PUNCT
dti-2660	271	1	disclosures	disclosure	VERB
dti-2660	271	2	conflict	conflict	NOUN
dti-2660	271	3	of	of	ADP
dti-2660	271	4	interest	interest	NOUN
dti-2660	271	5	:	:	PUNCT
dti-2660	271	6	the	the	DET
dti-2660	271	7	author	author	NOUN
dti-2660	271	8	has	have	AUX
dti-2660	271	9	participated	participate	VERB
dti-2660	271	10	in	in	ADP
dti-2660	271	11	workshops	workshop	NOUN
dti-2660	271	12	sponsored	sponsor	VERB
dti-2660	271	13	by	by	ADP
dti-2660	271	14	ibsa	ibsa	NOUN
dti-2660	271	15	and	and	CCONJ
dti-2660	271	16	goodlife	goodlife	PROPN
dti-2660	271	17	nederland	nederland	PROPN
dti-2660	271	18	.	.	PUNCT
dti-2660	272	1	funding	funding	NOUN
dti-2660	272	2	/	/	SYM
dti-2660	272	3	support	support	NOUN
dti-2660	272	4	and	and	CCONJ
dti-2660	272	5	role	role	NOUN
dti-2660	272	6	of	of	ADP
dti-2660	272	7	the	the	DET
dti-2660	272	8	sponsor	sponsor	NOUN
dti-2660	272	9	:	:	PUNCT
dti-2660	272	10	the	the	DET
dti-2660	272	11	publication	publication	NOUN
dti-2660	272	12	of	of	ADP
dti-2660	272	13	this	this	DET
dti-2660	272	14	article	article	NOUN
dti-2660	272	15	was	be	AUX
dti-2660	272	16	supported	support	VERB
dti-2660	272	17	by	by	ADP
dti-2660	272	18	an	an	DET
dti-2660	272	19	unconditional	unconditional	ADJ
dti-2660	272	20	grant	grant	NOUN
dti-2660	272	21	from	from	ADP
dti-2660	272	22	ibsa	ibsa	NOUN
dti-2660	272	23	.	.	PUNCT
dti-2660	273	1	references	reference	NOUN
dti-2660	273	2	1	1	NUM
dti-2660	273	3	.	.	PUNCT
dti-2660	274	1	yang	yang	PROPN
dti-2660	274	2	x	x	PROPN
dti-2660	274	3	,	,	PUNCT
dti-2660	274	4	chen	chen	PROPN
dti-2660	274	5	h	h	PROPN
dti-2660	274	6	,	,	PUNCT
dti-2660	274	7	zheng	zheng	PROPN
dti-2660	274	8	y	y	PROPN
dti-2660	274	9	,	,	PUNCT
dti-2660	274	10	qu	qu	PROPN
dti-2660	274	11	s	s	PROPN
dti-2660	274	12	,	,	PUNCT
dti-2660	274	13	wang	wang	PROPN
dti-2660	274	14	h	h	PROPN
dti-2660	274	15	,	,	PUNCT
dti-2660	274	16	yi	yi	PROPN
dti-2660	274	17	f.	f.	PROPN
dti-2660	274	18	disease	disease	PROPN
dti-2660	274	19	burden	burden	NOUN
dti-2660	274	20	and	and	CCONJ
dti-2660	274	21	long	long	ADJ
dti-2660	274	22	-	-	PUNCT
dti-2660	274	23	term	term	NOUN
dti-2660	274	24	trends	trend	NOUN
dti-2660	274	25	of	of	ADP
dti-2660	274	26	urinary	urinary	ADJ
dti-2660	274	27	tract	tract	NOUN
dti-2660	274	28	infections	infection	NOUN
dti-2660	274	29	:	:	PUNCT
dti-2660	274	30	a	a	DET
dti-2660	274	31	worldwide	worldwide	ADJ
dti-2660	274	32	report	report	NOUN
dti-2660	274	33	.	.	PUNCT
dti-2660	275	1	front	front	ADJ
dti-2660	275	2	public	public	ADJ
dti-2660	275	3	health	health	NOUN
dti-2660	275	4	.	.	PUNCT
dti-2660	276	1	2022;10:888205	2022;10:888205	X
dti-2660	276	2	.	.	X
dti-2660	276	3	crossref	crossref	PROPN
dti-2660	276	4	pubmed	pubmed	PROPN
dti-2660	276	5	2	2	PROPN
dti-2660	276	6	.	.	PUNCT
dti-2660	277	1	zeng	zeng	PROPN
dti-2660	277	2	z	z	PROPN
dti-2660	277	3	,	,	PUNCT
dti-2660	277	4	zhan	zhan	PROPN
dti-2660	277	5	j	j	PROPN
dti-2660	277	6	,	,	PUNCT
dti-2660	277	7	zhang	zhang	PROPN
dti-2660	277	8	k	k	PROPN
dti-2660	277	9	,	,	PUNCT
dti-2660	277	10	chen	chen	PROPN
dti-2660	277	11	h	h	PROPN
dti-2660	277	12	,	,	PUNCT
dti-2660	277	13	cheng	cheng	PROPN
dti-2660	277	14	s.	s.	PROPN
dti-2660	277	15	global	global	PROPN
dti-2660	277	16	,	,	PUNCT
dti-2660	277	17	regional	regional	ADJ
dti-2660	277	18	,	,	PUNCT
dti-2660	277	19	and	and	CCONJ
dti-2660	277	20	national	national	ADJ
dti-2660	277	21	burden	burden	NOUN
dti-2660	277	22	of	of	ADP
dti-2660	277	23	urinary	urinary	ADJ
dti-2660	277	24	tract	tract	NOUN
dti-2660	277	25	infections	infection	NOUN
dti-2660	277	26	from	from	ADP
dti-2660	277	27	1990	1990	NUM
dti-2660	277	28	to	to	ADP
dti-2660	277	29	2019	2019	NUM
dti-2660	277	30	:	:	PUNCT
dti-2660	277	31	an	an	DET
dti-2660	277	32	analysis	analysis	NOUN
dti-2660	277	33	of	of	ADP
dti-2660	277	34	the	the	DET
dti-2660	277	35	global	global	ADJ
dti-2660	277	36	burden	burden	NOUN
dti-2660	277	37	of	of	ADP
dti-2660	277	38	disease	disease	NOUN
dti-2660	277	39	study	study	NOUN
dti-2660	277	40	2019	2019	NUM
dti-2660	277	41	.	.	PUNCT
dti-2660	278	1	world	world	PROPN
dti-2660	278	2	j	j	PROPN
dti-2660	278	3	urol	urol	PROPN
dti-2660	278	4	.	.	PUNCT
dti-2660	279	1	2022;40(3):755	2022;40(3):755	PROPN
dti-2660	279	2	-	-	SYM
dti-2660	279	3	763	763	NUM
dti-2660	279	4	.	.	PUNCT
dti-2660	280	1	crossref	crossref	PROPN
dti-2660	280	2	pubmed	pubmed	PROPN
dti-2660	280	3	3	3	PROPN
dti-2660	280	4	.	.	PUNCT
dti-2660	280	5	gbd	gbd	NOUN
dti-2660	280	6	2019	2019	NUM
dti-2660	280	7	risk	risk	NOUN
dti-2660	280	8	factors	factor	NOUN
dti-2660	280	9	collaborators	collaborator	NOUN
dti-2660	280	10	.	.	PUNCT
dti-2660	281	1	global	global	ADJ
dti-2660	281	2	burden	burden	NOUN
dti-2660	281	3	of	of	ADP
dti-2660	281	4	87	87	NUM
dti-2660	281	5	risk	risk	NOUN
dti-2660	281	6	factors	factor	NOUN
dti-2660	281	7	in	in	ADP
dti-2660	281	8	204	204	NUM
dti-2660	281	9	countries	country	NOUN
dti-2660	281	10	and	and	CCONJ
dti-2660	281	11	territories	territory	NOUN
dti-2660	281	12	,	,	PUNCT
dti-2660	281	13	1990	1990	NUM
dti-2660	281	14	-	-	SYM
dti-2660	281	15	2019	2019	NUM
dti-2660	281	16	:	:	PUNCT
dti-2660	281	17	a	a	DET
dti-2660	281	18	systematic	systematic	ADJ
dti-2660	281	19	analysis	analysis	NOUN
dti-2660	281	20	for	for	ADP
dti-2660	281	21	the	the	DET
dti-2660	281	22	global	global	ADJ
dti-2660	281	23	burden	burden	NOUN
dti-2660	281	24	of	of	ADP
dti-2660	281	25	disease	disease	NOUN
dti-2660	281	26	study	study	NOUN
dti-2660	281	27	2019	2019	NUM
dti-2660	281	28	.	.	PUNCT
dti-2660	282	1	lancet	lancet	NOUN
dti-2660	282	2	.	.	PUNCT
dti-2660	283	1	2020	2020	NUM
dti-2660	283	2	oct	oct	PROPN
dti-2660	283	3	17;396(10258):1223	17;396(10258):1223	NUM
dti-2660	283	4	-	-	SYM
dti-2660	283	5	1249	1249	NUM
dti-2660	283	6	.	.	PUNCT
dti-2660	284	1	crossref	crossref	PROPN
dti-2660	284	2	pubmed	pubmed	PROPN
dti-2660	284	3	4	4	PROPN
dti-2660	284	4	.	.	PUNCT
dti-2660	284	5	gbd	gbd	NOUN
dti-2660	284	6	2019	2019	NUM
dti-2660	284	7	diseases	disease	NOUN
dti-2660	284	8	and	and	CCONJ
dti-2660	284	9	injuries	injury	NOUN
dti-2660	284	10	collaborators	collaborator	NOUN
dti-2660	284	11	.	.	PUNCT
dti-2660	285	1	global	global	ADJ
dti-2660	285	2	burden	burden	NOUN
dti-2660	285	3	of	of	ADP
dti-2660	285	4	369	369	NUM
dti-2660	285	5	diseases	disease	NOUN
dti-2660	285	6	and	and	CCONJ
dti-2660	285	7	injuries	injury	NOUN
dti-2660	285	8	in	in	ADP
dti-2660	285	9	204	204	NUM
dti-2660	285	10	countries	country	NOUN
dti-2660	285	11	and	and	CCONJ
dti-2660	285	12	territories	territory	NOUN
dti-2660	285	13	,	,	PUNCT
dti-2660	285	14	1990	1990	NUM
dti-2660	285	15	-	-	SYM
dti-2660	285	16	2019	2019	NUM
dti-2660	285	17	:	:	PUNCT
dti-2660	285	18	a	a	DET
dti-2660	285	19	systematic	systematic	ADJ
dti-2660	285	20	analysis	analysis	NOUN
dti-2660	285	21	for	for	ADP
dti-2660	285	22	the	the	DET
dti-2660	285	23	global	global	ADJ
dti-2660	285	24	burden	burden	NOUN
dti-2660	285	25	fig	fig	NOUN
dti-2660	285	26	.	.	PUNCT
dti-2660	286	1	5	5	NUM
dti-2660	286	2	patient	patient	ADJ
dti-2660	286	3	feedback	feedback	NOUN
dti-2660	286	4	on	on	ADP
dti-2660	286	5	using	use	VERB
dti-2660	286	6	the	the	DET
dti-2660	286	7	ialuadapter	ialuadapter	NOUN
dti-2660	286	8	®	®	NOUN
dti-2660	286	9	device	device	NOUN
dti-2660	286	10	.	.	PUNCT
dti-2660	287	1	data	data	VERB
dti-2660	287	2	the	the	DET
dti-2660	287	3	property	property	NOUN
dti-2660	287	4	of	of	ADP
dti-2660	287	5	the	the	DET
dti-2660	287	6	author	author	NOUN
dti-2660	287	7	.	.	PUNCT
dti-2660	288	1	https://doi.org/10.3389/fpubh.2022.888205	https://doi.org/10.3389/fpubh.2022.888205	PROPN
dti-2660	288	2	https://www.ncbi.nlm.nih.gov/pubmed/35968451	https://www.ncbi.nlm.nih.gov/pubmed/35968451	PROPN
dti-2660	288	3	https://doi.org/10.1007/s00345-021-03913-0	https://doi.org/10.1007/s00345-021-03913-0	NUM
dti-2660	288	4	https://www.ncbi.nlm.nih.gov/pubmed/35066637	https://www.ncbi.nlm.nih.gov/pubmed/35066637	NUM
dti-2660	288	5	https://doi.org/10.1016/s0140-6736(20)30752-2	https://doi.org/10.1016/s0140-6736(20)30752-2	VERB
dti-2660	288	6	https://pubmed.ncbi.nlm.nih.gov/33069327/	https://pubmed.ncbi.nlm.nih.gov/33069327/	PROPN
dti-2660	288	7	utis	utis	NOUN
dti-2660	288	8	in	in	ADP
dti-2660	288	9	the	the	DET
dti-2660	288	10	era	era	NOUN
dti-2660	288	11	of	of	ADP
dti-2660	288	12	amr136	amr136	NOUN
dti-2660	288	13	©	©	PROPN
dti-2660	288	14	2023	2023	NUM
dti-2660	288	15	the	the	DET
dti-2660	288	16	authors	author	NOUN
dti-2660	288	17	.	.	PUNCT
dti-2660	289	1	drug	drug	NOUN
dti-2660	289	2	target	target	NOUN
dti-2660	289	3	insights	insight	NOUN
dti-2660	289	4	issn	issn	VERB
dti-2660	289	5	1177	1177	NUM
dti-2660	289	6	-	-	SYM
dti-2660	289	7	3928	3928	NUM
dti-2660	289	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2660	289	9	of	of	ADP
dti-2660	289	10	disease	disease	NOUN
dti-2660	289	11	study	study	NOUN
dti-2660	289	12	2019	2019	NUM
dti-2660	289	13	.	.	PUNCT
dti-2660	290	1	lancet	lancet	NOUN
dti-2660	290	2	.	.	PUNCT
dti-2660	291	1	2020	2020	NUM
dti-2660	291	2	oct	oct	PROPN
dti-2660	291	3	17;396(10258	17;396(10258	NUM
dti-2660	291	4	):	):	PUNCT
dti-2660	291	5	1204	1204	NUM
dti-2660	291	6	-	-	SYM
dti-2660	291	7	1222	1222	NUM
dti-2660	291	8	.	.	PUNCT
dti-2660	292	1	crossref	crossref	PROPN
dti-2660	292	2	pubmed	pubmed	PROPN
dti-2660	292	3	5	5	PROPN
dti-2660	292	4	.	.	PUNCT
dti-2660	293	1	department	department	PROPN
dti-2660	293	2	of	of	ADP
dti-2660	293	3	health	health	PROPN
dti-2660	293	4	and	and	CCONJ
dti-2660	293	5	social	social	ADJ
dti-2660	293	6	care	care	NOUN
dti-2660	293	7	(	(	PUNCT
dti-2660	293	8	dhsc	dhsc	NOUN
dti-2660	293	9	)	)	PUNCT
dti-2660	293	10	.	.	PUNCT
dti-2660	294	1	uk	uk	PROPN
dti-2660	294	2	antimicrobial	antimicrobial	ADJ
dti-2660	294	3	resistance	resistance	NOUN
dti-2660	294	4	strategy	strategy	NOUN
dti-2660	294	5	and	and	CCONJ
dti-2660	294	6	action	action	NOUN
dti-2660	294	7	plan	plan	NOUN
dti-2660	294	8	.	.	PUNCT
dti-2660	295	1	2000	2000	NUM
dti-2660	295	2	.	.	PUNCT
dti-2660	296	1	online	online	INTJ
dti-2660	296	2	(	(	PUNCT
dti-2660	296	3	accessed	access	VERB
dti-2660	296	4	march	march	PROPN
dti-2660	296	5	2023	2023	NUM
dti-2660	296	6	)	)	PUNCT
dti-2660	296	7	.	.	PUNCT
dti-2660	297	1	6	6	X
dti-2660	297	2	.	.	X
dti-2660	297	3	murray	murray	PROPN
dti-2660	297	4	cjl	cjl	PROPN
dti-2660	297	5	,	,	PUNCT
dti-2660	297	6	ikuta	ikuta	PROPN
dti-2660	297	7	ks	ks	PROPN
dti-2660	297	8	,	,	PUNCT
dti-2660	297	9	sharara	sharara	NOUN
dti-2660	297	10	f	f	X
dti-2660	297	11	,	,	PUNCT
dti-2660	297	12	et	et	PROPN
dti-2660	297	13	al	al	PROPN
dti-2660	297	14	;	;	PUNCT
dti-2660	297	15	antimicrobial	antimicrobial	ADJ
dti-2660	297	16	resistance	resistance	NOUN
dti-2660	297	17	collaborators	collaborator	NOUN
dti-2660	297	18	.	.	PUNCT
dti-2660	298	1	global	global	ADJ
dti-2660	298	2	burden	burden	NOUN
dti-2660	298	3	of	of	ADP
dti-2660	298	4	bacterial	bacterial	ADJ
dti-2660	298	5	antimicrobial	antimicrobial	ADJ
dti-2660	298	6	resistance	resistance	NOUN
dti-2660	298	7	in	in	ADP
dti-2660	298	8	2019	2019	NUM
dti-2660	298	9	:	:	PUNCT
dti-2660	298	10	a	a	DET
dti-2660	298	11	systematic	systematic	ADJ
dti-2660	298	12	analysis	analysis	NOUN
dti-2660	298	13	.	.	PUNCT
dti-2660	299	1	lancet	lancet	PROPN
dti-2660	299	2	.	.	PUNCT
dti-2660	300	1	2022;399(10325	2022;399(10325	NUM
dti-2660	300	2	):	):	PUNCT
dti-2660	300	3	629	629	NUM
dti-2660	300	4	-	-	SYM
dti-2660	300	5	655	655	NUM
dti-2660	300	6	.	.	PUNCT
dti-2660	301	1	crossref	crossref	PROPN
dti-2660	301	2	pubmed	pubmed	PROPN
dti-2660	301	3	7	7	PROPN
dti-2660	301	4	.	.	PUNCT
dti-2660	302	1	o’neill	o’neill	AUX
dti-2660	302	2	j.	j.	PROPN
dti-2660	302	3	tackling	tackle	VERB
dti-2660	302	4	drug	drug	NOUN
dti-2660	302	5	-	-	PUNCT
dti-2660	302	6	resistant	resistant	ADJ
dti-2660	302	7	infections	infection	NOUN
dti-2660	302	8	globally	globally	ADV
dti-2660	302	9	:	:	PUNCT
dti-2660	302	10	final	final	ADJ
dti-2660	302	11	report	report	NOUN
dti-2660	302	12	and	and	CCONJ
dti-2660	302	13	recommendations	recommendation	NOUN
dti-2660	302	14	.	.	PUNCT
dti-2660	303	1	online	online	INTJ
dti-2660	303	2	(	(	PUNCT
dti-2660	303	3	accessed	access	VERB
dti-2660	303	4	march	march	PROPN
dti-2660	303	5	2023	2023	NUM
dti-2660	303	6	)	)	PUNCT
dti-2660	303	7	.	.	PUNCT
dti-2660	304	1	8	8	X
dti-2660	304	2	.	.	X
dti-2660	304	3	bonkat	bonkat	PROPN
dti-2660	304	4	g	g	PROPN
dti-2660	304	5	,	,	PUNCT
dti-2660	304	6	bartoletti	bartoletti	PROPN
dti-2660	304	7	r	r	NOUN
dti-2660	304	8	,	,	PUNCT
dti-2660	304	9	bruyere	bruyere	NOUN
dti-2660	304	10	f	f	PROPN
dti-2660	304	11	,	,	PUNCT
dti-2660	304	12	et	et	PROPN
dti-2660	304	13	al	al	PROPN
dti-2660	304	14	.	.	PUNCT
dti-2660	305	1	eau	eau	PROPN
dti-2660	305	2	guidelines	guideline	NOUN
dti-2660	305	3	on	on	ADP
dti-2660	305	4	urological	urological	ADJ
dti-2660	305	5	infections	infection	NOUN
dti-2660	305	6	.	.	PUNCT
dti-2660	306	1	edn	edn	NOUN
dti-2660	306	2	.	.	PUNCT
dti-2660	306	3	presented	present	VERB
dti-2660	306	4	at	at	ADP
dti-2660	306	5	the	the	DET
dti-2660	306	6	eau	eau	PROPN
dti-2660	306	7	annual	annual	ADJ
dti-2660	306	8	congress	congress	PROPN
dti-2660	306	9	,	,	PUNCT
dti-2660	306	10	milan	milan	PROPN
dti-2660	306	11	,	,	PUNCT
dti-2660	306	12	italy	italy	PROPN
dti-2660	306	13	,	,	PUNCT
dti-2660	306	14	2023	2023	NUM
dti-2660	306	15	.	.	PUNCT
dti-2660	307	1	isbn	isbn	ADJ
dti-2660	307	2	978	978	NUM
dti-2660	307	3	-	-	SYM
dti-2660	307	4	94	94	NUM
dti-2660	307	5	-	-	PUNCT
dti-2660	307	6	92671	92671	NUM
dti-2660	307	7	-	-	PUNCT
dti-2660	307	8	19	19	NUM
dti-2660	307	9	-	-	SYM
dti-2660	307	10	6	6	NUM
dti-2660	307	11	.	.	PUNCT
dti-2660	308	1	online	online	ADV
dti-2660	308	2	(	(	PUNCT
dti-2660	308	3	accessed	access	VERB
dti-2660	308	4	march	march	PROPN
dti-2660	308	5	2023	2023	NUM
dti-2660	308	6	)	)	PUNCT
dti-2660	308	7	.	.	PUNCT
dti-2660	309	1	9	9	X
dti-2660	309	2	.	.	X
dti-2660	309	3	gbd	gbd	NOUN
dti-2660	309	4	2019	2019	NUM
dti-2660	309	5	antimicrobial	antimicrobial	ADJ
dti-2660	309	6	resistance	resistance	NOUN
dti-2660	309	7	collaborators	collaborator	NOUN
dti-2660	309	8	.	.	PUNCT
dti-2660	310	1	global	global	ADJ
dti-2660	310	2	mortality	mortality	NOUN
dti-2660	310	3	associated	associate	VERB
dti-2660	310	4	with	with	ADP
dti-2660	310	5	33	33	NUM
dti-2660	310	6	bacterial	bacterial	ADJ
dti-2660	310	7	pathogens	pathogen	NOUN
dti-2660	310	8	in	in	ADP
dti-2660	310	9	2019	2019	NUM
dti-2660	310	10	:	:	PUNCT
dti-2660	310	11	a	a	DET
dti-2660	310	12	systematic	systematic	ADJ
dti-2660	310	13	analysis	analysis	NOUN
dti-2660	310	14	for	for	ADP
dti-2660	310	15	the	the	DET
dti-2660	310	16	global	global	ADJ
dti-2660	310	17	burden	burden	NOUN
dti-2660	310	18	of	of	ADP
dti-2660	310	19	disease	disease	NOUN
dti-2660	310	20	study	study	NOUN
dti-2660	310	21	2019	2019	NUM
dti-2660	310	22	.	.	PUNCT
dti-2660	311	1	lancet	lancet	NOUN
dti-2660	311	2	.	.	PUNCT
dti-2660	312	1	2022	2022	NUM
dti-2660	312	2	dec	dec	PROPN
dti-2660	312	3	17;400(10369):2221	17;400(10369):2221	NUM
dti-2660	312	4	-	-	SYM
dti-2660	312	5	2248	2248	NUM
dti-2660	312	6	.	.	PUNCT
dti-2660	313	1	crossref	crossref	PROPN
dti-2660	313	2	pubmed	pubmed	PROPN
dti-2660	313	3	10	10	PROPN
dti-2660	313	4	.	.	PUNCT
dti-2660	314	1	johansen	johansen	PROPN
dti-2660	314	2	te	te	PROPN
dti-2660	314	3	,	,	PUNCT
dti-2660	314	4	botto	botto	PROPN
dti-2660	314	5	h	h	PROPN
dti-2660	314	6	,	,	PUNCT
dti-2660	314	7	cek	cek	PROPN
dti-2660	314	8	m	m	PROPN
dti-2660	314	9	,	,	PUNCT
dti-2660	314	10	et	et	PROPN
dti-2660	314	11	al	al	PROPN
dti-2660	314	12	.	.	PROPN
dti-2660	314	13	critical	critical	ADJ
dti-2660	314	14	review	review	NOUN
dti-2660	314	15	of	of	ADP
dti-2660	314	16	current	current	ADJ
dti-2660	314	17	definitions	definition	NOUN
dti-2660	314	18	of	of	ADP
dti-2660	314	19	urinary	urinary	ADJ
dti-2660	314	20	tract	tract	NOUN
dti-2660	314	21	infections	infection	NOUN
dti-2660	314	22	and	and	CCONJ
dti-2660	314	23	proposal	proposal	NOUN
dti-2660	314	24	of	of	ADP
dti-2660	314	25	an	an	DET
dti-2660	314	26	eau/	eau/	ADJ
dti-2660	314	27	esiu	esiu	NOUN
dti-2660	314	28	classification	classification	NOUN
dti-2660	314	29	system	system	NOUN
dti-2660	314	30	.	.	PUNCT
dti-2660	315	1	int	int	NOUN
dti-2660	315	2	j	j	PROPN
dti-2660	315	3	antimicrob	antimicrob	PROPN
dti-2660	315	4	agents	agent	NOUN
dti-2660	315	5	.	.	PUNCT
dti-2660	316	1	2011	2011	NUM
dti-2660	316	2	;	;	PUNCT
dti-2660	316	3	38(suppl):64	38(suppl):64	PROPN
dti-2660	316	4	-	-	SYM
dti-2660	316	5	70	70	NUM
dti-2660	316	6	.	.	PUNCT
dti-2660	317	1	crossref	crossref	PROPN
dti-2660	317	2	pubmed	pubmed	PROPN
dti-2660	317	3	11	11	NUM
dti-2660	317	4	.	.	PUNCT
dti-2660	318	1	köves	köve	NOUN
dti-2660	318	2	b	b	NUM
dti-2660	318	3	,	,	PUNCT
dti-2660	318	4	cai	cai	PROPN
dti-2660	318	5	t	t	PROPN
dti-2660	318	6	,	,	PUNCT
dti-2660	318	7	veeratterapillay	veeratterapillay	NOUN
dti-2660	318	8	r	r	NOUN
dti-2660	318	9	,	,	PUNCT
dti-2660	318	10	et	et	PROPN
dti-2660	318	11	al	al	PROPN
dti-2660	318	12	.	.	PROPN
dti-2660	318	13	benefits	benefit	NOUN
dti-2660	318	14	and	and	CCONJ
dti-2660	318	15	harms	harm	NOUN
dti-2660	318	16	of	of	ADP
dti-2660	318	17	treatment	treatment	NOUN
dti-2660	318	18	of	of	ADP
dti-2660	318	19	asymptomatic	asymptomatic	ADJ
dti-2660	318	20	bacteriuria	bacteriuria	NOUN
dti-2660	318	21	:	:	PUNCT
dti-2660	318	22	a	a	DET
dti-2660	318	23	systematic	systematic	ADJ
dti-2660	318	24	review	review	NOUN
dti-2660	318	25	and	and	CCONJ
dti-2660	318	26	meta	meta	NOUN
dti-2660	318	27	-	-	PUNCT
dti-2660	318	28	analysis	analysis	NOUN
dti-2660	318	29	by	by	ADP
dti-2660	318	30	the	the	DET
dti-2660	318	31	european	european	PROPN
dti-2660	318	32	association	association	PROPN
dti-2660	318	33	of	of	ADP
dti-2660	318	34	urology	urology	NOUN
dti-2660	318	35	urological	urological	ADJ
dti-2660	318	36	infection	infection	NOUN
dti-2660	318	37	guidelines	guideline	NOUN
dti-2660	318	38	panel	panel	NOUN
dti-2660	318	39	.	.	PUNCT
dti-2660	319	1	eur	eur	PROPN
dti-2660	319	2	urol	urol	PROPN
dti-2660	319	3	.	.	PUNCT
dti-2660	320	1	2017;72(6	2017;72(6	NUM
dti-2660	320	2	):	):	PUNCT
dti-2660	320	3	865	865	NUM
dti-2660	320	4	-	-	SYM
dti-2660	320	5	868	868	NUM
dti-2660	320	6	.	.	PUNCT
dti-2660	321	1	crossref	crossref	PROPN
dti-2660	321	2	pubmed	pubmed	PROPN
dti-2660	321	3	12	12	NUM
dti-2660	321	4	.	.	PUNCT
dti-2660	322	1	deltourbe	deltourbe	PROPN
dti-2660	322	2	l	l	PROPN
dti-2660	322	3	,	,	PUNCT
dti-2660	322	4	lacerda	lacerda	PROPN
dti-2660	322	5	mariano	mariano	PROPN
dti-2660	322	6	l	l	PROPN
dti-2660	322	7	,	,	PUNCT
dti-2660	322	8	hreha	hreha	PROPN
dti-2660	322	9	tn	tn	PROPN
dti-2660	322	10	,	,	PUNCT
dti-2660	322	11	hunstad	hunstad	PROPN
dti-2660	322	12	da	da	PROPN
dti-2660	322	13	,	,	PUNCT
dti-2660	322	14	ingersoll	ingersoll	PROPN
dti-2660	322	15	ma	ma	PROPN
dti-2660	322	16	.	.	PUNCT
dti-2660	323	1	the	the	DET
dti-2660	323	2	impact	impact	NOUN
dti-2660	323	3	of	of	ADP
dti-2660	323	4	biological	biological	ADJ
dti-2660	323	5	sex	sex	NOUN
dti-2660	323	6	on	on	ADP
dti-2660	323	7	diseases	disease	NOUN
dti-2660	323	8	of	of	ADP
dti-2660	323	9	the	the	DET
dti-2660	323	10	urinary	urinary	ADJ
dti-2660	323	11	tract	tract	NOUN
dti-2660	323	12	.	.	PUNCT
dti-2660	324	1	mucosal	mucosal	ADJ
dti-2660	324	2	immunol	immunol	NOUN
dti-2660	324	3	.	.	PUNCT
dti-2660	325	1	2022;15(5):857	2022;15(5):857	NUM
dti-2660	325	2	-	-	SYM
dti-2660	325	3	866	866	NUM
dti-2660	325	4	.	.	PUNCT
dti-2660	326	1	crossref	crossref	PROPN
dti-2660	326	2	pubmed	pubmed	PROPN
dti-2660	326	3	13	13	PROPN
dti-2660	326	4	.	.	PUNCT
dti-2660	327	1	foxman	foxman	PROPN
dti-2660	327	2	b.	b.	PROPN
dti-2660	327	3	the	the	DET
dti-2660	327	4	epidemiology	epidemiology	NOUN
dti-2660	327	5	of	of	ADP
dti-2660	327	6	urinary	urinary	ADJ
dti-2660	327	7	tract	tract	NOUN
dti-2660	327	8	infection	infection	NOUN
dti-2660	327	9	.	.	PUNCT
dti-2660	328	1	nat	nat	PROPN
dti-2660	328	2	rev	rev	VERB
dti-2660	328	3	urol	urol	PROPN
dti-2660	328	4	.	.	PUNCT
dti-2660	329	1	2010;7(12):653	2010;7(12):653	NUM
dti-2660	329	2	-	-	PUNCT
dti-2660	329	3	660	660	NUM
dti-2660	329	4	.	.	PUNCT
dti-2660	330	1	crossref	crossref	PROPN
dti-2660	330	2	pubmed	pubmed	PROPN
dti-2660	330	3	14	14	PROPN
dti-2660	330	4	.	.	PUNCT
dti-2660	331	1	ingersoll	ingersoll	PROPN
dti-2660	331	2	ma	ma	PROPN
dti-2660	331	3	.	.	PROPN
dti-2660	331	4	sex	sex	NOUN
dti-2660	331	5	differences	difference	NOUN
dti-2660	331	6	shape	shape	VERB
dti-2660	331	7	the	the	DET
dti-2660	331	8	response	response	NOUN
dti-2660	331	9	to	to	ADP
dti-2660	331	10	infectious	infectious	ADJ
dti-2660	331	11	diseases	disease	NOUN
dti-2660	331	12	.	.	PUNCT
dti-2660	332	1	plos	plos	PROPN
dti-2660	332	2	pathog	pathog	PROPN
dti-2660	332	3	.	.	PUNCT
dti-2660	333	1	2017;13(12):e1006688	2017;13(12):e1006688	NUM
dti-2660	333	2	.	.	PUNCT
dti-2660	334	1	crossref	crossref	PROPN
dti-2660	334	2	pubmed	pubmed	PROPN
dti-2660	334	3	15	15	NUM
dti-2660	334	4	.	.	PUNCT
dti-2660	335	1	lipsky	lipsky	PROPN
dti-2660	335	2	ba	ba	PROPN
dti-2660	335	3	.	.	PUNCT
dti-2660	336	1	urinary	urinary	ADJ
dti-2660	336	2	tract	tract	NOUN
dti-2660	336	3	infections	infection	NOUN
dti-2660	336	4	in	in	ADP
dti-2660	336	5	men	man	NOUN
dti-2660	336	6	.	.	PUNCT
dti-2660	337	1	epidemiology	epidemiology	NOUN
dti-2660	337	2	,	,	PUNCT
dti-2660	337	3	pathophysiology	pathophysiology	NOUN
dti-2660	337	4	,	,	PUNCT
dti-2660	337	5	diagnosis	diagnosis	NOUN
dti-2660	337	6	,	,	PUNCT
dti-2660	337	7	and	and	CCONJ
dti-2660	337	8	treatment	treatment	NOUN
dti-2660	337	9	.	.	PUNCT
dti-2660	338	1	ann	ann	PROPN
dti-2660	338	2	intern	intern	PROPN
dti-2660	338	3	med	med	PROPN
dti-2660	338	4	.	.	PROPN
dti-2660	338	5	1989	1989	NUM
dti-2660	338	6	;	;	PUNCT
dti-2660	338	7	110(2):138	110(2):138	NUM
dti-2660	338	8	-	-	SYM
dti-2660	338	9	150	150	NUM
dti-2660	338	10	.	.	PUNCT
dti-2660	339	1	crossref	crossref	PROPN
dti-2660	339	2	pubmed	pubmed	PROPN
dti-2660	339	3	16	16	NUM
dti-2660	339	4	.	.	PUNCT
dti-2660	340	1	zeng	zeng	PROPN
dti-2660	340	2	g	g	PROPN
dti-2660	340	3	,	,	PUNCT
dti-2660	340	4	zhu	zhu	PROPN
dti-2660	340	5	w	w	PROPN
dti-2660	340	6	,	,	PUNCT
dti-2660	340	7	lam	lam	PROPN
dti-2660	340	8	w	w	PROPN
dti-2660	340	9	,	,	PUNCT
dti-2660	340	10	bayramgil	bayramgil	PROPN
dti-2660	340	11	a.	a.	NOUN
dti-2660	340	12	treatment	treatment	NOUN
dti-2660	340	13	of	of	ADP
dti-2660	340	14	urinary	urinary	ADJ
dti-2660	340	15	tract	tract	NOUN
dti-2660	340	16	infections	infection	NOUN
dti-2660	340	17	in	in	ADP
dti-2660	340	18	the	the	DET
dti-2660	340	19	old	old	ADJ
dti-2660	340	20	and	and	CCONJ
dti-2660	340	21	fragile	fragile	ADJ
dti-2660	340	22	.	.	PUNCT
dti-2660	341	1	world	world	PROPN
dti-2660	341	2	j	j	PROPN
dti-2660	341	3	urol	urol	PROPN
dti-2660	341	4	.	.	PUNCT
dti-2660	342	1	2020;38(11):27092720	2020;38(11):27092720	PROPN
dti-2660	342	2	.	.	PUNCT
dti-2660	343	1	crossref	crossref	PROPN
dti-2660	343	2	pubmed	pubmed	PROPN
dti-2660	343	3	17	17	NUM
dti-2660	343	4	.	.	PUNCT
dti-2660	344	1	dias	dias	PROPN
dti-2660	344	2	sp	sp	PROPN
dti-2660	344	3	,	,	PUNCT
dti-2660	344	4	brouwer	brouwer	PROPN
dti-2660	344	5	mc	mc	PROPN
dti-2660	344	6	,	,	PUNCT
dti-2660	344	7	van	van	PROPN
dti-2660	344	8	de	de	PROPN
dti-2660	344	9	beek	beek	PROPN
dti-2660	344	10	d.	d.	PROPN
dti-2660	344	11	sex	sex	PROPN
dti-2660	344	12	and	and	CCONJ
dti-2660	344	13	gender	gender	NOUN
dti-2660	344	14	differences	difference	NOUN
dti-2660	344	15	in	in	ADP
dti-2660	344	16	bacterial	bacterial	ADJ
dti-2660	344	17	infections	infection	NOUN
dti-2660	344	18	.	.	PUNCT
dti-2660	345	1	infect	infect	VERB
dti-2660	345	2	immun	immun	PROPN
dti-2660	345	3	.	.	PUNCT
dti-2660	346	1	2022;90(10):e0028322	2022;90(10):e0028322	PROPN
dti-2660	346	2	.	.	PUNCT
dti-2660	347	1	crossref	crossref	PROPN
dti-2660	347	2	pubmed	pubmed	PROPN
dti-2660	347	3	18	18	NUM
dti-2660	347	4	.	.	PUNCT
dti-2660	348	1	ligon	ligon	PROPN
dti-2660	348	2	mm	mm	PROPN
dti-2660	348	3	,	,	PUNCT
dti-2660	348	4	joshi	joshi	PROPN
dti-2660	348	5	cs	cs	PROPN
dti-2660	348	6	,	,	PUNCT
dti-2660	348	7	fashemi	fashemi	NOUN
dti-2660	348	8	be	be	VERB
dti-2660	348	9	,	,	PUNCT
dti-2660	348	10	salazar	salazar	NOUN
dti-2660	348	11	am	be	AUX
dti-2660	348	12	,	,	PUNCT
dti-2660	348	13	mysorekar	mysorekar	PROPN
dti-2660	348	14	iu	iu	NOUN
dti-2660	348	15	.	.	NOUN
dti-2660	348	16	effects	effect	NOUN
dti-2660	348	17	of	of	ADP
dti-2660	348	18	aging	age	VERB
dti-2660	348	19	on	on	ADP
dti-2660	348	20	urinary	urinary	ADJ
dti-2660	348	21	tract	tract	NOUN
dti-2660	348	22	epithelial	epithelial	ADJ
dti-2660	348	23	homeostasis	homeostasis	NOUN
dti-2660	348	24	and	and	CCONJ
dti-2660	348	25	immunity	immunity	NOUN
dti-2660	348	26	.	.	PUNCT
dti-2660	349	1	dev	dev	PROPN
dti-2660	349	2	biol	biol	PROPN
dti-2660	349	3	.	.	PUNCT
dti-2660	350	1	2023;493:29	2023;493:29	NUM
dti-2660	350	2	-	-	SYM
dti-2660	350	3	39	39	NUM
dti-2660	350	4	.	.	PUNCT
dti-2660	351	1	crossref	crossref	PROPN
dti-2660	351	2	pubmed	pubmed	PROPN
dti-2660	351	3	19	19	NUM
dti-2660	351	4	.	.	PUNCT
dti-2660	352	1	zychlinsky	zychlinsky	PROPN
dti-2660	352	2	scharff	scharff	VERB
dti-2660	352	3	a	a	PRON
dti-2660	352	4	,	,	PUNCT
dti-2660	352	5	rousseau	rousseau	PROPN
dti-2660	352	6	m	m	PROPN
dti-2660	352	7	,	,	PUNCT
dti-2660	352	8	lacerda	lacerda	PROPN
dti-2660	352	9	mariano	mariano	PROPN
dti-2660	352	10	l	l	PROPN
dti-2660	352	11	,	,	PUNCT
dti-2660	352	12	et	et	PROPN
dti-2660	352	13	al	al	PROPN
dti-2660	352	14	.	.	PROPN
dti-2660	353	1	sex	sex	NOUN
dti-2660	353	2	differences	difference	NOUN
dti-2660	353	3	in	in	ADP
dti-2660	353	4	il-17	il-17	ADV
dti-2660	353	5	contribute	contribute	VERB
dti-2660	353	6	to	to	ADP
dti-2660	353	7	chronicity	chronicity	NOUN
dti-2660	353	8	in	in	ADP
dti-2660	353	9	male	male	ADJ
dti-2660	353	10	versus	versus	ADP
dti-2660	353	11	female	female	ADJ
dti-2660	353	12	urinary	urinary	ADJ
dti-2660	353	13	tract	tract	NOUN
dti-2660	353	14	infection	infection	NOUN
dti-2660	353	15	.	.	PUNCT
dti-2660	354	1	jci	jci	PROPN
dti-2660	354	2	insight	insight	PROPN
dti-2660	354	3	.	.	PUNCT
dti-2660	355	1	2019;5(13):e122998	2019;5(13):e122998	NUM
dti-2660	355	2	.	.	PUNCT
dti-2660	355	3	pmid:31145099	pmid:31145099	PROPN
dti-2660	355	4	crossref	crossref	PROPN
dti-2660	355	5	pubmed	pubmed	PROPN
dti-2660	355	6	20	20	PROPN
dti-2660	355	7	.	.	PUNCT
dti-2660	356	1	clemens	clemens	PROPN
dti-2660	356	2	jq	jq	PROPN
dti-2660	356	3	,	,	PUNCT
dti-2660	356	4	erickson	erickson	PROPN
dti-2660	356	5	dr	dr	PROPN
dti-2660	356	6	,	,	PUNCT
dti-2660	356	7	varela	varela	PROPN
dti-2660	356	8	np	np	PROPN
dti-2660	356	9	,	,	PUNCT
dti-2660	356	10	lai	lai	PROPN
dti-2660	356	11	hh	hh	PROPN
dti-2660	356	12	.	.	PUNCT
dti-2660	356	13	diagnosis	diagnosis	NOUN
dti-2660	356	14	and	and	CCONJ
dti-2660	356	15	treatment	treatment	NOUN
dti-2660	356	16	of	of	ADP
dti-2660	356	17	interstitial	interstitial	ADJ
dti-2660	356	18	cystitis	cystitis	NOUN
dti-2660	356	19	/	/	SYM
dti-2660	356	20	bladder	bladder	NOUN
dti-2660	356	21	pain	pain	NOUN
dti-2660	356	22	syndrome	syndrome	NOUN
dti-2660	356	23	.	.	PUNCT
dti-2660	357	1	j	j	PROPN
dti-2660	357	2	urol	urol	PROPN
dti-2660	357	3	.	.	PUNCT
dti-2660	358	1	2022;208(1):34	2022;208(1):34	PROPN
dti-2660	358	2	-	-	SYM
dti-2660	358	3	42	42	NUM
dti-2660	358	4	.	.	PUNCT
dti-2660	359	1	crossref	crossref	PROPN
dti-2660	359	2	pubmed	pubmed	PROPN
dti-2660	359	3	21	21	NUM
dti-2660	359	4	.	.	PUNCT
dti-2660	360	1	nambiar	nambiar	PROPN
dti-2660	360	2	ak	ak	PROPN
dti-2660	360	3	,	,	PUNCT
dti-2660	360	4	arlandis	arlandis	PROPN
dti-2660	360	5	s	s	PROPN
dti-2660	360	6	,	,	PUNCT
dti-2660	360	7	bø	bø	ADJ
dti-2660	360	8	k	k	PROPN
dti-2660	360	9	,	,	PUNCT
dti-2660	360	10	et	et	PROPN
dti-2660	360	11	al	al	PROPN
dti-2660	360	12	.	.	PROPN
dti-2660	360	13	european	european	PROPN
dti-2660	360	14	association	association	PROPN
dti-2660	360	15	of	of	ADP
dti-2660	360	16	urology	urology	NOUN
dti-2660	360	17	guidelines	guideline	NOUN
dti-2660	360	18	on	on	ADP
dti-2660	360	19	the	the	DET
dti-2660	360	20	diagnosis	diagnosis	NOUN
dti-2660	360	21	and	and	CCONJ
dti-2660	360	22	management	management	NOUN
dti-2660	360	23	of	of	ADP
dti-2660	360	24	female	female	ADJ
dti-2660	360	25	non	non	ADJ
dti-2660	360	26	-	-	ADJ
dti-2660	360	27	neurogenic	neurogenic	ADJ
dti-2660	360	28	lower	low	ADJ
dti-2660	360	29	urinary	urinary	ADJ
dti-2660	360	30	tract	tract	NOUN
dti-2660	360	31	symptoms	symptom	NOUN
dti-2660	360	32	.	.	PUNCT
dti-2660	361	1	part	part	NOUN
dti-2660	361	2	1	1	NUM
dti-2660	361	3	:	:	PUNCT
dti-2660	361	4	diagnostics	diagnostic	NOUN
dti-2660	361	5	,	,	PUNCT
dti-2660	361	6	overactive	overactive	ADJ
dti-2660	361	7	bladder	bladder	NOUN
dti-2660	361	8	,	,	PUNCT
dti-2660	361	9	stress	stress	ADJ
dti-2660	361	10	urinary	urinary	ADJ
dti-2660	361	11	incontinence	incontinence	NOUN
dti-2660	361	12	,	,	PUNCT
dti-2660	361	13	and	and	CCONJ
dti-2660	361	14	mixed	mixed	ADJ
dti-2660	361	15	urinary	urinary	ADJ
dti-2660	361	16	incontinence	incontinence	NOUN
dti-2660	361	17	.	.	PUNCT
dti-2660	362	1	eur	eur	PROPN
dti-2660	362	2	urol	urol	PROPN
dti-2660	362	3	.	.	PUNCT
dti-2660	363	1	2022;82(1):49	2022;82(1):49	X
dti-2660	363	2	-	-	SYM
dti-2660	363	3	59	59	NUM
dti-2660	363	4	.	.	PUNCT
dti-2660	364	1	crossref	crossref	PROPN
dti-2660	364	2	pubmed	pubmed	PROPN
dti-2660	364	3	22	22	NUM
dti-2660	364	4	.	.	PUNCT
dti-2660	365	1	wagenlehner	wagenlehner	PROPN
dti-2660	365	2	fme	fme	PROPN
dti-2660	365	3	,	,	PUNCT
dti-2660	365	4	bjerklund	bjerklund	NOUN
dti-2660	365	5	johansen	johansen	PROPN
dti-2660	365	6	te	te	PROPN
dti-2660	365	7	,	,	PUNCT
dti-2660	365	8	cai	cai	PROPN
dti-2660	365	9	t	t	PROPN
dti-2660	365	10	,	,	PUNCT
dti-2660	365	11	et	et	PROPN
dti-2660	365	12	al	al	PROPN
dti-2660	365	13	.	.	PUNCT
dti-2660	366	1	epidemiology	epidemiology	NOUN
dti-2660	366	2	,	,	PUNCT
dti-2660	366	3	definition	definition	NOUN
dti-2660	366	4	and	and	CCONJ
dti-2660	366	5	treatment	treatment	NOUN
dti-2660	366	6	of	of	ADP
dti-2660	366	7	complicated	complicated	ADJ
dti-2660	366	8	urinary	urinary	ADJ
dti-2660	366	9	tract	tract	NOUN
dti-2660	366	10	infections	infection	NOUN
dti-2660	366	11	.	.	PUNCT
dti-2660	367	1	nat	nat	PROPN
dti-2660	367	2	rev	rev	VERB
dti-2660	367	3	urol	urol	PROPN
dti-2660	367	4	.	.	PUNCT
dti-2660	368	1	2020;17(10):586	2020;17(10):586	NUM
dti-2660	368	2	-	-	SYM
dti-2660	368	3	600	600	NUM
dti-2660	368	4	.	.	PUNCT
dti-2660	369	1	crossref	crossref	PROPN
dti-2660	369	2	pubmed	pubmed	PROPN
dti-2660	369	3	23	23	NUM
dti-2660	369	4	.	.	PUNCT
dti-2660	370	1	naber	naber	PROPN
dti-2660	370	2	kg	kg	PROPN
dti-2660	370	3	,	,	PUNCT
dti-2660	370	4	schito	schito	VERB
dti-2660	370	5	g	g	PROPN
dti-2660	370	6	,	,	PUNCT
dti-2660	370	7	botto	botto	PROPN
dti-2660	370	8	h	h	PROPN
dti-2660	370	9	,	,	PUNCT
dti-2660	370	10	palou	palou	PROPN
dti-2660	370	11	j	j	PROPN
dti-2660	370	12	,	,	PUNCT
dti-2660	370	13	mazzei	mazzei	ADJ
dti-2660	370	14	t.	t.	PROPN
dti-2660	370	15	surveillance	surveillance	NOUN
dti-2660	370	16	study	study	NOUN
dti-2660	370	17	in	in	ADP
dti-2660	370	18	europe	europe	PROPN
dti-2660	370	19	and	and	CCONJ
dti-2660	370	20	brazil	brazil	PROPN
dti-2660	370	21	on	on	ADP
dti-2660	370	22	clinical	clinical	ADJ
dti-2660	370	23	aspects	aspect	NOUN
dti-2660	370	24	and	and	CCONJ
dti-2660	370	25	antimicrobial	antimicrobial	ADJ
dti-2660	370	26	resistance	resistance	NOUN
dti-2660	370	27	epidemiology	epidemiology	NOUN
dti-2660	370	28	in	in	ADP
dti-2660	370	29	females	female	NOUN
dti-2660	370	30	with	with	ADP
dti-2660	370	31	cystitis	cystitis	NOUN
dti-2660	370	32	(	(	PUNCT
dti-2660	370	33	aresc	aresc	NOUN
dti-2660	370	34	):	):	PUNCT
dti-2660	370	35	implications	implication	NOUN
dti-2660	370	36	for	for	ADP
dti-2660	370	37	empiric	empiric	ADJ
dti-2660	370	38	therapy	therapy	NOUN
dti-2660	370	39	.	.	PUNCT
dti-2660	371	1	eur	eur	PROPN
dti-2660	371	2	urol	urol	PROPN
dti-2660	371	3	.	.	PUNCT
dti-2660	372	1	2008;54(5):1164	2008;54(5):1164	NUM
dti-2660	372	2	-	-	PUNCT
dti-2660	372	3	1175	1175	NUM
dti-2660	372	4	.	.	PUNCT
dti-2660	373	1	crossref	crossref	PROPN
dti-2660	373	2	pubmed	pubmed	PROPN
dti-2660	373	3	24	24	NUM
dti-2660	373	4	.	.	PUNCT
dti-2660	374	1	tandoğdu	tandoğdu	PROPN
dti-2660	374	2	z	z	PROPN
dti-2660	374	3	,	,	PUNCT
dti-2660	374	4	bartoletti	bartoletti	PROPN
dti-2660	374	5	r	r	PROPN
dti-2660	374	6	,	,	PUNCT
dti-2660	374	7	cai	cai	PROPN
dti-2660	374	8	t	t	PROPN
dti-2660	374	9	,	,	PUNCT
dti-2660	374	10	et	et	PROPN
dti-2660	374	11	al	al	PROPN
dti-2660	374	12	.	.	PUNCT
dti-2660	375	1	antimicrobial	antimicrobial	ADJ
dti-2660	375	2	resistance	resistance	NOUN
dti-2660	375	3	in	in	ADP
dti-2660	375	4	urosepsis	urosepsis	NOUN
dti-2660	375	5	:	:	PUNCT
dti-2660	375	6	outcomes	outcome	NOUN
dti-2660	375	7	from	from	ADP
dti-2660	375	8	the	the	DET
dti-2660	375	9	multinational	multinational	ADJ
dti-2660	375	10	,	,	PUNCT
dti-2660	375	11	multicenter	multicenter	ADJ
dti-2660	375	12	global	global	ADJ
dti-2660	375	13	prevalence	prevalence	NOUN
dti-2660	375	14	of	of	ADP
dti-2660	375	15	infections	infection	NOUN
dti-2660	375	16	in	in	ADP
dti-2660	375	17	urology	urology	NOUN
dti-2660	375	18	(	(	PUNCT
dti-2660	375	19	gpiu	gpiu	NOUN
dti-2660	375	20	)	)	PUNCT
dti-2660	375	21	study	study	NOUN
dti-2660	375	22	20032013	20032013	NUM
dti-2660	375	23	.	.	PUNCT
dti-2660	376	1	world	world	PROPN
dti-2660	376	2	j	j	PROPN
dti-2660	376	3	urol	urol	PROPN
dti-2660	376	4	.	.	PUNCT
dti-2660	377	1	2016;34(8):1193	2016;34(8):1193	NUM
dti-2660	377	2	-	-	SYM
dti-2660	377	3	1200	1200	NUM
dti-2660	377	4	.	.	PUNCT
dti-2660	378	1	crossref	crossref	PROPN
dti-2660	378	2	pubmed	pubmed	PROPN
dti-2660	378	3	25	25	NUM
dti-2660	378	4	.	.	PUNCT
dti-2660	379	1	kaußner	kaußner	PROPN
dti-2660	379	2	y	y	PROPN
dti-2660	379	3	,	,	PUNCT
dti-2660	379	4	röver	röver	PROPN
dti-2660	379	5	c	c	X
dti-2660	379	6	,	,	PUNCT
dti-2660	379	7	heinz	heinz	PROPN
dti-2660	379	8	j	j	PROPN
dti-2660	379	9	,	,	PUNCT
dti-2660	379	10	et	et	PROPN
dti-2660	379	11	al	al	PROPN
dti-2660	379	12	.	.	PUNCT
dti-2660	380	1	reducing	reduce	VERB
dti-2660	380	2	antibiotic	antibiotic	ADJ
dti-2660	380	3	use	use	NOUN
dti-2660	380	4	in	in	ADP
dti-2660	380	5	uncomplicated	uncomplicated	ADJ
dti-2660	380	6	urinary	urinary	ADJ
dti-2660	380	7	tract	tract	NOUN
dti-2660	380	8	infections	infection	NOUN
dti-2660	380	9	in	in	ADP
dti-2660	380	10	adult	adult	NOUN
dti-2660	380	11	women	woman	NOUN
dti-2660	380	12	:	:	PUNCT
dti-2660	380	13	a	a	DET
dti-2660	380	14	systematic	systematic	ADJ
dti-2660	380	15	review	review	NOUN
dti-2660	380	16	and	and	CCONJ
dti-2660	380	17	individual	individual	ADJ
dti-2660	380	18	participant	participant	NOUN
dti-2660	380	19	data	datum	NOUN
dti-2660	380	20	meta	meta	ADJ
dti-2660	380	21	-	-	PUNCT
dti-2660	380	22	analysis	analysis	NOUN
dti-2660	380	23	.	.	PUNCT
dti-2660	381	1	clin	clin	PROPN
dti-2660	381	2	microbiol	microbiol	PROPN
dti-2660	381	3	infect	infect	VERB
dti-2660	381	4	.	.	PUNCT
dti-2660	382	1	2022;28(12):1558	2022;28(12):1558	NUM
dti-2660	382	2	-	-	SYM
dti-2660	382	3	1566	1566	NUM
dti-2660	382	4	.	.	PUNCT
dti-2660	383	1	crossref	crossref	PROPN
dti-2660	383	2	pubmed	pubmed	PROPN
dti-2660	383	3	26	26	NUM
dti-2660	383	4	.	.	PUNCT
dti-2660	384	1	harding	harding	PROPN
dti-2660	384	2	c	c	PROPN
dti-2660	384	3	,	,	PUNCT
dti-2660	384	4	mossop	mossop	PROPN
dti-2660	384	5	h	h	PROPN
dti-2660	384	6	,	,	PUNCT
dti-2660	384	7	homer	homer	PROPN
dti-2660	384	8	t	t	PROPN
dti-2660	384	9	,	,	PUNCT
dti-2660	384	10	et	et	PROPN
dti-2660	384	11	al	al	PROPN
dti-2660	384	12	.	.	PROPN
dti-2660	384	13	alternative	alternative	NOUN
dti-2660	384	14	to	to	ADP
dti-2660	384	15	prophylactic	prophylactic	ADJ
dti-2660	384	16	antibiotics	antibiotic	NOUN
dti-2660	384	17	for	for	ADP
dti-2660	384	18	the	the	DET
dti-2660	384	19	treatment	treatment	NOUN
dti-2660	384	20	of	of	ADP
dti-2660	384	21	recurrent	recurrent	ADJ
dti-2660	384	22	urinary	urinary	ADJ
dti-2660	384	23	tract	tract	NOUN
dti-2660	384	24	infections	infection	NOUN
dti-2660	384	25	in	in	ADP
dti-2660	384	26	women	woman	NOUN
dti-2660	384	27	:	:	PUNCT
dti-2660	384	28	multicentre	multicentre	ADJ
dti-2660	384	29	,	,	PUNCT
dti-2660	384	30	open	open	ADJ
dti-2660	384	31	label	label	NOUN
dti-2660	384	32	,	,	PUNCT
dti-2660	384	33	randomised	randomise	VERB
dti-2660	384	34	,	,	PUNCT
dti-2660	384	35	non	non	ADJ
dti-2660	384	36	-	-	ADJ
dti-2660	384	37	inferiority	inferiority	ADJ
dti-2660	384	38	trial	trial	NOUN
dti-2660	384	39	.	.	PUNCT
dti-2660	385	1	bmj	bmj	PROPN
dti-2660	385	2	.	.	PUNCT
dti-2660	385	3	2022;376	2022;376	NUM
dti-2660	385	4	:	:	PUNCT
dti-2660	385	5	e068229	e068229	NOUN
dti-2660	385	6	.	.	PUNCT
dti-2660	386	1	crossref	crossref	PROPN
dti-2660	386	2	pubmed	pubmed	PROPN
dti-2660	386	3	27	27	NUM
dti-2660	386	4	.	.	PUNCT
dti-2660	387	1	gágyor	gágyor	PROPN
dti-2660	387	2	i	i	PROPN
dti-2660	387	3	,	,	PUNCT
dti-2660	387	4	bleidorn	bleidorn	PROPN
dti-2660	387	5	j	j	PROPN
dti-2660	387	6	,	,	PUNCT
dti-2660	387	7	kochen	kochen	PROPN
dti-2660	387	8	mm	mm	PROPN
dti-2660	387	9	,	,	PUNCT
dti-2660	387	10	schmiemann	schmiemann	VERB
dti-2660	387	11	g	g	PROPN
dti-2660	387	12	,	,	PUNCT
dti-2660	387	13	wegscheider	wegscheider	PROPN
dti-2660	387	14	k	k	PROPN
dti-2660	387	15	,	,	PUNCT
dti-2660	387	16	hummers	hummer	NOUN
dti-2660	387	17	-	-	PUNCT
dti-2660	387	18	pradier	pradier	NOUN
dti-2660	387	19	e.	e.	PROPN
dti-2660	387	20	ibuprofen	ibuprofen	PROPN
dti-2660	387	21	versus	versus	ADP
dti-2660	387	22	fosfomycin	fosfomycin	PROPN
dti-2660	387	23	for	for	ADP
dti-2660	387	24	uncomplicated	uncomplicated	ADJ
dti-2660	387	25	urinary	urinary	ADJ
dti-2660	387	26	tract	tract	NOUN
dti-2660	387	27	infection	infection	NOUN
dti-2660	387	28	in	in	ADP
dti-2660	387	29	women	woman	NOUN
dti-2660	387	30	:	:	PUNCT
dti-2660	387	31	randomised	randomise	VERB
dti-2660	387	32	controlled	control	VERB
dti-2660	387	33	trial	trial	NOUN
dti-2660	387	34	.	.	PUNCT
dti-2660	388	1	bmj	bmj	PROPN
dti-2660	388	2	.	.	PUNCT
dti-2660	389	1	2015;351	2015;351	NUM
dti-2660	389	2	:	:	PUNCT
dti-2660	390	1	h6544	h6544	PROPN
dti-2660	390	2	.	.	PROPN
dti-2660	390	3	crossref	crossref	PROPN
dti-2660	390	4	pubmed	pubmed	PROPN
dti-2660	390	5	28	28	PROPN
dti-2660	390	6	.	.	PUNCT
dti-2660	391	1	european	european	PROPN
dti-2660	391	2	medicines	medicines	PROPN
dti-2660	391	3	agency	agency	NOUN
dti-2660	391	4	(	(	PUNCT
dti-2660	391	5	ema	ema	PROPN
dti-2660	391	6	)	)	PUNCT
dti-2660	391	7	.	.	PUNCT
dti-2660	392	1	disabling	disable	VERB
dti-2660	392	2	and	and	CCONJ
dti-2660	392	3	potentially	potentially	ADV
dti-2660	392	4	permanent	permanent	ADJ
dti-2660	392	5	side	side	NOUN
dti-2660	392	6	effects	effect	NOUN
dti-2660	392	7	lead	lead	VERB
dti-2660	392	8	to	to	ADP
dti-2660	392	9	suspension	suspension	NOUN
dti-2660	392	10	or	or	CCONJ
dti-2660	392	11	restrictions	restriction	NOUN
dti-2660	392	12	of	of	ADP
dti-2660	392	13	quinolone	quinolone	NOUN
dti-2660	392	14	and	and	CCONJ
dti-2660	392	15	fluoroquinolone	fluoroquinolone	NOUN
dti-2660	392	16	antibiotics	antibiotic	NOUN
dti-2660	392	17	.	.	PUNCT
dti-2660	393	1	ema/795349/2018	ema/795349/2018	NOUN
dti-2660	393	2	.	.	PUNCT
dti-2660	394	1	2018	2018	NUM
dti-2660	394	2	.	.	PUNCT
dti-2660	395	1	online	online	INTJ
dti-2660	395	2	.	.	PUNCT
dti-2660	396	1	accessed	access	VERB
dti-2660	396	2	march	march	PROPN
dti-2660	396	3	2023	2023	NUM
dti-2660	396	4	.	.	PUNCT
dti-2660	397	1	29	29	NUM
dti-2660	397	2	.	.	PUNCT
dti-2660	398	1	mohapatra	mohapatra	PROPN
dti-2660	398	2	s	s	PROPN
dti-2660	398	3	,	,	PUNCT
dti-2660	398	4	panigrahy	panigrahy	NOUN
dti-2660	398	5	r	r	NOUN
dti-2660	398	6	,	,	PUNCT
dti-2660	398	7	tak	tak	NOUN
dti-2660	398	8	v	v	NOUN
dti-2660	398	9	,	,	PUNCT
dti-2660	398	10	et	et	PROPN
dti-2660	398	11	al	al	PROPN
dti-2660	398	12	.	.	PUNCT
dti-2660	398	13	prevalence	prevalence	NOUN
dti-2660	398	14	and	and	CCONJ
dti-2660	398	15	resistance	resistance	NOUN
dti-2660	398	16	pattern	pattern	NOUN
dti-2660	398	17	of	of	ADP
dti-2660	398	18	uropathogens	uropathogen	NOUN
dti-2660	398	19	from	from	ADP
dti-2660	398	20	community	community	NOUN
dti-2660	398	21	settings	setting	NOUN
dti-2660	398	22	of	of	ADP
dti-2660	398	23	different	different	ADJ
dti-2660	398	24	regions	region	NOUN
dti-2660	398	25	:	:	PUNCT
dti-2660	398	26	an	an	DET
dti-2660	398	27	experience	experience	NOUN
dti-2660	398	28	from	from	ADP
dti-2660	398	29	india	india	PROPN
dti-2660	398	30	.	.	PUNCT
dti-2660	399	1	access	access	PROPN
dti-2660	399	2	microbiol	microbiol	PROPN
dti-2660	399	3	.	.	PUNCT
dti-2660	400	1	2022;4(2):000321	2022;4(2):000321	X
dti-2660	400	2	.	.	PUNCT
dti-2660	401	1	crossref	crossref	PROPN
dti-2660	401	2	pubmed	pubmed	PROPN
dti-2660	401	3	30	30	PROPN
dti-2660	401	4	.	.	PUNCT
dti-2660	402	1	wagenlehner	wagenlehner	PROPN
dti-2660	402	2	f	f	PROPN
dti-2660	402	3	,	,	PUNCT
dti-2660	402	4	wullt	wullt	NOUN
dti-2660	402	5	b	b	NOUN
dti-2660	402	6	,	,	PUNCT
dti-2660	402	7	ballarini	ballarini	PROPN
dti-2660	402	8	s	s	PROPN
dti-2660	402	9	,	,	PUNCT
dti-2660	402	10	zingg	zingg	PROPN
dti-2660	402	11	d	d	PROPN
dti-2660	402	12	,	,	PUNCT
dti-2660	402	13	naber	naber	PROPN
dti-2660	402	14	kg	kg	PROPN
dti-2660	402	15	.	.	PUNCT
dti-2660	403	1	social	social	ADJ
dti-2660	403	2	and	and	CCONJ
dti-2660	403	3	economic	economic	ADJ
dti-2660	403	4	burden	burden	NOUN
dti-2660	403	5	of	of	ADP
dti-2660	403	6	recurrent	recurrent	ADJ
dti-2660	403	7	urinary	urinary	ADJ
dti-2660	403	8	tract	tract	NOUN
dti-2660	403	9	infections	infection	NOUN
dti-2660	403	10	and	and	CCONJ
dti-2660	403	11	quality	quality	NOUN
dti-2660	403	12	of	of	ADP
dti-2660	403	13	life	life	NOUN
dti-2660	403	14	:	:	PUNCT
dti-2660	403	15	a	a	DET
dti-2660	403	16	patient	patient	ADJ
dti-2660	403	17	web	web	NOUN
dti-2660	403	18	-	-	PUNCT
dti-2660	403	19	based	base	VERB
dti-2660	403	20	study	study	NOUN
dti-2660	403	21	(	(	PUNCT
dti-2660	403	22	gesprit	gesprit	PROPN
dti-2660	403	23	)	)	PUNCT
dti-2660	403	24	.	.	PUNCT
dti-2660	404	1	expert	expert	NOUN
dti-2660	404	2	rev	rev	PROPN
dti-2660	404	3	pharmacoecon	pharmacoecon	PROPN
dti-2660	404	4	outcomes	outcome	NOUN
dti-2660	404	5	res	re	NOUN
dti-2660	404	6	.	.	PUNCT
dti-2660	405	1	2018;18(1):107	2018;18(1):107	NUM
dti-2660	405	2	-	-	SYM
dti-2660	405	3	117	117	NUM
dti-2660	405	4	.	.	PUNCT
dti-2660	406	1	crossref	crossref	PROPN
dti-2660	406	2	pubmed	pubmed	PROPN
dti-2660	406	3	31	31	NUM
dti-2660	406	4	.	.	PUNCT
dti-2660	407	1	hooton	hooton	PROPN
dti-2660	407	2	tm	tm	PROPN
dti-2660	407	3	,	,	PUNCT
dti-2660	407	4	vecchio	vecchio	PROPN
dti-2660	407	5	m	m	PROPN
dti-2660	407	6	,	,	PUNCT
dti-2660	407	7	iroz	iroz	ADV
dti-2660	407	8	a	a	X
dti-2660	407	9	,	,	PUNCT
dti-2660	407	10	et	et	PROPN
dti-2660	407	11	al	al	PROPN
dti-2660	407	12	.	.	PROPN
dti-2660	407	13	effect	effect	NOUN
dti-2660	407	14	of	of	ADP
dti-2660	407	15	increased	increase	VERB
dti-2660	407	16	daily	daily	ADJ
dti-2660	407	17	water	water	NOUN
dti-2660	407	18	intake	intake	NOUN
dti-2660	407	19	in	in	ADP
dti-2660	407	20	premenopausal	premenopausal	ADJ
dti-2660	407	21	women	woman	NOUN
dti-2660	407	22	with	with	ADP
dti-2660	407	23	recurrent	recurrent	ADJ
dti-2660	407	24	urinary	urinary	ADJ
dti-2660	407	25	tract	tract	NOUN
dti-2660	407	26	infections	infection	NOUN
dti-2660	407	27	:	:	PUNCT
dti-2660	407	28	a	a	DET
dti-2660	407	29	randomized	randomized	ADJ
dti-2660	407	30	clinical	clinical	ADJ
dti-2660	407	31	trial	trial	NOUN
dti-2660	407	32	.	.	PUNCT
dti-2660	408	1	jama	jama	PROPN
dti-2660	408	2	intern	intern	PROPN
dti-2660	408	3	med	me	VERB
dti-2660	408	4	.	.	PUNCT
dti-2660	409	1	2018;178(11):1509	2018;178(11):1509	NUM
dti-2660	409	2	-	-	NOUN
dti-2660	409	3	1515	1515	NUM
dti-2660	409	4	.	.	PUNCT
dti-2660	410	1	crossref	crossref	PROPN
dti-2660	410	2	pubmed	pubmed	PROPN
dti-2660	410	3	32	32	NUM
dti-2660	410	4	.	.	PUNCT
dti-2660	411	1	kyriakides	kyriakides	PROPN
dti-2660	411	2	r	r	PROPN
dti-2660	411	3	,	,	PUNCT
dti-2660	411	4	jones	jones	PROPN
dti-2660	411	5	p	p	X
dti-2660	411	6	,	,	PUNCT
dti-2660	411	7	somani	somani	X
dti-2660	411	8	bk	bk	PROPN
dti-2660	411	9	.	.	PUNCT
dti-2660	412	1	role	role	NOUN
dti-2660	412	2	of	of	ADP
dti-2660	412	3	d	d	NOUN
dti-2660	412	4	-	-	PUNCT
dti-2660	412	5	mannose	mannose	NOUN
dti-2660	412	6	in	in	ADP
dti-2660	412	7	the	the	DET
dti-2660	412	8	prevention	prevention	NOUN
dti-2660	412	9	of	of	ADP
dti-2660	412	10	recurrent	recurrent	ADJ
dti-2660	412	11	urinary	urinary	ADJ
dti-2660	412	12	tract	tract	NOUN
dti-2660	412	13	infections	infection	NOUN
dti-2660	412	14	:	:	PUNCT
dti-2660	412	15	evidence	evidence	NOUN
dti-2660	412	16	from	from	ADP
dti-2660	412	17	a	a	DET
dti-2660	412	18	systematic	systematic	ADJ
dti-2660	412	19	review	review	NOUN
dti-2660	412	20	of	of	ADP
dti-2660	412	21	the	the	DET
dti-2660	412	22	literature	literature	NOUN
dti-2660	412	23	.	.	PUNCT
dti-2660	413	1	eur	eur	PROPN
dti-2660	413	2	urol	urol	PROPN
dti-2660	413	3	focus	focus	NOUN
dti-2660	413	4	.	.	PUNCT
dti-2660	414	1	2021;7(5):1166	2021;7(5):1166	NUM
dti-2660	414	2	-	-	SYM
dti-2660	414	3	1169	1169	NUM
dti-2660	414	4	.	.	PUNCT
dti-2660	415	1	crossref	crossref	PROPN
dti-2660	415	2	pubmed	pubmed	PROPN
dti-2660	415	3	33	33	NUM
dti-2660	415	4	.	.	PUNCT
dti-2660	416	1	prattley	prattley	PROPN
dti-2660	416	2	s	s	PROPN
dti-2660	416	3	,	,	PUNCT
dti-2660	416	4	geraghty	geraghty	PROPN
dti-2660	416	5	r	r	PROPN
dti-2660	416	6	,	,	PUNCT
dti-2660	416	7	moore	moore	PROPN
dti-2660	416	8	m	m	PROPN
dti-2660	416	9	,	,	PUNCT
dti-2660	416	10	somani	somani	X
dti-2660	416	11	bk	bk	PROPN
dti-2660	416	12	.	.	PUNCT
dti-2660	416	13	role	role	NOUN
dti-2660	416	14	of	of	ADP
dti-2660	416	15	vaccines	vaccine	NOUN
dti-2660	416	16	for	for	ADP
dti-2660	416	17	recurrent	recurrent	ADJ
dti-2660	416	18	urinary	urinary	ADJ
dti-2660	416	19	tract	tract	NOUN
dti-2660	416	20	infections	infection	NOUN
dti-2660	416	21	:	:	PUNCT
dti-2660	416	22	a	a	DET
dti-2660	416	23	systematic	systematic	ADJ
dti-2660	416	24	review	review	NOUN
dti-2660	416	25	.	.	PUNCT
dti-2660	417	1	eur	eur	PROPN
dti-2660	417	2	urol	urol	PROPN
dti-2660	417	3	focus	focus	NOUN
dti-2660	417	4	.	.	PUNCT
dti-2660	418	1	2020;6(3):593	2020;6(3):593	X
dti-2660	418	2	-	-	SYM
dti-2660	418	3	604	604	NUM
dti-2660	418	4	.	.	PUNCT
dti-2660	419	1	crossref	crossref	PROPN
dti-2660	419	2	pubmed	pubmed	PROPN
dti-2660	419	3	34	34	NUM
dti-2660	419	4	.	.	PUNCT
dti-2660	419	5	sihra	sihra	PROPN
dti-2660	419	6	n	n	PROPN
dti-2660	419	7	,	,	PUNCT
dti-2660	419	8	goodman	goodman	PROPN
dti-2660	419	9	a	a	X
dti-2660	419	10	,	,	PUNCT
dti-2660	419	11	zakri	zakri	NOUN
dti-2660	419	12	r	r	NOUN
dti-2660	419	13	,	,	PUNCT
dti-2660	419	14	sahai	sahai	NOUN
dti-2660	419	15	a	a	DET
dti-2660	419	16	,	,	PUNCT
dti-2660	419	17	malde	malde	PROPN
dti-2660	419	18	s.	s.	PROPN
dti-2660	419	19	nonantibiotic	nonantibiotic	PROPN
dti-2660	419	20	prevention	prevention	NOUN
dti-2660	419	21	and	and	CCONJ
dti-2660	419	22	management	management	NOUN
dti-2660	419	23	of	of	ADP
dti-2660	419	24	recurrent	recurrent	ADJ
dti-2660	419	25	urinary	urinary	ADJ
dti-2660	419	26	tract	tract	NOUN
dti-2660	419	27	infection	infection	NOUN
dti-2660	419	28	.	.	PUNCT
dti-2660	420	1	nat	nat	PROPN
dti-2660	420	2	rev	rev	VERB
dti-2660	420	3	urol	urol	PROPN
dti-2660	420	4	.	.	PUNCT
dti-2660	421	1	2018;15(12):750	2018;15(12):750	NUM
dti-2660	421	2	-	-	PUNCT
dti-2660	421	3	776	776	NUM
dti-2660	421	4	.	.	PUNCT
dti-2660	422	1	crossref	crossref	PROPN
dti-2660	422	2	pubmed	pubmed	PROPN
dti-2660	422	3	35	35	NUM
dti-2660	422	4	.	.	PUNCT
dti-2660	423	1	anger	anger	PROPN
dti-2660	423	2	jt	jt	PROPN
dti-2660	423	3	,	,	PUNCT
dti-2660	423	4	bixler	bixler	PROPN
dti-2660	423	5	br	br	PROPN
dti-2660	423	6	,	,	PUNCT
dti-2660	423	7	holmes	holmes	PROPN
dti-2660	423	8	rs	rs	PROPN
dti-2660	423	9	,	,	PUNCT
dti-2660	423	10	lee	lee	PROPN
dti-2660	423	11	uj	uj	PROPN
dti-2660	423	12	,	,	PUNCT
dti-2660	423	13	santiago	santiago	PROPN
dti-2660	423	14	-	-	PUNCT
dti-2660	423	15	lastra	lastra	PROPN
dti-2660	423	16	y	y	PROPN
dti-2660	423	17	,	,	PUNCT
dti-2660	423	18	selph	selph	PROPN
dti-2660	423	19	ss	ss	PROPN
dti-2660	423	20	.	.	PUNCT
dti-2660	423	21	updates	update	NOUN
dti-2660	423	22	to	to	PART
dti-2660	423	23	recurrent	recurrent	VERB
dti-2660	423	24	uncomplicated	uncomplicated	ADJ
dti-2660	423	25	urinary	urinary	ADJ
dti-2660	423	26	tract	tract	NOUN
dti-2660	423	27	infections	infection	NOUN
dti-2660	423	28	in	in	ADP
dti-2660	423	29	women	woman	NOUN
dti-2660	423	30	:	:	PUNCT
dti-2660	423	31	aua	aua	PROPN
dti-2660	423	32	/	/	SYM
dti-2660	423	33	cua	cua	PROPN
dti-2660	423	34	/	/	SYM
dti-2660	423	35	sufu	sufu	NOUN
dti-2660	423	36	guideline	guideline	NOUN
dti-2660	423	37	.	.	PUNCT
dti-2660	424	1	j	j	PROPN
dti-2660	424	2	urol	urol	PROPN
dti-2660	424	3	.	.	PUNCT
dti-2660	425	1	2022;208(3):536541	2022;208(3):536541	NUM
dti-2660	425	2	.	.	PUNCT
dti-2660	426	1	crossref	crossref	PROPN
dti-2660	426	2	pubmed	pubmed	PROPN
dti-2660	426	3	36	36	NUM
dti-2660	426	4	.	.	PUNCT
dti-2660	427	1	moussa	moussa	PROPN
dti-2660	427	2	m	m	PROPN
dti-2660	427	3	,	,	PUNCT
dti-2660	427	4	abou	abou	PROPN
dti-2660	427	5	chakra	chakra	PROPN
dti-2660	427	6	m	m	PROPN
dti-2660	427	7	,	,	PUNCT
dti-2660	427	8	dellis	delli	VERB
dti-2660	427	9	a	a	DET
dti-2660	427	10	,	,	PUNCT
dti-2660	427	11	moussa	moussa	PROPN
dti-2660	427	12	y	y	PROPN
dti-2660	427	13	,	,	PUNCT
dti-2660	427	14	papatsoris	papatsoris	PROPN
dti-2660	427	15	a.	a.	NOUN
dti-2660	427	16	pharmacotherapeutic	pharmacotherapeutic	PROPN
dti-2660	427	17	advances	advance	NOUN
dti-2660	427	18	for	for	ADP
dti-2660	427	19	recurrent	recurrent	ADJ
dti-2660	427	20	urinary	urinary	ADJ
dti-2660	427	21	tract	tract	NOUN
dti-2660	427	22	infections	infection	NOUN
dti-2660	427	23	in	in	ADP
dti-2660	427	24	women	woman	NOUN
dti-2660	427	25	.	.	PUNCT
dti-2660	428	1	expert	expert	NOUN
dti-2660	428	2	opin	opin	NOUN
dti-2660	428	3	pharmacother	pharmacother	NOUN
dti-2660	428	4	.	.	PUNCT
dti-2660	429	1	2020;21(16	2020;21(16	NUM
dti-2660	429	2	):	):	PUNCT
dti-2660	429	3	2011	2011	NUM
dti-2660	429	4	-	-	SYM
dti-2660	429	5	2026	2026	NUM
dti-2660	429	6	.	.	PUNCT
dti-2660	430	1	crossref	crossref	PROPN
dti-2660	430	2	pubmed	pubmed	PROPN
dti-2660	430	3	37	37	NUM
dti-2660	430	4	.	.	PUNCT
dti-2660	431	1	wagenlehner	wagenlehner	PROPN
dti-2660	431	2	fm	fm	PROPN
dti-2660	431	3	,	,	PUNCT
dti-2660	431	4	ballarini	ballarini	PROPN
dti-2660	431	5	s	s	PROPN
dti-2660	431	6	,	,	PUNCT
dti-2660	431	7	pilatz	pilatz	VERB
dti-2660	431	8	a	a	PRON
dti-2660	431	9	,	,	PUNCT
dti-2660	431	10	weidner	weidner	PROPN
dti-2660	431	11	w	w	PROPN
dti-2660	431	12	,	,	PUNCT
dti-2660	431	13	lehr	lehr	PROPN
dti-2660	431	14	l	l	PROPN
dti-2660	431	15	,	,	PUNCT
dti-2660	431	16	naber	naber	PROPN
dti-2660	431	17	kg	kg	PROPN
dti-2660	431	18	.	.	PUNCT
dti-2660	432	1	a	a	DET
dti-2660	432	2	randomized	randomized	ADJ
dti-2660	432	3	,	,	PUNCT
dti-2660	432	4	double	double	ADJ
dti-2660	432	5	-	-	PUNCT
dti-2660	432	6	blind	blind	ADJ
dti-2660	432	7	,	,	PUNCT
dti-2660	432	8	parallel	parallel	NOUN
dti-2660	432	9	-	-	PUNCT
dti-2660	432	10	group	group	NOUN
dti-2660	432	11	,	,	PUNCT
dti-2660	432	12	multicenter	multicenter	ADJ
dti-2660	432	13	clinical	clinical	ADJ
dti-2660	432	14	study	study	NOUN
dti-2660	432	15	of	of	ADP
dti-2660	432	16	escherichia	escherichia	NOUN
dti-2660	432	17	coli	coli	NOUN
dti-2660	432	18	-	-	PUNCT
dti-2660	432	19	lyophilized	lyophilize	VERB
dti-2660	432	20	lysate	lysate	NOUN
dti-2660	432	21	for	for	ADP
dti-2660	432	22	the	the	DET
dti-2660	432	23	prophylaxis	prophylaxis	NOUN
dti-2660	432	24	of	of	ADP
dti-2660	432	25	recurrent	recurrent	ADJ
dti-2660	432	26	uncomplicated	uncomplicated	ADJ
dti-2660	432	27	urinary	urinary	ADJ
dti-2660	432	28	tract	tract	NOUN
dti-2660	432	29	infections	infection	NOUN
dti-2660	432	30	.	.	PUNCT
dti-2660	433	1	urol	urol	PROPN
dti-2660	433	2	int	int	PROPN
dti-2660	433	3	.	.	PUNCT
dti-2660	434	1	2015;95(2):167	2015;95(2):167	NUM
dti-2660	434	2	-	-	SYM
dti-2660	434	3	176	176	NUM
dti-2660	434	4	.	.	PUNCT
dti-2660	435	1	crossref	crossref	PROPN
dti-2660	435	2	pubmed	pubmed	PROPN
dti-2660	435	3	38	38	NUM
dti-2660	435	4	.	.	PUNCT
dti-2660	436	1	vallée	vallée	PROPN
dti-2660	436	2	m	m	PROPN
dti-2660	436	3	,	,	PUNCT
dti-2660	436	4	bruyère	bruyère	PROPN
dti-2660	436	5	f.	f.	PROPN
dti-2660	436	6	non	non	ADJ
dti-2660	436	7	-	-	ADJ
dti-2660	436	8	antimicrobial	antimicrobial	ADJ
dti-2660	436	9	prophylactic	prophylactic	ADJ
dti-2660	436	10	measures	measure	NOUN
dti-2660	436	11	in	in	ADP
dti-2660	436	12	recurrent	recurrent	ADJ
dti-2660	436	13	urinary	urinary	ADJ
dti-2660	436	14	tract	tract	NOUN
dti-2660	436	15	infections	infection	NOUN
dti-2660	436	16	.	.	PUNCT
dti-2660	437	1	in	in	ADP
dti-2660	437	2	:	:	PUNCT
dti-2660	437	3	bjerklund	bjerklund	PROPN
dti-2660	437	4	johansen	johansen	PROPN
dti-2660	437	5	tewf	tewf	PROPN
dti-2660	437	6	,	,	PUNCT
dti-2660	437	7	matsumoto	matsumoto	PROPN
dti-2660	437	8	t	t	PROPN
dti-2660	437	9	,	,	PUNCT
dti-2660	437	10	cho	cho	PROPN
dti-2660	437	11	yh	yh	PROPN
dti-2660	437	12	,	,	PUNCT
dti-2660	437	13	krieger	krieger	PROPN
dti-2660	437	14	jn	jn	PROPN
dti-2660	437	15	,	,	PUNCT
dti-2660	437	16	shoskes	shoske	NOUN
dti-2660	437	17	d	d	PROPN
dti-2660	437	18	,	,	PUNCT
dti-2660	437	19	naber	naber	PROPN
dti-2660	437	20	kg	kg	PROPN
dti-2660	437	21	,	,	PUNCT
dti-2660	437	22	eds	ed	NOUN
dti-2660	437	23	.	.	PUNCT
dti-2660	437	24	urogenital	urogenital	ADJ
dti-2660	437	25	infections	infection	NOUN
dti-2660	437	26	and	and	CCONJ
dti-2660	437	27	inflammations	inflammation	NOUN
dti-2660	437	28	.	.	PUNCT
dti-2660	438	1	german	german	ADJ
dti-2660	438	2	medical	medical	ADJ
dti-2660	438	3	https://doi.org/10.1016/s0140-6736(20)30925-9	https://doi.org/10.1016/s0140-6736(20)30925-9	NUM
dti-2660	438	4	https://pubmed.ncbi.nlm.nih.gov/33069326/	https://pubmed.ncbi.nlm.nih.gov/33069326/	PROPN
dti-2660	438	5	https://www.gov.uk/government/publications/uk-antimicrobial-resistance-strategy-and-action-plan-engagement-exercise	https://www.gov.uk/government/publications/uk-antimicrobial-resistance-strategy-and-action-plan-engagement-exercise	ADJ
dti-2660	438	6	https://doi.org/10.1016/s0140-6736(21)02724-0	https://doi.org/10.1016/s0140-6736(21)02724-0	NOUN
dti-2660	438	7	https://www.ncbi.nlm.nih.gov/pubmed/35065702	https://www.ncbi.nlm.nih.gov/pubmed/35065702	PROPN
dti-2660	438	8	https://amr-review.org/sites/default/files/160525_final%20paper_with%20cover.pdf	https://amr-review.org/sites/default/files/160525_final%20paper_with%20cover.pdf	PROPN
dti-2660	438	9	https://uroweb.org/guidelines/urological-infections	https://uroweb.org/guidelines/urological-infection	NOUN
dti-2660	438	10	https://doi.org/10.1016/s0140-6736(22)02185-7	https://doi.org/10.1016/s0140-6736(22)02185-7	PUNCT
dti-2660	438	11	https://pubmed.ncbi.nlm.nih.gov/36423648/	https://pubmed.ncbi.nlm.nih.gov/36423648/	PROPN
dti-2660	438	12	https://doi.org/10.1016/j.ijantimicag.2011.09.009	https://doi.org/10.1016/j.ijantimicag.2011.09.009	NOUN
dti-2660	438	13	https://www.ncbi.nlm.nih.gov/pubmed/22018988	https://www.ncbi.nlm.nih.gov/pubmed/22018988	NUM
dti-2660	438	14	https://doi.org/10.1016/j.eururo.2017.07.014	https://doi.org/10.1016/j.eururo.2017.07.014	PROPN
dti-2660	438	15	https://www.ncbi.nlm.nih.gov/pubmed/28754533	https://www.ncbi.nlm.nih.gov/pubmed/28754533	NUM
dti-2660	438	16	https://doi.org/10.1038/s41385-022-00549-0	https://doi.org/10.1038/s41385-022-00549-0	NUM
dti-2660	438	17	https://www.ncbi.nlm.nih.gov/pubmed/35869147	https://www.ncbi.nlm.nih.gov/pubmed/35869147	NUM
dti-2660	438	18	https://doi.org/10.1038/nrurol.2010.190	https://doi.org/10.1038/nrurol.2010.190	ADJ
dti-2660	438	19	https://www.ncbi.nlm.nih.gov/pubmed/21139641	https://www.ncbi.nlm.nih.gov/pubmed/21139641	PUNCT
dti-2660	438	20	https://doi.org/10.1371/journal.ppat.1006688	https://doi.org/10.1371/journal.ppat.1006688	NOUN
dti-2660	438	21	https://www.ncbi.nlm.nih.gov/pubmed/29284060	https://www.ncbi.nlm.nih.gov/pubmed/29284060	NUM
dti-2660	438	22	https://doi.org/10.7326/0003-4819-110-2-138	https://doi.org/10.7326/0003-4819-110-2-138	PROPN
dti-2660	438	23	https://www.ncbi.nlm.nih.gov/pubmed/2462391	https://www.ncbi.nlm.nih.gov/pubmed/2462391	X
dti-2660	438	24	https://doi.org/10.1007/s00345-020-03159-2	https://doi.org/10.1007/s00345-020-03159-2	NUM
dti-2660	438	25	https://www.ncbi.nlm.nih.gov/pubmed/32221713	https://www.ncbi.nlm.nih.gov/pubmed/32221713	NUM
dti-2660	439	1	https://doi.org/10.1128/iai.00283-22	https://doi.org/10.1128/iai.00283-22	PROPN
dti-2660	439	2	https://www.ncbi.nlm.nih.gov/pubmed/36121220	https://www.ncbi.nlm.nih.gov/pubmed/36121220	NUM
dti-2660	439	3	https://doi.org/10.1016/j.ydbio.2022.11.003	https://doi.org/10.1016/j.ydbio.2022.11.003	PROPN
dti-2660	439	4	https://www.ncbi.nlm.nih.gov/pubmed/36368522	https://www.ncbi.nlm.nih.gov/pubmed/36368522	PROPN
dti-2660	440	1	https://doi.org/10.1172/jci.insight.122998	https://doi.org/10.1172/jci.insight.122998	PROPN
dti-2660	440	2	https://www.ncbi.nlm.nih.gov/pubmed/31145099	https://www.ncbi.nlm.nih.gov/pubmed/31145099	X
dti-2660	440	3	https://doi.org/10.1097/ju.0000000000002756	https://doi.org/10.1097/ju.0000000000002756	PROPN
dti-2660	440	4	https://www.ncbi.nlm.nih.gov/pubmed/35536143	https://www.ncbi.nlm.nih.gov/pubmed/35536143	PROPN
dti-2660	440	5	https://doi.org/10.1016/j.eururo.2022.01.045	https://doi.org/10.1016/j.eururo.2022.01.045	NUM
dti-2660	440	6	https://www.ncbi.nlm.nih.gov/pubmed/35216856	https://www.ncbi.nlm.nih.gov/pubmed/35216856	NUM
dti-2660	440	7	https://doi.org/10.1038/s41585-020-0362-4	https://doi.org/10.1038/s41585-020-0362-4	NUM
dti-2660	440	8	https://www.ncbi.nlm.nih.gov/pubmed/32843751	https://www.ncbi.nlm.nih.gov/pubmed/32843751	NUM
dti-2660	440	9	https://doi.org/10.1016/j.eururo.2008.05.010	https://doi.org/10.1016/j.eururo.2008.05.010	NOUN
dti-2660	441	1	https://pubmed.ncbi.nlm.nih.gov/18511178/	https://pubmed.ncbi.nlm.nih.gov/18511178/	PROPN
dti-2660	441	2	https://doi.org/10.1007/s00345-015-1722-1	https://doi.org/10.1007/s00345-015-1722-1	PROPN
dti-2660	441	3	https://www.ncbi.nlm.nih.gov/pubmed/26658886	https://www.ncbi.nlm.nih.gov/pubmed/26658886	NUM
dti-2660	442	1	https://doi.org/10.1016/j.cmi.2022.06.017	https://doi.org/10.1016/j.cmi.2022.06.017	ADP
dti-2660	442	2	https://www.ncbi.nlm.nih.gov/pubmed/35788049	https://www.ncbi.nlm.nih.gov/pubmed/35788049	NUM
dti-2660	442	3	https://doi.org/10.1136/bmj-2021-0068229	https://doi.org/10.1136/bmj-2021-0068229	NOUN
dti-2660	442	4	https://www.ncbi.nlm.nih.gov/pubmed/35264408	https://www.ncbi.nlm.nih.gov/pubmed/35264408	ADP
dti-2660	442	5	https://doi.org/10.1136/bmj.h6544	https://doi.org/10.1136/bmj.h6544	PROPN
dti-2660	442	6	https://www.ncbi.nlm.nih.gov/pubmed/26698878	https://www.ncbi.nlm.nih.gov/pubmed/26698878	PROPN
dti-2660	442	7	https://www.ema.europa.eu/en/documents/press-release/disabling-potentially-permanent-side-effects-lead-suspension-restrictions-quinolone-fluoroquinolone_en.pdf	https://www.ema.europa.eu/en/documents/press-release/disabling-potentially-permanent-side-effects-lead-suspension-restrictions-quinolone-fluoroquinolone_en.pdf	NOUN
dti-2660	442	8	https://doi.org/10.1099/acmi.0.000321	https://doi.org/10.1099/acmi.0.000321	PROPN
dti-2660	442	9	https://www.ncbi.nlm.nih.gov/pubmed/35355869	https://www.ncbi.nlm.nih.gov/pubmed/35355869	NUM
dti-2660	442	10	https://doi.org/10.1080/14737167.2017.1359543	https://doi.org/10.1080/14737167.2017.1359543	PROPN
dti-2660	442	11	https://www.ncbi.nlm.nih.gov/pubmed/28737469	https://www.ncbi.nlm.nih.gov/pubmed/28737469	X
dti-2660	442	12	https://doi.org/10.1001/jamainternmed.2018.4204	https://doi.org/10.1001/jamainternmed.2018.4204	PROPN
dti-2660	442	13	https://www.ncbi.nlm.nih.gov/pubmed/30285042	https://www.ncbi.nlm.nih.gov/pubmed/30285042	ADP
dti-2660	442	14	https://doi.org/10.1016/j.euf.2020.09.004	https://doi.org/10.1016/j.euf.2020.09.004	NOUN
dti-2660	442	15	https://www.ncbi.nlm.nih.gov/pubmed/32972899	https://www.ncbi.nlm.nih.gov/pubmed/32972899	NUM
dti-2660	442	16	https://doi.org/10.1016/j.euf.2019.11.002	https://doi.org/10.1016/j.euf.2019.11.002	NOUN
dti-2660	442	17	https://www.ncbi.nlm.nih.gov/pubmed/31806578	https://www.ncbi.nlm.nih.gov/pubmed/31806578	X
dti-2660	443	1	https://doi.org/10.1038/s41585-018-0106-x	https://doi.org/10.1038/s41585-018-0106-x	NOUN
dti-2660	443	2	https://www.ncbi.nlm.nih.gov/pubmed/30361493	https://www.ncbi.nlm.nih.gov/pubmed/30361493	PRON
dti-2660	443	3	https://doi.org/10.1097/ju.0000000000002860	https://doi.org/10.1097/ju.0000000000002860	X
dti-2660	443	4	https://www.ncbi.nlm.nih.gov/pubmed/35942788	https://www.ncbi.nlm.nih.gov/pubmed/35942788	PRON
dti-2660	443	5	https://doi.org/10.1080/14656566.2020.1795128	https://doi.org/10.1080/14656566.2020.1795128	NOUN
dti-2660	443	6	https://www.ncbi.nlm.nih.gov/pubmed/32717156	https://www.ncbi.nlm.nih.gov/pubmed/32717156	NUM
dti-2660	443	7	https://doi.org/10.1159/000371894	https://doi.org/10.1159/000371894	PRON
dti-2660	443	8	https://www.ncbi.nlm.nih.gov/pubmed/25721866	https://www.ncbi.nlm.nih.gov/pubmed/25721866	PROPN
dti-2660	443	9	pothoven	pothoven	ADJ
dti-2660	443	10	drug	drug	NOUN
dti-2660	443	11	target	target	NOUN
dti-2660	443	12	insights	insight	NOUN
dti-2660	443	13	2023	2023	NUM
dti-2660	443	14	;	;	PUNCT
dti-2660	443	15	17	17	NUM
dti-2660	443	16	:	:	SYM
dti-2660	443	17	137	137	NUM
dti-2660	443	18	©	©	PROPN
dti-2660	443	19	2023	2023	NUM
dti-2660	443	20	the	the	DET
dti-2660	443	21	authors	author	NOUN
dti-2660	443	22	.	.	PUNCT
dti-2660	444	1	published	publish	VERB
dti-2660	444	2	by	by	ADP
dti-2660	444	3	aboutscience	aboutscience	NOUN
dti-2660	444	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2660	444	5	science	science	NOUN
dti-2660	444	6	gms	gm	NOUN
dti-2660	444	7	;	;	PUNCT
dti-2660	444	8	2022	2022	NUM
dti-2660	444	9	,	,	PUNCT
dti-2660	444	10	version	version	NOUN
dti-2660	444	11	2022	2022	NUM
dti-2660	444	12	-	-	SYM
dti-2660	444	13	02	02	NUM
dti-2660	444	14	-	-	PUNCT
dti-2660	444	15	03	03	NUM
dti-2660	444	16	.	.	PUNCT
dti-2660	445	1	downloaded	download	VERB
dti-2660	445	2	march	march	PROPN
dti-2660	445	3	22	22	NUM
dti-2660	445	4	,	,	PUNCT
dti-2660	445	5	2023	2023	NUM
dti-2660	445	6	,	,	PUNCT
dti-2660	445	7	from	from	ADP
dti-2660	445	8	online	online	ADV
dti-2660	445	9	.	.	PUNCT
dti-2660	446	1	39	39	NUM
dti-2660	446	2	.	.	PUNCT
dti-2660	447	1	wawrysiuk	wawrysiuk	PROPN
dti-2660	447	2	s	s	PROPN
dti-2660	447	3	,	,	PUNCT
dti-2660	447	4	naber	naber	PROPN
dti-2660	447	5	k	k	PROPN
dti-2660	447	6	,	,	PUNCT
dti-2660	447	7	rechberger	rechberger	PROPN
dti-2660	447	8	t	t	PROPN
dti-2660	447	9	,	,	PUNCT
dti-2660	447	10	miotla	miotla	VERB
dti-2660	447	11	p.	p.	NOUN
dti-2660	447	12	prevention	prevention	NOUN
dti-2660	447	13	and	and	CCONJ
dti-2660	447	14	treatment	treatment	NOUN
dti-2660	447	15	of	of	ADP
dti-2660	447	16	uncomplicated	uncomplicated	ADJ
dti-2660	447	17	lower	low	ADJ
dti-2660	447	18	urinary	urinary	ADJ
dti-2660	447	19	tract	tract	NOUN
dti-2660	447	20	infections	infection	NOUN
dti-2660	447	21	in	in	ADP
dti-2660	447	22	the	the	DET
dti-2660	447	23	era	era	NOUN
dti-2660	447	24	of	of	ADP
dti-2660	447	25	increasing	increase	VERB
dti-2660	447	26	antimicrobial	antimicrobial	ADJ
dti-2660	447	27	resistance	resistance	NOUN
dti-2660	447	28	-	-	PUNCT
dti-2660	447	29	nonantibiotic	nonantibiotic	ADJ
dti-2660	447	30	approaches	approach	NOUN
dti-2660	447	31	:	:	PUNCT
dti-2660	447	32	a	a	DET
dti-2660	447	33	systemic	systemic	ADJ
dti-2660	447	34	review	review	NOUN
dti-2660	447	35	.	.	PUNCT
dti-2660	448	1	arch	arch	ADJ
dti-2660	448	2	gynecol	gynecol	PROPN
dti-2660	448	3	obstet	obstet	NOUN
dti-2660	448	4	.	.	PUNCT
dti-2660	449	1	2019;300(4):821	2019;300(4):821	NUM
dti-2660	449	2	-	-	SYM
dti-2660	449	3	828	828	NUM
dti-2660	449	4	.	.	PUNCT
dti-2660	450	1	crossref	crossref	PROPN
dti-2660	450	2	pubmed	pubmed	PROPN
dti-2660	450	3	40	40	NUM
dti-2660	450	4	.	.	PUNCT
dti-2660	451	1	loubet	loubet	PROPN
dti-2660	451	2	p	p	X
dti-2660	451	3	,	,	PUNCT
dti-2660	451	4	ranfaing	ranfae	VERB
dti-2660	451	5	j	j	PROPN
dti-2660	451	6	,	,	PUNCT
dti-2660	451	7	dinh	dinh	PROPN
dti-2660	451	8	a	a	X
dti-2660	451	9	,	,	PUNCT
dti-2660	451	10	et	et	PROPN
dti-2660	451	11	al	al	PROPN
dti-2660	451	12	.	.	PROPN
dti-2660	452	1	alternative	alternative	ADJ
dti-2660	452	2	therapeutic	therapeutic	ADJ
dti-2660	452	3	options	option	NOUN
dti-2660	452	4	to	to	ADP
dti-2660	452	5	antibiotics	antibiotic	NOUN
dti-2660	452	6	for	for	ADP
dti-2660	452	7	the	the	DET
dti-2660	452	8	treatment	treatment	NOUN
dti-2660	452	9	of	of	ADP
dti-2660	452	10	urinary	urinary	ADJ
dti-2660	452	11	tract	tract	NOUN
dti-2660	452	12	infections	infection	NOUN
dti-2660	452	13	.	.	PUNCT
dti-2660	453	1	front	front	ADJ
dti-2660	453	2	microbiol	microbiol	NOUN
dti-2660	453	3	.	.	PUNCT
dti-2660	454	1	2020;11:1509	2020;11:1509	NUM
dti-2660	454	2	.	.	NOUN
dti-2660	454	3	pmid:32719668	pmid:32719668	PROPN
dti-2660	454	4	crossref	crossref	PROPN
dti-2660	454	5	pubmed	pubmed	PROPN
dti-2660	454	6	41	41	NUM
dti-2660	454	7	.	.	PUNCT
dti-2660	455	1	williams	williams	PROPN
dti-2660	455	2	g	g	PROPN
dti-2660	455	3	,	,	PUNCT
dti-2660	455	4	hahn	hahn	PROPN
dti-2660	455	5	d	d	PROPN
dti-2660	455	6	,	,	PUNCT
dti-2660	455	7	stephens	stephens	PROPN
dti-2660	455	8	jh	jh	PROPN
dti-2660	455	9	,	,	PUNCT
dti-2660	455	10	craig	craig	PROPN
dti-2660	455	11	jc	jc	PROPN
dti-2660	455	12	,	,	PUNCT
dti-2660	455	13	hodson	hodson	PROPN
dti-2660	455	14	em	em	PRON
dti-2660	455	15	.	.	PUNCT
dti-2660	456	1	cranberries	cranberry	NOUN
dti-2660	456	2	for	for	ADP
dti-2660	456	3	preventing	prevent	VERB
dti-2660	456	4	urinary	urinary	ADJ
dti-2660	456	5	tract	tract	NOUN
dti-2660	456	6	infections	infection	NOUN
dti-2660	456	7	.	.	PUNCT
dti-2660	457	1	cochrane	cochrane	NOUN
dti-2660	457	2	database	database	PROPN
dti-2660	457	3	syst	syst	PROPN
dti-2660	457	4	rev	rev	PROPN
dti-2660	457	5	.	.	PROPN
dti-2660	458	1	2023;4(4):cd001321	2023;4(4):cd001321	NUM
dti-2660	458	2	.	.	PROPN
dti-2660	458	3	pubmed	pubmed	PROPN
dti-2660	458	4	42	42	NUM
dti-2660	458	5	.	.	PUNCT
dti-2660	459	1	cooper	cooper	PROPN
dti-2660	459	2	te	te	PROPN
dti-2660	459	3	,	,	PUNCT
dti-2660	459	4	teng	teng	PROPN
dti-2660	459	5	c	c	PROPN
dti-2660	459	6	,	,	PUNCT
dti-2660	459	7	howell	howell	PROPN
dti-2660	459	8	m	m	PROPN
dti-2660	459	9	,	,	PUNCT
dti-2660	459	10	teixeira	teixeira	NOUN
dti-2660	459	11	-	-	PUNCT
dti-2660	459	12	pinto	pinto	NOUN
dti-2660	459	13	a	a	PRON
dti-2660	459	14	,	,	PUNCT
dti-2660	459	15	jaure	jaure	VERB
dti-2660	459	16	a	a	PRON
dti-2660	459	17	,	,	PUNCT
dti-2660	459	18	wong	wong	PROPN
dti-2660	459	19	g.	g.	PROPN
dti-2660	459	20	d	d	PROPN
dti-2660	459	21	-	-	PUNCT
dti-2660	459	22	mannose	mannose	NOUN
dti-2660	459	23	for	for	ADP
dti-2660	459	24	preventing	prevent	VERB
dti-2660	459	25	and	and	CCONJ
dti-2660	459	26	treating	treat	VERB
dti-2660	459	27	urinary	urinary	ADJ
dti-2660	459	28	tract	tract	NOUN
dti-2660	459	29	infections	infection	NOUN
dti-2660	459	30	.	.	PUNCT
dti-2660	460	1	cochrane	cochrane	NOUN
dti-2660	460	2	database	database	PROPN
dti-2660	460	3	syst	syst	PROPN
dti-2660	460	4	rev	rev	PROPN
dti-2660	460	5	.	.	PUNCT
dti-2660	461	1	2022;8(8):cd013608	2022;8(8):cd013608	X
dti-2660	461	2	.	.	PUNCT
dti-2660	462	1	pubmed	pubmed	PROPN
dti-2660	462	2	43	43	NUM
dti-2660	462	3	.	.	PUNCT
dti-2660	463	1	lee	lee	PROPN
dti-2660	463	2	bs	bs	PROPN
dti-2660	463	3	,	,	PUNCT
dti-2660	463	4	bhuta	bhuta	PROPN
dti-2660	463	5	t	t	PROPN
dti-2660	463	6	,	,	PUNCT
dti-2660	463	7	simpson	simpson	PROPN
dti-2660	463	8	jm	jm	PROPN
dti-2660	463	9	,	,	PUNCT
dti-2660	463	10	craig	craig	PROPN
dti-2660	463	11	jc	jc	PROPN
dti-2660	463	12	.	.	PROPN
dti-2660	463	13	methenamine	methenamine	PROPN
dti-2660	463	14	hippurate	hippurate	NOUN
dti-2660	463	15	for	for	ADP
dti-2660	463	16	preventing	prevent	VERB
dti-2660	463	17	urinary	urinary	ADJ
dti-2660	463	18	tract	tract	NOUN
dti-2660	463	19	infections	infection	NOUN
dti-2660	463	20	.	.	PUNCT
dti-2660	464	1	cochrane	cochrane	NOUN
dti-2660	464	2	database	database	PROPN
dti-2660	464	3	syst	syst	PROPN
dti-2660	464	4	rev	rev	PROPN
dti-2660	464	5	.	.	PROPN
dti-2660	465	1	2012;10(10):cd003265	2012;10(10):cd003265	PROPN
dti-2660	465	2	.	.	PUNCT
dti-2660	466	1	crossref	crossref	PROPN
dti-2660	466	2	pubmed	pubmed	PROPN
dti-2660	466	3	44	44	NUM
dti-2660	466	4	.	.	PUNCT
dti-2660	467	1	botros	botros	PROPN
dti-2660	467	2	c	c	PROPN
dti-2660	467	3	,	,	PUNCT
dti-2660	467	4	lozo	lozo	PROPN
dti-2660	467	5	s	s	PROPN
dti-2660	467	6	,	,	PUNCT
dti-2660	467	7	iyer	iyer	PROPN
dti-2660	467	8	s	s	PROPN
dti-2660	467	9	,	,	PUNCT
dti-2660	467	10	et	et	PROPN
dti-2660	467	11	al	al	PROPN
dti-2660	467	12	.	.	PROPN
dti-2660	468	1	methenamine	methenamine	PROPN
dti-2660	468	2	hippurate	hippurate	PROPN
dti-2660	468	3	compared	compare	VERB
dti-2660	468	4	with	with	ADP
dti-2660	468	5	trimethoprim	trimethoprim	NOUN
dti-2660	468	6	for	for	ADP
dti-2660	468	7	the	the	DET
dti-2660	468	8	prevention	prevention	NOUN
dti-2660	468	9	of	of	ADP
dti-2660	468	10	recurrent	recurrent	ADJ
dti-2660	468	11	urinary	urinary	ADJ
dti-2660	468	12	tract	tract	NOUN
dti-2660	468	13	infections	infection	NOUN
dti-2660	468	14	:	:	PUNCT
dti-2660	468	15	a	a	DET
dti-2660	468	16	randomized	randomized	ADJ
dti-2660	468	17	clinical	clinical	ADJ
dti-2660	468	18	trial	trial	NOUN
dti-2660	468	19	.	.	PUNCT
dti-2660	469	1	int	int	NOUN
dti-2660	469	2	urogynecol	urogynecol	ADJ
dti-2660	469	3	j.	j.	PROPN
dti-2660	469	4	2022;33(3):571	2022;33(3):571	PROPN
dti-2660	469	5	-	-	SYM
dti-2660	469	6	580	580	NUM
dti-2660	469	7	.	.	PUNCT
dti-2660	470	1	crossref	crossref	PROPN
dti-2660	470	2	pubmed	pubmed	PROPN
dti-2660	470	3	45	45	NUM
dti-2660	470	4	.	.	PUNCT
dti-2660	471	1	damiano	damiano	PROPN
dti-2660	471	2	r	r	PROPN
dti-2660	471	3	,	,	PUNCT
dti-2660	471	4	quarto	quarto	NOUN
dti-2660	471	5	g	g	PROPN
dti-2660	471	6	,	,	PUNCT
dti-2660	471	7	bava	bava	PROPN
dti-2660	471	8	i	i	PROPN
dti-2660	471	9	,	,	PUNCT
dti-2660	471	10	et	et	PROPN
dti-2660	471	11	al	al	PROPN
dti-2660	471	12	.	.	PROPN
dti-2660	471	13	prevention	prevention	NOUN
dti-2660	471	14	of	of	ADP
dti-2660	471	15	recurrent	recurrent	ADJ
dti-2660	471	16	urinary	urinary	ADJ
dti-2660	471	17	tract	tract	NOUN
dti-2660	471	18	infections	infection	NOUN
dti-2660	471	19	by	by	ADP
dti-2660	471	20	intravesical	intravesical	ADJ
dti-2660	471	21	administration	administration	NOUN
dti-2660	471	22	of	of	ADP
dti-2660	471	23	hyaluronic	hyaluronic	ADJ
dti-2660	471	24	acid	acid	NOUN
dti-2660	471	25	and	and	CCONJ
dti-2660	471	26	chondroitin	chondroitin	NOUN
dti-2660	471	27	sulphate	sulphate	NOUN
dti-2660	471	28	:	:	PUNCT
dti-2660	471	29	a	a	DET
dti-2660	471	30	placebo	placebo	NOUN
dti-2660	471	31	-	-	PUNCT
dti-2660	471	32	controlled	control	VERB
dti-2660	471	33	randomised	randomised	ADJ
dti-2660	471	34	trial	trial	NOUN
dti-2660	471	35	.	.	PUNCT
dti-2660	472	1	eur	eur	PROPN
dti-2660	472	2	urol	urol	NOUN
dti-2660	472	3	.	.	PUNCT
dti-2660	473	1	2011;59(4):645	2011;59(4):645	NUM
dti-2660	473	2	-	-	SYM
dti-2660	473	3	651	651	NUM
dti-2660	473	4	.	.	PUNCT
dti-2660	474	1	crossref	crossref	PROPN
dti-2660	474	2	pubmed	pubmed	PROPN
dti-2660	474	3	46	46	NUM
dti-2660	474	4	.	.	PUNCT
dti-2660	475	1	ciani	ciani	PROPN
dti-2660	475	2	o	o	PROPN
dti-2660	475	3	,	,	PUNCT
dti-2660	475	4	arendsen	arendsen	NOUN
dti-2660	475	5	e	e	NOUN
dti-2660	475	6	,	,	PUNCT
dti-2660	475	7	romancik	romancik	PROPN
dti-2660	475	8	m	m	PROPN
dti-2660	475	9	,	,	PUNCT
dti-2660	475	10	et	et	PROPN
dti-2660	475	11	al	al	PROPN
dti-2660	475	12	.	.	PROPN
dti-2660	475	13	intravesical	intravesical	PROPN
dti-2660	475	14	administration	administration	PROPN
dti-2660	475	15	of	of	ADP
dti-2660	475	16	combined	combine	VERB
dti-2660	475	17	hyaluronic	hyaluronic	ADJ
dti-2660	475	18	acid	acid	NOUN
dti-2660	475	19	(	(	PUNCT
dti-2660	475	20	ha	ha	INTJ
dti-2660	475	21	)	)	PUNCT
dti-2660	475	22	and	and	CCONJ
dti-2660	475	23	chondroitin	chondroitin	NOUN
dti-2660	475	24	sulfate	sulfate	NOUN
dti-2660	475	25	(	(	PUNCT
dti-2660	475	26	cs	cs	PROPN
dti-2660	475	27	)	)	PUNCT
dti-2660	475	28	for	for	ADP
dti-2660	475	29	the	the	DET
dti-2660	475	30	treatment	treatment	NOUN
dti-2660	475	31	of	of	ADP
dti-2660	475	32	female	female	ADJ
dti-2660	475	33	recurrent	recurrent	ADJ
dti-2660	475	34	urinary	urinary	ADJ
dti-2660	475	35	tract	tract	NOUN
dti-2660	475	36	infections	infection	NOUN
dti-2660	475	37	:	:	PUNCT
dti-2660	475	38	a	a	DET
dti-2660	475	39	european	european	ADJ
dti-2660	475	40	multicentre	multicentre	NOUN
dti-2660	475	41	nested	nest	VERB
dti-2660	475	42	case	case	NOUN
dti-2660	475	43	-	-	PUNCT
dti-2660	475	44	control	control	NOUN
dti-2660	475	45	study	study	NOUN
dti-2660	475	46	.	.	PUNCT
dti-2660	476	1	bmj	bmj	PROPN
dti-2660	476	2	open	open	ADJ
dti-2660	476	3	.	.	PUNCT
dti-2660	477	1	2016;6(3):e009669	2016;6(3):e009669	PROPN
dti-2660	477	2	.	.	PUNCT
dti-2660	478	1	crossref	crossref	PROPN
dti-2660	478	2	pubmed	pubmed	PROPN
dti-2660	478	3	47	47	NUM
dti-2660	478	4	.	.	PUNCT
dti-2660	479	1	goddard	goddard	PROPN
dti-2660	479	2	jc	jc	PROPN
dti-2660	479	3	,	,	PUNCT
dti-2660	479	4	janssen	janssen	PROPN
dti-2660	479	5	daw	daw	PROPN
dti-2660	479	6	.	.	PUNCT
dti-2660	479	7	intravesical	intravesical	ADJ
dti-2660	479	8	hyaluronic	hyaluronic	ADJ
dti-2660	479	9	acid	acid	NOUN
dti-2660	479	10	and	and	CCONJ
dti-2660	479	11	chondroitin	chondroitin	NOUN
dti-2660	479	12	sulfate	sulfate	NOUN
dti-2660	479	13	for	for	ADP
dti-2660	479	14	recurrent	recurrent	ADJ
dti-2660	479	15	urinary	urinary	ADJ
dti-2660	479	16	tract	tract	NOUN
dti-2660	479	17	infections	infection	NOUN
dti-2660	479	18	:	:	PUNCT
dti-2660	479	19	systematic	systematic	ADJ
dti-2660	479	20	review	review	NOUN
dti-2660	479	21	and	and	CCONJ
dti-2660	479	22	meta	meta	ADJ
dti-2660	479	23	-	-	PUNCT
dti-2660	479	24	analysis	analysis	NOUN
dti-2660	479	25	.	.	PUNCT
dti-2660	480	1	int	int	NOUN
dti-2660	480	2	urogynecol	urogynecol	ADJ
dti-2660	480	3	j.	j.	PROPN
dti-2660	480	4	2018	2018	NUM
dti-2660	480	5	;	;	PUNCT
dti-2660	480	6	29(7):933	29(7):933	NUM
dti-2660	480	7	-	-	SYM
dti-2660	480	8	942	942	NUM
dti-2660	480	9	.	.	PUNCT
dti-2660	481	1	crossref	crossref	PROPN
dti-2660	481	2	pubmed	pubmed	PROPN
dti-2660	481	3	48	48	NUM
dti-2660	481	4	.	.	PUNCT
dti-2660	482	1	medina	medina	PROPN
dti-2660	482	2	m	m	PROPN
dti-2660	482	3	,	,	PUNCT
dti-2660	482	4	castillo	castillo	PROPN
dti-2660	482	5	-	-	PUNCT
dti-2660	482	6	pino	pino	PROPN
dti-2660	482	7	e.	e.	PROPN
dti-2660	483	1	an	an	DET
dti-2660	483	2	introduction	introduction	NOUN
dti-2660	483	3	to	to	ADP
dti-2660	483	4	the	the	DET
dti-2660	483	5	epidemiology	epidemiology	NOUN
dti-2660	483	6	and	and	CCONJ
dti-2660	483	7	burden	burden	NOUN
dti-2660	483	8	of	of	ADP
dti-2660	483	9	urinary	urinary	ADJ
dti-2660	483	10	tract	tract	NOUN
dti-2660	483	11	infections	infection	NOUN
dti-2660	483	12	.	.	PUNCT
dti-2660	484	1	ther	ther	INTJ
dti-2660	484	2	adv	adv	INTJ
dti-2660	484	3	urol	urol	PROPN
dti-2660	484	4	.	.	PUNCT
dti-2660	485	1	2019;11:1756287219832172	2019;11:1756287219832172	NUM
dti-2660	485	2	.	.	PUNCT
dti-2660	486	1	crossref	crossref	PROPN
dti-2660	486	2	pubmed	pubmed	PROPN
dti-2660	486	3	49	49	NUM
dti-2660	486	4	.	.	PUNCT
dti-2660	487	1	krinitski	krinitski	PROPN
dti-2660	487	2	d	d	PROPN
dti-2660	487	3	,	,	PUNCT
dti-2660	487	4	kasina	kasina	PROPN
dti-2660	487	5	r	r	NOUN
dti-2660	487	6	,	,	PUNCT
dti-2660	487	7	klöppel	klöppel	NOUN
dti-2660	487	8	s	s	PROPN
dti-2660	487	9	,	,	PUNCT
dti-2660	487	10	lenouvel	lenouvel	PROPN
dti-2660	487	11	e.	e.	PROPN
dti-2660	487	12	associations	associations	PROPN
dti-2660	487	13	of	of	ADP
dti-2660	487	14	delirium	delirium	NOUN
dti-2660	487	15	with	with	ADP
dti-2660	487	16	urinary	urinary	ADJ
dti-2660	487	17	tract	tract	NOUN
dti-2660	487	18	infections	infection	NOUN
dti-2660	487	19	and	and	CCONJ
dti-2660	487	20	asymptomatic	asymptomatic	ADJ
dti-2660	487	21	bacteriuria	bacteriuria	NOUN
dti-2660	487	22	in	in	ADP
dti-2660	487	23	adults	adult	NOUN
dti-2660	487	24	aged	aged	ADJ
dti-2660	487	25	65	65	NUM
dti-2660	487	26	and	and	CCONJ
dti-2660	487	27	older	old	ADJ
dti-2660	487	28	:	:	PUNCT
dti-2660	487	29	a	a	DET
dti-2660	487	30	systematic	systematic	ADJ
dti-2660	487	31	review	review	NOUN
dti-2660	487	32	and	and	CCONJ
dti-2660	487	33	meta	meta	ADJ
dti-2660	487	34	-	-	PUNCT
dti-2660	487	35	analysis	analysis	NOUN
dti-2660	487	36	.	.	PUNCT
dti-2660	488	1	j	j	PROPN
dti-2660	488	2	am	be	AUX
dti-2660	488	3	geriatr	geriatr	ADJ
dti-2660	488	4	soc	soc	NOUN
dti-2660	488	5	.	.	PUNCT
dti-2660	489	1	2021;69(11):3312	2021;69(11):3312	NUM
dti-2660	489	2	-	-	SYM
dti-2660	489	3	3323	3323	NUM
dti-2660	489	4	.	.	PUNCT
dti-2660	490	1	crossref	crossref	PROPN
dti-2660	490	2	pubmed	pubmed	PROPN
dti-2660	490	3	50	50	NUM
dti-2660	490	4	.	.	PUNCT
dti-2660	491	1	juthani	juthani	PROPN
dti-2660	491	2	-	-	PUNCT
dti-2660	491	3	mehta	mehta	PROPN
dti-2660	491	4	m	m	PROPN
dti-2660	491	5	,	,	PUNCT
dti-2660	491	6	quagliarello	quagliarello	NOUN
dti-2660	491	7	v	v	NOUN
dti-2660	491	8	,	,	PUNCT
dti-2660	491	9	perrelli	perrelli	PROPN
dti-2660	491	10	e	e	NOUN
dti-2660	491	11	,	,	PUNCT
dti-2660	491	12	towle	towle	PROPN
dti-2660	491	13	v	v	PROPN
dti-2660	491	14	,	,	PUNCT
dti-2660	491	15	van	van	PROPN
dti-2660	491	16	ness	ness	NOUN
dti-2660	491	17	ph	ph	NOUN
dti-2660	491	18	,	,	PUNCT
dti-2660	491	19	tinetti	tinetti	ADJ
dti-2660	491	20	m.	m.	NOUN
dti-2660	491	21	clinical	clinical	ADJ
dti-2660	491	22	features	feature	NOUN
dti-2660	491	23	to	to	PART
dti-2660	491	24	identify	identify	VERB
dti-2660	491	25	urinary	urinary	ADJ
dti-2660	491	26	tract	tract	NOUN
dti-2660	491	27	infection	infection	NOUN
dti-2660	491	28	in	in	ADP
dti-2660	491	29	nursing	nursing	NOUN
dti-2660	491	30	home	home	NOUN
dti-2660	491	31	residents	resident	NOUN
dti-2660	491	32	:	:	PUNCT
dti-2660	491	33	a	a	DET
dti-2660	491	34	cohort	cohort	NOUN
dti-2660	491	35	study	study	NOUN
dti-2660	491	36	.	.	PUNCT
dti-2660	492	1	j	j	PROPN
dti-2660	492	2	am	be	AUX
dti-2660	492	3	geriatr	geriatr	ADJ
dti-2660	492	4	soc	soc	NOUN
dti-2660	492	5	.	.	PUNCT
dti-2660	493	1	2009;57(6):963	2009;57(6):963	NUM
dti-2660	493	2	-	-	SYM
dti-2660	493	3	970	970	NUM
dti-2660	493	4	.	.	PUNCT
dti-2660	494	1	crossref	crossref	PROPN
dti-2660	494	2	pubmed	pubmed	PROPN
dti-2660	494	3	51	51	NUM
dti-2660	494	4	.	.	PUNCT
dti-2660	495	1	kwok	kwok	PROPN
dti-2660	495	2	m	m	PROPN
dti-2660	495	3	,	,	PUNCT
dti-2660	495	4	mcgeorge	mcgeorge	NOUN
dti-2660	495	5	s	s	PROPN
dti-2660	495	6	,	,	PUNCT
dti-2660	495	7	mayer	mayer	PROPN
dti-2660	495	8	-	-	PUNCT
dti-2660	495	9	coverdale	coverdale	PROPN
dti-2660	495	10	j	j	PROPN
dti-2660	495	11	,	,	PUNCT
dti-2660	495	12	et	et	PROPN
dti-2660	495	13	al	al	PROPN
dti-2660	495	14	.	.	PROPN
dti-2660	495	15	guideline	guideline	NOUN
dti-2660	495	16	of	of	ADP
dti-2660	495	17	guidelines	guideline	NOUN
dti-2660	495	18	:	:	PUNCT
dti-2660	495	19	management	management	NOUN
dti-2660	495	20	of	of	ADP
dti-2660	495	21	recurrent	recurrent	ADJ
dti-2660	495	22	urinary	urinary	ADJ
dti-2660	495	23	tract	tract	NOUN
dti-2660	495	24	infections	infection	NOUN
dti-2660	495	25	in	in	ADP
dti-2660	495	26	women	woman	NOUN
dti-2660	495	27	.	.	PUNCT
dti-2660	496	1	bju	bju	NOUN
dti-2660	496	2	int	int	PROPN
dti-2660	496	3	.	.	PUNCT
dti-2660	497	1	2022;130(suppl	2022;130(suppl	X
dti-2660	497	2	3):11	3):11	NUM
dti-2660	497	3	-	-	SYM
dti-2660	497	4	22	22	NUM
dti-2660	497	5	.	.	PUNCT
dti-2660	498	1	crossref	crossref	PROPN
dti-2660	498	2	pubmed	pubmed	PROPN
dti-2660	498	3	52	52	NUM
dti-2660	498	4	.	.	PUNCT
dti-2660	499	1	pigrau	pigrau	ADJ
dti-2660	499	2	c	c	NOUN
dti-2660	499	3	,	,	PUNCT
dti-2660	499	4	escolà	escolà	ADJ
dti-2660	499	5	-	-	PUNCT
dti-2660	499	6	vergé	vergé	NOUN
dti-2660	499	7	l.	l.	PROPN
dti-2660	499	8	recurrent	recurrent	PROPN
dti-2660	499	9	urinary	urinary	ADJ
dti-2660	499	10	tract	tract	NOUN
dti-2660	499	11	infections	infection	NOUN
dti-2660	499	12	:	:	PUNCT
dti-2660	499	13	from	from	ADP
dti-2660	499	14	pathogenesis	pathogenesis	NOUN
dti-2660	499	15	to	to	ADP
dti-2660	499	16	prevention	prevention	NOUN
dti-2660	499	17	.	.	PUNCT
dti-2660	500	1	med	med	PROPN
dti-2660	500	2	clin	clin	PROPN
dti-2660	500	3	(	(	PUNCT
dti-2660	500	4	barc	barc	PROPN
dti-2660	500	5	)	)	PUNCT
dti-2660	500	6	.	.	PUNCT
dti-2660	501	1	2020;155(4):171177	2020;155(4):171177	NUM
dti-2660	501	2	.	.	PUNCT
dti-2660	502	1	crossref	crossref	PROPN
dti-2660	502	2	pubmed	pubmed	PROPN
dti-2660	502	3	53	53	NUM
dti-2660	502	4	.	.	PUNCT
dti-2660	503	1	lovasz	lovasz	PROPN
dti-2660	503	2	s.	s.	PROPN
dti-2660	503	3	minimally	minimally	ADV
dti-2660	503	4	invasive	invasive	ADJ
dti-2660	503	5	device	device	NOUN
dti-2660	503	6	for	for	ADP
dti-2660	503	7	intravesical	intravesical	ADJ
dti-2660	503	8	instillation	instillation	NOUN
dti-2660	503	9	by	by	ADP
dti-2660	503	10	urological	urological	ADJ
dti-2660	503	11	syringe	syringe	NOUN
dti-2660	503	12	adapter	adapter	NOUN
dti-2660	503	13	(	(	PUNCT
dti-2660	503	14	mid	mid	PROPN
dti-2660	503	15	-	-	PROPN
dti-2660	503	16	ii	ii	ADJ
dti-2660	503	17	u.s.a	u.s.a	NOUN
dti-2660	503	18	.	.	PUNCT
dti-2660	503	19	)	)	PUNCT
dti-2660	504	1	for	for	ADP
dti-2660	504	2	catheter	catheter	NOUN
dti-2660	504	3	-	-	PUNCT
dti-2660	504	4	free	free	ADJ
dti-2660	504	5	instillation	instillation	NOUN
dti-2660	504	6	therapy	therapy	NOUN
dti-2660	504	7	of	of	ADP
dti-2660	504	8	the	the	DET
dti-2660	504	9	bladder	bladder	NOUN
dti-2660	504	10	in	in	ADP
dti-2660	504	11	interstitial	interstitial	ADJ
dti-2660	504	12	cystitis	cystitis	NOUN
dti-2660	504	13	/	/	SYM
dti-2660	504	14	bladder	bladder	NOUN
dti-2660	504	15	pain	pain	NOUN
dti-2660	504	16	syndrome	syndrome	NOUN
dti-2660	504	17	.	.	PUNCT
dti-2660	505	1	int	int	PROPN
dti-2660	505	2	j	j	PROPN
dti-2660	505	3	urol	urol	PROPN
dti-2660	505	4	.	.	PUNCT
dti-2660	506	1	2019;26(suppl	2019;26(suppl	PROPN
dti-2660	506	2	1):57	1):57	NUM
dti-2660	506	3	-	-	SYM
dti-2660	506	4	60	60	NUM
dti-2660	506	5	.	.	PUNCT
dti-2660	507	1	crossref	crossref	PROPN
dti-2660	507	2	pubmed	pubmed	PROPN
dti-2660	507	3	54	54	NUM
dti-2660	507	4	.	.	PUNCT
dti-2660	508	1	singer	singer	NOUN
dti-2660	508	2	m	m	PROPN
dti-2660	508	3	,	,	PUNCT
dti-2660	508	4	deutschman	deutschman	PROPN
dti-2660	508	5	cs	cs	PROPN
dti-2660	508	6	,	,	PUNCT
dti-2660	508	7	seymour	seymour	PROPN
dti-2660	508	8	cw	cw	NOUN
dti-2660	508	9	,	,	PUNCT
dti-2660	508	10	et	et	PROPN
dti-2660	508	11	al	al	PROPN
dti-2660	508	12	.	.	PUNCT
dti-2660	509	1	the	the	DET
dti-2660	509	2	third	third	ADJ
dti-2660	509	3	international	international	ADJ
dti-2660	509	4	consensus	consensus	NOUN
dti-2660	509	5	definitions	definition	NOUN
dti-2660	509	6	for	for	ADP
dti-2660	509	7	sepsis	sepsis	NOUN
dti-2660	509	8	and	and	CCONJ
dti-2660	509	9	septic	septic	ADJ
dti-2660	509	10	shock	shock	NOUN
dti-2660	509	11	(	(	PUNCT
dti-2660	509	12	sepsis-3	sepsis-3	NOUN
dti-2660	509	13	)	)	PUNCT
dti-2660	509	14	.	.	PUNCT
dti-2660	510	1	jama	jama	PROPN
dti-2660	510	2	.	.	PUNCT
dti-2660	511	1	2016;315(8):801	2016;315(8):801	NUM
dti-2660	511	2	-	-	SYM
dti-2660	511	3	810	810	NUM
dti-2660	511	4	.	.	PUNCT
dti-2660	512	1	crossref	crossref	PROPN
dti-2660	512	2	pubmed	pubmed	PROPN
dti-2660	512	3	https://books.publisso.de/en/publisso_gold/publishing/books/overview/52/288	https://books.publisso.de/en/publisso_gold/publishing/books/overview/52/288	PROPN
dti-2660	512	4	https://doi.org/10.1007/s00404-019-05256-z	https://doi.org/10.1007/s00404-019-05256-z	ADJ
dti-2660	512	5	https://www.ncbi.nlm.nih.gov/pubmed/31350663	https://www.ncbi.nlm.nih.gov/pubmed/31350663	AUX
dti-2660	512	6	https://doi.org/10.3389/fmicb.2020.01509	https://doi.org/10.3389/fmicb.2020.01509	PROPN
dti-2660	512	7	https://www.ncbi.nlm.nih.gov/pubmed/32719668	https://www.ncbi.nlm.nih.gov/pubmed/32719668	NOUN
dti-2660	512	8	https://www.ncbi.nlm.nih.gov/pubmed/37068952	https://www.ncbi.nlm.nih.gov/pubmed/37068952	NUM
dti-2660	513	1	https://www.ncbi.nlm.nih.gov/pubmed/36041061	https://www.ncbi.nlm.nih.gov/pubmed/36041061	NOUN
dti-2660	514	1	https://doi.org/10.1002/14651858.cd003265.pub3	https://doi.org/10.1002/14651858.cd003265.pub3	INTJ
dti-2660	515	1	https://www.ncbi.nlm.nih.gov/pubmed/23076896	https://www.ncbi.nlm.nih.gov/pubmed/23076896	INTJ
dti-2660	515	2	https://doi.org/10.1007/s00192-021-04849-0	https://doi.org/10.1007/s00192-021-04849-0	NUM
dti-2660	516	1	https://www.ncbi.nlm.nih.gov/pubmed/34115162	https://www.ncbi.nlm.nih.gov/pubmed/34115162	ADP
dti-2660	516	2	https://doi.org/10.1016/j.eururo.2010.12.039	https://doi.org/10.1016/j.eururo.2010.12.039	NOUN
dti-2660	516	3	https://www.ncbi.nlm.nih.gov/pubmed/21272992	https://www.ncbi.nlm.nih.gov/pubmed/21272992	NUM
dti-2660	516	4	https://doi.org/10.1136/bmjopen-2015-009669	https://doi.org/10.1136/bmjopen-2015-009669	PROPN
dti-2660	516	5	https://www.ncbi.nlm.nih.gov/pubmed/27033958	https://www.ncbi.nlm.nih.gov/pubmed/27033958	NUM
dti-2660	516	6	https://doi.org/10.1007/s00192-017-3508-z	https://doi.org/10.1007/s00192-017-3508-z	PROPN
dti-2660	516	7	https://www.ncbi.nlm.nih.gov/pubmed/29181550	https://www.ncbi.nlm.nih.gov/pubmed/29181550	PRON
dti-2660	517	1	https://doi.org/10.1177/1756287219832172	https://doi.org/10.1177/1756287219832172	NOUN
dti-2660	517	2	https://www.ncbi.nlm.nih.gov/pubmed/31105774	https://www.ncbi.nlm.nih.gov/pubmed/31105774	ADV
dti-2660	517	3	https://doi.org/10.1111/jgs.17418	https://doi.org/10.1111/jgs.17418	PROPN
dti-2660	517	4	https://www.ncbi.nlm.nih.gov/pubmed/34448496	https://www.ncbi.nlm.nih.gov/pubmed/34448496	NUM
dti-2660	517	5	https://doi.org/10.1111/j.1532-5415.2009.02227.x	https://doi.org/10.1111/j.1532-5415.2009.02227.x	NOUN
dti-2660	517	6	https://www.ncbi.nlm.nih.gov/pubmed/19490243	https://www.ncbi.nlm.nih.gov/pubmed/19490243	PROPN
dti-2660	518	1	https://doi.org/10.1111/bju.15756	https://doi.org/10.1111/bju.15756	VERB
dti-2660	518	2	https://www.ncbi.nlm.nih.gov/pubmed/35579121	https://www.ncbi.nlm.nih.gov/pubmed/35579121	NUM
dti-2660	518	3	https://doi.org/10.1016/j.medcli.2020.04.026	https://doi.org/10.1016/j.medcli.2020.04.026	PROPN
dti-2660	518	4	https://www.ncbi.nlm.nih.gov/pubmed/32561190	https://www.ncbi.nlm.nih.gov/pubmed/32561190	X
dti-2660	518	5	https://doi.org/10.1111/iju.13976	https://doi.org/10.1111/iju.13976	NOUN
dti-2660	518	6	https://www.ncbi.nlm.nih.gov/pubmed/31144753	https://www.ncbi.nlm.nih.gov/pubmed/31144753	X
dti-2660	518	7	https://doi.org/10.1001/jama.2016.0287	https://doi.org/10.1001/jama.2016.0287	PROPN
dti-2660	518	8	https://www.ncbi.nlm.nih.gov/pubmed/26903338	https://www.ncbi.nlm.nih.gov/pubmed/26903338	ADV